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Preface
A biosensor is defined as a detecting device that combines a transducer with a 
biologically sensitive and selective component. When a specific target molecule interacts 
with the biological component, a signal is produced, at transducer level, proportional to the 
concentration of the substance. Therefore biosensors can measure compounds present in the 
environment, chemical processes, food and human body at low cost if compared with 
traditional analytical techniques.  
This book covers a wide range of aspects and issues related to biosensor technology, 
bringing together researchers from 11 different countries. The book consists of 16 chapters 
written by 53 authors. The first four chapters describe several aspects of nanotechnology 
applied to biosensors. The subsequent section, including three chapters, is devoted to 
biosensor applications in the fields of drug discovery, diagnostics and bacteria detection. 
The principles behind optical biosensors and some of their application are discussed in 
chapters from 8 to 11. The last five chapters treat of microelectronics, interfacing circuits, 
signal transmission, biotelemetry and algorithms applied to biosensing. 
I want to express my appreciation and gratitude to all authors who contributed to this 
book with their research results and to InTech team that accomplished its mission with 
professionalism and dedication. 
Editor
Pier Andrea Serra 
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1. Introduction    
A biosensor can be defined as a device incorporating a biological sensing element connected 
to a transducer to convert an observed response into a measurable signal, whose magnitude 
is proportional to the concentration of a specific chemical or set of chemcials (Eggins 1996). 
According to the receptor type, biosensors can be classified as enzymatic biosensors, 
genosensors, immunosensors, etc. Biosensors can be also divided into several categories 
based on the transduction process, such as electrochemical, optical, piezoelectric, and 
thermal/calorimetric biosensors. Among these various kinds of biosensors, electrochemical 
biosensors are a class of the most widespread, numerous and successfully commercialized 
devices of biomolecular electronics (Dzyadevych et al., 2008).  In this chapter, we will focus 
on the enzyme-based electrochemical biosensors since enzyme electrodes have attracted 
ever-increasing attentions due to the potential applications in many areas. 
Enzyme-based electrochemical biosensors have been used widely in our life, such as health 
care, food safety and environmental monitoring. Health care is the main area in the 
biosensor applications, such as monitoring blood glucose levels and diabetics by glucose 
biosensors. Besides, the reliable detection of urea has potential applications for patients with 
renal disease either at home or in the hospital. Industrial applications for biosensors include 
monitoring fermentation broths or food processing procedures through detecting 
concentrations of glucose and other fermentative end products. The sensitive detection of 
phenolic compound is an important topic for environmental research because phenolic 
compouds often exist in the wastwaters of many industries, giving rise to problems for our 
living environment as many of them are very toxic.  
This chapter is on the enzyme-based electrochemical biosensors, which will begin with a 
section for enzyme immobilization methods due to their important roles in biosensors. The 
next section will focus on the recent advances in enzyme-based electrochemical biosensors. 
Nanomaterials play an important role in recent development of enzyme-based biosensors, 
thus some popular fabrication methods of nanomaterials will be briefly described towards 
their applications in nanomaterials synthesis. The emphsis of this chapter is on the recent 
advances particularly nanomaterials-based biosensors. Some important and intelligent 
nanomaterials including gold, ZnO, carbon nanotube and polypyrrole will be presented in a 
way to the current achievements in enzyme-based electrochemical biosensors. The last 
section of this chapter will discuss challenges currently faced to practical applications. 
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2. Enzyme immobilization methods 
In order to make a viable biosensor, the biological component has to be properly attached to 
the transducer with maintained enzyme activity. This process is known as  enzyme 
immobilization. Biosensors are usually designed with high enzyme loading to insure 
sufficient biocatalyst activities, and the enzymes are provided with an appropriate 
environment to sustain their activities. The local chemical and thermal environment can 
have profound effects on the enzyme stability. The choice of immobilization method 
depends on many factors, such as the nature of the biological element, the type of 
transducer used, the physicochemical properties of the analyte and the operating conditions 
in which the biosensor is to function, and overriding all these considerations is necessary for 
the biological element to exhibit maximum activity in its immobilized microenvironment 
(Singh et al., 2008). A detailed information on advantages and drawbacks of different 
methods for enzyme immobilization could be found in the literature (Buerk 1993; Eggins 
1996; Nunes & Marty, 2006). Generally, there are 4 regular methods for enzyme 
immobilization and they are briefly described as shown below: 
1. Adsorption: It is the simplest and fastest way to prepare immobilized enzymes. 
Adsorption can roughly be divided into two classes: physical adsorption and chemical 
adsorption. Physical adsorption is weak and occurs mainly via Van der Waals. 
Chemical adsorption is stronger and involves the formation of covalent bonds. Many 
substances adsorb enzymes on their surfaces, eg. alumina, charcoal, clay, cellulose, 
kaolin, silica gel, glass and collagen. For this method, there are good examples in the 
section of 3.2.1 of this chapter, in which physical adsorption is mostly used for enzyme 
immobilization in ZnO-based glucose biosensors.  
2. Entrapment: It refers to mixture of the biomaterial with monomer solution and then 
polymerised to a gel, trapping the biomaterial. However, this method can give rise to 
barriers to the diffusion of substrate, leading to the reaction delay. Besides, loss of 
bioactivity may occure through pores in the gel. The gels commonly used include 
polyacrylamide, starch gels, nylon, silastic gels, conducting polymers, etc.  
3. Covalent bonding: In this method, the bond ocuurs between a functional group in the 
biomaterial to the support matrix. Some functional groups which are not essential for 
the catalytic activity of an enzyme can be covalently bonded to the support matrix. It 
requires mild conditions under which reactions are performed, such as low 
temperature, low ionic strength and pH in the physiological range.  
4. Cross-linking: For this method, usually, biomaterial is chemically bonded to solid 
supports or to another supporting material such as cross-linking agent to significantly 
increase the attachment. It is a useful method to stabilize adsorbed biomaterials.  
Glutaraldehyde is the mostly used bifunctional agent.  The agents can also interfere 
with the enzyme activity , especially at higher concentrations.  
3. Enzyme-based electrochemical biosensors 
3.1 Fabrication techniques for nanomaterials 
Recent years witness the vigorous applications of various nanomaterials in the development 
of biosensors. Nanomaterials are generally referred to the materials with dimensions 
ranging from 1 to 100 nm, which have some special physicochemical characteristics 
resulting from their “small” size structures. Nanomaterials make contribution to the 
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improvement of the performance and stability of enzyme electrodes in the electrochemical 
biosensors, which can be fabricated by many various techniques. The generally used 
techniques for nanomaterials in biosensor applications are described briefly as follows.  
Wet chemical route, also called chemical solution deposition, is one of the most widely used 
to fabricate nanomaterials, especially nanoparticles. For wet chemical route, solution of 
chemical species will be involved during the process, which thus differs from dry chemical 
route. Briefly, it uses a liquid precursor, usually a solution of organometallic powders, 
dissolved in an organic solvent. Chemical reactions then occur in order to get purposeful 
product(s). It is a quite common method to be used for nanomaterials fabrication, especially 
in the application of electrochemical biosensors.  
The vapor-liquid-solid method is based on a mechanism for the growth of nanostructural 
materials with one-dimension from chemical vapor deposition, such as nanowires. It is 
generally very slow for a crystal to grow through direct adsorption of a gas phase onto a 
solid surface. During vapor-liquid-solid process, this problem is overcome by inducing 
catalytic liquid alloy phase to rapidly adsorb a vapor to supersaturation levels, and thus 
crystal growth can subsequently occur from nucleated seeds at the liquid-solid interface. 
The physical characteristics of nanowires grown in this manner is closely associated with the 
size and physical properties of the liquid alloy. 
Hydrothermal synthesis is a method to synthesize crystalline materials from high-
temperature aqueous solutions at high vapor pressures. The chemical reaction occurs in a 
vessel, which is separately from ambient environment. Hydrothermal synthesize will drive 
those hardly-dissolved compounds under normal conditions to dissolve in the solution 
under special conditions followed by recrystallization. The method can be used for the large 
crystal growth with high quality, where good control over composition is required. This 
method has been used for the fabrication of nanomaterials with low-dimentions.  
The sol-gel process, strictly, belongs to a wet-chemical technique (chemical solution 
deposition) for material fabrication. This process uses a chemical solution as the precursor 
for an integrated network (or gel) of either discrete particles or network polymers. The sol 
evolves towards the formation of a gel-like system with two phases (a liquid phase and a 
solid phase), whose morphologies range from discrete particles to continuous polymer 
networks. A drying process is generally required to remove the remaining liquid phase, 
during which a significant amount of shrinkage and densification occur. The precursor sol 
can be either deposited on a substrate to form a film or used to synthesize powders. The sol-
gel approach is a cheap and low-temperature technique that allows for the fine control of the 
product’s chemical composition.  
Thin films are thin material layers ranging from fractions of a nanometre to several 
micrometres in thickness. There are many popular deposition techniques for thin film 
deposition, such as evaporation, sputtering, chemical vapor depositions, etc. For example, 
evaporation in vacuum involves two basic processes: evaporation of a hot source material 
and then condensation of the material vapor on the cold substrate surface in the form of thin 
film. The average energy of vapor atoms reaching the substrate surface is generally low ( i.e. 
tenths of eV) and thus normally results in a porous and little adherent material.  Sputtering 
entails the bombardment of a target with energetic particles (usually positive gas ions), 
which causes some surface atoms to be ejected from the target.  These ejected atoms deposit 
onto the substrates in the vicinity of the target. The target can be kept at a relatively low 
temperature, and sputtering is especially useful for compounds or mixtures. Chemical 
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vapor deposition is done through exposure of the substrate to one of several vaporized 
compounds or reactive gases. A chemical reaction occurs initially near the substrate surface, 
producing desired material as it condenses on the substrate forming a layer of thin film. 
Commercial techniques often use very low pressures of precursor gas. 
3.2 Typical nanomaterials used in biosensors 
3.2.1 ZnO 
Among nanomaterials, ZnO has attracted much attention due to wide range of applications. 
ZnO as a wide band gap (3.37 eV) semiconductor plays an important role in optics, 
optoelectronics, sensors, and actuators due to its semiconducting, piezoelectric, and 
pyroelectric properties. Nanostructured ZnO not only possesses high surface area, 
nontoxicity, good biocompatibility and chemical stability, but also shows biomimetic and 
high electron communication features, making it great potential applications in biosensors. 
More importantly, as a biocompatible material, it has a high isoelectric point (IEP) of about 
9.5. This makes it suitable for absorption of proteins with low IEPs, as the protein 
immobilization is primarily driven by electrostatic interaction. ZnO with various 
nanostructures by same or different fabrication techniques has been widely used for enzyme 
immobilization in recent years. Fig. 1 gives some examples to show various ZnO 
nanostructures in different shapes by several various synthesis techniques.  
Wet chemical route is quite a popular method to fabricate various ZnO nanostructures, such 
as nanoparticles, nanorods and nanosheets. It had been proposed to use these ZnO 
naonostructures as platform for cholesterol oxidase (ChOx) immobilization via physical 
adsorption. For example, using ZnO nanoparticles for enzyme immobilization, the prepared 
biosensor had a high and reproducible sensitivity of 23.7 µA/cm2.mM, detection limit of 
0.37 nA and linear dynamic range from 1 to 500 nA (Umar et al., 2009). Recently, an ultra-
sensitive cholesterol biosensor was developed using flowerlike ZnO nanostructure, in which 
ChOx was immobilized to the surface of modified electrode via physical adsorption 
followed by the covering of Nafion solution. Such biosensor exhibited a very high and 
reproducible sensitivity of 61.7 µA/cm2.mM with a Michaelis-Menten constant (KM) of 2.57 
mM and fast response time of 5 s (Umar et al., 2009). A H2O2 biosensor was prepared using 
waxberry-like ZnO microstructures consisting of nanorods (8-10 nm) by wet chemical 
method (Cao et al., 2008). Such kind of ZnO microstructures with high surface area could 
provide the platform for the reduction of H2O2 by contributing excess electroactive sites and 
enhanced electrocatalytic activity. The transport characteristics of the electrode were 
controlled by diffusion process, and the prepared biosensor had a much wider linear range 
from 0.l5 to 15 mM.  
Gluose biosensors were also reported using ZnO nanocombs as platform by vapor-phase 
transport (Wang et al., 2006). For enzyme immobilization, glucose oxidase (GOD) were 
physically adsorpted to the nanocomb modified Au electrode, followed by Nafion solution 
covered on the surface of the modified electrode. The prepared biosensor had a diffusion-
controlled electrochemical behavior. The covered linear range was from 0.02 to 4.5 mM and 
the reported sensitivity was  15.33 µA/cm2.mM. The value of KM was as low as 2.19 mM. 
Using a similar technique, Weber et al. obtained ZnO nanowires with a typical length of 0.5-
2 µm and a diameter of 40-120 nm, which were grown on the substrate with an array of ZnO 
nanowires (Weber et al., 2008). Physical adsorption was also adopted to immobilize GOD 
onto the electrode. This kind of biosensor had a linear trend (0.1-10 mM). A reagentless 
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Fig. 1. ZnO nanostructure materials with various  shapes. (a) nanocombs by vapor-phase-
transport (Wang et al., 2006); (b) nanowires by vapor-liquid-solid (Weber et al., 2008); (c) 
microspheres consisting of nanosheets by wet chemical route (Lu et al., 2008); (d) nanonails 
by thermal evaporation (Umar et al., 2008); (e) nanowires by thermal evaporation (Zang et 
al., 2007); (f) nanorods by hydrothermal decomposition (Wei et al., 2006). 
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phenol biosensor was prepared by immobilizing tyrosinase on ZnO nanorods through 
electrostatic attraction and then covered by Nafion, in which ZnO nanorods were also 
fabricated by vapor-phase transport technique (Chen et al., 2008). Tyrosinase was adsorbed 
on the ZnO nanorods and its bioactivity can be well remained. Such prepared biosensor had 
a fast response within 5 s. The linear range of concentration spanned from 0.02 to 0.18 mM, 
and KM was calculated to be as low as 0.24 mM, reflecting a high affinity of tyrosinase to 
phenol on ZnO nanorods and a good bioactivity (Chen et al., 2008). 
Gluose biosensors were also reported using ZnO nanocombs as platform by vapor-phase 
transport (Wang et al., 2006). For enzyme immobilization, glucose oxidase (GOD) were 
physically adsorpted to the nanocomb modified Au electrode, followed by Nafion solution 
covered on the surface of the modified electrode. The prepared biosensor had a diffusion-
controlled electrochemical behavior. The covered linear range was from 0.02 to 4.5 mM and 
the reported sensitivity was  15.33 µA/cm2.mM. The value of KM was as low as 2.19 mM. 
Using a similar technique, Weber et al. obtained ZnO nanowires with a typical length of 0.5-
2 µm and a diameter of 40-120 nm, which were grown on the substrate with an array of ZnO 
nanowires (Weber et al., 2008). Physical adsorption was also adopted to immobilize GOD 
onto the electrode. This kind of biosensor had a linear trend (0.1-10 mM). A reagentless 
phenol biosensor was prepared by immobilizing tyrosinase on ZnO nanorods through 
electrostatic attraction and then covered by Nafion, in which ZnO nanorods were also 
fabricated by vapor-phase transport technique (Chen et al., 2008). Tyrosinase was adsorbed 
on the ZnO nanorods and its bioactivity can be well remained. Such prepared biosensor had 
a fast response within 5 s. The linear range of concentration spanned from 0.02 to 0.18 mM, 
and KM was calculated to be as low as 0.24 mM, reflecting a high affinity of tyrosinase to 
phenol on ZnO nanorods and a good bioactivity (Chen et al., 2008). 
ZnO nanowires can also be obtained using thermal evaporation, in which ZnS powders 
were thermal evaporated under controlled conditions with Au thin film as a catalyst layer 
(Zang et al., 2007). GOD was immobilized onto ZnO nanowires by physical adsorption. KM
and sensitivity could be modulated in a wide range by the variation of the loading amount 
of ZnO/GOD onto the electrode. Umar et al. also using thermal evaporation to synthesize 
ZnO nanonails (Umar et al., 2008), where Zn powder was used as reaction source of Zn, and 
oxygen was introduced into the system. The constructed biosensor exhibited a diffusion-
controlled electrochemical behavior with a linear calibration range from 0.1 to 7.1 mM. It 
showed a high sensitivity of 24.6 µA/cm2.mM, while KM was relatively higher around 15 
mM. Uric acid biosensor was prepared based on ZnO nanorods also by thermal evaporation 
(Zhang et al., 2004). Uricase with a low IEP of 4.3, was immobilized on ZnO nanorods by 
electrostatic attraction. The prepared biosensor had a linear range from 5 µM to 1 mM and 
detection limit of 2 µM. Besides, it had a lower KM of 0.24 mM and a good thermal stability 
(10 - 85oC).   
Among the various strategies followed, a useful and simple way for ZnO is to grown 
directly on electrode. This was realized in the work of Wei et al. (Wei et al., 2006), where 
ZnO nanorods with a hexagonal cross section were grown directly on the standard Au 
electrode by hydrothermal decomposition. Enzyme immobilization was done via the cover 
of GOD solution on the surface of the electrode. The prepared biosensor presented a quite 
fast response within 5 s and a high sensitivity of 23 µA/cm2.mM. It also had a low KM value 
of 2.9 mM  and a low detection limit of 10 µM.  
ZnO matrix by sol-gel procedure was developed for tyrosinase immobilization (Liu et al., 
2005). The porous and positively charged ZnO sol-gel matrix provided a moderate 
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microenvironment for the tyrosianse to remain its bioactivity. The so prepared biosensor 
had a sensitivity of 168 µA/mM, and the linear range covered from 0.15 to 40 µM (Liu et al., 
2005). Another kind of matrix of ZnO/chitosan was developed for tyrosinase 
immobilization by dispersion of ZnO nanoparticles into the chitosan solution (Li et al., 
2006). The matrix could provide a favorable microenvironment in terms of its isoelectric 
point for tyrosinase loading, and the immobilized tyrosinase could retain its bioactivity to a 
large extent. The biosensor using ZnO/chitosan matrix had a better performance than that 
using ZnO sol-gel matrix. KM was calculated to be 23 µM and the detection limit was lower 
to be 0.05 µM (Li et al., 2006).  
Different from above mentioned ZnO nanostructures, a new kind of nanostructure, 
nanoclusters, was proposed for a novel biosensor construction (Zhao et al., 2007). These 
ZnO nanoclusters doped by Co (2%) were obtained by nanocluster-beam deposition (Zhao 
et al., 2005; Zhao et al., 2007). Home-made electrode based on PET plate was used for 
enzyme immobilization instead of traditional standard electrode. Briefly, Ti ions from the 
plasma were implanted into PET plate, followed by a thin Au layer deposited on Ti-
implanted PET substrate by magnetron sputtering. After that ZnO-based nanoclusters were 
directly grown on the modified PET plate. Cross-linking was used via glutaraldehyde for 
enzyme immobilization. The prepared biosensor had a response time within 10 s and the 
sensitivity was over 13 µA/ cm2.mM. ZnO porous thin films by RF magnetron sputtering 
was also proposed for ChOx immobilization by physical adsorption. The film was grown 
under high pressure (50 mTorr) so as to creat native defects and therefore porous film 
formed. The prepared biosesnor had a KM of 2.1 mM. The wide linear range spanned from 
0.65 to 10.34 mM.  
In recent years, nanostructured inorganic-organic hybrid materials have emerged to 
fabricate biosensors by entrapping enzymes, which combine the physicochemical attributes 
of components to improves their features. Organic components (e.g. Nafion, chitosan) 
benefit the formation of defect-free inorganic membranes and make these membranes less 
brittle, and organic membranes can have their chemical and thermal stability improved by 
an inorganic phase. A H2O2 biosensor with good stability was developed with horseradish 
peroxidase (HRP) entrapped in the nanoporous ZnO/chitosan composite (Yang et al., 2005). 
The sensor exhibited a sensitivity of 43.8 µA/cm2.mM, and it retained 80% of its initial 
current response after 40 days. It is expected that the numerous nanoscaled cavities on the 
surface of the microspheres are highly advantageous for the entrapment of enzymes by 
sequestering in the cavities or binding on the surface of the microspheres. Using this 
approach, Lu et al. synthesized the porous ZnO microspheres consisting of nanosheets using 
wet chemical route (Lu et al., 2008). Hemoglobin (Hb) was entrapped in the composite film 
of Hb, ZnO and Nafion. Besides the good reproducibility and long-term stability, the 
prepared biosensor had a sensitivity of 137 µA/cm2.mM and a low KM of 0.143 mM. Other 
nanocomposite consisting of ZnO nanoparticles and chitosan was also reported to 
immobilize ChOx  by physical adsorption (Khan et al., 2008).  
More complex inorganic-organic composites are also commonly prepared in biosensor 
development by introducing other inorganic materials (e.g gold and multi-walled carbon 
nanotubes (MWCNTs)). It’s well known that gold and MWCNTs have been already used for 
enzyme immobilization to realize direct electron transfer between active sites and  electrode.  
Besides, the presence of biocompatible Nafion in the biocomposite film not only makes the 
film uniform, but also could lead to the increased activity of enzyme. Recently, a biosensor 
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under these approches was prepared using the platform consisting of ZnO, MWCNTs and 
Nafion, which showed a very high sensitivity of 1310 µA/cm2.mM  and a very low of KM of 
82.8 µM (Ma et al., 2009). The composites consisting of ZnO, Nafion and gold nanoparticles 
were also developed to entrap HRP for H2O2 biosensors (Xiang et al., 2009).  The biosensor 
had  a Km of 1.76 mM and a low detection limit of 9 µM. It showed reproducibility and 
good stability after one month. Other composites are also proposed consisting of ZnO 
crystals, gold nanoparticles and chitoson (Zhang et al., 2009). The principle of enzyme 
immobilization differed from the methods mentioned above. It is known that ZnO crystals 
with high IEP are suitable for the electrostatic adsorption of proteins with lower IEP. The 
positively-charged ZnO crystals and amine-derivatized chitosan could facilitate higher 
capability of assembling negatively charged nanogold through strong electrostatic 
adsorption and the covalent bonds between amine groups and gold (Zhang et al., 2009). 
Biocompatible nanogold could further allow HRP to be immobilized with well-remained 
bioactivity in addition to increased loading amount. The prepared biosensor can achieve 
sensitive electrochemical response to H2O2 at a potential of - 0.2 V.  Similar composites for 
enzyme immobilization was reported by Duan et al. (Duan et al., 2008), but the composites 
were mixed by the solutions of ZnO/chitosan, Hb and gold. The as-prepared biosensor has 
a fast response to H2O2 within 4 s and a detection limit of 0.097  µM.  
Recent advances in phenol biosensors witness the use of modern process in semiconductor 
industry, such as photolithograph for designed patterns. A new tyrosinase biosensor was 
constructed based on the covalent immobilization of tyrosinase by glutaraldehyde on the 
biofunctional ZnO nanorod microarrays via photolithograph (Zhao et al., 2009). The as-
prepared biosensor had a ultrahigh sensitivity of 287 µA/cm2.mM  and a detection limit of 
0.25 µM. The linearity covered a wide range from 1-150 µM.  
In the development of uric acid biosensor,  multilayer structure was introduced toward a 
highly sensitive and stable uric acid biosensor. Using ZnO nanoparticles and MWCNTs, 
multilayer structure was realized firstly by negatively charged MWNTs cast on pyrolytic 
wafers, followed by decoration of ZnO nanoparticles (Wang et al., 2009). Uricase was 
immobilized onto ZnO nanoparticles also by electrostatic attraction, and finally PDDA layer 
was coated on the surface of uricase. The as-prepared biosensor had a wide linear response 
range of 1mM to 5 M, a high sensitivity of 393 µA/cm2.mM. It also exhibited a long-term 
stability after 160 days.  
3.2.2 Gold 
Gold nanoparticles could provide a stable immobilization for biomolecules retaining their 
bioactivity. Moreover, electron transfer between redox proteins and electron surfaces is 
facilitated, which is induced by many factors, such as the high surface-to-volume ratio, high 
surface energy, decreased proteins-metal particles distance and the functioning as electron-
conducting pathways between prosthetic groups and the electrode surface from the gold 
nanoparticles.  Pingarron et al. recently reported a review on gold nanoparticle-based 
electrochemical biosensors, in which gold-based enzyme biosensor are summarized 
(Pingarron et al., 2008). Gold nanoparticles are normally synthesized by chemical route and 
electrodeposition.  
The electrodes are usually modified by gold in different ways to improve the performance 
of the biosensor. The electrode surface could be roughened by gold nanoparticles to enhance 
the interaction of enzyme with the electrode. An example is the construction of 
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acetylcholinesterase biosensor in which electrode was modified by electrodeposited gold 
nanoparticles at the electrode surface after hydrolysis of acethlthiocholine by the 
immobilization enzyme (Shulga & Kirchhoff, 2007). This method is valuable for the 
development of new devices for the sensitive detection of potentially dangerous and deadly 
neurotoxins. Carbon paste electrode could be modified by the colloidal gold consisting of 
pretreated graphite power with colloid gold solution and paraffin oil (Liu & Ju, 2003). GOD 
was immobilized onto the modified electrode via physical adsorption. Such kind of GOD 
biosensor can efficiently exclude the interference of commonly coexisted uric and ascorbic 
acid (Liu & Ju, 2003). The similar methodology is also favored for other substrate detection, 
such as phenol and hydrogen peroxide (Liu & Ju, 2002; Liu et al., 2003). Gold electrode can 
be modified by attachement of gold nanoparticles via covalent bond. These gold 
nanoparticles by chemical route were self-assembled on gold electrode by dithiol via Au-S 
bond, where dithiol was physically absorbed on the electrode surface by putting gold 
electrode immersed into a dithiol ethanol solution (Zhang et al., 2005). A cystamine 
monolayer was then chemisorbed onto those gold nanoparticles and exposed to an array of 
amino groups, after that GOD was immobilized by covalently attached to the cystamine 
modified electrode (Zhang et al., 2005). The scheme diagram in Fig. 2  shows the steps for 
above procedure. The so prepared biosensor provided a linear response to glucose from 20 
?M - 5.7 mM with a sensitivity of 88 µA/cm2.mM. The sensor had a good reproducibility 
and remained stable over 30 days.  
A wide variety of matrices, including inorganic materials, organic polymers, and other 
commercially available solid supports, have been used for enzyme immobilization. 
Chitosan, as mentioned in pervious part, is one of the most promising immobilization 
matrices due to its excellent properties. Colloidal gold nanoparticles have been also used as 
the matrix for the enzyme immobilization to retain the macromolecules’ bioactivity. The 
adsorption of colloidal gold nanoparticles on the chitosan membrane could provide an 
assembly of gold nanoparticle mulilayers and a suitable microenvironment similar to the 
native environment of biomolecules. Based on this approach, a disposal biosensor was 
fabricated for the rapid detection of H2O2 by entrapping HRP in colloidal gold nanoparticle-
modified chitosan membrane (Liu & Ju, 2003). The biosensor was characterized with good 
detection precision and storage stability. Based on a similar methodology, glucose (Luo et 
al., 2004) and HRP (Luo et al., 2005) biosensors were prepared by self-assembling gold 
bnanoparticles on chitosan hydrogel modified Au electrodes.  
Nanocomposites by combination of gold nanoparticles with inorganic or organic 
nanomaterials have shown to possess interesting properties, which can be profited for the 
development of electrochemical biosensors. An example of such nanocomposites is a 
colloidal gold-CNT composite electrode using Teflon as the non-conducting binding 
material (Manso et al., 2007). The constructed biosensor showeded significantly improved 
responses to H2O2, and the incorporation of GOD into the new composite matrix allowed 
the preparation of a mediatorless glucose biosensor with a remarkably higher sensitivity 
than that from other GOD-CNT bioelectrodes (Manso et al., 2007). Hybrid nanocomposites 
of gold nanoparticles and organic materials are proposed, in which gold and PPy are 
fabricated by wet chemical route using HAuCl4 and pyrrole as the reaction reagents (Njagi 
& Andreescu, 2007). The reaction occurs in mild aqueous conditions and doesn’t involve 
application of an electrical potential, surfactants or solvents that could affect the biological 
activity. A stable nanocomposite strongly adhered to the surface of GCE electrode and 
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enzyme was entrapped into the matrix. The fabricated biosensor showed high sensitivity for 
phenol detection, fast response time, good operational stability and reproducibility (Njagi & 
Andreescu, 2007).  
Fig. 2. Stepwise assembly of dithiol, gold, cystamine, IO4- oxidized GOD on a gold electrode, 
from paper (Zhang et al., 2005) 
Enzymes deposited in ordered monolayer or multilayer systems have an important 
significance for fabrication of biosensors and bioelectronic devices. Layer-by-layer self-
assembly technique based on electrostatic interaction attracts extensive interest due to its 
simplicity of the procedure, wide choice of the composition and thickness of the layer on the 
molecular level (Yang et al., 2006). This technique was originally developed by Decher and 
coworkers (Decher et al., 1992; Lvov et al., 1993) for linear polyelectrolytes and later 
extended to proteins, enzymes, nanoparticles, and so on (Feldheim et al., 1996; Caruso et al., 
1997; He et al., 1998). Using this technique, a glucose biosensor was constructed, in which 
PMMA dendrimers with modified gold nanoparticles were alternated with 
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poly(vinylsulfonic acid) layers on ITO electrodes (Crespilho et al., 2006). The method of 
cross-linking was chosen for enzyme immobilization (Crespilho et al., 2006). Other glucose 
biosensor by layer-by-layer self-assembled technique could also be realized consisting of 
different multilayer films with chitosan, gold nanoparticles and GOD (Wu et al., 2007). A 
method of layer-by-layer covalent attachment of enzyme molecules was proposed to 
overcome the unstability occurring in the layer-by-layer self-assembly technique casued by 
the driving force of electrostatic interaction. Such kind of biosensor was prepared by 
construction of multilayer films consisting of glucose oxidase and gold nanoparticles using 
cysteamine as a cross-linker based on two covalent reactions: Schiff bases reaction between 
aldehyde-group of IO4-oxidized GOD and amino-group of cysteamine, and covalent bond 
between gold nanoparticles (GNPs) and sulphydryl of cysteamine (Yang et al., 2006). Layer-
by-layer construction of GOD/GNPs multilayer film on an Au electrode were shown in Fig. 
3. The constructed biosensor exhibited a good stability and long lifetime up to 4 weeks.  
Fig. 3. Layer-by-layer construction of the GOD/gold nanoparticles multilayer films on an 
Au electrode (Yang et al., 2006). 
Sol-gel technology provides unique means to prepare there-dimensional networks suited for 
the encapsulation of biomolecules. Sol-gel hybrid materials prepared by physically 
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encapsulating gold nanoparticles into porous sol-gel networks have been used for the 
fabrication of biosensors. For instance, an acetylcholinesterase biosensor was constructed, 
where the sol-gel derived silicate network assembling gold nanoparticles provided a 
biocompatible microenvironment around the enzyme molecule to stabilize its biological 
activity and prevent them from leaking out of the interface (Du et al., 2008).   
3.2.3 CNT 
 CNTs are unique one-dimensional materials with unique properties such as good electrical 
conductivity, strong adsorptive ability and excellent bioconsistency. CNTs have led to 
development of many new techniques, and the applications in the biosensors have shown 
that CNTs have an electrocatalytic effect and fast electron-transfer rate between the 
electroactive species and the electrode.  
A biosensor could be simply fabricated using multi-walled CNTs (MWCNTs) as 
immobilization platform with direct electron transfer and enhanced catalytic effect. For 
example, bilirubin oxidase could be immobilized directly onto MWCNTs modified glassy 
carbon electrods (Weigel et al., 2007).  Direct electron transfer reactions of bilirubin oxidase 
occur and the incorporation of MWCNTs enhances the catalytic bilirubin oxidase reaction 
up to a factor of 26 (Weigel et al., 2007).   
An extremely robust, sensitive and selective galactose biosensor was proposed by the 
dispersion of single-wallled CNTs (SWCNTs) into a chitosan matrix to form a stable 
dispersion, followed by the chemical cross-linking with glutaraldehyde and free aldehyde 
groups produced a substrate for covalent immobilization of galactose oxidase (Tkac et al., 
2007). The detection of oxygen uptaken by galactose oxidase on chitosan/SWCNTs layer at - 
0.4 V was robust with a low detection limit of 25 µM.  
Activating CNT surfaces is an essential prerequisite in order to effectively improve the 
performance of the prepared biosensors. In practical, CNT solubilization in aqueous media 
is essential for CNTs as supporting matrix for the immobilization of proteins. This can be 
achieved by the surface functionalization of CNTs with ionic or hydrophilic groups or the 
functionalization of CNTs with water-soluable polymers. Based on this approach, MWCNTs 
are modified by redox polymer, poly(vinylimidazole) complexed with 
Os(4,4’dimethylbpy)2Cl(PVI-demeOs), resulting in the turning of MWCNT surface from 
hydrophobic to hydrophilic without changes of surface morporlogy (Cui et al., 2009). The 
prepared biosensor showed the enhanced sensing sensitivities induced by the redox 
polymer film, where the enzyme molecules was wired through the redox centers tethered on 
the mobile redox polymer backbones to the MWCNTs electrodes. MWCNTs could be 
modified by the coating of polyethylene imine (PEI) or poly(acrylic acid) (PAA) to obtain 
water-soluble MWCNTs (Yan et al., 2008). Recent development on the modified MWCNTs 
was to use O2 plasma to treat MWCNTs, and thus oxygen contained functional groups were 
introduced onto their surface without influencing their bulk properties (Lee et al., 2009).  
Attaching metal nanoparticles to CNT and to CNT sidewalls is of interest to obtain 
nanotube/nanoparticle hybrid materials with useful properties. By electrostatic interaction, 
CNTs could be coated with gold nanoparticles and further filled with gold nanocluster after 
heat treatment in NH3 (Jiang & Gao, 2003). Such heat treatment with NH3 could make CNTs 
open-ended and generate functional basic groups on the inner wall of the nanotubes.   
The composite of CNTs with other organic/inorganic materials has an important role in 
CNT-based enzyme biosensors. For instance, MWCNTs/PVP/Prussian blue (PB) composite 
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film were synthesized by casting films of MWCNTs wrapped with PB on Au electrodes 
followed by electrochemical deposition of PB on the matrix (Li et al., 2007). The modified 
electrode thus shows prominent electrocatalytic activity towards the reduction of hydrogen 
peroxidase, due to the remarkablely synergistic effect of the MWCNTs and PB. Hydrogen 
peroxide biosensor could be also prepared by entrapping HRP in a new ormosil composite 
doped with ferrocene monocarboxylic acid-bovine serum albumin conjugate and MWCNTs 
(Tripathi et al., 2006), which exhibited a very low mass transport barrier to the substrate. 
Nafion and chitosan as organic materials are quite popular in the CNTs-based 
nanocomposites. In addition, sol-gel matrix, like titania and silica, were applied for effective 
enzyme immobilization (Lee et al., 2007; Tiwari & Gong, 2008). Meanwhile, metal 
nanoparticles of platinum were also incorporated into the composites of chitosan and 
MWCNTs to improve the performance of the prepared biosensor (Tsai et al., 2008).   
Lactate detection is of great importance for the clinical analysis, fermentation as well as for 
food analysis. Enzyme-based electrochemical techniques for lactate detection is inexpensive, 
rapid and reliable compared to other methods, such as chromatographic and spectrometric 
analysis (Posner et al., 1996; Wulkan et al., 2001; Bariskaner et al., 2003; Fernandes et al., 
2003). One kind of lactate biosensor  was proposed by co-immobilization of lactate 
dehydrogenase (LDH) and Meldola’s Blue on MWCNTs through cross-linking with 
glutaraldehyde and agglutination with mineral oil (Pereira et al., 2007). The biosensor shows 
a good stability after 300 times of determinations within a wide linear response range (0.1-10 
mM). A MWCNT-CHIT-LDH nanobiocomposite film as a lactate biosensor was developed 
(Tsai et al., 2007), where MWCNT, chitosan, and LDH were mixed by a simple solvent-
evaporation process. The enzyme in this kind of biosensor was entrapped in the 
biocomposite and the prepared biosensor showed a much fast response around 3s. In 
addition to MWCNT and chitosan as immobilization materials, polyvinylimidazole-Os (PVI-
Os), can be also introduced into the biocomposite to form network structure (Cui et al., 
2007). In the nanocomposite of chitosan/PVI-Os/MWCNT/LOD(lactate oxidase), 
negatively charged LOD was entrapped by a positively charged chitosan. PVI-Os was used 
as a leachables electron mediator due to its polymeric redox form and its positive charge 
could also enhance the entrapment for LOD. Negatively charged CNT was designed as a 
cross-linker to network chitosan and PVI-Os for the nanocomposite. The prepared biosensor 
showed significantly improved conductivity, stability and electroactivity for lactate 
detection. The sensitivity could reach 19.7 µA/cm2.mM, and the low limit of detection of 5 
µM. Recently, a new kind of hybrid composite for lactat biosensor was developed by 
introducing double-walled CNTs (DWCNTs) into alginate gel (Ma et al., 2008). DWCNTs 
with two concentric grapheme cylinders have attracted great interests in recent years 
because of their unique coaxial structure and promising mechanical, electrical, optical and 
thermal properties over SWCNTs and MWCNTs. LDH was prepared by pre-adsorbed on 
DWCNTs and then they were incorporated into alginate gel followed by Ca+ cross-linking. 
The prepared lactate biosensor could greatly reduce the water loss and LDH leakage.  
Recent advances in CNT-based enzyme biosensors have shown to design a biocomposite 
biosensor so as to detect more than one substrate. An good example was given by a 
bienzyme biosensor with a bienzyme-channelling configuration, where toluidine blue 
functionalized MWCNTs were used for enzyme immobilization (Jeykumari & Narayanan, 
2009). The constructed biosensor shows a short response time (< 2s), good stability and anti-
interferant ability. Many efforts have been made to detect the biomolecules at very low 
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Fig. 4. Tilted cross-sectional schematics with corresponding SEM images portraying 
sequential fabrication process steps: (a) SWCNTs grown from the pores of the PAA via 
MPCVD, (b) electrodeposition of Pd to form Pd nanowires in pores and Pd nanocubes on 
SWCNTs and (c) electrodeposition to coat the existing Pd nanocubes with a thin layer of Au 
(Claussen et al., 2009). 
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concentrations. Networks of SWCNTs decorated with Au-coated Pd nanocubes are 
employed as electrochemical biosensors showing a limit of detection as low as 2.3 nM for 
H2O2, in which Au-coated Pd nanocubes were grown at the defect sites of template SWCNT 
networks through a simple electrodeposition process (Claussen et al., 2009). Fig. 4 shows the 
schematic fabrication process steps with corresponding SEM images. 
3.2.4 Polypyrrole 
Among various conducting polymers, polypyrrole (PPy) as an intelligent material plays an 
important role in the electrochemical biosensors for the purpose of increased 
electrochemical activity and sensitivity, owing to its good biocompatibility, conductivity, 
stability, and efficient polymerization at neutral pH as well as easy synthesis. PPy films can 
be easily formed from aqueous solutions by chemical or electrochemical routes,  and have a 
high degree of selectivity due to the inherent size-exclusion property. A recently good 
review on the applications of polymers in electrochemical biosensors could be found in the 
literature (Teles & Fonseca, 2008), in which polypyrrole was highlighted.  
In biosensor construction, PPy is often used as a conducting matrix and thus other 
organic/inorganic materials could be introduced into the matrix to further improve the 
performance of the biosensor. For example, stable and homogenous hybrid films consisting 
of PPy and copper hexacyanoferrate by electrochemical method were synthesized, aiming to 
obtain an electrocatalyst for H2O2 reduction in the presence of either Na+ or K+ ions (Fiorito 
et al., 2006). The constructed biosensor shows excellent catalytic properties towards H2O2
detection, with a performance higher than those observed for Prussian Blue and other 
analogues due to the electronic conductivity of the polymeric matrix (Fiorito et al., 2006).   
In practical, it is important to find ways to obtain PPy polymers with desirable properties 
for biosensor applications by introducing various dopants. For instance, electrical 
conductivity can be achieved in polymer films by doping or inserting anionic or cationic 
species during the process of polymerization. Besides, the incorporation of a large size 
dopant anion, such as polyvinyl sulphonate (PVS), p-toluene sulphonate (pTS), and 
dodecylbenzene sulphonate (DBS) into PPy films during electropolymerization makes PPy 
film more porous, which is very important for the facile immobilization of enzyme (Tsai et 
al., 1988). According to this strategy, by using electrochemical method, PPy-PVS(polyvinyl 
sulphonate) nanocomposite film could be easily fabricated onto ITO electrode, and the 
enzyme is immobilized by cross-linking via glutaraldehyde on the hybrid film. A good 
performance of the biosensor was exhibited in terms of dynamic range of detection, short 
response time, long lifetime and stability. PPy can also be doped with alginate. Alginate 
hydrogel supports are usually made by cross-linking the carboxyl group of the guluronic 
acid residue with a solution of cationic crosslinkers such as calcium choloride, barium 
chloride, strontium, etc., and thus enzyme could retain their activity in alginate hydrogels 
(Martinsen et al., 1989). By taking advantages of both of alginate and PPy, a novel composite 
was synthesized through providing a gel by Ca+ cross-linking (Ionescu et al., 2005), which 
exhibitis a greater enzyme retention as well as increased alginate stability towards the 
destructive effect of phosphate anions compared to the natural alginate gel. Recently, 
protonated sodium alginate (pSA) was also reported to be a dopant for electrogeneration of 
Ppy/pSA functionalized films for GOD immobilization. This was achieved via covalent 
bonding of carboxyl groups of the main chain of alginate with amino groups of the enzyme 
(Chen et al., 2008).  
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Layer-by-layer assembled technology has been also used in PPy-based biosensors. An 
example is that layer-by-layer assembled PPy and CNTs multilayer films were fabricated on 
Pt coated Polyvinylidene fluoride membrane, where PPy film was prepared by 
electrochemical polymerization and CNTs layers were coated by a vacuum filtration 
technique (Shirsat et al., 2008). Such multilayer structure provided an excellent matrix for 
the immobilization of enzyme, which possessed the favorable features of both PPy and 
CNTs. Cross-linking was chosen for GOD immobilization, and such prepared biosensor 
showed  enhanced linear range, response time and sensitivity (Gade et al., 2006).  
Interestingly, soluble PPy synthesized by the incorporation of sulfonate dopant anion could 
be well incorporated into microscopic polyacrylamide particles for glucose biosensing by 
concentrated emulsion polymerization method (Retama et al., 2005). The novelty of this 
method over conventional emulsion polymerization lies in the large volume of the aqueous 
dispersed phase used. The PPy/polyacrylamide microparticles showed the semi- 
conductivity, and GOD was immobilized in the microparticles by incorporating the enzyme 
into the aqueous phase of the concentrated emulsion before starting polymerization. To 
construct the biosensor, the obtained microparticles layer was covered and flattened around 
the platinum electrode surface using a dialysis membrane (Retama et al., 2005), and it 
showed the great interest for the application in glucose detection.  
Other types of PPy nanostructures, like PPy nanotubes have been also proposed for 
enhanced adsorption of glucose oxidase in glucose biosensors (Ekanayake et al., 2007), 
where PPy nanotube array was synthesized using a solution of pyrrole and NaPF6 at a fixed 
current density for 90 s. GOD was immobilized onto the electrode through physical 
adsorption. With this new approach, the constructed biosensor had exhibited remarkable 
improvement in the sensitivity, response time and linear range values.
4. Outlook 
This chapter mainly presents intelligent nanomaterials (e.g ZnO, gold, CNT and polyrrole) 
for construction of enzyme-based electrochemical biosensors to show the development in 
this area. To construct a biosensor with promising applications, it should be carefully 
considered to modify electrode in an effective way. The immobilization of enzyme onto the 
electrodes should be considered as another key step due to the important roles of the 
amount and bioactivity of immobilized enzyme on the performance of biosensors.  
There are many challenges currently faced towards practical applications of biosensors. For 
example, the construction of a biosensor with a low cost is still essential when considering 
the commercial devices. The major application field of biosensors is medical diagnostics 
with commercial devices. The biosensors in other areas, such as food industry and ecology,  
needed to be explored deeply for more applications. Challenges also exist to find ways to 
improve the performance criteria including high sensitivity, wider linear range, low limit of 
detection, fast response and repetitive ability. Research work now still keeps continuing to 
investigate more effective ways to construct enzyme-based electrochemical biosensors with 
more perfect performance.  
In the future development of electrochemical biosensors, the demands for portable and 
cheap biosensors with multifunctions (e.g. to detect several target analytes) will keep 
increasing for practical applications. Many thanks to the emergence of nanotechnology, 
many researchers could incorporate this technology into the biosensor construction to obtain 
novel structures. Miniaturization will play an important role in the trend of biosensor 
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development in the future. However, it may result in low current because of the decreased 
amount of immobilized enzyme onto the available active area. This can be overcom by the 
nanostructures, which enhance the sensitivity of a biosensor by one to two orders of 
magnitude, due to the large surface area per unit volume ration, which allows the 
immobilization of a larger amount of the enzyme. Overall, electrochemical biosensors with 
perfect performance towards commercial systems keep a main thrust in future research.  
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1. Introduction 
Studies of nanobiosensors based on semiconductor nanostructured metal oxides are of 
practical and theoretical importance in biological science, environmental science and 
analytical chemistry (Wang et al., 2005; Luo et al., 2006; Valentini & Palleschi (2008); Chopra 
et al., 2007). These one-dimensional nanostructured metal oxides have profound 
applications in optics, optoelectronics, sensors, and actuators duo to their semiconducting, 
piezoelectric, and pyroelectric properties (Wang et al., 2005; Chopra et al., 2007; Kerman et 
al., 2008; Chow et al., 2005). Nanostructured metal  oxides not only possesses high surface 
area, nontoxicity, good biocompatibility and chemical stability, but also shows fast electron 
communication features made the materials to be able to function as biomimetic membrane 
material to fix and modify proteins (Wang et al., 2005; Chopra et al., 2007; Valentini & 
Palleschi (2008)). These biomimetic and high electron communication features, high surface 
to volume ratio and electro-catalytic activity of the nanosized materials make them ideal as 
immobilization matrices, as transduction platform and/or mediators. Stability, sensitivity, 
selectivity and other analytical characteristics of biosensors are essential features to design 
desirable microenviroment for the direct electron transfer between the enzyme’s active sites 
and the electrode. To improve these characteristics various conventional materials matrices 
have been proposed. Among them nanostructured metal oxides matrices not only retain the 
bioactivity of the immobilized enzyme but also enhanced the sensing characteristics such as 
sensitivity, selectivity and low detection limit of the fabricated amperomatric enzymatic 
biosensors. Morphology of the nanosized material is one of the most ideally suited 
important factor to determine the properties for biosensor applications since they are 
conductive, biocompatible, easily functionalized while they have very large surface area. 
Nanosized metal oxides based electrochemical enzymatic biosensors have active surfaces 
that can easily be modified for immobilization of biomolecules. However, this advantage 
may not apply to many non-oxide semiconductor nanomaterials because their surfaces are 
not stable in an air environment, which leads to formation of an insulating native oxide 
layer and may degrade device reliability and sensitivity.  
Whereas, nanostructured metal oxides based electrochemical transducer surfaces promote 
the direct electron transfer reactions, amplify and orient the analytic signal of the 
biorecognition events. When a redox protein is immobilized on a biocompatible metal oxide 
electrode surface, it will exhibit reasonably fast electron transfer kinetic and permit the 
 Biosensors 24
electrochemical measurement of its substrate without addition of a mediator to the analyzed 
solution. Since the direct contact of redox protein with metal oxide surfaces usually leads to 
significant changes in protein structure, function and increased the bioactivity of the 
electrochemical enzymatic transducer. These electrochemical transducers are regarded as 
particularly suitable for direct and fast biosensing since they can convert the biological 
recognition event into a direct electrical signal. This means, that there is no need for complex 
signal transduction equipment and the detection can be accomplished with an inexpensive 
electrochemical analyzer. Electrochemical biosensing approaches include the intrinsic 
electroactivity of redox enzyme, electrochemistry of nanoparticles and metal oxide 
nanoparticles. Recently electrochemical enzymatic transducers have received considerable 
popularity in connection to the simple detection of analytes (proteins and enzymes), because 
of their rapid, high sensitivity, portability, low cost (disposability), simpler and minimal 
power requirements make them excellent candidate for analyte detection.The high 
sensitivity and wide linear range of such devices have opened new door in widespread 
biomedical applications such as clinical diagnosis (for cancer diagnostics and detection of 
infectious organisms), in environmental monitoring (for pesticide detection, heavy metal–
trace pollutant quantification, and genotoxic molecules), and finally in food quality control 
(for genetically modified organisms-GMOs-and several food toxins). In this article, we  
describe the importance of nano-structured metal oxides for fabrication of amperomatric of 
amperometric and voltammetric electrochemical enzymatic biosensors.  
2. Synthesis and properties of nanostructured metal oxides 
For the synthesis of nanostructured metal oxides various physical and chemical routes have 
been developed to determine their morphological properties and possible applications in 
biosensors (see in Table 1). Physical methods, which often involve vapor deposition, or ball 
milling process require subdivision of bulk precursors to nanoparticles. Chemical 
procedures start from reduction of metal ions to metal atoms, followed by controlled 
aggregation and separation of atoms from the bulk. The chemical methods or solution based 
chemistry methods are quit more suitable to obtaining small, uniform nanoparticles such as 
nanorods, nanowires, nanofibers, nanobelt, nanocomb, nanotubes and porous materials 
than the former for the particular biosensor applications of the nanomaterials. 
The properties of the nanoparticles generally depend on size, shape and stabilizing agents, 
which are controlled by the preparation conditions. Moreover, the size and the uniformity of 
the nanoparticles depend on the kind and the amount of reducing agent employed in 
synthesis. Recently, the use of MnO2 nanoparticles to construct an interface for direct 
electron transfer of redox proteins and retention of bioactivity is being extensively reported. 
One dimensional (1D) nanostructures (including rods, wires, belts, and tubes) provide a 
better model system for investigating the dependence of electronic transport, optical and 
mechanical properties on size confinement and dimensionality. They are also expected to 
play an important role as both interconnects and functional units in fabricating electronic, 
optoelectronic, electrochemical, and electromechanical devices with nanoscale dimensions. 
Considering the importance of metal oxides in catalysis, electrochemistry, functional 
ceramics, and sensors, their fabrication in nanostructured form with anisotropic 
morphology appears to be a particularly attractive goal and has been pursued in a number 
Nanostructured Metal Oxides Based Enzymatic Electrochemical Biosensors  25
Nanostructured Processing methods 




Solution based chemistry 
methods 
1 Pulse laser deposition 














4 Flame pyrolysis Molecular Beam Epitaxy 
Hydrothermal/solvothermal 
methods 
5 Laser ablation Atomic Layer Deposition
Supercritical fluid 
precipitation process 
7 Mechanical alloying techniques
Homogeneous/heterogeneous 
precipitation
8 Mechanical milling  Electrochemical deposition process
Table 1. General applied synthesis methods of nanostructured materials 
of laboratories. Much effort has been devoted to synthesized, characterized the novel 
properties and application of metal oxides such as nanofibers, nanorods, nanowires, and 
nanotubes. When developing a synthetic method for generating nanostructures, the most 
important issue that one need to address is the simultaneous control over dimensions, 
morphology (or shape), and mono-dispersbility (or uniformity).  
3. Electrocatalytic behavior of nanostructured metal oxides in the 
development of biosensor 
Numerous papers have been published in the literature indicating nanostructured metal 
oxides as a convenient component, forming an appropriate environment for the 
immobilization of enzyme at the electrode surface and its interaction with metallic or 
conducting electrode surface. Stable immobilization of macromolecular biomolecules on 
semiconducting metal oxide nano-surface with complete retention of their biological 
recognition properties is a crucial problem for the commercial development of miniaturized 
biosensor. Owing to large specific surface area and high surface free energy of nanoparticles 
can absorb enzymes strongly and play an important role in the immobilization of enzymes 
in construction of biosensor devices. Generally, the adsorption of enzymes directly onto 
naked surfaces of bulk materials may frequently result in their denaturation and loss of 
bioactivity. However, the adsorption of such enzymes onto the surfaces of nanoparticles can 
retain their bioactivity because of biocompatibile nature of metal oxides nanoparticles. Since 
most of the metal oxide nanoparticles carry high isoelectric point (>IEP), they can 
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electrostatically adsorb enzymes with different charges with the low isoelectric point 
enzymes or protiens. Wang et al., (2006) have applied ZnO nanocomb as a glucose sensing 
matrix that is most frequently used nanomaterial because they have high isoelectric point 
(IEP~9.5). Therefore, low isoelectric point enzymes and protein strongly adsorbed on the 
nanostructured metal oxide surface and provides direct electron communication between 
the enzymes and conducting electrode. For example, it is reported that ZnO nanorods (Wei 
et al., 2006) have high isoelectric point (IEP~9.5), it is suitable for immobilization of low 
isoelectric point enzymes such as glucose oxidase (GOx) or (IEP~4.2), cholesterol oxidase 
etc. The positively charged ZnO nanorods matrix not only provides a friendly 
microenvironment for immobilization of negatively charged GOx and retain its bioactivity, 
but also promotes electron transfer between GOx and the electrode to a large extent. Ansari 
et al., (2008) have immobilized GOx and cholesterol on sol-gel derived nanostructured CeO2
film deposited on indium-tin-oxide (ITO) glass plate for fabrication of glucose and 
cholesterol biosensors, respectively. Topoglidis et al.,(2000) firstly employed titanium 
nanoparticles for successfully immobilization of horseradish peroxidase to construct the 
H2O2 biosensor. Several investigators have studied the influence of nanoparticle size on the 
performance of the prepared biosensors and nanoparticles with smaller size were found to 
be more suitable for enzyme immobilization. Many similar studies have been reported for 
the construction of biosensors based on the immobilization of different enzymes with 
nanostructured metal oxides, such as glucose oxidase, cholesterol oxidase, urease, HRP, 
myoglobin, hemoglobin, cytochrome C, and tyrosinase etc. Other nanostructured metal 
oxides, such as CeO2, SnO2, Fe3O4, MnO2, Pr6O11, Sb2O3, TiO2, ZnO and ZrO2 nanoparticles 
have been used for the immobilization of enzymes for sensitive bioelectronic device 
development.
Electrical contacting of redox-enzymes with electrodes is a key process in the construction of 
third-generation enzyme electrodes. While enzymes usually lack direct electrical 
communication with electrodes due to the fact that the active centers of enzymes are 
surrounded by considerably thick insulating protein shells, and the electron transfer 
between electrodes and the active centers are blocked, the electro-catalytic properties of 
nanoparticles, mostly metal oxide nanoparticles at nanoscale dimensions made them 
suitable for enhancing the electron transfer between the active centers of enzymes and 
electrodes acting as electron transfer “mediators” or “electrical wires”. The conductance of 
metal oxides nanoparticles depend on their crystalline structure. It has been reported that 
the conductances of nanowires, nanotubes, nanoribbons, nanorods and nanofibers was 
superior in respect to other morphological nanomaterials. Due to the high electrical 
conductivity of the resulting dimension nanostructured metal oxides, these materials 
constructed sensors amplify the signal-to-noise ratio and the sensitivity by more than one 
order of magnitude compared to that observed at bulk materials electrodes. This improved 
analytic performance was due to both factors, such as the high enzyme loading and a better 
electrical communication ability of the nano-morphological structure and the active center 
of the biomolecules. This is known as the direct electron transfer ability of nanowires, 
nanotubes, nanorodes and nanofibers demonstrated that both flavin adenine 
dinucleotide(FAD) and glucose oxidase (GOx) were found to spontaneously adsorb 
(physical adsorption) to metal oxides nanoparticles (deposited on the conducting glass 
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electrodes by different casting process) and to display quasi-reversible one electron transfer 
reaction.
Several electroanalytical techniques such as cyclic voltammetry, pulse and square-wave 
voltammetry and electrochemical impedance spectroscopy have been employed to analyze 
the electron transport phenomena such as charge transfer, diffusional mass transport, 
adsorption, chemisorption, chemical reaction, and convection. Electroanalytical techniques 
can provide information on chemical, biochemical, and physical systems, which can 
supplement spectroscopic characterization and perhaps theoretical calculations. Since last 
decade, it was interesting to find that direct electron transfer of some redox proteins can also 
take place with the help of metal oxides nanoparticles without need for additional 
mediators. Modification of electrode surfaces with nanoparticles provides a 
microenvironment similar to that of the redox proteins in native systems and gives the 
protein molecules more freedom in orientation, thereby reducing the insulating effect of the 
protein shell for direct electron transfer through the conducting tunnels of metal oxide 
nanoparticles.
4. Performance of nanostructured metal oxide based enzymatic 
electrochemical biosensors 
Because of novel electrocatalytic behavior of nanostructured metal oxide, which combines 
characteristics of electrochemistry (e.g., simplicity, fast, high sensitivity & selectivity and 
low detection limit). Metal oxide nanoparticles exhibit higher ratios of surface area to 
volume than their bulk counterparts, so metal oxide nanoparticle modified electrochemical 
interfaces will provide larger electrochemically active areas and therefore probably lead to 
higher detection sensitivity for target molecules. Some novel nanoparticles, particularly 
manganese oxide (MnO2) nanoparticles, can easily act as enhancing agents for effective 
acceleration of electron transfer between electrode and detection molecules, so leading to 
more rapid current response for target molecules. Superparamagnetic iron oxide 
nanoparticles act as a supramolecular assembling unit with advanced functional properties 
for constructing a variety of architectures on the surface of electrodes and further tailoring 
of an electrochemical-sensing interface. These metal oxide nanoparticles conjugate with 
some important biomolecules (e.g., redox enzyme) and act as nano-connectors that activate 
redox enzymes or electrical labels for biorecognition events. Furthermore, metal oxide 
nanoparticles modified electrochemical interfaces behave as nanoelectrode ensembles; in 
principle, the electroanalytical limit of detection at a nanoelectrode ensemble can be much 
lower than that at an analogous macrosized electrode because, there is a bigger ratio 
between Faradaic and capacitive currents. Inspired by the important features of 
nanostructured metal oxide has been in full flourish recently and a great deal of literature 
has reported that metal oxide-modified interfaces have enhanced electrochemical signaling. 
Nanostructured metal oxide based enzymatic biosensors have excellent prospects for 
interfacing biological recognition events with electronic signal transduction so as to design a 
new generation of bioelectronic devices with high sensitivity. Indeed, there has been 
substantial progress in the past decade on enzymatic electrochemical biosensors. In this 
article, we have collected the recent research activities on nanostructured metal oxide based 
enzymatic electrochemical biosensors. 
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4.1 Glucose biosensors 
For determination of glucose, the reaction with glucose oxidase (GOX) enzyme electrode is 
shown with the following equations: 
                                    ?-glucose + O2? ?-gluconic acid + H2O2  (1) 
 H2O2? O2 + 2H+ + 2e-  (2) 
The amount of H2O2 produced in equation (1) is usually determined by amperometric 
method by oxidation at the working electrode according to equation (2). This is referred as 
an amperometric biosensor. Equation (2) shows that protons are produced in the follow-up 
oxidation reaction. The production amount of H2O2 is usually detected by measuring the 
current during the oxidation reaction in equation (2). GOx carried a negative charge 
normally immobilized by physically onto nanostructured metal oxide films fabricated by 
solution based chemistry or physical methods. These metal oxides with nanostructure could 
provide large surface to volume ratio and increased surface activity, making their unique 
advantages over other conventional materials for enzym immobilization and signal 
transduction. They could keep activity of enzyme due to the desirable microenvironment 
and enhance the direct electron transfer between the enzyme’s active sites and the electrode. 
It has been reported that the glucose biosensor based on nanostructured metal oxides has a 
high sensitivity, selectivity and fast response with low detection limit for hydrogen peroxide 
as compared to the other conventional materials, as discussed in the following reports. 
Kumar et al., (2008) have collected the applications of nanostructured ZnO for construction 
of electrochemical glucose biosensors, which are successfully applied in the development of 
a new glucose sensing platform for electrochemical glucose detection. As discussed earlier, 
nanostructured metal oxide platform possess several unique advantages such as high 
specific surface area, nontoxicity, chemical stability, electrocatalytic activity, and high 
electron communication features. The large specific surface energy and high electron 
communication features of the nanosized ZnO enhanced the electrochemical sensitivity of 
biomolecular reaction and rapid response with low detection limit. Nanosize metal oxide 
enhanced electrochemical sensitivity is based on the discovery that immobilized metal 
membranes either as a continuous film, particles, colloid or monolayer significantly 
amplifies the electrochemical signals following molecular recognition at enzyme electrodes. 
Wang and his co-workers (2006) synthesized ZnO nanocomb by vapor phase transport 
method to immobilization of GOx for sensitive detection of glucose. The electron transfer 
pathways between immobilized enzyme (GOx) molecules which are integrated with 
nanocomb ZnO. They suggetsted that, electrons are directly transferring from electrode to 
redox enzyme via nanosized ZnO nanocomb. The nanozied nanocomb provides a channel to 
communicate the electrons from enzyme to electrode surface. To understand of these 
pathways are very important to construct the nanostructured metal oxide based 
electrochemical enzymatic biosensors. The developed ZnO nanocomb glucose biosensor 
shows high sensitivity (15.33 ?A/cm2 mM) for glucose detection and high affinity of GOx to
glucose (the apparent Michaelis-Menten constant Kmapp = 2.19 mM) with low detection limit 
measured upto 0.02 mM. In another report, Wei et al., (2006) grows ZnO nanorods on 
standard gold electrode for use as an electrochemical biosensing interface at low potential 
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(+0.8V). Electrochemical characterization of the ZnO nanorod-GOx-modified system retains 
its bioactivity and can specifically catalyze the oxidation of glucose. Interestingly, it was 
found that the ZnO nanorods have high affinity with enzyme (GOx, the apparent Michaelis-
Menten constant Km = 2.9 mM) for higher loading of enzyme. This biosensor was highly 
reproducible sensitive (23.1 ?A cm?2 mM?1), selective and shows rapid response (5 s) toward 
glucose with a linear range covered from 0.01 to 3.45 mM of glucose and an experiment limit 
of detection of 0.01 mM. Zang et al., (2007) have immobilized GOx by physically and 
chemically onto ZnO nanowires for construction of high performance glucose sensor. The 
extended bioaffinity of enzyme with ZnO nanowires could be achieved by selecting the 
right metal oxide film thickness on the electrode surface, because in the presence of a thicker 
metallic layer, a diffusion barrier toward the glucose oxidation was observed. This effect 
produces the ease bioaffinity of glucose for the low loading of enzyme and avoiding the 
high detection limit of analyte. Moreover, this glucose sensor showed long term stability 
with the incorporation of the inorganic zinc oxide nanowire. Zhao et al., (2007) proposed 
new strategy for co-adsoprtion of GOx onto porous Co doped ZnO nanoclusters with an 
averaged particle size of 5 nm to construct a novel amperometric glucose sensing. 
Electrochemical characterization of the developed ZnO-based nanoclusters electrode shows 
nanoporous network structure, making them differ from undoped ZnO nanostructures and 
other low dimensional nanostructures. ZnO:Co nanoclusters-GOx system exhibited high 
electrocatalytic activity to impart high sensitivity(13.3 ?A/mA cm2), selectivity and low 
detection limit (20 ?M). 
Based on these electrocatalytic properties of the metal oxides, Li et al., (2001) applied porous 
nanocrystalline TiO2 for immobilization of GOx to electrochemically detection of glucose. 
Transmission electron microscopy, Infrared and Raman spectroscopy were employed to 
analyze the morphology of the material and interaction of the enzyme with nanocrystalline 
TiO2. The resulting biosensor shows rapid, stable and linear response in the concentration 
range of 0±3mM with apparent Michaelis-Menten constant Km of 6.08 mM. 
Umar et al., (2009) synthesized flower-shaped copper oxide nanostructured by simple low-
temperature hydrothermal process and used to fabricate highly sensitive amperometric 
glucose biosensor. They found the linear dynamic range from 0.01 to 10.0 mM with 
detection limit upto 1.37 ?M. The proposed glucose sensor exhibits reproducible sensitivity 
(47.19 ?AmM-1 cm-2) and fast response time less than 5 s. 
Ansari et al., (2008) have developed a simple, highly reproducible sensitive and selective 
method for electrochemical detection of glucose using by sol-gel derived nanostructured 
CeO2 film deposited onto gold electrode surface. The fabricated biosensor show linear 
amperomatric response (50–400 mg/dL) with low detection limit (12.0 ?M). Nanoporous 
sol-gel film provides higher loading and strong bioaffinity (Km = 13.55 ?M) of the enzyme to 
enhance the detection limit as well as shelf-life (12 weeks) of the bioelectrode. In another 
approach (Saha et al., 2009), similar group has developed nanoporous CeO2 film onto 
platinum electrode by pulse laser deposition method for immobilization of GOx to sensitive 
detection of glucose. Atomic force microscopy images were used to investigate the surface 
texture of the electrode surface before and after enzyme immobilization, which is porous in 
nature. The biosensor has linearity within the concentration range from 25–300 mg/dl.  
In order to explore applications of nanosized metal oxides for construction of 
electrochemical biosensors Yang et al., (2004) employed ZrO2/Chitosan nanoporous matrix 
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for adsorption of GOx to detect the glucose concentration. Electrochemical characterization 
demonstrated that chitosan membrane enhanced the adhesive ability to the electrode, which 
is increasing the enzyme affinity to the biometallic surface. The linearity of this biosensor 
was within the concentration range from 1.25 × 10?5 to 9.5 × 10?3M. This novel biosensor 
exhibited quite high response sensitivity (0.028 ?AmM?1) and low detection limit (1.0 × 
10?5M) useful for potential applications. In order to overcome the insolubility of the 
nonconducting biopolymer chitosan Kim et al., (2006) had employed Nafion to improve the 
adhesive ability as well higher enzyme loading. This bioelectrode show better stability for 
enzyme immobilization and detect the glucose concentration within the range of 0.03-15.08 
mM with a sensitivity of 3.40 ?A/mM and the detection limit of 0.037 mM.
Ansari et al., (2009) prepared sol–gel derived nanostructured tin oxide film onto indium-tin-
oxide (ITO) for glucose sensing. High bioaffinity of the enzyme (GOx) was observed to the 
sol-gel derived nanostructured tin oxide electrode which can be attributed to favorable 
conformation of GOx and higher GOx loading due to microenvironment of nanoporous sol–
gel derived Nano-SnO2 film. The proposed sensor was highly sensitive (2.687 
?Amg/dLcm2) and selective toward glucose sensing, which exhibits wide linearity 
concentration rage (10–300 mg/dL) and low detection limit (0.169 mg/dL). 
Another strategy was proposed to employed nanomaterials for construction of enzymatic 
biosensors for rapid, selective and highly reproducible sensitive detection of glucose 
concentrations from serum samples. Chen et al., (2008) have coupled the MnO2
nanoparticles with MWCNTs resulted in remarkable improvement of the electrocatalytic 
activity of the nanocomposite materials toward the electrode surface through synergistic 
effect. The proposed biosensor permits effective low potential amperometric detection. The 
biosensor exhibits excellent response performance to glucose with the linear range upto 28 
mM with a sensitivity of 33.19 ?AmM-1. In addition, chitosan was introduced into the MnO2
nanoparticles and electrochemically deposited on the electrod to immobilization of GOx for 
sensing glucose (Xu et al., 2004). Furthermore, the biosensor shows rapid response, high 
sensitivity, good reproducibility, long-term stability, and freedom of interference from other 
coexisting electroactive species. 
Another approach in the electrochemical sensor field concerns the assembling of a sensing 
platform based on the magnetic loading of ferrocene modified Fe3O4@SiO2 nanocomposite 
on electrode surface. The resulting magnetic nanocomposite brings new capabilities for 
electrochemical devices by combining the advantages of ferrocene and Fe3O4@SiO2
nanocomposite provides an alternative way for loading ferrocene on electrodes. 
Electrochemical measurements Indicated that ferrocene incorporated electrod exhibited 
higher electrocatalytic activity toward the redox processes of H2O2. The response for glucose 
was improve because of the presence of ferrocene in the nanocomposite electrode, higher 
sensitivity and extended linear range of response from 1.0 x 10-5 to 4.0 x 10-3 M with a 
detection limit of 3.2 ?M observed. Other glucose sensing applications of 
superparamagnetic iron oxide nanoparticles have been reported in literature (Wang et al., 
2006), such biosensor based on carbon nanotube (CNT)/Fe3O4 dispersed into chitosan, 
successfully used to detect glucose (Qu et al., 2007). It has been found that, CNTs enhanced 
the electroactive surface area for higher enzyme loading. Another report this group 
proposed polyaniline coated CNT/Fe3O4 nanocomposite for glucose sensing (Liu et al., 
2008). Due to the ability of carbon nanotubes to promote electron-transfer reactions, the high 
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conducting properties of polyaniline and the sensitivity of presented electrochemical 
glucose biosensors were remarkably improved. It was found that CNTs can promote the 
electroactive surface area and can accelerate the rate of electron transfer between the redox-
active enzyme and the electrode.
A novel approach have introduced for glucose sensing by Salimi et al., (2007). They found 
the excellent electrochemical performance of electrochemically co-deposited nickel oxide 
nanoparticles and GOx onto the glassy carbon electrode surface. The resulting biosensor 
showed strong adsorption of GOx to the nickel nanoparticles (the apparent Michaelis–
Menten constant of 2.7 mM), which improved the enzyme loading and detect the glucose 
concentration with wide concentration range from 30 ?M to 5 mM. Nickel nanoparticles 
facilitating the direct electron transfer between the active site of enzymes and surface of the 
electrodes. The corresponding detection sensitivity was 446.2 nA/mM. 
4.2 Cholesterol biosensors 
Cholesterol oxidase (ChOx) is most commonly used enzyme in the construction of 
cholesterol biosensor. Cholesterol oxidase is a flavin-enzyme (flavin-adenine-dinucleotide) 
that produces hydrogen peroxide according to the reaction. 
 Cholesterol + O2? 4-Cholesten-3-one + H2O2  (3) 
The structure of cholesterol oxidase reveals deeply buried active sites occupied by water 
molecules in the absence of its substrate steroids. Cholesterol oxidase is industrially and 
commercially important for application in bioconversions for clinical determination of total 
or free serum cholesterol in the serum samples. More recently, cholesterol biosensor based 
on physically cholesterol oxidase onto metallic oxide nanoparticle have been applied to 
determine the cholesterol concentration from the serum samples some of them are 
summarized here. Singh et al., (2007) revealed the effective applications of nanoporous ZnO 
film fabricated by rf sputtering method on gold electrode for cholesterol detection. The 
biosensor showed excellent linear sensing response to cholesterol with in concentration 
range from 25–400 mg/dl. In another report nanostructured ZnO film deposited onto ITO 
electrode via sol-gel chemical rout represented reproducible, highly linear response in a 
wide concentration range (5–400 mg/dl) and fast response time (10 s) to cholesterol(Solanki 
et al., 2009). The high sensitivity (0.059 ?A/mg dl?1 cm?2) and moderate detection potential 
(+0.8 V) led to cholesterol low detection limit of 0.5 mg/dl. In another approach (Khan et al., 
2008) these authors dispersed ZnO nanoparticles in chitosan matrix for film fabrication onto 
conducting electrode by selective immobilization of cholesterol oxidase to construct the 
cholesterol biosensor. ZnO-chitosan nanocomposite films deposited on ITO electrode 
surface were mechanically stable due to excellent film forming ability of chitosan. The 
resulting biocompatible nanocomposite of ZnO/chitosan has been applied as matrix to 
covalently immobilize cholesterol oxidase, considering that chitosan has abundant amino 
groups, exhibits excellent film-forming ability for the solubility in slightly acidic solution 
due to the protonation and insolubility in solution with pH above pKa 6.3. High sensitivity 
(1.41×10?4 Amgdl?1) with a wide linear concentration range from 5-300 mgdl?1 of cholesterol 
with a detection limit as 5mg dl?1 was achieved. This cholesterol biosensor can be used to 
estimate cholesterol in serum samples. An attractive electrochemical protocol for measuring 
cholesterol based on ZnO nanoparticles grow at low temperature has been proposed by 
Umar et al., (2009). The novelty of this work concerns the observed electro-catalytic activity 
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of the ZnO-ChOx based nanocomposite bioelectrode demonstrating the ultra sensitivity for 
cholesterol sensing at a low potential and at higher current values. These optimized 
nanocomposite electrodes showed significantly better performance than those obtainable 
from flower shaped ZnO nanostructured (used here for comparison) in terms of linear range 
of concentration (0.001–0.5 ?M), low detection limit (0.00037?M), higher sensitivity (23.7 ?A
?M cm-2) ) and response time of 5 s. Finally, an excellent amperomatric response was 
measured at low temperature synthesized ZnO nanoparticles bioelectrode might be due to 
synthesized procedure as well as particle size effect on the matrix performance. 
Sol-gel derived nanostructured CeO2 film had been applied to immobilization ChOx for 
cholesterol sensing. Electrochemical signal of cholesterol concentration was linear in a wide 
range from 10–400 mg/dL and high sensitivity 2.08 mA (mgdL-1 cm-2). A low value of 
Michaelis–Menten constant (Km) was achieved 2.08 mM indicates strong ChOx affinity to 
cholesterol and no interference was found in the presence of cholesterol (Ansari et al., 2008). 
Chitosan as a biocompatible, nontoxic and nonconducting natural biopolymer applied in 
biosensor. Chitosan has strong adhesive ability to the substrate to improve the enzyme 
adsorption on the substrate surface. Tin oxide nanoparticles introduced into the chitosan 
matrix enhanced the electrocatalytic activity of the biopolymer for sensitive cholesterol 
detection. High linear response was measured over the concentration range of 10 – 400 
mg/dL with low detection limit of 5 mg/dL. Good stability and reproducibile sensitivity 
(34.7 ?A/mg dL-1 cm-2) to cholesterol detection within response time 5 s (Ansari et al., 2009). 
Kouassi et al.,(2005) have studied the activity of cholesterol oxidase immobilized on 
magnetic nanoparticles via carbodiimde chemistry. The enzyme activity was well preserved 
upon binding onto the nanoparticle when subjected to thermal and various pH conditions. 
Kinetic studies showed a significant improvement in magnetic nanoparticles bound 
cholesterol oxidase owing to the large surface area and high chemical and thermal stability 
of magnetic nanoparticles, which enhanced the electrocatalytic activity of the 
nanocomposite. 
4.3 Hydrogen peroxide biosensors 
Sensitive and accurate determination of a small quantity of H2O2 is of great importance, 
because H2O2 is not only a byproduct of several highly selective oxidases, but also an 
essential mediator in biology, medicine, industry, and many other fields. Different 
configurations for the design of the H2O2 biosensors have been reviewed. In fabrication of 
H2O2 biosensor, there are two major issues to realize the application of electrochemical 
technique. First, the key process is to retain the biologic activity of the redox protiens (HRP, 
myoglobin, hemoglobin, cytochrom C etc.) immobilized on the electrode surface in its native 
status. Another key factor is to electrically connect redox protiens with the electrode surface, 
which can provide a pathway of electron transfer between the redox center of protienes and 
the electrode surface. The simplest method is direct adsorption of native enzyme on the 
electrode surface for direct transferring of electron to the electrode. In order to fabricate 
sensitive and selective biosensor a variety of materials have been employed to modify the 
electrodes as a bridge of electron transfer between the redox center of enzymes and the 
electrode surface. 
Some metal oxide nanoparticles have been extensively used in bioaffinity sensors for 
immobilized heme proteins to detect the H2O2. Because, nanometer size materials gives rise 
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to high reactivity and other beneficial physical properties (electrical, electrochemical, optical 
and magnetic). Furthermore, direct electron transfer ability of the nanosized metal oxide 
made them able to function as biomimic membrane material to fix and modify proteins. The 
direct electrochemical responses of heme-protien have been achieved on the nanostructured 
metal oxide film. Many proteins have been employed to construct the potential H2O2
biosensors, such as HRP, cytochrome c, myoglobin, and hemoglobin, are capable of 
reducing H2O2 electrocatalytically. (Zhu et al., 2007; Liu et al., 2005; Zhao et al., 2006; Lu  et 
al., 2008; Duan et al., 2008; Xiang  et al., 2009). The improved electro-catalytic ability of the 
microperoxidase/ZnO nanoparticles co-modified electrode was measured, which greatly 
promote the direct electron transfer between the protein and electrode. The fast electron 
transfer between them beneficial to developing more sensitive H2O2 biosensors. Zhao et al., 
(2006) have employed nanoporous ZnO film deposited on graphite electrode to measured 
the electrocatalytic response of NO2- and H2O2 by immobilization of myoglobin.The 
entrapped myoglobin realized fast direct electron transfer with the electrode and displayed 
an elegant catalytic activity toward the reduction of hydrogen peroxide, nitrite, and 
trichloroacetic acid. This mediator-free biosensor showed linear response within the 
concentration range from 1.0 x10-5 to 1.8 x 10-4 mol L-1 and 4.8 x 10-6 to 2.0 x 10-4 mol L-1 and 
detection limit 4.0 x 10-6 mol L-1, 2.0 x 10-6 mol L-1 for NO2- and H2O2, respectively. Liu et al., 
(2005) used hydroquinone as a mediator for covalent immobilization of HRP enzyme for 
sensing of H2O2. The linearity of this fabricated biosensor was achieved of1.0 x10-5 to 1.8 x 
10-3M with a low detection limit 2.0 ?M. Good reproducibility sensitivity and stability was 
found retained about 78% upto 40 days. An enhanced sensitivity and selectivity of the 
Nafion mixed flower like ZnO-gold nanocomposite was measured, due to negatively 
charged gold nanoparticles provides a tunnel to transfer the electron from surface to 
electrode. On the other hand Nafion is a proton-conductive and biocompatible 
perfluorosulfonate linear polymer that exhibits excellent film-forming ability, which 
improves the proteins loading as well as communication of the electron on the matrix. 
Therefore, the immobilized protein on the substrate represented strong affinity (the 
apparent Michaelis–Menten constant Km =1.76mM). The biosensor have linear response in a 
wide concentration rang 1.5×10?5 to 1.1×10?3 M and detection limit is 9.0×10?6M (Xiang et al., 
2009). Lu et al., (2008) have developed porous nanosheet-based ZnO microspheres for the 
construction of direct electrochemical H2O2 biosensor. In this context, porous ZnO 
nanosheet permit a direct electron transfer between redox proteins and bulk electrode 
materials, allowing electrochemical sensing to be performed without using electron-transfer 
mediator. ZnO nanosheet efficiently improved the electron transfer rate between the analyte 
and the electrode surface with an apparent Michaelis-Menten constant (Km) of 143 ?M for 
the peroxide sensing. The developed biosensor displayed good performance for the 
detection of H2O2 and NaNO2 with a wide linear range of 1–410 and 10–2700 ?M,
respectively. Duan et al., (2008) prepared complex film containing of hemoglobin, nano 
ZnO, chitosan and nano Au to immobilized onto glassy carbon electrode for H2O2 sensing. 
Chitosan improved the film forming ability to the substrate and presence of gold 
nanoparticles enhanced electrocatalytic performance such as reproducible high sensitivity, 
linearity (1.94 x 10-7 - 1.73 x 10-3 mol L-1) and detection limit (9.7x 10-8 mol L-1) of the 
fabricated bioelectrode. 
To fabricate a highly reproducible sensitive and selective biosensor based on direct electron 
transfer from enzymes to the electrode surface. Recently, research activities have been 
directed toward combining the advantageous feature of sol-gel derived nanostructured TiO2
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film and the glassy carbon electrode fabrication. So-gel network is helpful to retain the 
biological activity on the matrix. These matrixes preserve the native stabilities and 
reactivities of biological macromolecules for sensing. Amperomatric biosensor provid a 
wide linear calibration range from 4.0×10–6 M to 1.0×10–3 M, with a detection limit of 8.0×10–
7 M (Xu et al., 2002; Yu & Ju et al., 2002). A similar strategy has been followed by Yu and Ju 
(2002) to immobilize HRP onto sol-gel modified porous titania matrix. Sol-gel network 
provide long term stability of enzyme in storage and showed strong bioaffinity to the 
substrate (Km = 1.89 ± 0.21 mM). The biosensor provided a wide linear calibration range 
(0.08 to 0.56 mM) with a detection limit of 1.5 ?M and high sensitivity (61.5 ?AmM-1) for 
monitoring of H2O2. The biosensor retained 80% of its original activity after two months of 
operation. The developed sol-gel TiO2 films represent good sensitivity and long term 
stability for enzymes immobilization, owing to its high surface area for enzyme loading and 
good biocompatibility. Some investigators have been fabricated titania nanoparticles to 
immobilize heme protein for H2O2 detection (Kumar et al., 2008; Zhao et al., 2008; Lo et al., 
2008; Curulli et al., 2007). They suggested that the nanoparticles promote the electron 
transfer rate efficiently from enzyme to the electrode surface. Titania nanotubes exhibited 
superior biosensing capabilities towards H2O2. Owing to their large surface area, titania 
nanotubes provides friendly microenvironment for enzyme loading and improve the 
stability of the entrapped enzymes (the apparent Michaelis-Menten constant Km = 140??M). 
Heme proteins (myoglobin) in these films facilitated relatively faster electron transfer (kET = 
86 ± 7 s-1) and catalytic activity than that between myoglobin in the solution and bare 
electrodes ((Liu et al., 2005). Most studies reported (Topoglidis et al., 2000) in literature are 
based on immobilization of protein which were focused on layered or mesopore structured 
materials due to their higher specific surface area.  They found that titania nanotubes based 
biosensor exhibited high sensitivity to H2O2 and low detection limit (0.6 ?M). Xiao et al., 
(2007) have analyzed the electrocatalytic ability of HRP-TiO2 nanotube arrays, they 
possessed appreciably different sensitivities to H2O2 due to their different conductivity. 
They suggested that TiO2 nanotube arrays demonstrated the best sensitivity for H2O2 in the 
range of 10-5–3x10-3 M at pH 6.7 and at a potential of -600 mV. Titania nanotubes containing 
thionine were electrochemically deposited on Ti substrate to immobilization of HRP for 
H2O2 sensing. The constructed biosensor has linear response to the H2O2 concentration from 
1.1x 10-5 to 1.1 x 10-3 M and detection limit was optimized as 1.2 x 10-6 M (Liu et al., 2005). 
The sensor was fabricated by electrochemical deposition of nanotubular TiO2 and platinum 
nanoparticles at very low potential (+ 0.3 V) for amperomatrically detection of H2O2. They 
found amperomatric signals were linear that is proportional to hydrogen peroxide 
concentration in the range 4 x 10-6 to 1.25 x 10-3 M and detection limit of the sensor was 4.0 
?M (Cui et al., 2008). Zhang et al., (2004) have presented that TiO2 nanoparticles exhibited 
better biosensing capabilities towards H2O2. The sensor was fabricated by casting the 
mixture of HRP solution and aqueous titanium oxide nanoparticles dispersed onto pyrolytic 
graphite electrode. They found that the constructed biosensor presented a better 
amperomatric response at 0 V with a larger sensitivity and a wider linear range. Viticoli and 
his co-workers (2006) have developed third-generation biosensors based on TiO2 nano-
structured films. They found that, functionalised TiO2 thin films deposited on Si substrates 
exhibited high sensitivity, low detection limit (~10-6 M) and fast response time to H2O2.
 Liu et al., (2003) have reported amperomatric biosensor based on sol-gel derived 
nanoporous ZrO2 for H2O2 sensing. The resulting biosensor exhibited high sensitivity (111 
?AmM?1) for H2O2 over a wide concentration range from 2.5×10?7 to 1.5 × 10?4 mol l?1, fast 
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response (10 s). This biosensor was stabile over 3 months. Liu et al., (2004) measured the 
direct electrochemistry and thermal stability of hemoglobin immobilized onto nanometer-
sized ZrO2 modified pyrolytic graphite electrode. They suggested that nanometer-sized 
ZrO2 and dimethyl sulfoxide accelerate the electron transfer rate between hemoglobin and 
the electrode. The modified electrode showed a high thermal stability up to 74oC. The 
response was linear for H2O2 over the concentration ranging from 1.5 to 30.2 ?M with a 
detection limit of 0.14 ?M. Zong et al., (2007) reported reagent less biosensor based on 
hemoglobin modified zirconia nanoparticles for H2O2 detection. They examined the 
enzymatic activity with the zirconia nanoparticles that is strongly co-adsorbed to the surface 
nanoparticles and showed an excellent electrocatalytic activity to the reduction of H2O2.
They found fast electron transfer (electron transfer rate constant = 6.46 s?1) between the 
surfaces adsorbed enzyme (hemoglobin) and electrode. A wide linear concentration range 
for H2O2 was achieved 0.8 to 132 ?M and low detection limit 0.12 ?M. This research group 
proposed another strategy for H2O2 sensing by co-adsorption of myoglobin on zirconia 
nanoparticles enhanced grafted collagen hybrid composite (Zong et al., 2007). Grafted 
collagen provided a good matrix for protein immobilization and biosensing preparation. 
This method was useful for monitoring H2O2 in practical samples with the satisfactory 
results. They examined that ZrO2- grafted collagen matrix accelerate the electron transfer 
between Mb and the electrode with a surface-controlled process and an electron transfer rate 
constant of 3.58±0.35 s?1 at 10–500mVs?1. The linearity of the biosensor to H2O2 concentration
was from 1.0 to 85.0 ?Mwith the limit of detection of 0.63 ?M. Tong et al., (2007) applied 
HRP-ZrO2 nanocomposite deposited by electrochemical method on gold electrode for 
fabrication of sensitive electrochemical biosensor. Under optimized conditions such as pH 
and potential, biosensor exhibited linear amperomatric response for H2O2 in a wide 
concentration range from 0.02 - 9.45mM with a detection limit of 2 ?M. In another approach 
HRP was covalently immobilized on DNA/electrodeposited ZrO2/modified, gold electrode. 
They suggetsted that sandwich DNA provides a microenvironment for the immobilization 
of enzyme or protiens and promotes electron transfer between HRP and the electrode 
surface. The resulting biosensor (HRP–ZrO2/Au electrode) showed a linear response to 
H2O2 over a concentration range from 3.5 ?M -10 mM with a detection limit 0.8 ?M. The 
optimized bioelectrode represent excellent electrochemical performance such as sensitivity, 
reproducibility and response time for sensitive and selective detection of H2O2 in clinical 
samples (Tong et al., 2007). 
Magnetic nanoparticles are promising materials in fabrication of biosensors and bioreactors. 
Among magnetic nanoparticles, Fe3O4 nanoparticles are the most commonly used magnetic 
materials because of their good biocompatibility, strong superparamagnetic property, low 
toxicity and easy preparation. Iron oxide nanocomposites matrices have applied for covalent 
immobilization of heme proteins for sensitive biosensor device development. The sensitivity 
of the fabricated biosensors depends on the proteins immobilization procedure on the 
conducting electrode. Several immobilization procedures have been used for the enzyme 
immobilization on the nanomaterials electrode surface, through them can examine the 
electron transfer features of bioelectrode (Cao et al., 2006; Cao et al., 2003; Zhao et al., 2006; 
Zhang et al., 2007). The direct immobilization of redox protein or enzyme without mediator 
onto nanomaterials electrode surface has an advantageous procedure among them due to 
sensitive and selective detection of analyte. Studies of direct electrochemistry of protein or 
enzymes at electrodes serve as a basis for building electrochemical biosensors, enzymatic 
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bioreactors, and biomedical devices. Cao et al., (2006) investigated the direct 
electrochemistry of heme protein immobilized on Fe3O4 nanoparticles for highly 
reproducible sensitive H2O2 sensing. This approach simplified such devices without using 
mediators and is of particular significance for fabrication the third generation biosensors. 
Direct electrochemical study can also establish a model for mechanistic studies of electron 
transfer between enzymes in biological systems. The direct electron transfer of haemoglobin 
by immobilizing it on Fe3O4 nanoparticle multilayer films was investigated (Zhao et al., 
2006). The good sensitivity and long-term stability of the biosensor was measured indicating 
that the direct immobilization of heme proteins on Fe3O4 matrix is a promising substrate for 
hydrogen peroxide sensing. These films were constructed on several conductive bases 
(glassy carbon electrode, ITO glass, and Al foil) by first electrodeposition of chitosan/Fe3O4
thin films and then a layer-by-layer assembly using phytic acid and chitosan/Fe3O4. To 
enhance the sensitivity of the biosensor and minimize the problems of mediators, Zhao et 
al., (2005) fabricated a H2O2 biosensor based on Prussian blue modified magnetic 
nanoparticles. The synthesized nanoparticles catalyze the reduction of H2O2 without 
mediator. Crosslinked glutaraldehyde chemistry have used to covalent immobilization of 
hemoglobin onto carbon-coated iron nanoparticles for sensitive amperomatric hydrogen 
peroxide sensing. The resulting nanocomposite provides a shelter for the enzyme to retain 
its bioactivity under considerably extreme conditions, and the iron nanoparticles in the 
biocomposite offer excellent affinity to enzyme. The electrocatalytic response exhibited a 
linear dependence on H2O2 concentration in a wide range from 3.1 mM to 4.0 mM with a 
detection limit of 1.2 mM (Zhang et al., 2007). Hrbac et al., (2007) have reported 
amperomatrically H2O2 detection by adsorption of heme protein on iron oxide nanoparticles 
(hematite, maghemite, amorphous Fe2O3, ?-Fe2O3 and ferrihydrite) deposited carbon past 
electrode. Prussian blue modified iron oxide nanopartilces based electrode exhibited 
excellent amperomatric response towards detection of hydrogen peroxide such as linearity 
(8.5 mM) and reproducible sensitivity, response time (<3 s) with detection limit was 2 x 10-5
M. HRP was immobilized on gold modified nanoporous silica based magnetic 
microparticles matrix for H2O2 sensing. The analytical performance of the resulting 
biosensor was characterized by electrochemical techniques. The resulting bioelectrode 
provided a linear response to H2O2 over a concentration range comprised between 5 x 10-7-
1.3 x 10-4 M with a detection limit of 4 x 10-7 M (Elyacoubia et al., 2006). Lin et al., (2005) have 
fabricated a CH-Fe3O4 nanocomposite modified glassy carbon electrode for determination of 
H2O2. The linearity range was obtained as 4-5 mM with detection limit 7.6 and 7.4 ?mol/L 
and biosensor was stable up to 9 months. 
Attempts have been made to applied sol-gel tin oxide matrix to heme proteins 
immobilization for rapid detection of H2O2 (Jia et al., 2005a&b; Topoglidis et al., 2003). Sol-
gel derived bioelectrodes showed better analytical performance in respect to other 
conventional method prepared bioelectrodes, such as faster response, wider detection range, 
lower detection limit, better affinity, higher enzyme loading, simpler operation and better 
storage stability for electrochemical detection of hydrogen peroxide due to the introduction 
of the collagen to form well-distributed porous three-dimensional structure. The linear 
concentration range of the biosensor was from 0.01-0.25 mM. (Jia et al., 2005a). The smaller 
Km (the apparent Michaelis-Menten constant value Km = 0.345 mM) value was measured 
means that the immobilized HRP onto SnO2 film possesses higher enzymatic activity, and 
exhibits higher affinity to H2O2. (Jia et al., 2005b) 
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Ansari et al., (2009) have applied nanostructured CeO2 film deposited onto indium-tin-oxide 
(ITO) glass substrate by solution casting process to immobilization of HRP via 
physiosorption technique for H2O2 reduction. The designed biosensor exhibited acceptable 
stability (5 weeks), wide linearity range (1.0–170 ?M) for H2O2 concentration, long-term 
shelf life and good reproducibility. A similar approach has been used to fabricate an 
amperometric hydrogen peroxide biosensor based on electrochemically deposited 
PANI/CeO2 nanocomposite films onto ITO electrode (Ansari et al., 2009). Polyaniline is 
used to modify the electrocatalytic activity of the CeO2. Polyaniline CeO2 nanoparticles 
served as a linker for rapid detection of H2O2. This property results in an electrocatalytic 
activity of the immobilized HRP to the reduction of H2O2, used for preparation of H2O2
sensors. The proposed biosensor showed excellent performance for H2O2 sensing such as 
sensitivity (159.6 nA/mM), detection limit (50 mM), long time stability (8 weeks) and fast 
response time. 
MnO2 nanoparticles and dihexadecyl hydrogen phosphate composite film have been used 
as an enzyme (HRP) immobilization matrix with enhanced activity and stability (Yao et al., 
2006). Manganese dioxide (MnO2) nanoparticles have been proved to be a catalytic 
substance to promote the decomposition of H2O2 to O2. The MnO2nanoparticles can retain 
the bioactivity of proteins to a large extent and accelerate the electron transfer between 
proteins and electrodes. The biosensor was optimized under optimal conditions which 
showed high sensitivity (2.66×105 ?AM?1cm?2) wide linear concentration range of 1.2×10?7–
2.0×10?3 M with a substantially low detection limit of 8.0×10?8 M.
Antimony oxide bromide (AOB) nanorods dispersed in chitosan have been applied for H2O2
biosensor (Lu et al., 2006). Chitosan is a biopolymer has an excellent film-forming ability 
and biocompatibility. The solubility of antimony oxide bromide nanorods in these 
biopolymers facilitates the construction of electrochemical biosensing platform. AOB 
nanorods mixed with chitosan were placed on the surface of a glassy carbon electrode 
results in a robust AOB-chitosan film, which facilitates the electrooxidation of NADH. The 
fabricated biosensor has a linear response from 1–121 ?M with a correlation coefficient of 
0.993. They found the bioelectrode displayed good sensitivity (1.44mAcm-2M-1) and 
reproducibility, wide linear range, low detection limit, fast response and excellent long-term 
stability. 
4.4 Urea biosensor 
Zinc oxide nanoparticles have been introduced into the chitosan solution to immobilization 
of urease enzyme for urea sensing. Chitosan film containing ZnO have been deposited onto 
ITO electrode for covalent immobilization of urease. The possibility to combine both 
properties, such as the higher surface area and electrocatalytic effect exhibited from ZnO, 
with the surface adhesive properties of chitosan can be used to manipulate and control the 
analytic signal in the presence of a specific substrate. The marked electrocatalytic activity 
toward urea permits effective low-potential amperometric biosensing. The optimum 
configuration for biosensors has allowed highly sensitive (0.13 ?A/mM cm-2), fast response 
time (10 s), and highly selective (0% interference of at glucose (5 mM), ascorbic acid (0.05 
mM), uric acid (0.1 mM), cholesterol (5 mM), and lactic acid (5 mM) at maximum 
physiological levels) analytes quantification with lower detection limit (3 mg/dl), higher 
reproducibility and long shelf life upto 3 month (Pratima et al., 2009). Hubalek et al., (2007) 
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have developed nickel nanoelectrode to determined the urease by electrochemical and 
votammetry methods. Ansari el al. (2009) prepared sol-gel-derived titanium oxide–cerium 
oxide (TiO2–CeO2) nanocomposite film deposited onto ITO-coated glass substrate for urea 
sensing. A biosensor was fabricated by casting the mixture of enzymes (urease and 
glutamate dehydrogenase) on nanobiocomposite for determination of urea concentration. 
The performance of the sensor showed sensitive determination of urea with a linear range 
from10–700 mg/dL, response time of 10 s, sensitivity as 0.9165 ?Acm-2mM-1, detection limit 
of 0.166 mM with negligible interference from physiological levels of uric acid, cholesterol, 
glucose, and ascorbic acid (Ansari et al., 2009). Recently, Zhang et al., (2004) reported the use 
of uricase immobilized ZnO nanorods dispersed into Nafion placed onto glassy carbon 
electrodes (GCE) as a new platform for developing enzymatic biosensors. They found that, 
ZnO nanorods derived electrode retained the enzyme bioactivity and enhance the electron 
transfer between the enzyme and the electrode. In the presence of an electron mediator 
electrode showed high affinity (Km = 0.238 mM) to the electrode and excellent 
electrocatalytic response such as linearity dependence on the uric acid concentration 
ranging from 5.0×10?6 to 1.0×10?3 mol L?1 with a detection limit of 2.0×10?6 mol L?1.
Functionalized multiwalled carbon nanotubes (MWCNTs) mixed with tin oxide has applied 
for the fabrication of reagentless amperomatric uric acid biosensor. MWCNTs have used as 
an electron promoter which efficiently enhanced the electron transfer rate between the 
enzyme and electrode surface. This biosensor exhibited a linear dependence on the uric acid 
concentration over the range from 1.0 x 10-7 to 5.0 x 10-4 mol L-1 with little ascorbic acid 
interference in physiological level (Zhang et al., 2005). In a novel strategy based on titanate 
nanotubes have developed by Liu et al., (2006) for measuring the biosensing properties 
amperomatrically. Titania nanotubes have deposited onto glassy carbon electrode for 
selective detection of dopamine in the presence of ascorbic acid and uric acid. The linear 
calibration curve for dopamine was observed over the concentration range 0.1–30 lM in a 
physiological solution that contains 0.1 mM AA and 0.3 mM uric acid. 
4.5 Choline biosensor 
Choline is also an important component of phospholipids (lecithin and sphingomyelin), 
which is required for the synthesis of the neurotransmitter acetylcholine precursor. Choline 
found in central and peripheral nervous systems of mammals. Therefor, direct monitoring 
of choline from the serum samples by enzyme-based biosensors have emerged as most 
promising field. A number of enzyme electrodes, with immobilized ChOx, were reported 
for choline determination based on the detection of liberated H2O2. Amperometric 
biosensors based on the immobilization of bi-enzymes HRP and ChOx for the determination 
of choline were also reported. In the single enzyme system as following Eq.,  
 choline  +  O2 ?  betaine aldehyde +  H2O2   (4) 
In the presence of oxygen, choline is converted by ChOx, producing H2O2. Then H2O2 can be 
subsequently detected with the help of conducting materials electrodes. Bai et al., (2007) 
have used MnO2 nanoparticles based electrod for sensitive determination of choline 
concentration. MnO2 nanoparticles modified electrode in the presence of H2O2 exhibited bi-
direction electrocatalytic ability toward the reduction/oxidation of H2O2. The amperomatric 
signal was linear of choline chloride in the concentration range 1.0 x 10-5 – 2.1 x 10-3 M and 
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no obvious interference from ascorbic acid and uric acid was observed in physiological level 
(Bai et al., 2007). Similar nanocomposite material–based on electrochemical H2O2/choline 
biosensors have been developed by modifying a glassy carbon electrode with chitosan and 
three different dimensionality (amorphous MnO2 nanoparticles, ?-MnO2 nanoparticles, and 
?-MnO2 nanowires)/GCE film (Bai et al., 2008). They found the biocatalytic activity of the 
three different nanostructures for the determination of choline amperomatrically in the 
following order: amorphous MnO2 > ?-MnO2 > ?-MnO2. Due to the different specific 
surface areas of the nanomaterials, the amount of enzyme entrapped on MnO2 electrode 
surface is different that is depend on crystalline structures, and dimensionality of the 
materials. Therefor, the biosensors based on ?-MnO2 nanoparticles and ?-MnO2 nanowires 
represent excellent electrochemical response for amperometric detections of choline chloride 
in the linear ranges of 2.0×10-6-5.8×10-4 M and 1.0×10-6-7.9×10-4 M with the detection limits of 
1.0 and 0.3 ?M, respectively. For sensitive determination of choline and acetylcholine, 
bovine serum albumin and choline oxidase co-adsorbed electropolymerized poly (N-
acetylaniline) film/sol–gel ZnO membrane prepared onto Pt electrode. They suggested that 
BSA improved the stability and activity of the enzymes on sol-gel derived electrode. The 
resulting biosensors at an applied potential of +0.6V exhibited fast response, expanded 
linear response in the concentration range of 1.0×10?6 to 1.5×10?3M to acetylcholine with a 
detection limit of 6.0×10?7 M and a linear response range up to 1.6×10?3 M to choline with a 
detection limit of 5.0×10?7 M (Yang et al., 2005).
4.6 Phenol biosensors 
Phenolic compounds are very toxic, showing adverse effects on animal and plants which are 
often exist in the wastewaters of many industries. Therefore, the identification and 
quantification of such compounds are very important for environment monitoring. Li et al., 
have developed phenolic biosensor based on ZnO nanoparticles. ZnO nanoparticles 
dispersed chitosan nanocomposite provid an advantageous microenvironment in terms of 
its favorable isoelectric point for tyrosinase loading and the immobilization of tyrosinase 
enzyme. They suggested that nanocomposite electrode retained its activity to a large extent 
and facilitated the electron communication on the electrode surface at a large extent.The 
resulting biosensor has 95% of steady-state current within 10 s, and the sensitivity was 182 
?A mmol-1L. The linear range for phenol was determined from 1.5 x 10-7 to 6.5 x 10-5 mol L-1
with a detection limit of 5.0 x 10-8 mol L-1(Li et al.,). Another approach mediator free sol-gel 
derived ZnO matrix has used for phenol sensing. The performance of the developed 
biosensor was such as linearity (1.5 x 10-7 to 4.0 x 10-5 mol L-1), sensitivity (168 ?Ammol L-1), 
detection limit (8.0 x 10-8 mol L-1) fast response time long term stability (2 weeks) (Liu et al., 
2005). Zhang et al., (2003) have applied hybrid sol-gel titania matrix for the construction of 
sensitive mediator free tyrosinase biosensor. Under optimum pH titania retained the 
tyrosinase activity and stability attached on to the surface of a glassy carbon electrode. The 
reproducible high sensitivity 15.78?A?M?1cm?2 and low detection limit 1 × 10?8 M was 
achieved for monitoring phenols.
To determination of pesticides in vegetable samples Yang et al., (2005) have proposed an 
acetylcholinesterase biosensor based on nanoparticles ZrO2/chitosan. Acetylcholinesterase 
was covalently immobilized onto ZrO2/chitosan nanocomposite matrix. The experimental 
conditions were optimized showed that pesticides inhibit the activity of enzyme with an 
effect of decreasing of oxidation current. The linear response was achieved  from 9.90 x 10-6
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to 2.03 x 10-3 M, 6.6 x 10-6 to 4.4 x 10-4 M, 1.0 x 10-8 to 5.9 x 10-7 M and 8.6 x 10-6 to 5.2 x 10-4 M 
acetylcholinesterase, phoxim, malathion and dimethoate, respectively with the detection 
limit of 1.3 x 10-6 M for phoxim. The proposed samples have used to determine pesticides in 
real vegetable samples.
A chitosan film containing MnO2 nanoparticles was electrodeposited on glassy carbon 
electrode to covalent immobilization of lactate oxidase for the determination of lactate 
concentrations. Due to their excellent film-forming ability and strong adsorbability of 
enzyme on the nanocomposite electrode surface. They found linear response to lactate in the 
range of 0.020–4.0 mM, with reproducibile high sensitivity (3.98 ?Acm?2 mM?1) and long-
term stability (Wang et al., 2006).
Umar et al., (2009) have employed ZnO nanowires coated onto gold electrode for ultra-
sensitive determination of hydrazine by amperometrically. The proposed biosensor has 
reproducible high sensitivity 12.76??Acm?2 nM?1, low detection limit, 84.7 nM, fast response 
time less than 5 s, good linear range from 500 - 1200nM with correlation coefficient of R =
0.9989.
Magnetic core–shell (Fe3O4–SiO2) nanoparticles modified film onto the surface of carbon 
past electrode for covalently immobilization of Laccase enzyme, done by chemical cross-
linking with glutaraldehyde and free aldehyde groups to determined the hydroquinone 
concentration. Magnetic core–shell nanoparticles provide microenvironment for retaining 
the bioactivity of laccase. The linear range for hydroquinone was determination as 1×10?7 to 
1.375×10?4 M, with a detection limit of 1.5×10?8 M and 95% steady-state current was reached 
within 60 s (Zhang et al., 2007). 
5. Conclusions  
The unique electrocatalytic properties of the metal oxides and the ease of metal oxide 
nanostructured fabrication make them extremely interesting materials for electrochemical 
enzymatic biosensor applications. The application of nanostructured metal oxides in such 
sensing devices has taken off rapidly and will surely continue to expand. This article 
provides a review on current research status of electrochemical enzymatic biosensors based 
on various new types of nanostructured metal oxides such as nanotubes, nanorods, 
nanobelts, and nanowires. These nanostructured-based amperomatric biosensors represent 
a powerful detection platform for electrochemical enzymatic biosensors. It is a crucial 
requirement of consumers to design simple, affordable, reliable and portable 
electrochemical biosensors, which provides novel key features, including high sensitivity, 
selectivity, fast response, low detection limit, fast response with minimum intereferences 
from bulk species and could operate at low potential. Such electrochemical biosensors could 
be useful for diagnosing and monitoring infectious disease, monitoring the pharmokinetics 
of drugs, detecting cancer, and disease biomarkers, analyzing breath, urine and blood for 
drugs of abuse. It is only a matter of time before such protocols are used for routine 
diagnostic applications. 
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1. Introduction      
Carbon nanotubes (CNTs) have been the focus of considerable studies since their discovery 
by Iijima (Iijima, 1991). CNTs are considered to be formed by the folding of graphene layers 
into carbon cylinders. They are of two distinct structural types: single-walled carbon 
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs). A SWCNT is a single 
shell extending from end to end with 1.3-2 nm tube diameter. A MWCNT is composed of 
several coaxial shells, each formed with rolled graphite sheets, with diameters varying from 
2 to 50 nm and the distance between sheets being about 0.34 nm. CNTs have many new 
applications to electronic devices, such as field-effect transistors (Maki et al., 2006; Ohnaka 
et al., 2006) and gas sensors (Ueda et al., 2006; Wongwiriyapan et al., 2005), because of their 
unique electronic properties, unique geometric structure, high mechanical strength, and 
high chemical stability.  
Recently, amperometric biosensors using CNTs have been increasingly reported. The typical 
structure of a CNT-based amperometric biosensor is the combination of biomacromolecules 
(e.g., enzymes) and CNTs in the vicinity of the electrode. Because of the well-defined 
nanostructure of CNTs, a good connection between CNTs and enzymes can be obtained. 
CNTs also enhance the electron transfer from reaction center of enzyme to electrode. 
Therefore, high performance of biosensor characteristics can be realized. Many strategies 
has been reported: the treatment of CNTs with nitric or sulfonic acid in order to introduce 
the chemically active functional groups (Liu et al., 2005a; Gooding et al., 2003; Azamian et 
al., 2002; Kim et al., 2006; Li et al., 2005; Liu et al., 2006), which enables subsequent 
modification. Another strategy is the dispersion of CNTs with a binder such as Nafion (Tang 
et al., 2004; Tsai et al., 2005; Hrapovic et al., 2004; Lee et al., 2007), Teflon (Wang & 
Musameh, 2003), sol-gel (Gavalas et al., 2004; Salimi et al., 2004; Yang et al., 2006; 
Kandimalla et al., 2006), poly(methyl methacrylate) (PMMA) (Rege et al., 2003), redox 
hydrogel (Joshi et al., 2005; Wang et al., 2006), poly(dimethyldiallylammonium chloride) 
(Zhao & Ju, 2006; Yan et al., 2007), chitosan (Liu et al., 2005b; Rivas et al., 2007), and 
electropolymerized film (Tsai et al., 2006; Pan et al., 2005). However, these methods require 
that enzymes and other biomolecules receive careful treatment in order to retain their 
tertiary structure. Moreover, when using such wet processes, it is difficult to control the 
nanoscale fabrication. A method where the CNTs are directly treated by plasma has recently 
been reported (Khare et al., 2005; Khare et al., 2004; Khare et al., 2002; Plank et al., 2005). The 
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advantage of this modification is that chemically active functional groups, such as amino 
and carboxyl groups can be easily introduced on the side wall and/or edge of the CNTs 
without contamination. Also, our group proposed an amperometric biosensor based on a 
plasma polymer (Muguruma & Karube, 1999; Muguruma et al., 2000; Muguruma et al., 
2005; Muguruma & Kase, 2006; Muguruma et al., 2006).  
With this in mind, the combination of the PP and/or plasma modification has been explored 
with a CNT-based amperometric biosensor application. Here we choose a glucose oxidase as 
a model of enzyme family because of the most popular amperometric biosensor. The 
proposed strategy not only simplifies the configuration of the CNT-based biosensor 
composed of plasma polymer (PP) and the enzyme, but also provides high performance 
biosensor characteristics, such as high sensitivity, high selectivity toward targets, and 
reliability. 
2. Plasma polymerization for biosensor design 
In this section, the methods of preparation and the properties of plasma polymer are briefly 
described (Yasuda, 1985). The plasma polymer (PP) is achieved in a glow discharge or 
plasma in the vapor phase. The resulting polymer was directly deposited onto the substrate 
as a thin film. The typical apparatus for plasma polymerization is shown in Figure 1. The 
monomers are vaporized and filled into the chamber. Gas monomers and liquid monomers 
can be supplied by bombs and reservoirs, respectively. The starting monomer gases may not 
contain the type of functional groups (e.g. double bond) normally associated with 
conventional polymerization. The pressure and flow rate are appropriately controlled. The 
electromagnetic power is supplied to generate active species for polymerization and glow 
discharge occurs. Inductive coils or capacitance are used for the power supply and a radio 
frequency (RF) of 13.56 MHz is industrially available. The thin film is deposited onto the 
surface of substrate with a typical deposition rate of 10-100 nm/min. The parameters for 
polymerization are discharge power and frequency, monomer structure, reactor type, flow 
rate of monomer, plasma pressure, substrate temperature and substrate position (Yasuda, 
1985). The properties of the film are attributed to the fact that the polymerization occurs 
with the participation of many active species in the plasma state. The structure of the 
ethylene plasma-polymerized films is, for example, different from that of polyethylene 
films. The latter consists of chains with a regular repeat unit whereas the former tends to 
form an irregular three-dimensional crosslinked network.  
Introduction of surface amino groups with plasma polymer is a common step in biosensor 
fabrication processes. The surface amino group has dual characteristics; one is 
hydrophilicity, which allows for dense loading of biological components onto the film 
surface, and the other is its behavior as a seed for subsequent chemical grafting, such as 
changing the surface properties and covalent bond immobilization to prevent leaching of 
immobilized biomaterials. Allylamine is the most popular monomer for providing surface 
amino groups. Allylamine PP has been used as a porous membrane modification for reverse 
osmosis applications, due to the hydrophilic nature of the polymer backbone (Bell et al., 
1975). Biomedical applications of allylamine PP were first reported by Muratsugu et al. 
(Muratsugu et al., 1991) in which the F(ab’)2 fragments of antibody proteins were densely 
immobilized on the surface of allylamine PP. Allylamine PPs were subsequently widely 
used in biomedical applications (Mahoney et al., 2004; Kurosawa et al., 2002; Basarir et al., 
2007; Zhang et al., 2003; Zhang et al., 2005). The PP surfaces of ethylenediamine (EDA) and 
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alkylamines have amino groups and have also been used in biomedical applications (Jung et 
al., 2006; Nakanishi et al., 1996; Wang et al., 2003). The resulting film is sometimes different 
from that of the original monomer structure, because the plasma polymerization process 
involves fragmentation and reorganization in the presence of highly energetic active species. 
Therefore, plasma control during the production of biomedical PPs is the central issue; for 
example, the acetonitrile PP surface (Hiratsuka et al., 2000) and surfaces prepared by plasma 
treatment of nitrogen (Everhart & Reilley, 1981), ammonia (Hollahan et al., 1969), and a 
mixture of N2/H2 (Meyer-Plath et al., 2003) gas have amino groups, despite the original 
monomers having no amino groups. Chemical derivative X-ray electron spectroscopy (XPS) 
surface analysis and infrared (IR) spectroscopy of acetonitrile have shown that surface 
nitrogen is present not only as amino groups, but also as other nitrogen-based functional 
groups, such as C–NH-C, C-N=N-C, –C=N-, and –CN (Hiratsuka et al., 2000; Muguruma, 
2008). The structure of the PP is characterized by highly branched and incompletely 
crosslinked aliphatic hydrocarbon backbone chains containing nitrogen atoms, and double 
bonds (C=C) are interspersed along the chains. 
In summary, characteristics of PP include (i) easily control of the thickness range from 
several ten nanometer to micrometer, (ii) processing that facilitates the wetness and charge 
control of the surface properties, (iii) good adhesion to the substrate, (iv) ability to protect 
against interferant agents, and (v) an affinity with biological components. Therefore, PPs are 
suitable for the interfacial design between a biological component (enzyme) and an 
electrode. 
3. Optimization for device fabrication 
3.1 Device fabrication procedure 
The preparation scheme is shown in Fig. 2. The device was formed on a 0.15-mm-thick glass 
substrate, with planar dimensions of approximately 50 × 50 mm2.  All the metal layers were 
sputter-deposited and patterned by a masking process. The glass slides used to make the 
thin film electrodes were boiled in a hydrogen peroxide/ammonia/water solution 
(approximately 1:1:8 by volume) for 1 h, and then rinsed with water and acetone. Au thin 
films were deposited using sputtering apparatus (VEP-1000, Ulvac Inc., Tokyo, Japan). A 40-
nm-thick Cr intermediate layer was used to promote the adhesion of the Au layer.  The 
dimension of the opening for the working electrode was 5×5 mm2.  
A plasma generator (VEP-1000, Ulvac Inc., Tokyo, Japan) was used to deposit a 6-nm-thick 
acetonitrile-PP (AN-PP) (first/lower PP) onto the sputtered Au electrode at 150 W and 
under a pressure of 0.6 Pa for a deposition time of 60 s. The CNTs were dispersed in a 1:1 
mixed solution of ethanol and phosphate buffer solution (20 mM, pH 7.4) in which the 
optimized CNT concentration was 0.75 mg mL-1. The CNT suspension was deposited 
dropwise onto the PP surface, and then dried in a vacuum oven. Subsequently, the CNT-
adsorbed surface was treated with nitrogen plasma under the following parameters: power, 
100 W (optimized); flow rate, 15 mL min-1; pressure, 3 Pa; exposure time, 60 s.  The enzyme 
was then added by dropping an aliquot of GOx (10 mg mL-1) in phosphate buffer (20 mM, 
pH 7.4) onto the film. One hour later, the device was washed with water. Finally, the 
enzyme-adsorbed surface was overcoated with a second AN-PP (6 nm thickness), using the 
same deposition parameters as that for the first PP. The devices were stored in a refrigerator 
at 4 °C until use.
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Cyclic voltammetry was performed using an electrochemical analyzer (Model 701A, ALS 
Instruments, West Lafayette, IN), with a three-electrode configuration. A reference electrode 
(Ag/AgCl, RE-1C) and a counter electrode (platinum wire) were purchased from 
Bioanalytical Systems Inc. Electrochemical measurements were carried out in a 10 mL vessel 
at ambient temperature (20±1 °C). A phosphate buffer (20 mM, pH 7.4) was used as the 
supporting electrolyte. The measurement was carried out at least four times. 
The fabricated amperometric biosensor based on CNT and PP has a unique sandwich-like 
structure of PP/GOx/CNT/PP/Au. The device was fabricated with a dry-chemistry basis of 
the layer-by-layer process. Figure 3 showed the SEM image of the device surface. In Fig 3a, 
the distinct CNT was not observed probably because surface concentration of CNT was 
small. Nevertheless, the large current response was obtained (discuss below). Therefore, the 
electrochemical contact is completed in this process. Fig. 3b supports the fact that the flat 
and homogeneous surface for enzyme immobilization is obtained. The each step of the 
fabrication processes was optimized.  
3.2 Effectiveness of CNT 
The effectiveness of using CNTs was examined and the results are given in Fig. 4. The 
amperometric response of the device with CNTs (PP/GOx/CNT/PP/Au, Fig. 4d) was 16-
fold larger than that without CNTs (PP/GOx/PP/Au, Fig. 4a). The current response to the 
enzymatic reaction given by the CNT-PP electrode was the largest, and more than any other 
PP-based enzyme electrode, such as electron transfer mediators (Muguruma & Kase, 2006) 
and platinum electrodes (Muguruma et al., 2000). The obtained maximum current density of 
ca. 0.4 mA cm-2 was comparable with that of other CNT-based biosensors (Tang et al., 2004; 
Joshi et al., 2005; Pan et al., 2005; Patolsky et al., 2004).  
Two mechanisms can be considered for the large current response; the direct electron 
transfer via the CNTs, and the catalytic ability of the CNTs (Merkoçi et al, 2005; Wang and 
Musameh, 2003; Salimi et al, 2004; Liu et al., 2005) toward hydrogen peroxide generated by 
the enzymatic reaction. The latter is supported by the fact that oxidation currents with CNT-
based electrodes start at around +0.2 V. The electrode with sputtered platinum (Pt), which 
also has catalytic ability (PP/GOx/PP/Pt, Fig. 4b), displays an oxidation peak at >+0.2 V. 
The current at >+0.6 V for PP/GOx/CNT/PP/Au (Fig. 4d) was much larger than that for 
PP/GOx/PP/Pt, which suggests that the CNTs provide enhancement of electron transfer as 
an electron conductive component of the electrode. (a) The manuscript must be written in 
English, (b) use common technical terms, (c) avoid abbreviations, don't try to create new 
English words, (d) spelling: Follow Merriam Webster´s Collegiate Dictionary, Longman or 
Oxford Dictionaries. 
3.3 Effectiveness of the first PP layer between the Au electrode and CNTs 
he current observed for the electrode with the first PP layer (PP/GOx/CNT/PP/Au, Fig. 
4d) after glucose addition was much larger than that for the electrode without the PP layer 
(PP/GOx/CNT/Au, Fig. 4c), which indicates that the first PP layer acts as an interface 
between the Au electrode and the GOx-CNT complex. In fact, a densely packed array of 
GOx molecules can be formed on the hydrophilic and positively charged surface of 
acetonitrile PP than on a bare Au electrode. Because the enzyme layer on the PP surface is 
two dimensional, this process does not depend on the thickness or the loading amount of 
the enzyme (Muguruma et al., 2000; Muguruma et al., 2006).
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The background current of the electrode with the first PP layer (Fig. 4c) was smaller than 
that for the device without the PP layer (Fig, 4d). Two reasons are considered for this. One 
reason is that the nano-sandwich structure does not enlarge the effective geometric area (i.e. 
very flat surface) of the electrode, and the other is that the PP layer appears to present a 
diffusion barrier to the supporting electrolyte, causing a partitioning between the electrode 
and the bulk solution (Muguruma et al., 2000). 
From atomic force microscopic measurements of the surface, the dimension of a GOx 
molecule is observed as a compact ellipsoid with an approximate dimension of 12.2×8.3 nm2
(Muguruma et al., 2006). One dimension of a single-walled CNT (1.2-2.0 nm) is smaller than 
that of a GOx molecule; therefore, an effective electrochemical contact of the GOx-CNT-Au 
electrode can be achieved.  
3.4 Optimization for GOx-CNT mixture 
Since the CNTs are chemically inert and insoluble in most solvents, solution casting of the 
CNT layer was achieved by temporal dispersion of the CNTs in solution. The cyclic 
voltammetry (CV) response of the PP/GOx/PP/Au biosensor with a CNT layer cast using a 
1:1 mixture of buffer and ethanol displayed a response higher than that of CNT layers cast 
using only buffer or only ethanol, as shown in Fig. 5. This confirms that the 1:1 
buffer/ethanol mixture provides a more stable CNT suspension, as shown by the 
photograph of vial suspensions in Fig. 5.  However, this suspension is less stable than that 
obtained by other processes using binder such as Nafion, polypyrrole, and surfactants 
(Hrapovic et al., 2004; Joshi et al., 2005; Wang et al., 2006; Gavalas et al., 2004; Merkoçi et al., 
2005). Therefore, it is probable that the CNT layer is mechanically and electrically loose 
(probably slack packing).  Combined with the subsequent plasma treatment, a high sensor 
response was obtained (Fig. 5c).  This method for the formation and modification of a CNT 
layer is a very simple and clean process. 
3.5 Optimization of CNT concentration in solution for CNT layer casting formation 
Optimization of the CNT concentration in the suspension solution for casting was carried 
out.  Figure 6 shows CVs obtained in the presence and absence of glucose as a function of 
the CNT concentration. Comparing Figs. 6a and 6b, it can be seen that the current due to 
glucose addition to the device with CNTs at 0.75 mg mL-1 was larger than that with 0.3 mg 
mL-1. From the CV with the largest concentration of 15 mg mL-1 (Fig. 6), both the oxidation 
and background currents increased.  The CNT acts as the catalyst or direct electron transfer 
via CNT (discussed next section). From these mechanisms, in spite of higher concentration 
of CNT, the output current in higher CNT concentration of 15 mg/ml decreased than that of 
0.75 mg mL-1. This is because the amount of CNT is so large compared with enzyme GOx 
that generation of hydrogen peroxide and electron due the enzymatic reaction toward 
glucose reduced. This shows that the design for enzyme-CNT electrode need to consider the 
balance between the amount of enzyme and CNT. Therefore, the optimized concentration of 
CNTs was determined as 0.75 mg mL-1, due to the largest increment in current with glucose 
addition.  
3.6 Optimization of plasma power for treatment of CNT layer 
A subsequent CNT modification on the first PP layer is a key step. The CNT is directly 
treated by oxygen or nitrogen plasma instead of a wet-chemical treatment for CNTs. The 
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effectiveness of plasma treatment on the CNT was investigated. The fabricated 
amperometric biosensor has a unique sandwich-like structure denoted as the basic structure 
of PP/GOD/PT/CNT/PP/Au. Figure 8 show cyclic voltammograms obtained in the 
absence and presence of glucose. First, the effectiveness of CNTs and oxygen plasma 
treatment (PT) for CNTs was investigated. The current responses of the devices without 
CNTs (PP/GOx/PP/Au, Fig. 8a) and oxygen plasma treatment (PP/GOx/CNT/PP/Au, 
Fig. 7b) were much smaller than that of the optimized device (PP/GOx/PT-
70W/CNT/PP/Au, Fig. 7f). The higher the power of oxygen plasma for modifying CNTs, 
the larger the increase in current for sensor response. In PP/GOx/PT-60W/SWCNT/PP/Au 
(Fig. 7e) and PP/GOx/PT-70W/SWCNT/PP/Au (Fig. 7f), upon the addition of glucose, the 
observed current changed markedly with a large increase in oxidation current. Additionally, 
we confirmed that the current observed for the electrode with the first PP layer 
(PP/GOx/PT/CNT/PP/Au) after glucose addition was 4-5-fold larger than that for the 
electrode without the PP layer (PP/GOx/PT/CNT/Au), which indicates that the first PP 
layer acts as an interface between the Au electrode and the GOx-CNT complex. 
Figure 8 summarizes the current of the PP/GOx/CNT/PP/Au device as a function of 
plasma power for the treatment of CNTs on the first PP layer (CV data were shown in Fig. 
7). It was concluded that the optimal plasma power for CNT-treatment was 70-100 W. The 
oxidation current response to 48 mM glucose initially increases, plateaus, and then 
decreases with increasing plasma power treatment of the CNTs. At less than 70 W, the CNT 
modification is insufficient for suitable contact with the GOx. At more than 150 W, the 
current decreases, because the higher energy of the plasma species has etched the 
mechanical structure of CNTs and a detrimental effect on the electronic properties of the 
CNTs. However, the electronic properties of CNTs were almost retained less than 100-W of 
the plasma power because the large current sensor response was comparable with the other 
CNT-base biosensor (Azaman et al., 2002; Hrapovic et al., 2004; Tsai et al., 2005). 
These results indicate that both PP and nitrogen (or oxygen) plasma modification is an 
effective strategy for fabrication of an enzyme-friendly platform in CNT-based 
amperometric biosensors. The effectiveness of the nitrogen or oxygen plasma treatment is 
probably due to the introduction of carboxyl or amino groups to the side wall surface of the 
CNTs. This experimental evidence of introduction of functional groups is experimentally 
reported by Khare’s group (Khare et al., 2005; Khare et al., 2004; Khare et al., 2002).  
As a result, the hydrophobic surface of the CNTs is changed to a stable hydrophilic 
environment that facilitates contact with GOx. Additionally, when comparing between 
nitrogen and oxygen plasma treatment, the current response with nitrogen plasma was 
slightly larger than that with oxygen plasma. This is attributed to difference of functional 
groups. Nitrogen plasma treatment can introduce positive charge (amino) groups, whereas 
oxygen plasma treatment can introduce nagetive charge (carboxyl) groups (Everhart and 
Reilly, 1981). Therefore, the negatively charged GOx (pI = 4.2) is densely loaded onto 
positively charged surfaces than onto negatively charged surfaces (Muguruma et al., 2006).  
3.7 Comparison between single- and multi-walled CNT 
Figure 9 shows the responses of several glucose sensors, each of which was prepared using 
different types of CNT: single-walled CNT and multi-walled CNT (SWCNTs, 20-30-nm-
diameter MWCNTs, and 40-70-nm-diameter MWCNTs). When comparing these CNTs, the 
increment in current is SWCNTs > 20-30-nm-diameter MWCNTs > 40-70-nm-diameter 
MWCNTs. SWCNTs are the most suitable materials among CNTs. However, the 
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relationship between current due to glucose and plasma power for the treatment of 
MWCNT is unclear. The possible explanation for this is that the GOx molecule is a compact 
ellipsoid with approximate dimensions of 12.2 × 8.3 nm2 (measured by atomic force 
microscopy) (Muguruma et al., 2005). Then, the redox center exists at the smaller pocket in 
the larger (10 nm) three-dimensional structure of GOx. The dimension of SWCNTs (1.2-2 
nm) is smaller than that of GOx, whereas that of MWCNTs (> 20 nm) is larger than that of 
GOx. Therefore, almost all of the reaction centers of GOx were intact and connected to 
SWCNTs.  
3.8 Effectiveness of the second PP layer over the immobilized enzyme 
The final step was the overcoating of acetonitrile PP (denoted as the second PP layer) onto 
the immobilized GOx and CNTs. Our group has already reported that the GOx adsorbed on 
the surface was more deeply embedded, immobilized within the second acetonitrile PP 
layer (Muguruma & Kase, 2006). Two thicknesses were investigated for the second PP 
coating; 10 nm and 20 nm. The 10-nm-thick PP layer probably provides a coating to 
completely cover the adsorbed enzyme because the height of the GOx monolayer was 6-7 
nm (Muguruma & Kase, 2006). In spite of the fact that GOx was treated by high-energy 
plasma, the response to 2.5 mM glucose with the second PP coating film is almost the same 
as that with no second PP layer on the device; that is, the initial enzymatic activity of GOx is 
retained. This means that under milder exposure to organic plasma, the enzyme does not 
become seriously dysfunctional, as previously demonstrated (Muguruma et al., 2005; 
Muguruma and Kase, 2006). The fact that the glucose response of the devices with and 
without the second PP layer were similar shows that the coating is not a barrier toward 
access by glucose.  
Figure 10 shows a comparison of the amperometric response due to an interferant (ascorbic 
acid) and glucose. The maximum level of ascorbic acid under physiological conditions is 0.5 
mM. From our previous report, the first acetonitrile PP layer reduces the effect of 
interference. This was attributed to the first PP layer serving a role as an anti-fouling coating 
against oxidizing interference (Muguruma et al., 2000). The first PP layer can incompletely 
eliminate the current due to interference. In fact, the device without a second acetonitrile PP 
layer (GOx/CNT/PP/Au) shows a current of 2 ?A due to 0.5 mM ascorbic acid in which 
this is similar with the current due to the response of 0.14 mM glucose (Fig. 10a). If the 
coating film is thicker, then the oxidation current due to ascorbic acid is smaller. The effect 
of addition of ascorbic acid to the response of the device with a 20-nm-thick PP coating 
(PP/GOx/CNT/PP/Au) was negligible (almost similar with background, Fig. 10c), because 
the access of ascorbic acid to the CNTs is blocked by the second PP coating. Therefore, the 
second PP layer completely eliminates interference and enables the selective detection of 
glucose.   
The other advantage of the second PP layer is also demonstrated in Fig.11. The operational 
stability under continuous polarization at +0.8 V in the presence of 48 mM glucose was 
investigated. For the device without the second PP coating, the current decreased to 25% of 
the initial current after 24 h, due to leaching of the physically adsorbed GOx and CNTs onto 
the first PP layer. In contrast, the electrochemical response of the device with the second PP 
layer retained a current response of more than 90%. This suggests that the overcoating with 
a second acetonitrile PP layer prevents leaching and contamination of the GOx and CNTs.  
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3.9 Mechanism of sensor response 
Two mechanisms can be considered for the large current response.  One is the catalytic 
activity of the CNTs (Kim et al., 2006; Tang et al., 2004; Hrapovic et al., 2004) toward 
hydrogen peroxide generated by the enzymatic reaction. GOx specifically catalyzes the 
oxidation of glucose as follows: 
? ?-D-glucose + O2 ?(Gox) D-gluconic acid + H2O2,  (1) 
and the CNT catalyzes the reaction of hydrogen peroxide as follows: 
 H2O2?  2H+ + O2 + 2e-.  (2) 
The Au electrode receives the electron, and as a result, the current increases.  
The other mechanism is the direct electron transfer via the CNTs, and a possible mechanism is  
? ?-D-glucose + GOx(FAD) ? ?-gluconolactone + GOx(FADH2)  (3) 
 GOx(FADH2) + 2Mox? GOx(FAD) + 2Mred + 2H+   (4) 
 2Mred? 2Mox + 2e-  (5) 
where FAD locates in the vicinity of the reaction center of GOx, and M represents an 
electron transfer mediator.  
4. Sensor performance 
The previous sections have presented the optimization of the sensor fabrication process 
based on CNTs and PP. Here, the sensor performance of the optimized device is 
demonstrated. In Fig. 12, a steady state amperometric response at +0.8 V vs. Ag/AgCl was 
demonstrated for a wide range of glucose concentration (0.025-14 mM). The remarkable 
characteristic is the small background current (0.35 ± 0.013 ?A) compared with the glucose 
response, indicating there is no need to calibrate the baseline for the glucose measurement. 
This is because the nano-sandwich structure and the permiselective coating of the first PP 
layer on the Au electrode provide effective electrochemical communication.  
The nanometer size sandwich-like configuration provides a suitable distance for 
electrochemical communication between the electrode and the reaction center of the 
enzyme. As a result, a short response time (<4 s, 95% to maximum response) was obtained. 
The detection limit (signal/noise ratio: 3) of 6 ?M is much lower than that of GOx/PP/Pt 
electrode (0.25 mM) (Muguruma et al., 2000). Since the devices were fabricated in the same 
batch, reasonable reproducibility (relative standard deviation: 3%, n=4) from sample-to-
sample was obtained.  
Figure 13 show the current vs. glucose concentration based on the data from Fig. 12. The 
characteristics of this device display good linearity (r=0.993) in the low concentration region 
(0.025-2.2 mM) and the sensitivity was 42 ?A mM-1 cm-2. Deviation from linearity is 
observed at higher (>5 mM) glucose concentration, representing a typical characteristic of 
the Michaelis-Menten model. The apparent Michaelis-Menten activity (KMapp) of the 
immobilized enzyme was calculated according to the Lineweaver-Burk plot shown in the 
upper inset of Fig. 13. According to this, the KMapp is calculated to be 11 mM. This value is 
similar to that of other CNT-based glucose biosensor (Tang et al., 2004; Liu et al., 2005) and 
is smaller than that of GOx in solution (33 mM) (Liu et al., 2005). 
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5. Conclusion 
A new simple and reliable method for the fabrication of a CNT-based amperometric 
biosensor was demonstrated. CNTs and GOx enzyme were sandwiched between 6-nm-thick 
PPs on a sputtered gold electrode. Optimization of the casting formation of a CNT layer 
onto the lower PP was stressed. An organic plasma polymer coating method and a 
semiconductor-technology-compatible layer-by-layer process provided a well-defined 
nanocomposite of enzyme, CNTs, and PPs. This highly efficient electron transfer system was 
able to detect a relevant bioelectrochemical signal equal to 0.44 mA cm-2. This also suggests 
that the PP and/or plasma process is a suitable interface design for electrochemical 
communication from the reaction center of GOx to an electrode via CNTs. The method 
presented here can be easily extended to other biosensor devices using other enzymes and 
proteins.  As a simple dry process intended for mass production, this might be of benefit to 
the development of microscale and/or arrayed sensors. 
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Fig. 2. Schematic representation of the fabrication of an amperometric biosensor based on 
CNT and PPs. (a) Au electrodes are sputtered onto a glass substrate through a metal mask. 
(b) A 6-nm-thick acetonitrile plasma-polymerized film (first PP) was deposited. (c) Solution 
casting is used to form the CNT layer.  (d) Nitrogen plasma treatment of the CNT layer. (e) 
Solution casting of the enzyme layer onto the CNT layer. (f) Immobilized GOx is overcoated 
by a second PP.  
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(a)
(b)
Fig. 3. Scanning electron microscopic image of (a) casting CNTs on the first PP and (b) the 


























































Fig. 4. Glucose response by cyclic voltammetry in the absence and the presence of glucose. 
The sweep rate was 50 mV s-1, the glucose concentration 48 mM, and the electrolyte used 
was a pH 7.4, 20 mM phosphate buffer solution. The structures of the devices are  
(a) PP/GOx/PP/Au  
(b) PP/GOx/PP/Pt  
(c) PP/GOx/CNT/Au, and  
(d) PP/GOx/CNT/PP/Au.  












































Fig. 5. Cyclic voltammetry of the biosensor response in the presence or absence of glucose. 
Sweep rate: 50 mV s-1. Glucose concentration: 48 mM; pH 7.4; 20 mM phosphate buffer 
solution. Carbon nanotubes were dispersed in (a) buffer solution, (b) ethanol, and (c) 1:1 


























































(a) (b) (c) (?)
Fig. 6. Cyclic voltammograms of the fabricated amperometric glucose sensor using GOx, 
CNTs, and PP (PP/GOx/CNT/PP/Au) as a function of the CNT concentration used for 
casting the CNT layer.  CNT concentrations: (a) 0.3, (b) 0.75, (c) 1.5, and (d) 15 mg mL-1.
Arrow directions indicate the glucose concentration increments at 0, 2.5, 14, and 48 mM.  
Conditions: 20 mM phosphate buffer; pH=7.4; 20 °C; scan rate, 50 mV s-1; electrode area 
(geometric), 25 mm2. . Photograph: Vials of CNT dispersions after 4 h.  



















































































Fig. 7. Cyclic voltammograms of the fabricated amperometric biosensor using SWCNTs and 
PP in the absence and presence of glucose. Arrow direction represents the glucose 
concentration increments at 0, 2.5, 14, 35, and 48 mM. Conditions: 20 mM phosphate buffer; 
pH=7.4; 20 °C; scan rate, 50 mV s-1; electrode geometrical area, 25 mm2. (a) 
PP/GOD/PP/Au. (b) PP/GOD/CNT/PP/Au. (c) PP/GOD/PT-30W/CNT/PP/Au. (d) 
PP/GOD/PT-50W/CNT/ PP/Au. (e) PP/GOD/PT-60W/CNT/ PPF/Au. (f) PP/GOD/PT-

















Fig. 8. Dependence of the current response on the plasma power for treatment of the CNT 
layer on the first PP. Cyclic voltammetry was performed at +0.8 V in the presence of 48 mM 
glucose, with a sweep rate of 50 mV s-1 in an electrolyte of pH 7.4 20 mM phosphate buffer 
solution.  































































Fig. 9. Calibration of devices in 20 mM phosphate buffer (pH 7.4) with different types of 
CNTs, (a) SWCNTs, (b) 20-30-nm-diameter MWCNTs, and (c) 40-70-nm-diameter MWCNTs 
nm as a function of oxygen plasma power for treatment of CNTs: rhombus, 30 W; circle, 40 
W; triangle, 50 W; inverse triangle, 60 W; closed square, 70 W; open square, no plasma. The 


















AA 0.5mM AA 0.5mM
G 2.5mM G 2.5mM G 2.5mM
Fig. 10. Amperometric response to 0.5 mM ascorbic acid (AA) and 2.5 mM glucose (G). 
Acetonitrile plasma polymer coating on the immobilized enzyme: (a) no PP overcoating 
(GOx/CNT/PP/Au), (b) 10 nm PP overcoat, (10 nm PP/GOx/CNT/PP/Au), and (c) 20 nm 
PP overcoat (20 nm PP/GOx/CNT/PP/Au). The polarized potential was +0.8 V vs. 
Ag/AgCl. The electrolyte was a pH 7.4 20 mM phosphate buffer solution.  















Fig. 11. Operational stability of the biosensor under continuous operation.  The polarization 
potential was +0.8 V vs. Ag/AgCl at a glucose concentration of 48 mM, with an electrolyte 
of pH 7.4; 20 mM phosphate buffer solution.  Working electrodes are (a) GOx/CNT/PP/Au 
(no overcoating) and (b) PP/GOx/CNT/PP/Au.   





































Fig. 12. Time-current response to sequential glucose addition at concentrations of 0.025, 
0.049, 0.073, 0.096, 0.14, 0.19, 0.25, 0.45, 0.66, 0.88, 1.3, 1.7, 2.3, 4.2, 6.1, 8.1, 12, and 14 mM. The 
electrode was 20 nm PP/GOx/CNT/PP/Au, the polarized potential was +0.8 V vs. 
Ag/AgCl, with an electrolyte of pH 7.4 20 mM phosphate buffer solution. Inset: 










































Fig. 13. Calibration plot for glucose response using the data in Fig. 12. Correlation line at 
low glucose concentration range (0-2.2 mM); sensitivity of 42 mA mM-1 cm-2 (r = 0.993). 
Lower inset: Enlargement of the low concentration range. Upper inset: Lineweaver-Burk 
plot. Imax, 0.44 mA cm-2; KMapp, 11 mM. 
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1. Introduction 
A biosensor can be generally defined as a device that consists of a biological recognition 
system, often called a bioreceptor, and a transducer [1]. The combination of nanotechnology 
and biosensor has leaded a new discovery called Nano-biosensor [2]. Advances in this field 
potentially created useful approaches to new detection methods and revolutionize the way 
in of biosensing. Nano-biosensor, although still an emerging technology, promise fast, 
accurate, and inexpensive ways to measure an extremely wide variety of analytes produced 
or consumed in biological and biochemical processes, as well as ways to measure more 
directly the activity of biological systems or their components [3]. 
One feature of DNA sensors that could make both goals attainable is the utilization of a 
transduction mechanism that is nano-scale and can be easily integrated with CMOS 
technology. The ultimate goal of researchers is to develop a suitable base requires a base that 
can interact individually, requiring a detector of a similar size [2]. Molecular electronic 
properties have usually been examined using electrodes with nanoscale wires (nanowires) 
as small as the molecular sizes, fabricated by electron-beam lithography (EBL), 
photolithography or electromigration methods [3-6]. However, these techniques are very 
expensive due to its low throughput. In this study we present parallel processes for 
nanometer pattern generation on a wafer scale with resolution comparable to the best 
electron beam lithography. 
The focus of this work is the fabrication of nanowire based on spacer patterning lithography 
(SPL); a type of size reduction technique. The design and fabrication of nanowire using SPL 
require the proper selection and integration of material and methodology. Up to this point, 
we describe the design of specifying the process flow and material that is appropriate to 
fabricate the device using conventional CMOS process. The process flow involves every step 
in SPL including the deposition of a sacrificial layer, the definition of vertical step by means 
of lithography and etch-back process, the deposition of a conformal layer, final anisotropic 
etching and formation of gold pad by Physical Vapor Deposition (PVD). 
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Fig. 1. Step Requirement for fabricating Nanowire using SPL 
1.1 Operation  principle 
The operation principle of the sensor is as follows. Any tiny size sample like DNA should be 
bound ligand with an absorbed receptor on the Si nanowires. When molecules are fixed 
between them, it can change the charge carrier density of the wires. This change of charge 
carrier density results in an effective change of conductance by time that can be monitored 
electronically. The sensor structure allows for direct conversion of molecular recognition 
and binding events to electronic signals. [3] 
Fig. 2. Operation principle of nanowire filled with DNA [7]. 
2. Experimental details 
In this research, the following flow is used to conduct the research starting from material 
used until the detection of DNA hybridization.  
2.1 Starting material 
The 4 inch silicon-on-insulator (SOI) wafers is used as starting material with a BOX 
thickness of 160 nm, a top Si layer of 160 nm thickness and boron doped 9–23 ?cm. 
Reported benefits of SOI technology relative to conventional silicon (bulk CMOS) processing 
include: 
? Lower parasitic capacitance due to isolation from the bulk silicon, which improves 
power consumption at matched performance. 
? Resistance to latchup due to complete isolation of the n- and p- well structures. 
Silicon on insulator (SOI) wafer is used to reduce parasitic device capacitance and thus 
improve the final device performance. Prior to fabrication process, the first step is to check 
the wafer type from its specification, measure wafer thickness (Si thickness), measure the 
sheet resistance and check the dopant type. After doing this, lightly scribe the backside of 
each wafer, protect the top surface, using the sribe tool provided. Mark gently but make it 
Design and Fabrication of Nanowire-Based Conductance Biosensor  
using Spacer Patterning Technique  73
Fig. 3. Research methodology flow 
visible and place scribed wafer in container. Wafer is cleaned before each process. Then, the 
SOI wafer is doped with boron on the silicon layer using spin on dopant technique. 
Concentration and sheet resistance is checked again to make sure the doping process gives 
effect to the structure. 
2.2 Mask specification and layout design 
As for the lithography process, three photomask are employed to fabricate the nanowire 
using conventional photolithography technique. Commercial Chrome mask is expected to 
be used in this research for better photomasking process. Mask 1 is used to develop the 
sidewall, Mask 2 is used for the gold pad and Mask 3 is for the test channel. The photomask 
is designed using AutoCAD and then printed onto a chrome glass surface. 
Fig. 4. Mask design for Nanowire fabrication 
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3. Process fabrication development  
The fabrication of nanowire in this research uses the Spacer Patterning Lithography (SPL) 
method which is low-cost and compatible to standard CMOS fabrication process. Spacer 
patterning lithography coupled with anisotropic etching using ICP-RIE is the two main 
processes used in this experiment to fabricate this silicon nanowire. Electrical properties of 
silicon nanowire are then controlled by choosing a silicon substrate with an intended dopant 
type and concentration.  
3.1 Spacer patterning lithography 
The process begins with the deposition of the 200-500 nm layer layer of silicon oxide (SiO2)
as the sacrificial layer on a clean highly doped SOI wafer following by the first mask pattern 
on top of it. This SiO2 and Si3N4 are deposited by Plasmalab 80 plus Compact Plasma System 
by Oxford Instruments, plasma enhance will deposit the SiO2 layer before making the 
proper mask alignment on top of it. The conditions are 700 sccm N2O, 150 sccm Ar, 1000 mT 
pressure, 30 Watt power and 150oC temperature for SiO2. After deposition, photo resist (PR) 
solution will be loaded onto the SiO2 layer before making the proper mask alignment on top 
of the PR. By using MIDAS exposure system (by applying UV light through a mask), pattern 
from the first mask is transferred on the PR. Buffered Oxide Etch (BOE) can be used to 
remove the silicon oxide layer but in this case, vertical profile is needed, so dry etch is the 
choice to etch the silicon oxide layer. Prior to this, development and etching process using 
SAMCO ICP-RIE inductive coupled plasma – reactive ion etching at 2.5nm s-1, the pattern 
layer is finally moved onto the SiO2 layers. The conditions are 50 sccm CF4, 30 sccm Ar, 250V 
bias, 800Watt ICP power and 5 Pa pressure. This recipe etched produced vertical sidewall 
profile with an angle 82o-88o. The residue PR is then removed using the Plasma-PreenII-862 
system by Plasmatic Systems Inc. Then, a thin layer about 100nm-200nm of Silicon Nitride 
(Si3N4) is deposited on top of it. The conditions are 60 sccm Ar, 285 sccm N2, 600mT 
pressure, 25 Watt power and 150oC temperature.
This thin layer of Silicon Nitride (Si3N4) is deposited uniformly onto the SOI to create the 
layer for spacer formation (the main process of the SPL technique). The spacer is  
then defined using ICP-RIE etching by removing the silicon oxide. The spacer formed will 
be the next mask for the highly doped crystalline silicon substrate. The nanowire is then 
defined using ICP-RIE etching by removing the silicon. This process is the critical step  
on fabrication process, since it determines the nanowire size and dimension as can see in 
Figure 5.  
3.2 Gold pad contact formation 
Prior characterization and electrical testing, contact point is formed by deposition of aurum 
(gold) material prior to the fabricated nanowire. Gold is used to have a good reliability via 
contact and it has a very good conductivity. This is to ensure the device has a good electron 
flow and no bias effect to the sensing nanowire. 
A layer of 500nm thick of Aurum is deposited using E-beam Evaporator onto the surface of 
the fabricated nanowire. The layer is then coated and patterned using photolithography 
process to form the contact point. Aqua Regia is used for etching.  Finally, the photoresist 
layer is removed to expose the gold pad for contact. 
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Fig. 5. Layer by layer alignment and patterning method. 
Fig. 6. Process flow of gold pad. 
3.3 Test channel formation 
Figure 7 shows the fabrication of the Si3N4 passivation layer which uses the Si3N4 to isolate 
the testing area and the electrical contact point. Starting with the deposition of the Si3N4
using Plasma Enhanced Chemical Vapor Deposition (PECVD), a layer of Si3N4 is deposited 
on the surface of the nanowire and the gold pad. Then, a photoresist is coated and patterned 
using photolithography process. Inductively Coupled Plasma Reactive-Ion-Etching (ICP-
RIE) is used to etch the Si3N4 between the patterns and exposed the nanowire area for DNA 
sample drop and contact point.  Finally, the photoresist layer is removed to form the Si3N4
passivation layer. 
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Fig. 7. Si3N4 passivation layer process flow 
4. Detection of DNA hybridization  
There are two types of sample needs to be prepared and tested in this experiment. 
     
Fig. 8. DNA sample 
Preparation of 2 sample known as separate ds-DNA (Probe DNA) and various unknown ss-
DNA (Target DNA). The Probe DNA is a known reference sample DNA for testing the 
unidentified Target DNA. The mixture of these 2 DNA will hybridize or not is known 
earlier for testing purpose. 
The process of identification starts with the Probe DNA is denatured by heat or chemical 
denaturant and placed in solution or on a solid substrate, forming a reference segment. 
Then, a various unknown ss-DNA (Target DNA) is prepared. Unknown DNA sample is 
introduced to the reference segment. The complement of the reference segment will 
hybridize to it. This concentration must be suitable to the size of nanowire area. 
Identification of electrical form is counter measured to test the sample and conclude the 
result. The semiconductor parameter analyzer (SPA) system is used to characterize the 
conductivity of the nanowire. Spectrum analyzer (SA) is used to manipulate the output 
signal and easier identification process. 
A DNA molecule is positioned on the nanowires by electrostatic trapping from a dilute 
aqueous buffer. This technique was developed for the trapping of single molecules, and has 
been shown to be successful for a variety of nanoparticles. 
In this procedure, the reference plane of the first-tier calibration was placed in the first pad, 
as described above. The reference plane of the second-tier calibration was located at the 
second contact pads fabricated on the silicon substrate. The signal line of this nanowire 
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fabricated in the second level of metal (metal 2), and its ground plane was fabricated in the 
first level of metal (metal 1). This allowed us to directly measure the scattering parameters 
of the contact pads we had fabricated on the silicon wafer. 
Fig. 9. Signal identification 
Fig. 10. Pad to pad measurement of different nanowire pattern using spectrum analyzer / 
semiconductor parameter analyzer 
5. Results and discussions 
A 1?m thick hard mask oxide is depositedon a SOI wafer and followed by 100nm thickness 
of Si3N4 conformal layer is deposited on the hard mask oxide by LPCVD. This Si3N4 layer 
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serves as a sacrificial support for the sidewall spacers patterning. The pattern transfer is 
carried out using MIDAS MDA400M UV with light source of 350 Watt intensity system 
through the photomask glass with chrome pattern to the 1 µm positive photoresist layer. 
After resist development, etching process is conducted by plasma reactive ion etching (RIE). 
The Si3N4 is removed by CHF3/Ar based plasma etch, which provide high etch selectivity of 
Si3N4 to oxide layer. Based on Figure 11, after removing the oxide layer, the sidewall Si3N4
spacer is left and it serves as a hard mask to etch the underlying silicon layer to form as 
silicon nanowire. The resulting pattern sidewall profile was observed by scanning electron 
microscope. The pattern is not ideally vertical, showing some broadening feature from top 
to bottom layer but this condition is still acceptable for forming spacer using SPL technique. 
The SiO2 etched produced vertical sidewall profile with an angle 82o-88o as can see in Figure 
7. The length of nanowire totally depends on width of spacer. This certain restriction of 
nanowire length as long as the uniformity of anisotropic etching could cover up the whole 
wafer size.  
Fig. 11. Image of sidewall and spacer formation under SEM 
The height of the spacer were not perfectly the same because of the Si layer is over etched 
during etch back process and it is not easy to confirm the height of two separating layer 
while etching.  
Subsequently, the silicon layer is then anisotropically etched by CF4/O2 based plasma ion 
etch. This nanowire is formed on a top of 90 nm silicon layer with underlying of 150 nm 
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oxide layer and boron-doped of 9-23 ohm-cm. The hard mask oxide is removed by the same 
recipe from before. Figure 12 shows SEM photographs of the nanowire.
Fig. 12. The SEM image of the silicon nanowires. 
Then, the two metal electrodes which are designated as source (S) and drain (D) are 
fabricated on top of individual nanowire using photolithography process. A 10 nm of Ti and 
followed by 50 nm of Au layer is evaporated on the silicon nanowire surface. Aqua regia 
was used to etch the Au layer and Ti layer in room temperature. Au is used as probing point 
because of good conductivity and low interconnection resistance.  
   
Fig. 13. HPM image observed the connected nanowire between the two electrode pads and 
the 3-D model of overall pattern fabricated on the sample. 
Characterization and optimization of the fabricated nanowire is the crucial steps in the 
development of this biosensor. It’s extremely important to produce the perfect nanowire at 
the nano-scale resolution [9].  
6. Summary 
The sublithographic nanowire was fabricated by the spacer lithography. We have shown an 
example application of these techniques. Experiments show the nanowire conductive 
conductor can be fabricated by spacer lithography and used for the detection of DNA 
hybridization without labeling. DNA hybridization was detected by conductance 
measurements, and the conductance was found to decrease as input frequency decreases 
when hybridization occurs. Due to the full compatibility with silicon microfabrication 
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technology, DNA chips without any requirement of labeling process are thus practical 
which can be capable of cost reduction and dramatically speed up evaluation of DNA 
hybridization. 
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1. Introduction 
Biosensors measure the real-time reversible interactions between biologically-relevant 
molecules independent of labels. Typically, they harness an optical phenomenon to detect 
the binding of a solution molecule (analyte) to its immobilized partner (ligand) on a sensor 
and record the output as a “sensorgram”, which tracks the binding signal in arbitrary units 
proportional to mass sensed at the surface of the biosensor as a function of time. These 
cutting-edge biophysical tools are revolutionizing our understanding of molecular-level 
processes because they reveal an entire binding profile between unlabeled reactants and 
dissect it into kinetic components from which an affinity can be deduced. By definition, the 
affinity or equilibrium dissociation constant (KD, in units of molar concentration, M) is the 
ratio of the kinetic rate constants (kd/ka) where kd is the dissociation rate constant in units of 
reciprocal seconds (1/s) and ka is the association rate constant in units of 1/Ms. Knowing the 
affinity of an interaction is important to drug discovery because it affects the dose at which a 
drug is efficacious; drugs that bind their targets tightly can be administered at lower levels 
than those that bind weakly and thus are less likely to exhibit undesirable side-effects and 
are more cost-effective. End-point analyses, like ELISA, are less informative and rely upon 
labeling the reactants and adsorbing one of them, which can spoil their native activity, give 
high non-specific background signals, and limit the scope of an assay. Biosensors are 
commonplace in industrial and academic research laboratories worldwide and the Biacore 
technology has dominated the commercial sector for almost two decades. Recently, other 
manufacturers have innovated on the concept of a flow cell and how samples are handled to 
increase the number of interactions that can be studied simultaneously in an automated 
mode, enable longer measurements, and consume less sample (Rich & Myszka, 2007). 
1.1 Diverse biosensor configurations 
Fig. 1 depicts the way in which three different biosensor platforms address samples. The 
Octet is a fairly new technology that uses bio-layer interferometry by employing fiber-optic 
sensors incorporated on disposable tips. Another emerging technology, the ProteOn, uses 
surface plasmon resonance (SPR) and gold sensor chips, as does the Biacore. For more 
information about the principles upon which these detectors are based, the reader is referred 
to the manufacturers’ websites; www.fortebio.com, www.bio-rad.com, and 
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www.biacore.com. By reversing the configuration where now the sensors move to the 
samples, the Octet renders the microfluidics that delivers samples to a stationary sensor chip 
in the ProteOn and Biacore systems, unnecessary. The Octet adopts a well-based dip-and-
read format in which a column of up to eight sensor tips immerses into samples held in an 
open shaking microplate (Fig. 1A). Binding steps are defined by moving these sensors along 
the rows in the plate and the tips are discarded at the end of the assay. Dipping into samples 
rather than injecting them allows the Octet to measure longer association times and re-use 
samples within an assay or recover them for other uses. The ProteOn also processes samples 
in parallel, delivering them via six injections that flow perpendicularly to create a unique 
six-by-six interaction array (Fig. 1B). This generates 36 “reaction spots” (shown by the red 
squares in Fig. 1B) where flowpaths intersect and 42 “interspots” (in each direction), which 
provide a local-referencing option as an alternative to traditional whole-channel referencing. 
In contrast, the Biacore 3000 injects one sample at a time over up to four serially-addressed 
flow cells, one of which typically serves as a reference channel (Fig. 1C).   
Fig. 1. Sample addressing in (A) Octet QK, (B) ProteOn XPR36, and (C) Biacore 3000 
biosensors. The sample plate used in A is black. 
The above-named SPR platforms support a limited number of immobilized ligands per 
experiment and rely upon being able to regenerate them. In contrast, the Octet can analyze 
up to 96 ligands per experiment on inexpensive single-use sensors that can be regenerated to 
make an assay more cost-effective. The throughput offered by the ProteOn may make 
regeneration unnecessary if the 36 interactions that can be addressed in a single binding 
cycle cover all the desired permutations. An unique advantage of the Octet’s configuration 
is that ligands can be loaded offline onto batches of sensors, which increases the number of 
ligands that can be studied in a single run and speeds up the assay because fewer steps need 
to be performed online.
1.2 The importance of benchmark studies 
It is important to assess the performances of emerging technologies relative to well-establish 
ones since biosensors are now routinely multiplexed to meet the demands of drug discovery 
for higher throughput. Determining whether there is consensus across different biosensor 
platforms operated by independent users has been a theme of several benchmark studies 
(Rich et al., 2009; Navratilova et al., 2007; Katsamba et al., 2006; Papalia et al., 2006; Cannon 
et al., 2004; Myszka et al., 2003). The largest and most recent of these engaged 150 
participants from 20 countries who used instruments from ten different manufacturers. 
These collaborations enhance the biosensor community’s ability to design experiments and 
provide insights into the variability of biosensor data where it can become difficult to 
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discriminate between sub-optimal instrument quality and an unskilled user. Inspired by 
these studies and the continuing evolution of biosensors, we compared the performances of 
two parallel-processing platforms, namely the Octet QK and the ProteOn XPR36 interaction 
array, head-to-head with the serial flow Biacore 3000 unit that represents the current 
“workhorse” of the biosensor research community as judged from it being the most 
frequently cited platform in the literature (Rich & Myszka, 2008). First, we addressed 
binding kinetics which is perceived as the signature role of biosensors based upon the 
abundance of literature on the topic. Then we explored competitive binding which, despite 
its relevance to drug discovery, is scarcely reported on in the literature. 
2. Comparing binding kinetics from different biosensors 
2.1 Model interaction system 
For the purpose of comparing instruments side by side and to enable other investigators to 
reproduce our work, we adopted a commercially available antigen/antibody pair as a 
model system. The murine monoclonal antibody 4901 (Wong et al., 1993) was chosen 
because it binds various forms of calcitonin gene-related peptide (CGRP) with affinities that 
fall within a measurable range (high picomolar to mid-nanomolar) and allows for facile 
regeneration in all assay orientations. CGRP is implicated in migraine and other types of 
pain and thus interfering with its biological activity is relevant to drug discovery (Geppetti 
et al., 2005). We studied wild-type (1-37) rat-CGRP-alpha (rCGRP?) and 1-37, 26-37, and 32-
37 forms of human-CGRP? (hCGRP?), which spanned molecular masses of 609Da to 
3806Da and bound antibody 4901 with affinities ranging from 0.5nM to about 500nM. We 
oriented the assay in three different ways. First, we presented naked peptides to antibody-
coupled sensors. Secondly we presented Fab fragments to N-biotinylated peptides that were 
captured via streptavidin sensors. Lastly, we deduced an affinity of the CGRP/4901 
interactions indirectly via solution competition. The following sections describe each assay 
orientation as published elsewhere (Abdiche et al., 2008).  
2.2 Binding solution antigen to sensors coupled with antibody 
When the goal is to generate binding kinetics, it is prudent to present a monomeric partner 
in solution so that its binding can be modeled easily without interference of avidity 
(Myszka, 1999). Therefore, one way to study the CGRP/4901 interaction was to allow the 
solution peptides to bind amine-coupled antibody. None of the peptides could be detected 
directly on the Octet due to their binding signals being within instrument noise, but all were 
clearly visible on the SPR platforms; small molecule analysis is routine on the Biacore 3000 
(Navratilova et al., 2007; Papalia et al., 2006; Cannon et al., 2004; Myszka et al., 2003) and 
was first described on the ProteOn by Bravman et al., 2006. These authors introduced a 
method called “one-shot kinetics” that exploits the parallel injection mode of the ProteOn to 
deliver in a single step a six-membered dilution series of the analyte over six surfaces of 
immobilized ligand with varying binding capacities. This generates a robust data set 
because a large number of binding curves are fit simultaneously to converge upon an 
unique pair of kinetic rate constants, whose ratio gives a global affinity for the interaction. 
Using this method, we analyzed four peptides binding to multiple levels of coupled 4901 by 
regenerating the immobilized antibody after each “one-shot” series and duplicating every 
injection. The kinetic analysis of one of these peptides, namely hCGRP? 32-37, is shown in 
Fig. 2A. This interaction was also amenable to an equilibrium analysis (Frostell-Karlsson et 
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al., 2000) as a non-kinetic route to the affinity owing to all the binding responses reaching 
plateau values within the association phase (Fig. 2B). 
Fig. 2. One-shot kinetics on the ProteOn. (A) Primary data (noisy lines) for hCGRP? 32-37 
binding five levels of coupled antibody 4901 (where 1-5 depict the high to low surface 
capacities) and their simultaneous fit to a simple kinetic model (solid lines) that gave a KD of 
147nM ±1% standard error for the fit. (B) Alternate analysis of the same data set by plotting 
the equilibrium binding responses (arrowed in panel A) from all five surfaces as a function 
of injected peptide concentration and fitting them simultaneously to a global KD of 149nM 
±3% standard error for the fit. 
Fig. 3. Kinetic rate constants determined in two assay orientations. Not all permutations of 
biosensor, peptide, and assay orientation were investigated (see Table 1). Diagonal dotted 
lines trace the isoaffinities. 
The ProteOn and Biacore platforms returned remarkably similar kinetic rate constants for an 
array of CGRPs binding coupled 4901 IgG (Fig. 3, solid symbols) and the affinity ranking 
was consistent with 4901’s known species-selectivity and its epitope that incorporates the 
ten most C-terminal residues of CGRP. 
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2.3 Binding solution Fab to sensors coated with peptide 
Another assay orientation that we explored was the direct binding of Fab to N-biotinylated 
full-length peptides on streptavidin or neutravidin sensors. This method was less 
convenient than the one described above because the reagents had to be modified. While the 
Fab was easily detectable on the Octet, it rebound the CGRP-saturated tips, to different 
extents depending upon the CGRP used, as evidenced by the deviation of the dissociation 
phase from a single exponential decay (black lines in Fig. 4A and 4B). While rebinding is a 
drawback of the Octet’s well-based format, it was rectified by spiking the dissociation buffer 
with high concentrations of a tight-binding competing antigen (100?M rCGRP?) (red lines 
in Fig. 4A and 4B). 
Fig. 4. Primary Octet data for “one-shot” kinetics of 4901 Fab binding streptavidin tips 
coated with (A) rCGRP? or (B) hCGRP?, dissociating them into buffer (black) or a sink 
(red). (C) and (D) show the kinetic fits (in black) of the “sinked” data (in color) in panels A 
and B, respectively. The global fit in D is for quadruplicate analyses on one column of tips. 
Not only did the fitted kinetic rate constants and affinities (Table 1) describe the Octet data 
very well (Fig. 4C and 4D), but they agreed closely with those obtained for similar analyses 
on ProteOn and Biacore platforms (Fig. 5) and previously published values (Zeller et al., 
2008). The Octet and ProteOn data were performed in a parallel “one-shot” kinetic mode 
whereas the Biacore data were collected in a serial multi-cycle mode by regenerating the 






























































Fig. 5. Direct comparison of 4901 Fab interacting with hCGRP? surfaces on different 
biosensors. The measured data and their global fits are overlaid. The timing of the binding 
steps varied according to the biosensor used. 
2.4 Determining affinity via solution competition 
While the Octet cannot detect small molecules directly, it can access affinities indirectly via 
solution competition. An advantage of deducing a solution affinity is that it is unbiased by the 
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assay orientation and unaffected by the immobilization process. In this type of experiment, 
two binding partners are mixed in solution at various concentrations and the free 
concentration of one of them is probed by an immobilized molecule whose affinity is not being 
measured. An appealing feature of our model system was that the sensors could be coated 





































Fig. 6. Solution competition on the Octet using rCGRP?-saturated tips to probe for free 
antibody binding sites in (A) standard curve (twofold serial dilution of 4901) and (B) 
inhibition curve (fivefold serial dilution of hCGRP? 26-37 into a fixed concentration of 4901). 
(C) Overlay plot of the inhibition by rCGRP? (red) and 1-37 (blue), 26-37 (green), and 32-37 
(grey) hCGRP? with fits in black. 
Similar results were obtained on all three biosensors (Table 1), but only the Biacore was 
sensitive enough to work at the sub-nanomolar concentrations of fixed antibody binding sites 
needed to estimate the tight affinity of the rat peptide. Ideally, the concentration of the partner 
being detected at the sensor (in this case, the antibody) should be fixed (at or) far below the 
anticipated affinity of the solution interaction being measured in order for binding to be driven 
by affinity. If it is fixed far above the anticipated affinity of the solution interaction, then 
binding will be driven mainly by concentration and thus will instead determine the antibody’s 
“active concentration” by titrating out CGRP in a stoichiometric manner. 
2.5 Comparing assay orientations in affinity measurements 
The ProteOn and Biacore returned virtually identical kinetics (Fig. 3) regardless of the assay 
orientation used, while those determined on the Octet were typically within twofold of them 
with direct binding of small molecules beyond its detection limit (Table 1). The affinity of 
the rCGRP?/4901 interaction was consistently around 0.5nM by SPR by all three methods, 
suggesting that neither binding partner had been adversely affected upon immobilization or 
modification. In contrast, the wild-type hCGRP? discriminated between the Fab and intact  
CGRP? CGRP binding coupled 4901 4901 Fab binding CGRP on sensor Solution competition with IgG (or Fab) 
 Octet ProteOn Biacore Octet ProteOn Biacore Octet ProteOn Biacore 
Rat 1-37 ND 0.565 0.569 2 0.612 0.432 ND ND 0.54 (0.45) 
Hu 1-37 ND 5.78 4 36 16.2 17.3 28 (22) 7 (20.3) 5.8 (18.2) 
Hu 26-37 ND 8.13 9.55 NT NT NT 38 (27) 34 (23.6) 44 (23.1) 
Hu 32-37 ND 147 202 NT NT NT 500 (280) 370 (224) 460 (239) 
Table 1. Affinities (KD, nM) of CGRP?/4901 interactions determined in various assay 
orientations on different biosensors. ND=not determined due to lack of sensitivity. NT=not 
tested. Values are the mean of replicate experiments (with typical standard deviation <20%) 
or the global fit of a single measurement (with typical standard error <1%) 
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IgG; the Fab bound hCGRP? on chip with a threefold weaker affinity than its IgG 
counterpart with the trend being corroborated by solution competition measurements. In a 
separate experiment, we confirmed that the naked and N-biotinylated peptides bound with 
identical kinetics when flowed over coupled IgG. Our results demonstrate that the assay 
orientation can affect the results as much or more than the biosensor used. 
3. Exploring blocking assays on biosensors 
The next application we explored was competitive binding because of its relevance to drug 
discovery. Most drugs functioning as antagonists are aimed at blocking a natural interaction 
such as that between a ligand and its receptor. Monoclonal antibodies (Abs) are becoming 
increasingly utilized as therapeutic entities in blocking these ligand-receptor interactions.  
An epitope is defined as the three-dimensional region on an antigen (Ag) where an antibody 
binds. Discriminating Abs based on their epitope rather than their apparent affinity for the 
target Ag is often more important because of established protocols for affinity maturation by 
protein engineering, while changing an epitope to a desired one is not typically possible. We 
decided to illustrate the use of biosensor blocking assays in the context of epitope binning 
(Abdiche et al., 2009).
3.1 Sandwiching assays in the context of epitope binning 
Biosensors are essentially mass-based detectors. Therefore, determining whether an Ab 
blocks another’s ability to bind Ag is simply a yes/no read-out, regardless of the assay 
orientation used. Under conditions that favor complete blocking, i.e. overlapping epitopes, 
no binding response will be detected at the sensor for any of the arrowed interactions in Fig. 
7. In contrast, a binding signal at each of these interactions identifies a pair of Abs that can 
coexist on the Ag at distinct, non-overlapping epitopes and thus form a sandwich complex. 
Using this yes/no detection of the arrowed interactions, we assign Abs to epitope bins 
according to their blocking profiles relative to one another. 
Fig. 7. Three assay orientations that can be used in epitope binning. In each case, the antigen 
binds the black Ab before the red Ab. 
In order for two Abs to belong to the same bin, they must block one another and exhibit 
similar blocking profiles when each is paired with the other Abs in the test panel. Thus, the 
observation that two Abs block one another is necessary but not sufficient to conclude that 
they belong to the same bin. Once two Abs have been assigned to the same bin it is possible 
that another Ab will be discovered in the future that blocks one and not the other, thus 
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resolving them into different bins. We used six Abs (1-6) against a dimeric Ag to illustrate 
“in tandem” and “premix” methods and six different Abs (A-F) against an unrelated 
monomeric Ag to illustrate the “classical sandwich” method. We performed each assay on 
the three above-mentioned biosensors and since all biosensors gave similar results we only 
show data from the ProteOn because its two-dimensional interaction array makes it 
particularly well-suited to pairwise and combinatorial approaches to binning. The following 
sections describe each assay orientation in turn.  
3.2 In tandem binning 
In tandem blocking is probably the simplest conceptually. It involves coating the sensors 
with Ag and presenting two Abs one after another, namely a “saturating Ab” followed by a 
“competing Ab” (Fig. 7A). Fig. 8 shows how we performed an in tandem binning on the 
ProteOn and addressed 36 pairs of Abs in a single binding cycle with a complete set of six 
“self-blocking” controls along the diagonal of the interaction array. Consolidating the results 
into a matrix that can be read horizontally or vertically (Table 2) revealed three blocking 
patterns or “bins”, namely Ab1 and 3; Ab2 and 4; and Ab5 and 6. Thus, Ab1 and 3 each 



















































Fig. 8. In tandem binning. (A) Immobilizing Ag on all vertical channels. (B) Saturating with six 
Abs (1-6) on separate vertical channels. (C) Competing with the same Abs (1-green, 2-pink, 3-
blue, 4-cyan, 5-black, and 6-orange) in the horizontal direction, where the plots are grouped 
and named (in red) by the “saturating” Ab that was prebound to the immobilized Ag. 
3.3 Premix binning 
We used the same set of reagents, namely Abs1-6 raised against a dimeric Ag, to illustrate 
the premix approach, which involved premixing the Ag separately with a large molar excess 
of each Ab, and then presenting these preformed complexes to an array of Abs coupled to  
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Saturating Ab Competing Ab 
 1 2 3 4 5 6 
1 SB B B B NB NB
2 B SB B B B B 
3 B B SB B NB NB
4 B B B SB B B 
5 NB B NB B SB B 
6 NB ? NB ? ? SB (?)
Table 2. Blocking matrix for in tandem binning. Y = blocks, N = does not block, SS=self-
sandwich control, ? = intermediate. 
the chip (Fig. 7B). Three controls are needed to validate the assay. First, the premixed Abs 
themselves in the absence of Ag should be presented to the naked coupled Abs to confirm 
that they do not bind one another non-specifically; indeed, one should confirm empirically 
that all three assay orientations depicted in Fig. 7 are free of non-specific Ab/Ab 
interactions. Second, the Ag is premixed with buffer to establish the Ag-binding response 
expected to each of the coupled Abs. Third, the Ag should be premixed with a solution 
counterpart of each coupled Ab on the chip to demonstrate that the premixed Abs are at 
high enough concentrations to self-block. 
On the ProteOn, a premix binning experiment involves coupling an array of Abs along the 
vertical channels and then injecting Ag premixed with an array of Abs along the horizontal 
channels. Ag premixed with buffer is used as the sixth sample. Thus, in a single binding 
cycle, we addressed 36 interactions that incorporated six Ag-only controls, five self-blocking 
controls, and 25 sandwiching pairs. Relative to the Ag-only response, a premixed Ab either 
abolished or augmented binding, consistent with it respectively blocking or sandwiching 
with the coupled Ab (Fig. 9). Of the six Abs tested, only Ab6 (orange curve) did not fully 
block Ag binding at the concentration tested, even against itself when coupled on chip, 
consistent with this Ab’s weak affinity for the Ag. The premix binnings agreed with those 





























Fig. 9. Premix binning. One example of each blocking pattern is shown, grouped by coupled 
Ab. Premixed Abs are distinguished by color (2-pink, 3-green, 4-blue, 5-black, 6-orange, and 
none-red). The different response values of the three panels reflect the different coupled 
levels of Abs 2, 3, and 5. 
3.4 Classical sandwich binning 
The classical sandwich assay involves coupling an Ab onto the sensor, binding Ag, and then 
binding another Ab (Fig. 7C). Only monomeric Ags can be binned in this way because 
multivalent Ags could potentially bind the coupled Ab with one subunit and the solution 
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Ab with another subunit, even if the two Abs in question bound overlapping epitopes. On 
the ProteOn, this assay involves coupling six Abs in the vertical direction and then rotating 
to the horizontal direction to inject Ag followed by an array of Abs. By matching the 
sandwiching Abs to the coupled ones, a complete set of “self-sandwich” controls are 
generated along the diagonal of the interaction array. Based on the patterns of blocking 
activity shown for the six Abs in Fig. 10 when paired against one another, B and F binned 
together, D and E binned together, and A and C were unique because they each sandwiched 
with the other five Abs. 
Fig. 10. Classical sandwich binning. Panels are grouped and labeled by the coupled Ab (A-F) 
and colored by the sandwiching Ab (A-black, B-blue, C-red, D-green, E-orange, and F-pink).  
3.5 Intermediate responses 
Although it is obvious in most of our examples when Abs did and did not bind, some Abs 
bound with intermediate responses that introduced uncertainty into whether they blocked 
or sandwiched. For example, the panel marked Ag/Ab6 in Fig. 8C shows an in tandem 
binning result where the competing array was exposed to “free” and “Ab-bound” Ag 
because Ab6 dissociated rapidly from the Ag (arrowed in Fig. 8B) rather than “saturating” 
it, as desired. However, when Ab6 was used in the “competing” step (orange curves in Fig. 
8C) it clearly binned with Ab5 (black curves). Similarly, premixing Ab6 gave an 
intermediate binding response (orange curves, Fig. 9) because it was at a concentration 
below its affinity for the Ag (which was unknown at that time). In general, weak binders 
like Ab6 should be assigned the role of “competing” Ab when studied in tandem or “on 
chip” in the premix or classical sandwich methods. However, Abs that dissociate rapidly 
from their Ag may be inappropriate candidates for coupling in classical sandwich assays 
because there may be insufficient Ag bound when a sandwiching Ab is presented 
subsequently. Since weak binders can often give ambiguous results when studied in some 
assay orientations, it is prudent to switch the roles of the two Abs in question and/or 
explore other orientations to verify a result. 
Ag heterogeneity is another possible source of ambiguity in interpreting biosensor blocking 
data because consensus across all three assay orientations assumes that the Ag is a uniform 
population. If it is not, the assay orientations may give conflicting outcomes. 
4. Future directions 
Recently, a number of next-generation Octet units have been released that provide solutions 
to some of the shortcomings of the QK platform. One improvement is a better signal-to-
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noise that may now make the direct detection of small molecules possible and allow for 
lower surface capacities that may be preferred for kinetic runs. Moreover, their 384-well 
plate formats enable higher throughputs by addressing 16 interactions at once and trays of 
sensor tips can be re-racked to extend their lifetime. 
5. Conclusion 
Assay orientation can affect the results as much or more than the biosensor used. While the 
ProteOn XPR36 and Biacore 3000 platforms returned virtually identical affinities within each 
assay orientation tested, the Octet QK’s lower sensitivity made it amenable to fewer uses 
and required a sink to abolish rebinding artifacts. Despite these limitations, the Octet’s 
affinities were within twofold of those determined by SPR. Binning results were comparable 
across the three biosensors, but differed in throughput due to each platform’s unique 
configuration that could be exploited in creative assay design. Biosensors are versatile and 
reliable tools that continue to evolve and provide valuable information on diverse molecules 
in a research, diagnostic, and drug discovery setting above and beyond binding kinetics. 
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1. Introduction:  
Urea is one of the final products of protein metabolism. In clinical analysis and dairy 
industry urea is a very significant parameter as excess in blood serum from its permissible 
range causes dysfunction of the kidney. Hence, its analysis is significant and is carried out 
frequently in various laboratories [1, 2]. Urea is an omnipresent compound present in blood 
and various organic fluids. It passes directly into milk through diffusion. Therefore, milk is 
the second major biological sample for the study of urea concentration [3]. A periodic 
monitoring of urea in milk can be used to predict the state of animal’s health and predict the 
protein requirement in its diet [4]. Besides milk, presence of urea in agricultural land as a 
pollutant due to excessive use fertilizers is also widely known. Various methods used for the 
determination of urea (without use of biocatalyst) are gas chromatography, calorimetric and 
flourimetric analysis etc [5]. However, these methods need sample pretreatment which 
stands as a major disadvantage in their versatility of applications. Alongside, these methods 
can not used for field monitoring. Therefore, devices developed based on biocatalyst 
“urease” to analyze urea also known as urea biosensors are of vital importance. The first 
urea biosensor was developed by Guilbault et al. [6] followed by many clinical and 
biochemical analysts. For the fabrication of the urea biosensor, urease is immobilized over a 
substrate. The immobilized urease there after catalyzes the urea conversion in to ammonium 
and bicarbonate ions based on enzyme substrate reaction. Many biosensors have been 
developed for the determination of urea in the biological samples namely spectrometry [7-
9], potentiometry with application of pH sensitive electrode or an ion selective electrode or 
an ion sensitive field effective transistor [10-13], conductometry [14-16], coulometry [17], 
amperometry [18] and inductometry [19]. Amongst these methods, detection through 
electrochemical mode is highly adopted and versatile. This method involves the use of 
electrochemical urea biosensor. In the development of electrochemical urea biosensors, 
immobilization of urease over electrodes is the key parameter which decides the sensitivity 
and reproducibility of the sensor.    
Urea biosensors are collectively formed by biorecognition layer - biocatalyst i.e. urease, a 
biotransducer – to read change in physical environment and convert into electronic signal. 
The complete working principle of the biotransducer component of urea biosensor is shown 
in Scheme 1. For making biotransducer and choice of substrate, conducting polymers are 
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most widely being researched. These materials have a key advantage in facilitating the 
conversion of physiochemical change into an electronic signal. A close harmony between the 
selective biorecognition system and physiochemical transducer also helps in overall 
performance of the biosensor.  
Scheme 1. The biotransducer components of a urea biosensor composed of biorecognition 
layer having an intimate contact with transducer. 
2. Various electrochemical techniques of urea sensing based on conducting 
polymers: 
The electrode configuration of the conducting polymer based biosensor varies according to 
the sensing mechanism. A potentiometric and amperometric signals can be read through a 
single electrode [20]. Conductometric sensor devices, on the other hand, are most easily 
monitored by passing charge between two electrodes. Further low cost biosensors can be 
obtained using screen printed electrodes and reducing its size that is called miniaturized 
screen printed biosensors. Eggenstein et al [2] described urea sensitive biosensor electrode in 
the shape of test strips. Further, Trivedi et al [21] developed a miniaturized low cost screen 
printed disposable NH4+ ion sensitive electrode with double matrix membrane. Detection 
and estimation of urea in milk sample in this sensor is based on potentiometric changes 
occurring at the interface.    
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As mentioned before, in urea biosensors the enzyme immobilized to the electrode surface 
catalyzes the hydrolysis of the urea, in an overall reaction leading to the formation of 
ammonium, bicarbonate and hydroxide ions as shown below: 
Urea +3H2O     Urease     2NH4+ + HCO3- + OH-
The ionic products of the above reaction change the electronic properties of the biosensor 
electrode (modified with conducting polymers), which can be observed by various 
electrochemical techniques as follows: 
2.1 Conductometric technique  
There are many processes taking place in the vicinity of the polymer film which may lead to 
change in mobility and density of the carriers which thereby lead to a change in 
conductivity of these polymers. Conducting polymers are most suitable for conductimetric 
biosensor fabrication as their conductivity is sensitive to surrounding ions and their 
mobility. In case of conductimetric biosensor film conductivity can be calculated by four 
probe or two probe DC interrogation. In two probe interrogation, resistance of the polymer 
film is measured at a fixed potential with an increasing concentration of analyte. However, 
in case of four probe interrogations current is measured by sweeping the potential with the 
polymer fixed between a pair of interdigited microelectrode [22]. Current developed due to 
the potential drop is related to the film conductivity. The reason of potential drop is the 
interaction of analyte gaseous or ionic product cause the degree of doping of the polymer 
directly affects the conductivity. Sometimes analyte interactions cause a conformational 
transition of the polymer chain from “compact coil” to an “expanded coil” through the 
process of secondary doping, which might be accompanied by concomitant change in 
conductivity [23, 24]. Both types of interrogation have been applied for urea biosensors as 
the products of enzymatic reaction in both the methods are able to change the electronic 
property of the polymer.
These biosensors can be fabricated by putting enzyme layer over the polymeric transducer. 
Jha et. al. [25] used electropolymerized polyaniline-polystyrene (PANI-PSS) with 
brevibacterium ammoginase as a biocatalyst for urea biosensor. The immobilized cell works 
as a source of unpurified urease to develop conductometrc urea biosensor. The pH 
dependent change in resistivity of the polymer was also used as a basis for sensing. The 
response was linear over a range of 0-75mM urea with a sensitivity of 0.125 mM-1. Ortega et. 
al. [26] reported a urea biosensor based on NH3 gas interaction by two probe method with 
DBSA-doped polyaniline-poly(styrene-co-potassium acrylate in a poly(n-butyl 
methacrylate) matrix. He also estimated urea concentration normal to pathological level. 
2.2 Impedimetric technique: 
Impedimetric transducer measures the effect of sinusoidal varying, nonperturbing voltage 
relative to a suitable reference electrode in term of impedance. The current originate allows 
the transfer function to real (Z”) and imaginary (Z’) component of impedance that changes 
as a function of the concentration of the analyte after each exposure. The impedimetric 
response can be measured either at one frequency (electrochemical impedance EI) or in a 
frequency range (electrochemical impedance spectroscopy EIS) [27]. The response might be 
direct or indirect depending on the interactions of the analyte with the recognition layer 
embedded in the conducting polymer or the analyte convert into some reaction product 
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after reacting with recognition layer and affects the carrier density (doping) or mobility 
(swelling) of the conducting polymer. Enzymatic biosensor based on conducting polymer 
comes in the category of the indirect and genosensors in the direct impedimetric 
biotransducer either by EI or EIS. There is still a debate whether impedimetric biosensor is 
truly or signal comes from the conformational change of the polymer. Ho et. al. [19] formed 
an impedimetric urea biosensor based on poly(methyl vinyl ether)/maleic anhydride which 
transformed rapidly in response to alkaline pH which was a link to enzyme reaction 
between urea and urease. The polymer was screen printed onto the interdigited screen 
printed carbon electrode and the electrode was overlaid with absorbent pad containing the 
associated enzyme. This type of electrode design was used for simple integrated and 
disposable sensor for clinical use. 
2.3 Amperometric technique: 
Amperometry is most commonly used technique for biosensors based on conducting 
polymers. Devices based on amperometry measure the change in current as a consequence 
of specific chemical reactions which take place at biotransducer electrode surface under non-
equilibrium condition. The principal of the amperometry is based on the efficiency of the 
electron transfer between the biomolecule and underlying electrode surface in presence of 
electron mediator or conducting polymer. Moreover, amperometric biosensors are not only 
limited to the redox enzyme but also related to the biocatalyst reaction and interaction of the 
reaction product with conducting polymer to induce change in current [28]. Urea biosensor 
is the typical example of biocatalytic amperometric biosensor where ammonium ion which 
is a product of biocatalytic reaction interacts with polymer to induce a change in 
conductivity of the polymer. Adeloju et al [18] developed an amperometric urea biosensor 
based on flow injection analysis (FIA) to get linear responses between 3-15mg/l at the 
optimum condition of pH and potential of buffer and electrode respectively. The presence of 
interfering ions (KCl and KNO3) at the concentration upto 0.01 M did not interfere with the 
estimation of the urea in blood and urine samples without any pretreatment. Rajesh et al 
[29] reported an amperometric urea biosensor with urease covalently immobilized with 
conducting copolymer poly (N-3 aminopropyl pyrrole-co-pyrrole) film. Amperometric 
response was measured as a function of concentration of urea, at a fixed bias voltage of 0.0 V 
vs. Ag/AgCl in a phosphate buffer (pH=7.0). The electrode gave a linear response range of 
0.16-5.02 mM. W. J. Cho [30] described a new procedure for the urea determination through 
polyaniline-Nefion composite electrode which effectively sensed ammonium ion by 
amperometric technique. The sensor showed a detection limit as low as 0.5 µM (very less) 
with short response time. Nefion shortened the diffusion path and thus increased the 
sensitivity of the biosensor.                                                                                                                                             
2.4 Potentiometric technique: 
Electrochemical estimation of the urea is mainly carried out using potentiometric techniques 
because of a simpler mode of construction of the sensor electrode, detection and general 
availability of the instrumentation required for their utilization. On the other hand, for fully 
exploiting this technique, more durable and maintenance-free ion-selective electrodes (ISEs) 
which can be easily miniaturized are needed. Conducting polymers are widely studied for 
estimation of the urea by pH sensitive potentiometric technique. These polymers not only 
act as good transducers but also unique support to the immobilization of the enzyme due to 
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having capability for direct electron transfer between enzyme and polymer through the ?
electron (hydrophilic and hydrophobic interaction). In the following, we shall discuss about 
the critical parameters of solid state potentiometric urea biosensor based on conducting 
polymer pH transducer. 
2.4.1 Conducting polymer based pH transducers: 
pH sensor is widely known amongst all types of chemical sensors. A unique property 
possessed by conducting polymers is their low resistivity and conjugation. In addition, 
conducting polymers are known for better electronic communication through pi electrons. 
They also enhance ion to electron transduction performance of sensors and thereby increase 
the linear dynamic sensitivity, response time and stability of the sensor [31-40]. pH sensor is 
a type of chemical sensor extensively studied for the identification of the hydrogen ion 
concentration of the medium depending on the interaction and ion exchange between 
polymer and hydrogen ion in the bulk. Conducting polymer found in various oxidation 
states depends on pH and potential change affects conductivity, thus the change in the 
electronic parameter (change in electronic structure) measured by different type of 
electrochemical techniques for the identification of the pH. The mechanism of the 
potentiometric pH sensor based on conducting polymer is directly related to protonic 
interaction of the monomers. Amino group containing polymers have high affinity to the 
proton due to their behavior as protonation/deprotonation nitrogen i.e. Lewis base site [41]. 
The second mechanism based on the reaction of H+ onto amino groups because of 
polarization creates local charge density excess at the electrode surface in comparison to the 
bulk concentration. The pH response mechanism of membrane may be represented by the 
following equation [42]:  
The build up of charges on the inside of the conducting polymer membrane is proportional 
to the amount of hydrogen ions in the external solution as shown in figure 1.  
The potential difference across the membrane in the potentiometric mode of detection is 
proportional to the logarithm of the ionic concentration in the external solution.  
Undissociated acidic groups (not participating in the doping) also participate in the H+
sensitivity [43]. Various conducting polymers having some weak acidic groups over their 
backbone (self doped polymers) can explored for the pH sensor application, structures of 
some of them have been shown below in figure 2. 
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Fig. 2. Electronic structure of self doped conducting polymers 
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Amongst the various conducting polymers, polyaniline has been found most suitable for pH 
sensing in aqueous medium. Pandey et. al. [44] found that hydrophobic ion exchanger used 
as a dopant for the polyaniline synthesis in acetonitrile facilitates pH estimation in the both 
aqueous and non-aqueous medium. Potentiometric chemical sensors relate open circuit 
potential to the concentration of analyte (with the generation of constant dipolar potential 
essentially required for baseline recovery after each addition of the electrolyte) by using an 
ion-selective or conducting polymer based electrode as a physical transducer. 
These are selective, have large dynamic ranges and are nondestructive. They are frequently 
used for pH sensing. During the last decade, enormous efforts have been made on 
developments of potentiometric pH transducer based on polymer modified electrode. 
Charge over the polymer (oxidation state) is compensated by the counter i.e. dopants, 
thereby giving the ion exchanging opportunity to the polymer [45]. Thus the performance of 
the sensor is affected by oxidation state and structure of the polymers. Responses of various 








Limit (M) Reference 
Polyaniline (PANI) pH 2-9 52.7 1×10-9 T. Lindfors et. al. [48]
Polypyrrole N.M 58 N.M H. Kaden et. al. [49]
Polyaniline ultrathin films pH 3-9 55-59 1.0×10-9 C. H. Ge et. al. [50]
Polyaniline and poly 
(o-ethoxyaniline) 3 < pH < 9–10 ~60 or 50 1.0×10
-9 C Slim et. al. 
[51]
Polypyrrole (PPy)   2-11 48 1.0×10-11 B. Lakard et. al [42] 
Polydiethylenetriamine  
(PPPD) 2-11 34 1.0×10
-11 B. Lakard et. al 
[42]
Polyethyleneimine  (PEI)  2-11 46 1.0×10-10 B. Lakard et. al [42]
Polypropyleneimine  (PPI) 2-11 43 1.0×10-10 B. Lakard et. al [42]
Orthomethoxyaniline 
and ortho-methylaniline 2-11 63.6 NM 
C. A. Lindino et. al. 
[52]
Polyaniline and its 
substituted derivatives 2-9 62.9±0.9 1×10
-9 T. Lindfors et. al. 
[53]
Table 1. pH sensing parameter of a number of reported conducting polymers. 
2.4.1.1 Effect of polymer composites on pH responses:  
It is reported that conducting polymers having some more ion exchanging moieties viz 
functional group, dopant and other polymer modifier to form composites or blends not only 
affect total pH sensitivity but give stable immobilization matrix also. Different insulation 
polymer has been tried as a matrix for sensing membrane. PVC derivatives with carboxylate 
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groups (~1.8 %) got much more attention by the researchers. The reason is the COOH 
groups which principally remain undissociated. The weak acidic PVC or similar polymers 
are partly protonated upon contact with the aqueous solution and are being used to 
fabricate so-called ionophore-free H+-selective liquid membrane electrodes. 
Prissanaroon-Ouajai et al. [46] developed pH sensor based on polypyrrole (PPy) with 
hydroquinone monosulphate and oxalate co-doping. Co-doped PPy showed the response 
slope of -54.67±7 mV/pH and a non-Nernstian slope of -35.0±7 mV/pH.  
In our work for the first time we used 5-carboxy polyindole (5-carboxy PIn) and 5-carboxy 
PIn-Polyvinyl chloride carboxylated (PVC carboxylated) composite for the development of 
pH transducers. Incorporation of the functional group over polyindole and PVC 
(carboxylated) in polyindole matrix not only increases the sensitivity of the sensor but also 
provided stability to the sensing membrane. Besides, it also facilitated post synthetic 
processing. We measured the pH dependence of our electrodes by recording the open 
circuit potential in various buffer solutions ranging from pH 10 to 1 in 5ml buffer solution of 
0.1mM using standard addition or batch method at the constant stirring of 100 rpm. Before 
each measurement, the sensor was immersed into pure water in order to ensure the same 
starting conditions (for batch method). Results are presented in figure 3 for 5-carboxy PIn 
and 5-carboxy PIn-carboxylated PVC composites based sensors. Both the electrodes 
demonstrated very good linearity. For 5-carboxy Pin and 5-carboxy PIn-Polyvinyl chloride 
carboxylated composite, we found a slope of 38.5 and 47.5 mV/pH respectively, which 
showed semi Nernstian behavior indicating that less than one proton per electron is 
involved in changing the stationary potential. 
Fig. 3. Potentiometric pH sensing behavior of 5-carboxy PIn (Red) and 5-carboxy PIn-
carboxylated PVC composite (Black) 
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2.4.1.2 Effect of Multiwall carbon nanotube (MWCNT)-Carboxylated on pH responses:  
CNTs are well known as suitable materials for chemical sensing in which electron exchange 
is the basis of the mechanism. CNTs networks form an electrical contact to an outer device; 
whereas the sensitive coating acts as a transducer and converts physical phenomenon into 
electrical signals. Carbon is also known to give a pH response. In addition, it was found that 
thin carbon nanotube networks work as a conductive and transparent backbone structures 
for conducting polymer coating thereby increasing the electronic conductivity of the system. 
Use of carboxylated CNTs increases pH sensitivity with polymer not only due to the 
undissociated carboxylic group but also due to its reduced size which increases effective 
surface area. Kaempgen et. al [47] found that in polyaniline coated over CNT, pH response 
falls in the range of super Nernstian and linearity in response increases with increase in the 
amount of polyaniline. MWNTs helps in the total pH sensitivity of the electrode. Similarly 
our synthesized nanocomposite showed an increase in slope up to 69mV/pH for wide range 
of pH 10-1.0 as shown in figure 4.   








































Fig. 4. Potentiometric pH sensing behavior of 5-carboxy PIn-carboxylated PVC-
Carboxylated MWNTs nanocomposite. 
2.4.2 Importance of conducting polymers for biosensors: 
Biosensor is an electroanalytical device which transduces a physicochemical change in the 
presence of biological or biologically derived molecule such as enzymes, tissues, bacteria, 
yeast, antibodies/antigens, liposomes, organelles and DNA etc. Biosensors represent a new 
trend emerging in the diagnostic technology. Various types of matrices have been proposed 
for the immobilization of enzymes such as membranes, gels, carbon, graphite, silica, 
polymeric films etc. Conducting polymers are attractive materials for electron transfer over 
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the surface of the electrode as well for immobilization [54, 55]. The overall performance of 
electrochemical biosensor is characterized by metal substrate, biocatalyst immobilization 
and electronic and morphological properties of the conducting polymer. There are some 
advantages of using conducting polymers as transducing materials. Firstly, they are easy to 
synthesize through chemical and electrochemical polymerization techniques. Secondly, the 
ease of fabrication of sensors from these materials on substrate either by spin coating and/or 
drop casting from solution or directly by anodic electrochemical polymerization from an 
electrolyte solution [56, 57]. These polymers can be synthesized over the electrodes by 
electropolymerization also. The biosensor development by two different ways of polymer 
thin film formation is shown in Scheme 2.  
Scheme 2. Schematic representation of conducting-polymer based biosensors fabrication 
technique by different methods of polymer film formation on solid and conducting 
substrate.
Biomolecules can be directly immobilized with the electropolymerization process to get 
these molecules in a specific arrangement or orientation. It is a widely adopted method for 
biosensor development. Beside, chemically synthesized polymers have their own 
advantages in post synthesis modification to desired mechanical and electrical properties. 
Moreover, these polymers can be molded by other materials which are more suitable for 
biomolecules immobilization which helps in enhancement of various properties. 
Conducting polymer is being researched as a material to enhance various analytical 
transduction properties of biosensors such as speed, sensitivity and versatility because of 
availability of various stable electronic states. Electrical (electronic state) and mechanical 
properties of conducting polymers can also be tailored by applying electrical stimuli thus 
affect the biochemical transduction performance. In the biosensor application conducting 
polymers can perform various roles viz. as a catalyst, a redox mediator, an ON/OFF switch, 
Urea Biosensor based on Conducting Polymer Transducers  103
ion sensitive membrane and as chemiresistor which shows change in the resistivity because 
of biochemical reaction. Due to biochemical reaction between the analyte and biomolecule 
various products are formed viz. proton, different ion and gases etc. These products related 
to a specific type of analyte which modulates the electronic and optical properties of the 
conducting polymer [58-61, 45], and thereby becomes a source of typical analytical signal 
which can be monitor at the electrode surface by various electrochemical techniques either 
in the change in impedance, change in open circuit potential (dipolar potential) change in 
current at fixed applied potential and conductivity etc. The sensitivity of the biosensor 
depends upon the electron relay between conducting polymer and solid electrode support 
over which polymer is fabricated. Here, we chemically synthesized 5-carboxy polyindole (5-
carboxy PIn) by using two miscible solvents (water and ethanol) and prepared polymer 
used for the composite formation by solution casting method [62]. Carboxylated PVC and 
MWNTs used as a conventional and nanofiller (20 and 10wt. % respectively). Use of the 
filler not only modifies mechanical, morphological and electrical properties of the polymer 
but also helps to improve the chemical and biosensor performance of the polymers. 
2.4.3 Immobilization of urease over the polymer membrane for urea biosensor:  
Solid state biosensors are adopted more as compared to liquid state as the stability of the 
enzyme is very less in the liquid state. The immobilization of the biological component 
should be at the environmental conditions otherwise it results in decreased enzyme activity. 
Thus research is going on in the field of solid state biosensor based on polymer [63]. The 
activity of immobilized molecules depends upon various parameters such as surface area, 
porosity, hydrophilic character of immobilizing matrix, reaction conditions and the 
methodology chosen for immobilization [64, 65]. The popularity of using conducting 
polymers in biotransducer application is mainly due to various reasons such as availability 
of a spectrum of immobilization techniques for bioreceptor (even molecule through cell) 
location, each of which is compatible with maintaining bioactivity, faithful presentation of 
the bioreceptor to the analyte, and controlled thickness of the biorecognition layer. All these 
parameters are related to polymer suitable for immobilization due to rough, porous and 
hydrophilic nature. The incorporation of large size dopants, dodecylbenzene sulphonate 
(DBS) into polypyrrole film during electropolymerization makes PPy more porous [66, 67]. 
Moreover the incorporation of the nanoparticle in the conducting polymer not only 
increases the surface area and nanofabrication but also changes various properties viz 
morphological and electrical which help in the immobilization of the biomolecules and 
better performance of the biosensor by proper diffusion of the analyte specific product [68]. 
Enzyme over the immobilization matrix must be in the form of a thin layer with efficient 
loading. The immobilization of the suitable enzyme on the surface of the sensing electrode is 
a critical step in fabricating the biosensor of required choice. Additionally, the method used 
for enzyme immobilization should not affect the quality of the urea biosensor in terms of 
cost per use; it’s easiness in carrying and its effectiveness in the transducer performance [69]. 
Immobilization of urease in conducting polymer can be achieved by several techniques.  
These include physical adsorption, electrochemical entrapment, chemical cross linking and 
covalent coupling. These methods have their own advantages and disadvantage as 
mentioned in table2.  
The steps involving in different type of immobilization method are shown in Scheme 3. 
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Way of 
immobilization Advantage Disadvantage Reference 
Physical
adsorption
No structural change 
of biocatalyst and 
cheap, fast 
immobilization 
Physical interaction easily 
braked by change in 
environment condition 
cause leaching 
M. J. Syu et. al. 
[75]
Entrapment One step biosensor fabrication, low cost 
Unsymmetrical 
distribution of biocalatyst 
cause diffusion barrier 
S. B. Adelojo 
et. al. [18] 
Cross linking Stable interaction, moderate cost 
Side effect of chemical 
used for immobilization, 
it take time, difficult 
enzyme recovery 
W. J. Cho [30] 
Covalent bonding 
Stable interaction 
with high enzyme 
loading 
Side effect of chemical 
used for immobilization, 
it take time, difficult 
enzyme recovery 
Rajesh et. al. 
[29]
Table 2. Different method of biomolecule immobilization 
Scheme 2. Schematic representation of process in different immobilization methods. 
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Amongst all the immobilization methods covalent immobilization is the most advanced one. 
In this method biomolecule is incorporated in the conducting polymer matrix through 
complementary functional group chemistry. This way of immobilization confers strong 
interaction between polymer and biomolecule that can be achieved by amide or ester 
linkage in the presence of some coupling agent. Covalent immobilization not achieved in 
polymer only can be participate with other moieties (having functional group) present with 
conducting polymer after modification viz plasticizer or fillers. Covalent immobilization not 
only inhibits leaching of the enzyme but also provides thin coating of the enzyme which 
facilitates fast ionic movement thereby increasing sensitivity and long life stability of the 
biosensor. Rajesh et. al [29] immobilized urease in the copolymer poly-(N-3 
aminopropylpyrrole-co-pyrrole) in the presence of 1-ethyl -3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) as coupling agent in 
aqueous medium. 95% baseline recovery in 40 second was thereafter observed. Thus it can 
be concluded that carbodiimide coupling reaction has a feature of strong covalent bonding 
with the enzyme with the matrix, which in turn is responsible for high enzyme loading at 
the surface of polymeric modified electrode.  
We used 5-carboxy PIn, 5-carboxy PIn-carboxylated PVC and 5-carboxy PIn-carboxylated 
PVC-MWNT composites for immobilization of urease and studied morphological 
properties. After composite formation film became porous with carboxylated PVC. Due to 
MWNT surface area increased which is good for immobilization of urease. This matrix was 
further applied for covalent immobilization in the presence of coupling agent DCC and 
NHS. Treatment of DCC and NHS was carried out in cyclohexane; immobilization was 
carried out in aqueous solution of the enzyme in distilled water. 
2.4.4 Mechanism of potentiometric urea biosensors based on conducting polymer: 
Potentiometric measurements are based on monitoring potential values under a zero current 
flow regime (under equilibrium), in order to determine the analytical concentration of 
desired components after catalytic reaction between biomolecule and analyte in the sample 
solution [43, 70-72]. Source of potential may be a physical phenomena not involving explicit 
redox reactions but having non-zero free energy initial conditions because of enzymatic 
reaction and ionic gradient. For instance ion concentration gradient over the surface of 
sensing membrane is one of such phenomena and ionic potential similar to dipolar 
potential. Potentiometric sensor either symmetric or asymmetric depends on the 
homogeneous and heterogeneous interface between the dipolar layers of charges. 
Conducting polymer or solid state ion selective electrodes (ISEs) based potentiometric 
sensor falls in the asymmetric type because ionic dipolar layer is generated at the interface 
of liquid and solid phases [73]. Since the biochemical reaction between analyte and urease 
change pH due to the formation of ammonia and carbondioxide, it can be analysed using 
pH sensitive or H+ exchanger moieties through potentiometric mode of detection [74]. In 
addition, potentiometric sensor for detection of ammonia, and ammonium ion generated by 
enzymatic reaction, using ISE are being studied [75]. The major problem for pH sensitive 
electrode is that the sensor response is strongly dependent on the buffer capacity of the 
sample. This is because the pH change produced in the course of the enzymatic reaction is 
suppressed by the buffer used. The general problem of ammonium sensitive electrode is 
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interference by Na+, K+ and Ca+ ion, which are present in the serum and other biological 
derive fluid. Potentiometric response is affected by various parameters viz. concentration of 
the buffer, pH of the buffer, loading of the enzyme, temperature, stirring rate etc. Sensor 
gives best response at an optimum condition of these parameters [1, 76]. Polymers both 
intrinsically conducting and non conducting, have played a prominent role in pH sensitive 
potentiometric sensor as well for urea biosensor. Some of the ureabiosensor based on pH 
sensitive conducting polymer using potentiometric technique is shown in table 3.  
























~50mV pHPotentiometry 1mM 10-68mM 






~26.6mV pHPotentiometry 20µM ~60µM-to mM
P. C. Pandey 







Potentiometry 0.02mM 0.3-30mM 
Osaka et. al. 
[77]
Table 3. pH transducer based urea biosensor with different conducting polymers 
We developed potentiometric urea biosensor fabricated using 5-carboxy PIn-Carboxylated 
PVC composite based on solid state pH transducer. A classical two electrode cell required 
for the estimation of urea by potentiometric technique having one H+ ion sensitive electrode 
coated with enzyme urease and reference electrode. Total response of Urease/PIn-PVC/Pt 
biosensor electrode gave 130±10mV/ change in urea concentration of 10-6-10-1 M (24.6 
mV/decade) as shown in figure 6. The linearity obtained for the above biosensor in the 
range of 10-5-10-1M. Lower detection limit of the biosensor was 10-5 M concentration of urea. 
The apparent Michaelis-Menten constant Km is an indicator of the enzyme-substrate reaction 
kinetics and used to evaluate the biological activity of the immobilized enzyme. Two linear 
ranges were obtained viz., 10-6-10-4 M and 10-3 to 10-1M. The reciprocal of apparent Michaelis-
Menten constant (lower concentration region) in the present study was found to be -
1/Kmapp=-5.276882x10-6 for Urease/5-carboxy polyindole-carboxylated PVC electrode in the 
lower concentration range (when the enzyme was 20µl, optimum loading of enzyme), which 
is lower than any other urea sensor reported in literature so far. 
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Fig. 6. Potentiometric response of the biosensor (Urease (20?l) /PIn-PVC/Pt) to increasing 
urea concentration (10-6-10-1)M. 1 mM Tris–HCl buffer (pH 7.0) calibration curve (Inset) 
2.4.4.1 Carboxylated-MWCNTs-Conducting polymer composite based urea biosensor: 
CNTs are used to increase the biosensor sensitivity because for their electron relay 
properties and at times due to interaction with analyte products. 5-carboxy PIn-carboxylated 
PVC- carboxylated MWNT composite was used for urea biosensor. The response for the 
urea increased up to 152±10mV for urea concentration in the range of 10-6-10-1 M. In the 
presence of MWCNTs biosensor showed slope of 28.4 mV/decade of urea concentration (for 
10-6-10-1 M concentration of urea) in well accordance with its super Nerstien pH response of 
the same composite as shown in figure 7. 
3. Effect of enzyme loading on urea biosensor response: 
The amount of urease over the transducing membrane affects activity, response time and 
linear dynamic range due to thickness of sensing membrane and amount of enzyme. 
Activity of the biosensor was used to estimate the minimum enzyme unit required for the 
construction of the biosensor. In our biosensor we found that the lower and higher urea 
concentration responses of the biosensor can be altered by changing the loading of the 
urease over the electrode. When the loading was less (5-10 µl) biosensor was more sensitive 
in the lower concentration (10-6-10-3M) range and vise versa. 
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Fig. 7. Potentiometric response of the biosensor (Urs(20?l) /PIn-PVC-MWCNT/Pt) to 
increasing urea concentration (10-6-10-1)M. 1 mM Tris–HCl buffer (pH 7.0) calibration cure 
(Inset)
4. Stability of the urea biosensor: 
Stability of the conducting polymer based biosensor depends on the chemical stability (for 
long term usage) and electrochemical stability (for short term usage) of the conducting 
polymer layer over the solid substrate and enzyme layer immobilized with the polymer 
matrix. Stability of both of the components over the conducting electrode directly or 
indirectly affects the overall performance of the biosensor. Stability of the conducting 
polymer is measured by two parameters, firstly their inherent stability of the conductive 
and electroactive material (related to it functioning) and secondly their stable deposition 
over the electrically conducting substrate (physical stability) [28]. The ion exchange into and 
out of the conducting polymer creates concomitant dynamic change in the polymer (due to 
expansion and contraction) and causes interfacial shear stress there by causing leaching of 
the polymer from the surface. The interaction between polymer film and underlying 
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electronic conducting substrate is primarily hydrophobic in nature and is supported by 
some weak forces. Several attempts have been made to improve the adhesion of conducting 
polymer onto the conducting substrate for long term applications by using rough surface 
electrode, giving thiol modified polymer and by providing functional group over the 
substrate with the help of some chemical [78-82]. Through functional group chemistry, a 
stable deposition of the polymer has been achieved. Long term stability of the enzyme over 
the matrix is an important factor for consideration in the construction of the biosensor, since 
this is not only beneficial for the biosensor transport but it also reduces measurement cost. 
In addition due to the efficient coupling it is easy to achieve monolayer (thin and regular) 
deposition of the enzyme over the polymer which is good for the biosensor sensitivity. This 
could be achieved only; there would be strong and efficient bonding between enzyme and 
immobilizing material [69]. Biosensor developed here is highly stable and sensitive when 
enzyme immobilization is processed and stored at 50C. When the biosensor developed at 
room temperature sensitivity of the biosensor was in the range of 10-4-10-1 M and at 50C it 
was responsive in broader range (10-6 - 10-1M). The stability experiment was carried out in 
0.1M urea concentration for two months, keeping biosensor electrode at 50C. It was found 
that the biosensor was stable for ~2 months with 75% degradation of the enzyme, similar to 
the recently reported urea biosensor having immobilization through carbodiimide coupling 
reaction.
5. Estimation of urea in biological sample 
Urea is an important parameter which is frequently analyzed in biological samples such 
blood serum, urine and milk. Urea concentration in the above constituents above an 
optimum quantity directly affects the human health. The normal range of urea in blood is 
between 1.7- 8.3 mmol/l and levels increased up to 100 mM/l under pathophysiological 
condition affect the normal functioning of kidney [75]. The proposed urea biosensor was 
performed in human serum after 50 times dilution using standard addition method. The 5-
carboxy polyindole/PVC electrode immobilized with 20 ul urease enzyme was used for the 
estimation of blood urea in the blood serum of healthy volunteers using three point 
calibration methods. The concentration of the urea in the blood was found to be 9.5x10-5 M
(in 50 times diluted) or 4.75x10-3 M (in real sample) using standard addition method as 
shown in figure 8.  
In this chapter potentiometric pH sensors and urea biosensors using conducting polymer 
composite and nanocomposite materials are discussed especially based on carboxyl 
functionalized polyindole conducting polymer. We have tried to identify the role of various 
materials and there capability to influence the performance of a sensing device based on pH 
transducer. We have also considered the effect of the different materials, processing, 
immobilization and morphology of the conducting polymer composite systems on sensing 
property. Finally we close our discussion along with work done by our group. The sensors 
and biosensors developed are compared with earlier known sensors and found to be more 
sensitive and stable over the others. We not only reported improved pH solid state sensor 
and urea biosensors based on such pH transducers but also showed the importance and 
potential of the novel carboxyl functionalized polyindole conducting polymer composites 
and nanocomposites for future direction for  sensor and biosensor technology. 
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Fig. 8. Potentiometric response in blood serum. Three point calibration curve of this 
response to estimate urea concentration (Inset) 
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1. Introduction 
The detection of various types of microbial agents with harmful effects on human 
population is required in different situations including civil rescue and security units, 
homeland security, military operations in field, protection of public buildings and 
transportation systems including airports, metro and railway stations. Such situations need 
quickly responding, but sufficiently specific detection systems which could be satisfied by 
portable, rapid and simple instrumentation based on the bioanalytical detection principles 
(Lim et al., 2005; Gooding, 2006). For bioagents as microbes, viruses and toxins, various 
types of immunochemical devices seem to be preferred for the early response, good 
sensitivity and continuous monitoring capabilities. The detection occurs on the phenotype 
level, thus no extraction of the genetic material from the agent is required, which is the case 
for methods based on the polymerase chain reaction PCR (Paddle, 1996; Iqbal et al., 2000). 
Our efforts in the biodection area started few years ago; the research on the electrochemical 
immunosensors for bioagents developed from the previous projects focused on the enzyme-
based detection of chemical agents (Krej?í et al., 2008). The principle was amperometric 
biosensor with immobilized cholinesterase, its inhibition was indication of the presence of 
target compounds (organophosphate nerve agents) in the surrounding air. From the 
technological point of view, the biosensor employed thick film based sensors produced by 
screen-printing; the bioanalytical module was easily exchangable. The whole device BioNA 
was small enough (~ 0.5 kg) for hand-held use and it allowed for several hours of 
continuous operation. The acquired experience was further directed to the development of 
electrochemical immunosensors for bioagents detection. 
The detection of bioagents was originally purely military-oriented task due to the long-
lasting historical development of biological warfare agents (BWA). The common 
classification of bioagents comes from the Centers for Disease Control and Prevention (CDC, 
www.cdc.gov). BWA are classified in categories A, B and C. The category A contains the 
most danger agents suitable for easy dissemination and rapid transmition among persons 
resulting in high mortality; the following microbes are on this list: Bacillus anthracis,
Clostridium botulinum toxin, Yersinia pestis, Variola major, Francisella tularensis and several 
viruses causing hemorrhagic fevers - Ebola, Marburg and Machupo. The category B includes 
lower mortality agents moderately easily disseminating, and the category C consists of 
pathogens that could potentially be engineered for mass dissemination. Overall, some 1400 
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infectious organisms are pathogenic to humans, including some 200 viral and 500 bacterial 
species (Taylor et al., 2001). F. tularensis was chosen as a model category A microorganism 
for development and verification of performance of the immunosensor device in our case; 
this was because this microbe has traditionally been investigated in the Department of 
Immunology of Military Academy in Hradec Králové for many years (Janovská et al., 2007). 
2. Tularemia and Francisella tularensis 
2.1 Description of the bacterium and the disease 
Tularemia belongs to diseases of wild animals as hares, rabbits and rodents; it can be spread 
by ticks, flies and mosquitoes. The infection can also be obtained from contaminated food, 
water supply and soil. Occasionally, humans become infected, too. The most frequent 
disease manifestations are ulceroglandular, glanular, oculoglanular, oropharyngeal, 
pneumonic, typhoidal and septic, the onset of tularemia is quite fast and symptoms as high 
fever 38-40 °C, body aches and dry cough can be observed. For disease treatment, antibiotics 
as streptomycin and gentamicin are widely recommended and tetracycline and 
chloramphenicol are alternatives (Enderlin et al., 1994). 
Francisella tularensis is small and nonmotile gram-negative coccobacillus. As the causative 
agent of tularemia, it is highly infective and only few microbes aspirated from the 
surrounding air are able to initiate the disease. For this reason, it was included in the 
category A of potential biological weapons. F. tularensis used to be divided into subtypes A 
and B. At present, four subspecies are described; the most virulent is the subsp. tularensis
(subt. A; sometimes also named as nearctica, it occurres in the North America and was 
reported in Europe), holartica (subt. B; also referred as palaeartica, it is found in the North 
America as well as in Eurasia), mediaasiatica (central Asia) and novicida (it was isolated from 
water supplies in Utah). 
2.2 Assay methods 
Significant efforts exist towards rapid detection of Francisella in various types of samples 
including air, soil and food. For effective detection in the case of its bioterroristic missuse or 
for any preventive monitoring, very high sensitivity needs to be achieved, as only few 
microbes must trigger the positive result. Otherwise, the assay would become inefficient. 
When cultivation tests are used, the best growth is observed in cysteine-enriched broths and 
blood or chocolate-supplemented agars. The characteristically opalescent colonies are 
formed after 24 to 48 hours of incubation at 37 ºC in wet atmosphere. A wide range of 
immunoassays was described including microagglutination (Özcürümez et al., 2004) and 
ELISA (Schmitt et al., 2005). The PCR is typically focused on the tul4 and fopA genes 
encoding 17 and 43 kDa outer membrane proteins, respectively (Emanuel et al., 2003). In the 
case of soil samples, the lowest limit of detection reached only 20 CFU per 1 g of soil 
(Whitehouse & Hottel, 2006). The real-time PCR based on SYBR Green I and tul4 gene for F. 
tularensis LVS achieved limit of detection of 0.69 fg of genomic DNA (Sellek et al., 2008). An 
extensive review of detection methods was published recently (Pohanka et al., 2008).  
3. Immunosensing of Francisella
For bioanalytical detection of Francisella, various types of immunosensors were developed 
and tested. Generally, immunosensors for microbes employ specific capture of the target 
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cells in the sensitive area of a suitable transducer followed by formation of an 
immunocomplex (Fig. 1A). The specific antibodies are mostly prepared against microbial 
antigens exposed at the cellular surface. Antibodies become immobilized at the sensing 
surface, and binding of the microbes is followed either directly in real time using 
piezoelectric and optical devices (Fig. 1A), or indirectly using suitable enzyme labeled 
secondary antibody and an electrochemical measuring system (Fig. 1B). 
          
Fig. 1. Schematic view of direct (A) and indirect (B) immunosensors for detection of 
microbial cells and the direct detection of anti FT antibodies (C). The variants (A, B) employ 
immobilized capture anti FT antibody, which is specifically binding the target microbe. 
Alternatively (C), the immobilized FT antigen binds antibodies specific against it. The signal 
becomes generated in real time for the direct formats (A, C). For the indirect case (B), the 
captured microbial cell is labeled with the secondary antibody conjugated to a suitable 
enzyme label. After washing, the bound enzyme converts the added substrate into a 
measurable product and signal is generated as the last step of the assay. 
Properties of the existing immunosensors for detection of Francisella are summarized in the 
following Table 1. 
The direct measurement seems very attractive as signal is generated in real time - 
immediately after addition of the sample, and no additional reagents are required. 
However, as shown in Table 1, most direct devices provide detection capabilities only for 
microbial contents above 105 CFU/ml; a better sensitivity of assays was demonstrated for 
some of the indirect devices, where the use of sandwich assay formats with enzyme- or 
fluorophore-labelled secondary antibodies provides higher specificity and improved 
detection limits around 104 and even 103 CFU/ml. On the other hand, these formats employ 
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additional immunoreagents (Fig. 1B) and also more complex manipulation. The limits of 
detection required for sufficiently sensitive assay of microbial agents in the form of 
bioaerosols in air are hard to achieve; a partial improvement can be expected due to the 
collection systems capturing microbes from the air to the liquid phase (cyclones), though 
this was not yet demonstrated for Francisell tularensis.
Principle / Assay details LOD(CFU/ml)
Length
(min) Reference 
optical bidiffractive grating biosensor / D ID M 
R 3·10
4 50 O'Brien et al., 2000 
RAPTOR, fiber optic biosensor / ID M R 1·105 10 Anderson et al., 2000 
fluorescence immunosensor / ID M R 5·105 15 Taitt et al., 2002 
piezoelectric immunosensor / D (IgM clusters) 5·106 35 Pohanka & Skládal, 2005 
optial protein chip, sandwich / ID M 2·106 60 Huelseweh et al., 2006 
magnetic biosensor, sandwich, freq. mixing / 
ID, R 1·10
4 > 60 Meyer et al., 2007 
piezoelectric immunosensor / D 1·105 5 Pohanka & Skládal, 2007 
electrochemical immunosensor / ID, M 1000 25 Skládal et al., 2006 
Table 1. Immunosensors proposed for detection of Francisella tularensis. Abbreviations: 
format D direct, ID indirect (with label), R repeated use, M multianalyte. LOD, limit of 
detection 
4. Immunosensor for detection of tularemia 
As it was mentioned above, the detection of cells of Francisella is currently not satisfactory 
compared to the high infectivity, when only few aspirated microbes start the disease. 
However, the progress of the disease after infection takes few days before clinical symptoms 
become manifested. Thus, as an alternative to the rather complicated detection of few 
microbes, an early identification of preclinical symptoms in infected individuals should be 
considered. In fact, tularemia can be treated with antibiotics effectively if detected shortly 
after infection. An early detection of the infection in the pre-clinical phase thus can be very 
valuable for the cases when the detection of microbes fails due to low contents under LOD 
of the assay. This task should employ measurement of anti-Francisella antibodies in serum 
where these appear during immunological defence of human body against infection. 
The immunosensors developed for this purpose in our group will be described in the 
following text. Again, the formats of such assys can be direct (shown in Fig. 1C) and indirect 
where the captured anti-Francisella antibodies from serum are labeled similarly as in Fig. 1B.  
For testing of this approach, the mouse model was used (no human samples from 
individuals suffering with tularemia were available in our country) and the safe live 
vaccination strain of Francisella tularensis LVS was used. As direct and indirect assay 
formats, piezoelectric and electrochemical immunosensors were developed and tested, 
respectively.
4.1 Immunization of mice 
As an animal model for tularemia, a group of female mice BALB/c was used (specific 
pathogen free, supplied by BioTest Konárovice, Czech Rep.). Mice were immunized by F. 
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tularensis in order to obtain the immunized mouse serum (IMS); another control group was 
immunized with Escherichia coli to obtain control (CMS) and the last group provided normal 
serum (NMS) to serve as a blank. 
F. tularensis was applied subcutaneously with 10% of the lethal dose LD50 (0.1 ml of solution 
containing 105 CFU/ml. A similar amount of E. coli was inoculated as a negative control. On 
the days 1, 2, 4, 5, 6, 7, 10, 14 and 21 after immunization, three mice per each group were 
bled under anesthesia and the collected blood sample was incubated at 37.0 °C for 30 min, 
the clot was separated and serum was obtained as supernatant after two centrifugations at 
3000g for 3 min. Serum samples were stored frozen at -20 ºC in aliquots and thawed before 
measurements. All experiments on animals were realized strictly according to local 
legislation. 
4.2 Direct piezoelectric immunosensor 
The piezoelectric quartz crystals with gold electrodes (10 MHz, International Crystal 
Manufacturing) were modified with a monolayer of cystamine, to which the F. tularensis
antigen was covalently linked using glutaraldehyde (Pohanka et al., 2007a). The crystal was 
fixed in a flow-through cell and all assay steps were performed in a flow-through set-up, the 
solutions at the input were exchanged manually. After stabilization of the initial 
background frequency (signal) in buffer for 2 to 5 min, the sample was introduced for 5 min 
to measure its association with the immobilized antigen. Afterwards, a zone of buffer 
followed and finally, the surface was regenerated for repeated use with 50 mM NaOH with 
0.1% Triton X-100. The typical real-time signals for both blank serum and sera from infected 
mice are shown in Fig. 2, left part, regeneration phase is not shown. The experimental 



















y = A2 + (A1-A2)/[1 + exp((x-x0)/d)]
A1 = 25.8 ± 2.7   A2 = 88.7 ± 1.5






Fig. 2. Progress of infection with Francisella in mouse followed using the piezoelectric 
immunosensor. Levels of anti-Francisella antibodies were measured in mouse sera taken in 
the indicated days after innoculation. Response traces (left) and plot of responses (decrease 
of frequency as signal) vs. time (right). Specific sensor contained FT antigen covalently 
linked to the sensing surface, the reference sensor was modified with bovine serum 
albumin.
The crude non-purified (only diluted 10-times) sera collected from the infected mice on days 
1, 3, 5, 7, 10 and 14 after inoculation were measured. NMS from healthy mice and CMS from 
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mice immunized by E. coli served as negative controls. Each sample was diluted ten times. 
The overall progress of antibody production is presented in Fig. 2, right part. The infection 
process was obvious even on the 1st day after innoculation; the signal of 33 Hz resulted for 
IMS while NMS provided only 28 Hz. The rapid increase of response continued to the 5th 
day (87 Hz) and the further increase was slower achieving maximum at 95 Hz on the 14th 
day. This behaviour corresponds with the first manifested symptoms of disease around the 
5th day from infection (Ohara et al., 1991). No relevant difference between signal of NMS 
and CMS was observed. The control sensor containing immobilized bovine serum albumin 
as sensing element provided signals below 5 Hz with all the tested sera – CMS, NMS as well 
as IMS; this proves specifity of the immunosensor assay. 
The obtained results were evaluated using the t-test (IMS vs. NMS, both measured on the 
specific immunosensor with immobilized LVS antigen, n = 3). The results measured on the 
1st day after inoculation can be classified as positive with the probability level of 0.95, 
results from the following days (3rd and higher) were always detected with the probability 
level of 0.99. The RSD values for the NMS and IMS (day 14) samples were 2.3% and 2.4% for 
intra-day measurements (n = 5). 
Fig. 3. The compact piezoelectric immunosensor (left) with integrated flow-through cell. The 
flow of solutions is realized using the miniperistaltic pump (right). The exchangable 
piezoelectric quartz crystal is shown in front. 
4.3 Indirect amperometric immunosensor 
The amperometric immunosensor was based on the gold screen-printed 4-channel electrode 
array (AC8, BVT Technologies), F. tularensis antigen was covalently immobilized on the self-
assembled monolayer of cysteamine (Pohanka & Skládal, 2007b). The serum sample was 
measured in duplicate together with control and blank; 2.5 µl of diluted serum was directly 
dropped on the working electrode and incubated for 5 min. After washing, the anti-mouse 
peroxidase-labeled tracer Ab (SwAmPx, Sevapharma) was added and incubated for 5 min. 
Finally, the surface-bound peroxidase was measured amperometrically in a flow-through 
system: 
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Thus generated signal traces are shown in Fig. 4, left part, for the blank serum (non-infected 
mouse) and from sera obtained from infected mice taken in the indicated days after 
infection. The responses of sera (decrease of current) from individual days are shown in the 
right part together for both F. tularensis (immunized) and E. coli (control) groups. 
The blank signal for NMS varied near around 21 nA without exhibiting any pronounced trend; 
similar but slightly higher response was observed for the control serum; CMS provided a 
higher signal (22 to 25 nA) in comparison with NMS. The IMS samples taken one day after 
immunization demonstrated a signal above 23 nA which was continuously increasing in the 
















y = A2 + (A1-A2)/[1 + exp((x-x0)/d)]
A1 = 22.5 ± 3.3   A2 = 39.2 ± 1.1






Fig. 4. Progress of infection with Francisella in mouse followed using the amperometric 
immunosensor. Response traces (left) and plot of responses (decrease of current as signal) 
vs. time (right). Specific sensor contained FT antigen covalently linked to the sensing 
surface, sera from non-imunized mice served as control. 
Significantly higher signals from IMS were measured on the 5th day after immunization 
(32.2 ± 1.6 nA) in comparison with CMS (25.0 ± 1.9 nA). Statistically, distinguishing IMS and 
CMS in one day after immunization was questionable; the probability of difference was on 
the level 0.60 (t-test). In the following sampling on days 2 and 4, the probability grew up to 
the levels 0.75 and 0.89, respectively, and starting on the 5th day, the probability level was 
above 0.99. 
The developed amperometric immunosensor provided good reliability and sensitivity of 
assays. A small amount of 2.5 ?l sample was based on appropriately diluted 0.1 ?l of 
original sera. Consequently, this technique can be applied in field laboratories. The 
instrumentation used for measurements (Fig. 5) is fully portable and battery operated (> 10 
hours after full charge). After insertion of the strip sensor to the cell, the measuring sequence 
is fully automated using a script-based programming. The flow-through format was 
adopted due to better precision of assays; if the measurement will be based on a drop of 
substrate mixture, further miniaturization can be feasible. An important parameter of the 
assay is the speed of measurement. Here, the limiting step was measurement of the output 
signal (5 min). The other assay steps such as preincubation with sample and regeneration 
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can be parallelized and include unlimited number of biosensors. Thus, considering four 
measuring spots per the strip, up to ten measuring cycles corresponding to 40 assays can be 
realized within one hour. 
Fig. 5. The amperometric immunosensor detector ImmunoSMART. In the left part of the 
front pannel, four miniature peristaltic pumps are connected to minitubes with bioreagents. 
The flow-through cell fixed in the holder contains the exchangable screen-printed 
immunosensor. 
4.4 Correlation of results from piezoelectric and amperometric immunosensors 
To compare evaluation of sera originated from infected mice, the results obtained from both 












Linear fit: y = A + Bx
A = 0.33?? 0.12   B = 0.57 ? 0.14
R = 0.901
Fig. 6. Correlation of results for detection of anti FT antibodies in immunized mouse sera 
between piezoelectric and amperometric immunosensor; normalized data were used for 
correlation.
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comparison, data from both systems were normalized; the results were divided by the 
maximal observed response to be within the 0 to 1 range. A linear correlation was obtained 
(R = 0.901), however, the slope of the linear regression was not equal to 1 as well as the 
intercept value was significantly different from 0. Obviously, this is due to the higher 
proportion of the binding fraction of serum immunoglobulins able to recognize a wider 
group of microbial antigens even before the infection with F. tularensis took place; this was 
affecting response of the amperometric immunosensor significantly more than the 
piezoelectric one. In fact, the simplified assay procedure for the latter one seems 
advantageous, as there can not be any influence of the tracer binding. In addition, based on 
the statistical t-test data, the direct piezoelectric system allowed earlier to resolve the sera 
originating from control and infected mice. 
5. Future trends 
Despite the promising results allowing rather fast identification of infection with tularemia, 
the straightforward detection and identification of bioagents remains challenging. 
Fig. 7. Schematic representation of an amperometric immunosensor linked to the cyclone 
device for detection of bioaerosols. 
In real situations, the monitoring of air for presence of danger bioagents should be carried 
out with sufficiently low limits of detection. For this reason, sampling of the monitored air 
should be realized with the help of a cyclone system, which captures particles from air and 
concetrates them in a small volume of solution. Thus obtained sample can be subsequently 
analyzed with either direct or indirect immunosensor (Fig. 7). For detection of bioagents, the 
amperometric detector should be preferred, as the use of enzyme labels provides 
significantly enhanced sensitivity compared to direct protocols (Table 1). The system based 
on the developed immunosensor detector ImmunoSMART and a commercially available 
cyclone SASS 2300 (Research International) is shown in Fig. 8. A program controlling both 
subsystems was developed in order to allow synchronized operation. 
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Fig. 8. Set-up for analysis of bioaerosols consisting of the detector ImmunoSMART and 
cyclone SASS 2300 (Research International). 
For model detection of microbes in bioaerosols, the completely safe strain of Escherichia coli
DH5? was used as Francisella must not be disseminated in air. In this case, sampling of air 
was carried out using a cyclone device for 10 min and the accumulated sample was 
transferred to the ImmunoSMART device. Preliminary unpublished results indicate 
feasibility of detection of 100 CFU/l in air, the total time of analysis being around 20 min. 
6. Conclusion 
The amperometric and piezoelectric immunosensors suitable for assay of Francisella 
tularensis and the associated disease tularamia are developed. A novel method for the 
indirect detection was based on the measurement of anti tularemic antibodies in serum 
samples of infected mice as a model microorganism. The direct piezoelectric biosensor was 
able to detect the onset of the infection process very early, even one day after injection of the 
bioagent. The advantage of this method is a simple direct arrangement with low cost of 
analysis. The proposed concept of the immunosensor seems to be suitable also for screening 
of human sera. The current efforts are mainly focused on the direct detection of harmful 
bioagents as bacteria, viruses, toxins and other pathogen and biosensors play quite 
important role. However, for the highly toxic bioagents causing infection in only a very 
small dose (low concentration, few microorganisms only), the primary detection could 
potentially fail and the bioagents will remain undetected. In this case, the highly sensitive 
complementary detection of the infection becomes extremely important. In adddition, a 
novel method for the indirect detection of Francisella tularensis was based on the screen-
printed electrochemical sensing array with four measuring spots. The advantage of this 
multichannel sensor is the option for simultaneous measurement of the tested sample and 
ImmunoSMART
cyclone S2300
flow cell with 
immunosensor
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the control negative blank. In this way, the acquired responses will allow compensation of 
fluctuations in assay conditions (temperature, flow rate stability, decrease of the binding 
capacity, etc.). This becomes quite important when the developed immunosensor becomes 
utilized in field conditions. 
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1. Introduction 
The parallel discovery of the catalytic potential of RNA by Tom Cech and Sydney Altman at 
the beginning of the 1980s completely changed our view of the capabilities of RNA 
molecules and won them the Nobel prize in 1989 (Kruger et al., 1982; Guerrier-Takada et al., 
1983). Since then, many new roles have been discovered and assigned to RNA, including the 
ability to form complex multitasking, supramolecular machines, such as ribosomes or 
spliceosomes, in which RNAs play leading roles. While only about 1.5 % of the human 
genome codes directly for protein sequences, a large fraction of it is nonetheless transcribed 
to produce many noncoding RNAs (ncRNA) that carry out important cellular functions 
(International Human Genome Sequencing Consortium, 2004). The structures and functions 
of some ncRNA have been extensively characterized, for example, ribosomal RNAs (rRNA), 
transfer RNAs (tRNA), small nuclear and nucleolar RNAs (snRNA and snoRNA). Moreover, 
applications of recent technological advances are revealing new classes of ncRNA molecules 
with novel or yet unknown functions, ranging in size from very small (20-30 nts) to 
thousands of nucleotides long. Small ncRNA (~20-30nts in length) include microRNA 
(miRNA), Piwi-interacting RNA (piRNA), small interfering RNA (siRNA), trans-acting 
siRNA (ta-siRNA), natural antisense transcript siRNA (nat-siRNA) and small scan RNA 
(scnRNA) all of which help regulate various stages of gene expression (Choudhuri, 2009). 
The functions of “long noncoding RNA” are still not understood, but they seem to be 
involved in transcriptional and epigenetic gene regulation (Ponting et al., 2009). 
Many ncRNAs form distinct yet very diverse three-dimensional structures to carry out their 
functions (Noller, 2005; Staple & Butcher, 2005; Montange & Batey, 2008). These functions 
include fundamental roles at all stages of gene expression including chromosome 
remodeling, transcriptional and translation regulation, mRNA processing, transport, and 
localization, protein translocation and posttranslational modification. RNA molecules use 
various mechanisms to participate in these processes. For example, miRNA, siRNA and 
piRNA inhibit gene expression by hybridizing to complementary sequences of target 
mRNAs in association with RISC ribonucleoprotein complexes and either temporarily block 
translation or target the mRNA for destruction (Carthew, 2006; Bushati & Cohen, 2007; 
Boyd, 2008). Riboswitches, usually located in the 5' untranslated region (5’-UTR) of mRNA, 
also inhibit translation, but do so by forming specific three-dimensional structures, that 
respond to small molecule metabolites that are products of the pathway to which the gene 
belongs. Upon binding cognate metabolites, riboswitches undergo conformational changes 
in their secondary and tertiary structures which usually result in suppression of 
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transcription or translation. Some riboswitches actually function as ribozymes, resulting in 
self-cleavage of the mRNA and complete inactivation of the mRNA (Montange & Batey, 
2008; Winkler et al., 2004). 
Defects in RNA expression or processing due to mutations and misregulation can lead to 
serious diseases (Cooper et al., 2009). Recent studies of miRNA suggest their important role 
in cancer biology (Lee & Dutta, 2009). The expression levels of specific miRNA are highly 
correlated with tumor, tissue type or disease stage. Aberrant miRNA levels are also 
involved in other diseases, including Tourette's syndrome, fragile X syndrome, myotonic 
dystrophy, and schizophrenia (Abelson, 2005; Caudy et al., 2002; Bilen et al., 2006; Perkins et 
al., 2007).
All RNAs are produced by transcription in the nucleus, where most processing also takes 
place. Processing may require transport of RNA between specific locations in the nucleus 
(Vargas et al., 2005). Once mature, most RNAs are exported to the cytoplasm through the 
nuclear pores (Stewart, 2007; Kelly & Corbett, 2009), where some may be shuttled back to 
the nucleus (Hwang et al., 2007; Takano et al., 2005). Once in the cytoplasm, RNAs maybe 
further transported to specific sites to carry out their functions, depending on the cell type, 
its developmental stage, environmental signals or perturbations.    
2. Review of RNA detection/visualization methods 
 Several general methods for in situ or in vivo visualization of RNA processing and transport 
are currently being used. However, none are as powerful and versatile as methods 
developed to visualize proteins in vivo that employ autofluorescent proteins such as green 
fluorescent protein (GFP) and its relatives. Autofluorescent ptotein (AFP) technology was 
made possible by a series of advances beginning with the isolation of GFP from jellyfish in 
1962 by Osamu Shimomura. It was not until much later, however, that GFP was cloned by 
Douglas Prasher (1992) and expressed in different microorganisms by Martie Chalfie 
(Shimomura, 2009; Chalfie, 2009; Shimomura et al., 1962; Prasher et al., 1992; Chalfie et al.; 
1994). Later, Roger Tsien contributed to this field by engineering a whole library of GFP 
color mutants with increased photostabilities and a wide range of absorption and emission 
frequencies (Tsien, 2009; Shaner et al., 2004; Wang et al., 2004; Heim et al., 1995). In 
conjunction with advances in fluorescence microscopy and new spectroscopic tools, AFP 
technology enabled the development of general purpose methods for intra-cellular genetic 
tagging to monitor the motions and interactions of two or more proteins simultaneously. 
This methodology involves genetic fusion of an autofluorescent protein to the protein of 
interest and its localization at the subcellular level by fluorescence microscopy in vivo
(Bertrand et al., 1998). Unfortunately, no autofluorescent RNA molecules have been 
discovered to date that can be used to both detect and monitor RNA in vivo.  Given the 
important and diverse roles RNA molecules play in living cells, developing new tools for in
vivo monitoring of RNA dynamics is crucial for better understanding RNA transport, 
localization, and functional interactions. 
2.1 FISH and molecular beacons probes 
Traditional methods for determining which RNAs are produced by a given cell population 
involve cell disruption and total RNA extraction and its analysis in vitro using various tools 
to identify and quantify specific RNAs. Currently available methods include polymerase 
chain reaction (PCR), to amplify low copy RNA, Northern Blotting, to separate cellular RNA 
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by size, microarrays and serial analysis of gene expression (SAGE) for high throughput 
detection of many RNAs at once. Most techniques require the extraction of RNA from cell 
populations although some have been adapted for single-cell analysis. The ability to study 
RNA in a single live cell offers new capabilities for investigating gene expression to better 
understand RNA function in living cells. This chapter focuses exclusively on fluorescence-
based methods, which at this time seem to be the best adapted for in vivo real-time RNA 
visualization to yield subcellular spatial information. 
Fluorescence-based techniques have gained popularity for several reasons. While 
radioactive labeling and autoradiography are potentially more sensitive, fluorescent-based 
methods have the advantages of 1) using labels with long shelf lives, 2) low toxicity and ease 
of handling, and 3) high resolution imaging at the single cell level. Moreover, a variety of 
fluorophores and quenchers, which differ in excitation and emission wavelength, 
fluorescence lifetime, and anisotropy, are commercially available. This makes fluorescent-
based methods excellent candidates for high-throughput screening and real-time in vivo
detection.  
Several recent reviews provide a critical evaluation of fluorescent methods that are currently 
available for live-cell RNA imaging (Bao et al., 2009; Rodriguez et al., 2007; Tyagi, 2009; 
Schifferer & Griesbeck, 2009, Raj & van Oudenaarden, 2009). Modern fluorescent 
visualization approaches can be subdivided into the two main groups with respect to how 
the fluorescent probe is delivered (Figure 1). The traditional and still most widely used 
method is fluorescent in situ hybridization (FISH) (Moter & Gobel, 2000; Amann et al., 2001), 
which makes use of short exogenous oligonucleotide probes (about 15-30 nts in length) that 
carry a fluorophore tag and are complementary to a selected sequence in the target cellular 
RNA molecule. The main limitation of FISH is that the emission signal of bound and 
unbound probes is about the same, so cells must be fixed prior to hybridization and then 
extensively washed to remove unbound probes, which otherwise interferes with the desired 
signal. Newer “quenched probe“ methods for in vivo RNA visualization employ 
fluorophore-labeled hybridization probes to which quencher molecules are also attached to 
quench the emission of the fluorophore when the probe is not bound to the target RNA
(Figure 1A). This approach eliminates the need for washing unbound probes and allows 
direct imaging of RNA in intact cells. A variety of probe designs have been implemented to 
position the quencher close to the fluorophore in the unbound state while separating them 
when the probe binds to its target. "Molecular beacons" (MBs) are the best-known examples 
of this class of probes (Tyagi and Kramer, 1996; Tyagi et al.; 1998). In the simplest design, the 
quenched probe forms a hairpin stem-loop structure in which the loop sequence is 
complementary to the target RNA and the fluorophore and quencher molecules are attached 
to the 5' and 3' ends of the probe. The terminal four to six bases of the 5’ and 3’ ends are 
complementary, so that in the absence of the target they form a short double helical stem 
that brings the quencher close to the fluorophore, thus quenching its fluorescence. Upon 
recognition of the target sequence, the hairpin stem of the probe unfolds. This separates the 
fluorophore from the quencher and restores fluorophore emission. For more information 
about the design and use of molecular beacons as probes for in situ hybridization the reader 
is referred to the recent publications on the subject (Silverman & Kool, 2005; Tsourkas et al., 
2003; Wang et al., 2009; Bao et al., 2009). Numerous variations of quenched probes, which 
aim to improve the signal-to-background ratio, increase in vivo stability or target specificity, 
have been introduced (Bao et al., 2009). A major concern is to balance specificity and binding 
kinetic on- and off-rates. Increasing the length of the probe sequence complementary 
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Fig. 1. Schematic representation of several strategies for in vivo RNA visualization. The 
target RNA is represented as a blue strand containing an orange probe hybridization site or 
protein-binding motifs.  A. Probe-target hybridization using “quenched” probes (green 
strands with attached fluorophore (red) and quencher (black). “Quenched” probes are 
optically silent in the absence of target. Molecular beacons (on the left) form helical stem that 
brings quencher close to chromophore. Upon target binding, the terminal stem is disrupted, 
separating the fluorophore-quencher pair and restoring fluorescence. Strand-displacement 
probes (on the right) are the pairs of complementary sequences. Upon target recognition, 
green strand forms more stable probe-target hybridization complex leading to the black 
strand displacement and yielding emission signal. B. RBP-AFP strategy. Multiple binding 
motifs for a specific RBP are genetically encoded into the 3’-UTR region of the target RNA 
(orange region of the sequence). RNA-binding protein (shown in pink) is than fused with 
GFP (green color) that serves as a fluorescent reporter. When both modified target RNA and 
RBP-GFP construct are co-expressed in the cell, RBP-GFP constructs interact with target 
RNA resulting in high localization of fluorescent signal.  
to the target increases specificity so long as (i) the melting temperature for exactly matching 
sequences is greater than physiological temperature and (ii) the melting temperature for 
single-base mismatches remains below this temperature. If the hybridization sequence is too 
short, unintended targets may also be bound thus decreasing specificity. If it is too long, one 
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or more mismatches may be tolerated, decreasing specificity and reducing off-rates from 
correct targets and thus decreasing the biosensor’s responsiveness to decreases in levels of 
the target RNA. 
To increase in vivo stability and prevent Rnase H degradation of the probe, oligonucleotides 
with modified backbone have been introduced, including 2’-O-methyl modified MBs, locked 
nucleic acid MBs (LNA-MBs) and peptide nucleic acid MBs (PNA-MBs). For further 
information regarding these modifications, the following publications should be consulted 
(Tsourkas et al., 2002; Wang et al., 2005, Kuhn et al., 2002).  
A number of innovations have been proposed to improve the signal-to-noise ratio of 
molecular beacons such as dual fluorescence resonance energy transfer (FRET) MBs and 
quenched autoligation (QUAL) probes (Santangelo et al., 2004; Santangelo et al., 2006; 
Satterfield et al., 2007). Dual FRET MBs involve a pair of quenched probes that bind to 
adjacent sites on the target RNA. One probe contains a FRET donor, and the other a FRET 
acceptor. When both are bound to the target, the donor can transfer its excitation energy to 
the acceptor, producing FRET emission. A further improvement to dual probes is the use of 
quenched autoligation (QUAL) probes which bind to adjacent sites and autoligate forming a 
single long probe that binds to the target with high specificity (Silverman and Kool, 2005). 
However QUAL probes have the disadvantage of binding essentially irreversibly to targets 
and hence cannot be used to monitor decreases in target RNAs dynamically. 
Quantum dots, gold or silver nanoparticles and photoluminescent polymers were recently 
introduced as alternatives to organic fluorescent dyes for labeling hybridization probes 
(Algar et al., 2009; Kim et al., 2008). Quantum dots are brighter and have better resistance to 
photobleaching than organic fluorophores. Moreover, quantum dots possess broad 
absorption bands and narrow tunable emission bands that are desirable for optical 
multiplexing. In comparison with conventionally labeled probes, that have a tendency to 
accumulate rapidly in nuclei when microinjected, probes conjugated to quantum dots 
remain in the cytoplasm (Chen et al., 2007). Photoluminescent polymers and gold 
nanoparticles have better quenching efficiencies as compared to organic dyes (Kim et al., 
2008).
Disadvantages of FISH and “quenched probe” techniques include the requirements for 
time-consuming and expensive chemical modifications of probe sequences to covalently 
attach fluorophore and quencher molecules. Moreover, these conjugates are not able to 
diffuse directly into cells and require perturbation or disruption of the membranes. 
2.2 RNA labelling with AFP conjugates 
2.2.1 General GFP-based strategy 
GFP and related autofluorescent proteins, proven immensely useful in visualizing proteins 
in vivo, have also been adapted for detection of RNA molecules in vivo (Bertrand et al., 1998; 
Valencia-Burton et al., 2007). The basic approach involves the genetic fusion of an RNA-
binding protein domain (RBP) to an auto-fluorescent protein such as GFP (Figure 1B). The 
simultaneous genetic modification of the gene for the cellular RNA of interest incorporates 
an RNA sequence that is recognized by the RBP domain in the target RNA at a location, that 
does not interfere with its function. This approach was demonstrated by Bertrand and 
coworkers, who genetically fused the coat protein from the bacterial phage MS2 to GFP to 
track in vivo mRNA encoded from a gene into which multiple MS2 coat protein-binding sites 
were inserted (Bertrand et al., 1998). When the RBP-GFP fusion and the modified target 
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RNA are co-expressed in the same cells, multiple copies of RBP-GFP bind to the target RNA, 
producing a strong fluorescent signal. However, RBP-GFP constructs also emit in their 
unbound forms and contribute to the background signal. Thus, the need to bind multiple 
copies of RBP-GFP to the target RNA is to achieve adequate signal-to-background ratio. The 
disadvantage is the relatively large size of the fluorescent probe complex, which can 
potentially interfere with RNA transport and localization. 
2.2.2 “Split-GFP” 
To reduce the background signal from unbound RBP-GFP, the “protein fragment 
complementation” (PFC) or “split-GFP” methodology was introduced (Valencia-Burton et 
al., 2007). This method involves the application of rational protein design to separate the 
autofluorescent protein sequence into two parts that do not fluoresce individually and can 
be expressed separately. Each part is fused to a different RBP domain. In the presence of a 
target RNA that is engineered to contain adjacent binding motifs specific to the two RBPs, 
the two protein fragments are brought together to reconstitute an intact fluorescent protein. 
In addition to reduced background signal, this method has the virtue that it does not require 
introducing exogenous RNA fluorescent probes, and can therefore be considered a label-free 
method.  The main disadvantage of this method is the fact that signal generation is 
essentially irreversible, limiting its use for real-time dynamics of RNA expression levels. An 
additional limitation of AFP-based methods is the relatively large size of the protein tag 
(~270 kDa for multiple copies), which raises concerns that transport and localization of the 
target RNA may be perturbed (Bao et al, 2009; Tyagi, 2009).  
We compare the features and advantages/disadvantages of the latter-mentioned methods 
for in vivo imaging of RNA in Table 1. Rows specify probe and target parameters or 
additional limitations/advantages. Hybridization probes are subdivided into FISH probes 
(column 2) and “quenched probes“, including MBs (Column 3); autofluorescent probes 
(AFP), including GFP, are subdivided into fused (Column 4) and split formats (Column 5). 
An alternative imaging strategy involves fluorogen-binding aptamers (column 6,7) and will 
be discussed in the next section, starting with a brief overview of aptamer selection 
technology and extending to a detailed discussion of how aptamers have been adapted for 
use as biosensors. These methods are not as developed as RBP-AFP and hybization methods 
but show potential for further development for in vivo use. 
3. Aptamer-based RNA detection 
3.1 Overview of aptamer technology 
Aptamers are functional, single-stranded RNA or DNA oligonucleotides, usually 30 to 100 
nts in length, artificially selected from combinatorial libraries for high binding affinities to 
specific molecular targets. Combinatorial libraries of oligonucleotides, randomized at 
desired sequence positions and comprising up to 1016 different sequences, can be easily 
generated by modern nucleic acid synthesizers. The process of screening a randomized 
oligonucleotide pool to identify and amplify sequences that perform a specific function is 
called “Systematic Evolution of Ligands by Exponential Enrichment” (SELEX) and was 
introduced almost 20 years ago (Tuerk & Gold, 1990; Ellington & Szostak, 1990). SELEX has 
been used to obtain high affinity aptamers to almost any conceivable target and has even 
been adapted to obtain catalytic nucleic acids (ribozymes and DNAzymes) by selecting for  
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Table 1. Comparative analysis of in vivo RNA visualization methods. *-calculations based 
on 330 Da per nucleotide. 
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transition-state analogues (Weigand et al., 2006; Schlosser et al., 2006). This technology has 
therefore revolutionized the field of sensing chemistry by enabling researchers to 
systematically generate numerous aptamers targeting a diverse range of analytes. Large 
numbers of RNA and DNA aptamers have been obtained by this method in the past 20 
years, targeting a broad range of small molecules including organic dyes, amino acids, 
cofactors, carbohydrates and nucleotides, as well as proteins and nucleic acids (Klussmann, 
2006). Aptamers against different classes of antibiotics, proteins and even whole cells have 
already found wide applications in biosensing, diagnostics, drug development and 
nanomedicine, as recently reviewed by other authors (Liu et al., 2009; Cho et al., 2009).
Aptamers provide a nucleic acid-based alternative technology to monoclonal antibodies for 
specific recognition of diverse molecular targets. Aptamer selection exhibits a number of 
advantages over monoclonal antibody technology including: 1) versatility in designing 
selection strategies; 2) lower cost; and 3) easy scale-up and production as no cell or animal 
culture is needed. Other advantages of using nucleic acid aptamers in biosensors include 
their relatively small sizes, high analyte specificities and high affinities (Kds down to pM 
range), low toxicities and immunogenicities, and amenability to chemical modification to 
suit the desired application. Finally, they are small enough that their 2D structures can be 
reliably predicted and their 3D structures solved by NMR solution methods, which 
facilitates “tuning up” their chemical and biological properties. 
 SELEX begins with chemical synthesis of a randomized DNA pool. If selection of an RNA 
aptamer is the goal, the DNA pool is transcribed prior to the selection procedure. Next, the 
pool is incubated with the target molecule to achieve efficient binding. This is followed by a 
carefully designed selection step to sequester those DNA or RNA oligonucleotides in the 
pool exhibiting the desired functional properties - this selection process being the most 
crucial step. Finally, the amplification step enriches the pool, and the entire cycle is repeated 
for a sufficient number of times to obtain a pool comprising only molecules with a desired 
functional property. The original SELEX procedure has been modified to achieve higher 
affinity and specificity of aptamer products (e.g. Negative SELEX, Counter SELEX), to 
improve selection towards more complex targets (e.g. Genomic SELEX, Deconvolution-
SELEX, Tissue-SELEX) or to select aptamers with novel functional properties (e.g.Covalent 
SELEX, Photo-SELEX) (Stoltenburg et al., 2007).  
The Ellington group established a database of aptamers that is current as of 2006 and 
provides aptamer  targets, sequences, details regarding selection procedures and references 
to original publications. It can be accessed at http://aptamer.icmb.utexas.edu/site (Lee et 
al., 2004). 
3.2 Fluorogen-binding aptamer-based systems with light-up properties 
Organic dyes were the first targets used to develop the SELEX methodology for RNA and 
DNA (Ellington & Szostak, 1990; Ellington & Szostak., 1992). Recent work has been directed 
to obtain aptamers that target fluorogenic dyes, with the aim of developing new in vivo
tagging systems for cellular RNA molecules as alternatives to RBP-GFP fusion constructs. 
However, initial selections of fluorophore-binding aptamers were actually intended for 
other purposes. For example, Malachite Green (MG) dye has long been known to generate 
hydroxyl free radicals when irradiated with visible light. Liao et al exploited this property in 
1994 by conjugating MG to antibodies to target proteins in vivo, a technique called 
“Chromophore-assisted laser inactivation” (Liao et al., 1994). This inspired Grate and 
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Wilson to select an RNA aptamer to bind MG and selectively target specific RNA molecules 
for inactivation in vivo (Grate & Wilson, 1999). An RNA aptamer to Hoechst dye 33258 was 
also selected to study gene regulation while RNA aptamers for Sulforhodamine B and 
Fluorescein were selected for potential in vivo RNA labeling (Werstuck & Green, 1998; 
Holeman et al, 1998). Werstuck and Green showed that they could regulate a gene in vivo
which had been modified by the insertion of the Hoechst dye by adding the dye to the 
medium (Werstuck & Green, 1998).  
This earlier work was subsequently adapted to obtain high-affinity aptamers that specifically 
bind to fluorogenic dyes, defined as molecules which exhibit minimal emission when free in 
solution, but which fluoresce intensely when tightly bound. Any strategy where an increase in 
emission signal occurs upon specific binding to a target is called a "light-up" methodology, and 
fluorogen-aptamer complexes are often referred to as “fluoromodules” or “light-up pairs”. The 
performance of sensing systems is usually quantified in terms of “fluorescence enhancement” 
and so it is important to define what is meant by this term. For classic molecular beacons or 
FRET probes, fluorescence enhancement is defined as the ratio of the emission of the probe 
bound to its cognate target divided by the emission of free probe in the absence of the target. 
For light-up dye/aptamer pairs, fluorescent enhancement is defined as the ratio of the 
emission of the light-up dye bound to its aptamer divided by the emission of the free dye in 
solution. For biosensors employing light-up dye/aptamer pairs allosterically linked to target 
recognition domains, fluorescence enhancement is defined as the ratio of the emission of the 
dye in the presence of both biosensor and target divided by the emission of the dye in the 
presence of the biosensor alone. In genetic fusions of dye-binding aptamers with target RNAs, 
fluorescence enhancement is the ratio of the emission of the dye bound to the aptamer fused 
with the target RNA divided by the emission of the dye in the presence of the target lacking 
aptamer modules. 
We focus the rest of this section on efforts to design light-up pairs and to adapt them for use 
as biosensors to detect and image specific molecules in vitro and in vivo. We begin with the 
MG aptamer light-up pair, which exhibits the most dramatic increase in fluorescence (Figure 
2). Triphenylmethane dyes such as MG exhibit low fluorescence when free in solution due 
to deactivation channels associated with torsional motion of phenyl groups. When placed in 
environments that restrict these motions, these dyes become strongly fluorescent. 
Babendure et al were the first to observe that MG fluorescence increased dramatically when 
the dye is bound to the aptamer selected by Grate and Wilson, and thus subsequent works 
focused on adapting this light-up pair for biosensing (Babendure et al., 2003; Grate & 
Wilson, 1999). Crystal structure analysis of the MG aptamer bound to tetramethylrosamine 
(TMR), a MG analog, revealed that it comprises an RNA helix containing a large and 
asymmetrical internal loop (Baugh et al., 2000). The nucleotides of the internal loop form a 
series of stacking and non-Watson-Crick basepairing interactions to create a unique binding 
pocket that restricts the flexibility of the dye and keeps it in a highly fluorescent state 
(Figure 2A, 2B). The high affinity of this aptamer for MG (Kd=117 nM) and the high 
fluorescence enhancement that results from binding (2360-fold) have encouraged several 
groups to apply it to create programmable nucleic acid biosensing platforms (Babendure et 
al., 2003; Stojanovic & Kolpashchikov, 2004; Hirabayashi et al., 2006; Afonin et al., 2008). 
These will be described in more detail in the next section after we cover other efforts to 
develop new light-up pairs. 
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3.3 Novel approaches for  “light-up” dye/aptamer pairs selection 
Sando and coworkers suggested a new route for generating specific light-up pairs starting 
with a conventional fluorescent DNA-staining dye that exhibits a number of favorable 
characteristics, including cell permeability, solubility, and stability in cellular environments 
(Sando et al., 2007; Sando et al., 2008). The key idea to this approach was demonstrated 
using Hoechst dye 33258, a widely used fluorescent stain for dsDNA molecules that 
fluoresces upon binding to the minor groove of dsDNA. To adapt this dye for more specific 
light-up applications, a variety of chemical modifications of the dye were employed to 
reduce or completely suppress its nonspecific affinity for dsDNA. The most effective 
modification of the dye for this purpose was the addition of two t-Butyl groups to its 
terminal phenol ring (The resulting “Hoechst 33258 derivative” is shown in Figure 2C). 
Next, SELEX was used to obtain a DNA aptamer that bound Hoechst 33258 derivative with 
Kd = 878 nM and enhanced fluorescence emission by 191-fold (Sando et al., 2007). Further 
work obtained an improved RNA aptamer showing higher affinity for the dye (Kd=35 nM) 
but somewhat reduced emission enhancement (56-fold).  
A similar strategy was adapted by Constantin and coworkers to design a novel fluorogenic 
cyanine dye, Dimethyl Indole Red (DIR) (Constantin et al., 2008). Cyanine dyes such as 
thiazole orange (TO) and its derivatives are fluorogenic intercalation dyes that comprise two 
heterocycles separated by a methine group. Substitution in TO of a bulky dimethylindole 
heterocycle in place of the thiazole ring sterically hindered intercalation. Addition of an 
anionic propylsulfonate group further minimized nonspecific interactions with nucleic acids 
by increasing electrostatic repulsion (DIR is shown in Figure 2C). An RNA aptamer was 
obtained for DIR by SELEX that binds with Kd=87 nM and 60-fold emission enhancement. 
An advantage of the cyanine dyes is that they have relatively narrow emission bands, their 
emission wavelength maxima easily varied by chemical modification. As a group, their 
emission maxima cover much of the visible spectrum and extend into the near infrared.  
Another recently developed approach for creating light-up dyes is to start with a dye that 
emits when free in solution and to covalently attach electron donor groups that quench its 
emission by a photo-induced electron transfer (PET) process (Sparano & Koide, 2005; 
Sparano & Koide, 2007). Aptamers that bind exclusively to the quencher moieties are then 
selected. The idea is to obtain aptamers that can block electron transfer and thereby restore 
emission of the fluorophore moiety. The PET approach was demonstrated in principle using 
2',7'-dichlorofluorescein (DCF) as a fluorophore and N-(p-methoxyphenyl)-piperazine 
(MPP) as a quencher (Figure 2D). An RNA aptamer for the MPP quencher moiety was 
obtained by SELEX and was indeed found to enhance DCF fluorescence in the DCF/MPP 
conjugate in a concentration-dependent manner. As the authors pointed out, however, this 
particular DCF-MPP/aptamer system is unsuitable for in vivo applications because the 
fluorescence enhancement is only about 13-fold at 100 ?M aptamer concentration (Sparano 
& Koide, 2007). 
A novel class of light-up probes for RNA detection was developed by Stojanovic's group by 
conjugating nonspecific fluorogenic intercalating dyes such as thiazole orange (TO) to small 
molecules such as GMP and AMP, for which RNA aptamers have previously been obtained 
(Pei et al., 2009). The GMP aptamer binds the GMP-TO conjugate with Kd=60 nM and a 500-
fold fluorescence enhancement (Figure 3). Similar results were obtained with an AMP aptamer 
and AMP-TO conjugate. To adapt this approach for in vivo use, multiple copies of the 
appropriate aptamer would have to be inserted into the gene encoding the cellular RNA to 
New Ideas for in vivo Detection of RNA  137
Fig. 2. Light-up dye/aptamer pairs and their properties. A. Malachite Green (MG) aptamer 
3D structure with basepairs annotated with Leontis-Westhof  nomenclature. Watson-Crick 
Edges are shown in circles, Hoogsteen Edges in squares, and the Sugar Edges in triangles 
(Leontis & Westhof, 2001). Hollow symbols indicate trans basepairs and filled symbols, cis 
basepairs. Boxes indicate nucleotides pairing with more then one base. B. 3D stereo view of 
the X-ray structure of the MG aptamer binding to tetramethylrosamine (PDB file: 1f1t). 
Nucleotides are colored to match the annotated 3D structure. C. Several examples of 
fluorogenic dyes for which nucleic acid aptamers have been obtained to create “light-up“ 
pairs. In case of MG, phenyl ring (PhMG) mentioned in text is circled. D. Schematic 
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representation of a strategy use to obtain a new “light-up” pair (Sparano & Koide, 2005). 
Dichlorofluorescein (DCF, shown in green) is attached to two quencher molecules (shown in 
black). Photoinduced electron transfer (PET, blue arrows) quenches fluorescence. Binding of 
an aptamer selected to bind exclusively to the quencher moieties blocks PET, leading to the 
recovery of emission. Lower panel. Binding affinities and fluorescence enhancements of the 
light-up pairs described in this chapter. 
be visualized, and the small-molecule dye conjugate would have to be delivered into the cell 
by an appropriate mechanism (for a review of cellular delivery systems, see Bao et al., 2009). 
The main drawback of this approach is competition for aptamer binding by endogenous 
molecules (for example, cellular GMP or AMP). Nevertheless, this approach has great 
potential, as the number of small molecules that can be used here is almost limitless. 
Fig. 3. Stojanovic’s strategy for RNA detection. Thiazole Orange (TO), a fluorescent 
intercalator, is conjugated to a small molecule (blue hexagon). RNA aptamer (pink region) 
specific for its target binds the small molecule and forces TO binding to double-stranded 
region at the specific location.  
3.4 Fluorogen-binding aptamers as signalling elements for label-free, specific nucleic 
acid detection 
Some of the disadvantages of other RNA imaging methods (described above in section 2.1 
and 2.2) may potentially be overcome using label-free approaches based on fluorogen-
binding aptamers. First, aptamers can be entirely composed of unmodified RNA, allowing 
genetic fusion to genes coding for cellular RNAs of interest (Figure 4B). This has the 
advantage of endogenous synthesis of the targeting sequence. Moreover, these aptamers, 
even when used in multiple copies, do not significantly increase the size of the cellular 
RNA, and only the imaging dye needs to be introduced exogenously, as most organic dyes 
are able to diffuse into cells. Finally, dyes with suitable light-up characteristics and low 
affinity for cellular targets can be expected to give low background signals. 
However, selecting appropriate sites for aptamer insertion remains a critical issue. To obtain 
valid imaging results one must ensure that the insertion of the aptamer molecules does not 
disrupt functionally important target RNA secondary or tertiary structure or protein-
binding sites. In cases where the organism of interest is difficult to genetically modify, these 
aptamers can be coupled to a specific target recognition domain and introduced 
exogenously using a variety of delivery methods (Figure 4A).  
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3.4.1 Allosteric aptamer-based sensors 
Aptamers have been conjugated to other aptamers forming “allosteric aptamers” or to 
ribozymes forming “aptazymes” (Soukup, 2004; Silverman, 2003). Stojanovic and 
Kolpashchikov first reported the design of novel allosteric sensing systems produced by 
coupling the MG-binding RNA aptamer through a “communication module” to each of a 
series of specific aptamers for ATP, FMN (flavin monomucleotide), and theophylline. These 
“allosteric aptamers” are capable of transducting binding information between the two 
aptamers (Stojanovic & Kolpaschikov, 2004). They showed that binding of the target 
molecule to its respective aptamer domain caused a significant conformational change in the 
RNA sensor that was relayed through the communication module to the MG aptamer 
module so as to enable it to bind MG and produce a fluorescent signal. 
Within a year, Kolpashchikov adapted this concept to create an allosteric RNA aptamer 
probe system to sense specific nucleic acid targets (Kolpashchikov, 2005). The MG aptamer 
domain of the probe was divided into two fragments, each of which also contained half of 
the sequence complementary to the target DNA (see Figure 5). In the presence of the target, 
the complementary “binding arms” of the binary probe hybridize cooperatively to the 
target, forming a three-way junction structure and reconstituting the MG aptamer by 
stabilizing the helix containing it. The probe-target complex then binds MG and renders it 
Fig. 4. Label-free approaches for in vivo RNA imaging. A. Allosteric coupling of fluorogen-
binding aptamer to another target recognition element. B. Genetic fusion of the fluorogen-
binding aptamer to target RNA sequence. 
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Fig. 5. Binary MG-aptamer based sensor (Kolpashchikov, 2005). Analyte-promoted assembly 
and stabilization of binary biosensor to form MG aptamer (shown in green color). 
fluorescent, signaling the presence of the analyte. A 20-fold fluorescence enhancement was 
reported for this biosensor in the presence of 2 ?M concentration of the target, with 
discrimination factors greater than 20-fold for half of the sequences differing from the 
intended analyte by single nucleotide substitutions. Sando and coworkers tested the 
applicability of Kolpashchikov’s strategy to design a binary probe using their novel light-up 
Hoechst derivative/DNA aptamer light-up pair (see section 2.2 above) (Sando et al., 2007). 
The same design principle was used: the DNA aptamer for the Hoechst dye was split into 
two molecules, each of which contains half of the sequence complementary to the target. 
When the target DNA binds to the complementary regions of the binary probe, a three-way 
junction forms which restores the DNA aptamer structure and allows it to bind to the 
Hoechst dye. These binary DNA probes showed 70-fold fluorescence enhancement; correct 
analyte was discriminated from single-mismatches by a factor of 15. 
A major hurdle in designing probes for specifically detecting or imaging biological RNAs in 
complex environmental or whole cell samples is the presence of secondary structure in the 
target RNA, which may compete with probe binding, thus reducing the binding affinity of 
the biosensor. Paranemic binding between two pre-formed nucleic acid structures was 
originally developed for DNA nanotechnology by Seeman and coworkers (Shen et al., 2004) 
and subsequently demonstrated in RNA (Afonin et al., 2008). Paranemic binding provides 
the means to design probes targeting internal loop structures in the RNA analyte in a 
programmable, sequence-specific manner that obviates the need to unfold the target to 
expose extended single-stranded regions. Paranemic binding can be applied for recognition 
of symmetrical internal loops ranging in size from 4 to 8 nucleotides (Afonin et al., 2008), as 
well as asymmetrical loops which have different numbers of bases in each strand (Novikova 
et al, unpublished observations). Afonin et al coupled the MG aptamer to an RNA 
paranemic binding motif to establish proof-of-principle for programmable sensing of pre-
folded RNA secondary structures using paranemic binding (Afonin et al., 2008). To make 
MG binding contingent upon binding of the target RNA, the position and orientation of the 
aptamer motif was optimized relative to the paranemic binding motif. In the resulting 
constructs, crucial non-WC basepairs that “zip-up” the MG binding site and fix MG in its 
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fluorescent state only form in the presence of the target RNA, as shown in Figure 6. Using 
several different probe and target sequences, the generality of this approach was 
demonstrated. Target sequences were bound with low nM affinity and fluorescence 
enhancements ranged from 6 to 15-fold. Furthermore, it was shown that single-base 
mismatches could be discriminated by about a factor of 13. 
The key principle of the sensing strategies described above involves the incorporation of a 
fluorogen-binding aptamer within the probe structure in such a way that fluorogen binding 
depends upon the specific recognition and binding to the target. 
Fig. 6. Paranemic RNA biosensor for folded RNA molecules (Afonin et al., 2008) A. 3D 
model of the biosensor-target complex. B. Schematic representation of the paranemic 
assembly of the MG-aptamer containing biosensor (grey)with the pre-folded analyte RNA 
(in blue). Formation of the recognition complex stabilizes the Malachite Green (MG) 
aptamer structure (in green). C. 3D stereo view of the MG aptamer (Baugh et al., 2000; PDB 
file 1f1t). D. Corresponding annotation of the 3D structure using Leontis-Westhof basepair 
annotations (Leontis and Westhof, 2001). Bases are numbered as in X-ray (1f1t). U12 (blue) 
of target RNA interacts with A21 of biosensor probe RNA (in grey), stabilizing the flanking 
A11/U22 (grey) basepair of the biosensor, which interacts with A26 (red) in the aptamer to 
“zip-up“ the MG binding site. 
3.4.2 Genetic fusion of fluorogen- or fluorophore-binding aptamers and target RNA 
sequences 
In the previous section, we described strategies for RNA detection and visualization using 
hybridization probes allosterically coupled to fluorogen-binding aptamers. A related 
approach is to genetically encode the fluorogen- or fluorophore-binding aptamer directly 
into the gene sequence of a cellular RNA of interest. Sando et al. recently reported the 
selection of an effective RNA aptamer for Hoechst 33258 derivative and the insertion of five 
tandem repeats of this aptamer sequence on the 3’ side of the stop codon of the luciferase 
gene (Sando et al., 2008). They showed that transcription of the mRNA containing the 
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tandem aptamers could be monitored in vitro by fluorescence in the presence of the dye, and 
observed a 5-fold enhancement compared to parallel transcription of the same mRNA 
lacking the aptamer sequences. The authors call this method "blue fluorescent RNA” and 
reported Kd=35 nM for binding of the dye to the isolated aptamer, but did not report 
apparent Kd’s in the context of the mRNA construct. 
Eydeler et al. reported detailed measurements of the Sulforhodamine B-binding aptamer 
(SRB2m), selected by Holeman et al (1998), fused to a variety of genetic constructs, including 
intact EGFP-mRNA produced in vivo and assayed in vitro in the presence of other cellular 
RNAs (Eydeler et al., 2009). They used fluorescence correlation spectroscopy (FCS), a 
method that allows one to obtain diffusion constants and other kinetic parameters from 
fluorescence fluctuations generated by molecules diffusing in and out of the focal volume. 
They reported Kd’s ranging between 120 nM and 1130 nM for different constructs containing 
single aptamer modules compared to Kd~238 nM for the isolated aptamer. Tandem repeats 
of the aptamer sequence in these constructs showed a significant increase in binding 
affinities, with Kd values of 60-70 nM. The lowest apparent binding affinity of 
Sulforhodamine B was observed for aptamer embedded into EGFP-coding mRNA (kd~1.13 
?M), which was attributed to improper RNA folding. Even though the binding of 
Sulforhodamine B to its aptamer SRB2m does not cause a significant emission change (this is 
not a “light-up” pair), this work shows the value of using multiple tandem copies of 
aptamers and points out the need for careful consideration of target secondary structure to 
obtain optimal in vivo results.
Zhang and co-workers inserted the MG aptamer sequence into the cloned  gene of V.
proteolyticus 5S rRNA so that the aptamer motif replaced  Helix 5 and Loop C of the 5S 
molecule (Zhang et al., 2009). They transcribed the 5S/ MG aptamer chimera in vitro and 
showed that it binds to MG and enhances its fluorescence to a comparable extent as free 
aptamer (Kd  ~ 900 nM for 5S/MG chimera vs. Kd ~ 800 nM for isolated aptamer,  Baugh et 
al., 2000; cf. Kd ~ 117 nM, Babendure et al., 2003). They also expressed the 5S/MG chimera 
from a plasmid in E. coli cells and observed fluorescence enhancement of MG dye added to 
the medium, although they did not report detailed in vivo measurements.  
Applications of light-up dye/aptamer pairs are not solely limited to sensing nucleic acids. 
Other applications for these technologies have been proposed and are under development. 
For example, MG dye was conjugated to kinesin-driven microtubules to develop mobile 
bioprobes that can capture MG aptamer-tagged mRNAs from a transcription mixture and 
sequester them in a microfluidic device for high-throughput screening (Hirabayashi et al., 
2006).
4. Conclusions 
To date, remarkable progress has been made to visualize specific RNA molecules with high 
spatial and temporal resolution in living cells. These studies have begun to reveal detailed 
mechanisms of RNA trafficking, localization and turnover (Bratu et al., 2003, Lange et al., 
2008; Zimyanin et al., 2008). However, significant challenges remain to render these 
methods more generally applicable and to overcome shortcomings of currently used 
methods. The ideal RNA biosensing system should be easy to deliver to living cells, non-
toxic and non-perturbing to cellular functions. It should penetrate all parts of the cell 
homogeneously and be chemically stable in different cellular environments. The fluorescent 
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reporter of the biosensor should have high absorptivity and quantum yield  (brightness) as 
well as good photostability and low phototoxicity. The sensor system should be easy to 
implement, so that different RNA targets can be studied without extensive optimization. It 
should allow optical multiplexing so that interactions between two or more cellular RNAs 
(or RNA and protein) can be monitored. It should only fluoresce when bound to the 
intended target and otherwise produce low background fluorescence. It should bind 
specifically to the intended target with minimal binding to targets having similar sequence 
and should exhibit fast binding kinetics to monitor rapid changes in RNA concentration. 
Finally, it should allow for studying specific RNAs in whole tissues or organs. Of course, no 
current method possesses all these desired characteristics.  
Currently, hybridization probes offer the greatest variety and versatility in choice of 
fluorescent reporters as they can be conjugated to semiconductor quantum dots, in addition 
to a wide variety of organic dyes. However, they still require exogenous delivery which can 
perturb cell functions. Hybridization methods suffer from signal sensitivity issues for two 
reasons. Unmodified targets generally bind only one hybridization probe and degraded 
probes release fluorescent reporters. To minimize degradation, hybridization probes are 
usually synthesized with resistant, modified backbones (see above). To increase sensitivity, 
multiple copies of the complementary binding sequence can be introduced in the target gene 
(van den Bogaard & Tyagi, 2009). Whether or not the target is genetically engineered, the 
use of hybridization probes raises several concerns related to choosing appropriate binding 
sites on the target RNAs. First the target sites should have relatively weak secondary 
structures to allow the probe to bind with high affinity with minimal competition. Second 
the selected binding sites should not participate in crucial functions, especially related to the 
processing, localization, or regulation of the target RNA. Hybridization probes targeting 
RNA sequences that bind other cellular factors can potentially interfere with these processes 
and produce spurious imaging results.   
Autofluorescent protein (AFP) probes are synthesized intra-cellularly from gene fusions 
directly encoded in cell lines or from plasmids that can be introduced by transfection. These 
methods are less perturbing than those used to deliver hybridization probes. Moreover, AFP 
probes can be directed to desired cellular compartments with appropriate peptide targeting 
sequences. However, the use of AFP probes requires insertion of RNA binding protein 
(RBP) recognition sites into target RNA sequences, which also requires attention to target 
RNA sequence to avoid interfering with RNA function, but is potentially less sensitive to 
RNA secondary structure. One disadvantage of the general AFP strategy is that unbound 
probes are also fluorescent. This has been largely solved by the “split-AFP“ approach, but 
this method has the disadvantage that signal generation is irreversible upon reconstitution 
of the  fluorescent protein. Contrary to common perceptions, autofluorescent proteins also 
have phototoxicity issues, as under irradiation, they produce reactive oxygen species that 
can damage cells (Remington et al., 2006). 
New methods, employing fluorogen-binding aptamers, hold promise of addressing many of 
the shortcomings of the two currenty used methods. First, aptamer-based methods are 
generally simpler and potentially more flexible and can be readily adapted to the particular 
application.  Like AFP probes and unlike hybridization probes, the aptamers themselves can 
be produced endogenously. They can be either genetically encoded in the target RNA or 
produced from plasmids. Of course, they can also be introduced exogenously like 
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hybridization probes if that is required.  Like hybridization probes and unlike AFP probes,  
there is no need for co-expressing additional fusion constructs that require additional time 
to mature and that need to be balanced in their expression to target RNA expression levels– 
a significant simplification of the procedure. Additionally, because fluorogen-binding 
aptamers can be genetically integrated in their targets, signal generation is rapidly and 
completely eliminated upon RNA degradation, thus reducing background and false-
positive rates providing further improvement over both AFP and hybridization methods. 
Finally, the aptamer size is quite insignificant compared to protein-based probes. However, 
it is not yet well established how many tandem aptamers are required to achieve adequate 
sensitivity for single-molecule detection in vivo. Based on recent studies, it appears that 
tandem repeats of aptamers domains in target RNA are preferred to achieve proper aptamer 
folding and significant increase in binding affinities. Unlike hybridization probes, only free 
fluorogenic dyes need to penetrate cells when genetically encoded aptamers are used and 
there is no need to covalently attach the fluorescent reporters and quenchers to the probe. 
However, a number of challenges must be met for fluorogen-binding aptamers to become 
practical alternatives to the currently used methods. First of all, the number of available 
fluorogenic dyes is still quite limited and they have not been adequately tested for 
suitability in vivo. Further work is needed to identify which fluorogenic dyes have low in
vivo toxicity and phototoxicity, low background fluorescence, and produce sufficient signal 
when bound specifically to their target aptamers to make single-molecules detection 
possible in vivo with modern imaging methods. For example, MG, while exhibiting low 
background fluorescence, has substantial phototoxicity issues. Cyanine dyes appear 
promising. In addition to DIR, a number of cyanine dyes with reduced affinity to 
nonspecific nucleic acids and substantial light-up signal have been synthesized by 
Armitage’s group and tuned to emit across the visible spectrum and even into the near-
infrared (Ozhalici-Unal et al., 2008; Shank et al., 2009). Second, a challenge for future work is 
to expand the available choices of light-up pairs by selection of new aptamers that 
specifically bind new improved fluorogenic dyes, including near-IR emitters. Just as new 
AFPs emitting in the NIR have recently been reported (Shu et al., 2009), new aptamer/NIR 
dye light-up pairs will make it possible to detect signals from specific molecules located 
deep inside tissues (Amiot et al., 2008). While, a number of innovative approaches for 
aptamer/dye pair selection have been developed in vitro, most of them have been tested 
only in vitro. Thus, more in vivo testing is a high priority to determine which fluorogenic 
dyes and aptamer-based biosensing platforms are suitable for in vivo use. Finally, improved 
bioinformatic methods are needed to identify optimal sites for aptamer insertion or 
hybridization into target RNAs.       
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1. Introduction    
Small biomolecules (< 2 kDa) are crucial to a wide range of biochemical processes in the 
human body. Their diverse functions can include acting as hormones, neurotransmitters and 
pheromones. Small molecules are typically found in the blood stream and their 
concentrations can often be indicative of the biochemical functioning of the organism. This is 
particularly true of the steroids, a major class of small molecule hormone.  
Measurement of steroid concentrations is commonly performed to track the progression of 
the fertile cycle, to detect pregnancy and to help diagnose hormonal diseases (Clark et al., 
1998). Immunoassay techniques dominate the market for hormonal assays. These assay kits 
utilise the highly selective binding of an antibody to its target antigen to detect small 
molecule analytes in highly complex matrices. Typically, for small molecules, the assay will 
consist of a plate or tube onto which the antibody is immobilised and the sample is passed 
over the plate surface along with an aliquot of labelled antigen. The label used is either 
radiochemical (radioimmunoassay (RIA)) or enzyme-based (enzyme-linked immunosorbent 
assay (ELISA)). The labelled antigen occupies the un-bound sites on the immunoassay plate 
and the signal obtained from the label by either measuring the resultant radiation, or 
through enzyme catalyzed colour changes, gives a standard curve from which the 
concentration of the free analyte can be determined. 
Small molecule targets are typically found in complex matrices such as blood and saliva 
where high molecular mass components predominate. These include proteins that can in 
some cases bind to the steroid hormone of interest. Their large size relative to the target 
antigen can also serve to sterically impede antibody binding to the steroid. Furthermore, 
large molecule contaminants can also bind to immunoassay surfaces causing biofouling that 
can further interfere with assay results. 
Despite their widespread application, RIA and ELISA are practically limited to use in 
centralised laboratory environments where careful control of the experimental conditions 
can be exercised. They typically involve multiple steps that require trained operators and in 
the case of RIA they involve the use of radioisotopic labels that require specialised handling 
and represent a significant health hazard. Analysis is also very labour intensive and 
consequently quite expensive. Samples therefore must be transported to a laboratory and 
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testing and processing of results typically takes several hours-days. This arrangement is 
inadequate for a wide range of applications that need results in much shorter timeframes. 
To help address these issues, there has been much research devoted to the development of 
immunochromatographic test strip technology (Weller, 2000). This technology has been 
utilised for detection of drug residues (Chen et al., 2009) and drugs of abuse by transferring 
the immunoassay process onto a single-use test strip that generates a colour response after 
the sample has flowed over the immobilised protein conjugate. Such tests however, are 
largely semi-quantitative and so can be of limited use when a concentration result is 
required rather than a simple yes/no answer. 
Biosensors offer a very promising means of achieving more versatile determination of small 
molecule concentrations in diverse matrices. A biosensor is an instrument that utilises a 
biomolecule/s, such as an enzyme or antibody, to interact with the target molecule being 
measured. From this interaction an electrical signal is then generated which can be used to 
determine the concentration of the target compound. Biosensors are typically classified 
according to the biochemical interaction used and the method of transduction. For detection 
of small molecules, antibody based biosensors are a logical choice as they retain the excellent 
specificity of antibodies allowing for detection in complex matrices, including those with a 
number of structurally similar compounds present in the same sample, as is the case with 
the steroid hormones. Furthermore, their relatively high binding affinities allow efficient 
uptake of the analyte from the sample and thus maximise the number of binding events and 
the biosensor signal. High quality antibodies are widely available for a broad range of small 
molecule analytes, including most of the physiologically significant steroid hormones. 
When we examined the range of transduction technologies available for small molecule 
biosensing, we decided to investigate the use of the quantum optical-electrical phenomenon 
known as surface plasmon resonance (SPR). When a photon of light is incident on a noble 
metal surface (typically gold or silver) it can couple with the electrons in the metal, exciting 
the electrons and causing them to move as a single electrical entity known as a plasmon 
which propagates parallel to the metal surface. As the plasmon oscillates it generates an 
electric field that extends about 300 nm out from the metal surface (Homola et al., 1999). At a 
particular angle where the energy transfer from the photon to the plasmon is well matched a 
resonance occurs, significantly increasing energy transfer from the photon to the plasmon 
and causing a corresponding decrease in reflectance.  If mass is bound to the surface within 
this 300 nm range then it perturbs the plasmon and, for a photon of fixed wavelength, shifts 
the resonance angle. If the plane of the metal surface is fixed, then the resonance wavelength 
can be identified by scanning through a range of angles of incidence for the photon and 
determining the resonance angle (Mullet et al., 1998). An SPR biosensor effectively measures 
minute changes in refractive index corresponding to binding events on the sensor surface 
(Homola, 2008). SPR biosensors can typically achieve resolutions down to 1 resonance unit 
(RU) which is 1 x 10-6 refractive index units (Stenberg et al., 1991). SPR biosensors can 
effectively detect binding by molecules as small as about 2 kDa, but smaller molecules 
generate insufficient changes in bound mass and so cannot be directly measured adequately. 
This poses particular challenges for detecting small molecules. In this case it is necessary to 
detect the binding of an antibody to an analyte conjugated sensor surface or to tag the small 
molecule with a large molecular mass tag and use this to bind to un-bound antibody sites on 
the sensor surface. Once the binding event/s have taken place, then the sensing surface can 
be returned to its original state by application of a suitable regeneration cocktail, allowing 
some re-use of the surface. 
Surface Plasmon Resonance Biosensors for Highly Sensitive Detection of Small Biomolecules  153
BIAcore SPR instruments have been widely used for years for the analysis of biomolecular 
interactions. It is extensively applied as a research tool to examine antibody / antigen 
(McCormick et al., 2004; Kubitschko et al., 1997), oligonucleotide / complementary 
oligonucleotide (Kai et al., 1999), receptor / target (Zhang et al., 2004) and host / guest 
(Chen et al., 2002) interactions. These instruments contain sophisticated microfluidics and 
temperature control units and range from the conventional four channel versions such as 
BIAcore 3000, to the more recent array format in the BIAcore Flexchip. The instruments use 
chips which contain the gold sensing surface and can be docked and un-docked from the 
main instrument as required. The work discussed in this chapter uses either a BIAcore 2000 
or 3000 in the 4-channel format with a carboxymethylated (CM) dextran coating. 
SPR biosensor assays have the advantages that binding data can be collected in real-time as 
the sensorgram (plot of response vs. time) is generated and so there is no need to wait for 
the signal development of an entire immunoassay plate to obtain results. This makes the 
technology particularly amenable to use in applications where data is required to inform 
decisions in near-real-time, such as in the diagnosis of disease or in the study of human 
hormonal responses. Furthermore, SPR assays are semi-automated. Once the samples are 
loaded into an instrument such as a BIAcore, then a wizard program can run the assay 
automatically and feed results to your desktop. With pre-prepared standards very little 
pipetting is required and this significantly reduces costs. SPR assays also do not use any 
radioactive labels. Increasingly, SPR biosensor technology is improving to the extent that a 
number of more compact and affordable options are now appearing on the market thus 
beginning a wider dissemination of the technology beyond large, well-funded centralised 
laboratories.
Potentially SPR is a very sensitive transduction technique where only small changes in 
refractive index are required to generate signal. This means that provided the immunoassay 
format and surface coating chemistries are well-designed, very sensitive assays can be 
achieved. However, in the case of small molecule immunoassay, the lack of mass in the 
analyte means that specialised enhancement technologies need to be applied to achieve the 
very low detection limits needed for measurement at the physiologically relevant 
concentrations found in certain biological fluids, including saliva. 
It is very easy for steric hindrance to occur between the small molecule and the large 
antibodies used or between the small molecule and the sensing surface. If the analyte is 
sterically impeded from binding to the antbody this reduces the sensor signals that can be 
obtained and worsens the sensitivity of the immunoassay. Given that an SPR sensor detects 
bound mass on the sensor surface, if large molecules bind non-specifically to the surface 
then they will generate an SPR signal which can obscure the signal results from specific 
immunoassay binding of the analyte. This risk is particularly high if the sample matrix 
contains high concentrations of high molecular mass species, such as in the case of saliva 
which is rich in mucins. For a given assay it is very beneficial to be able to use the same 
biosensor surface over and again many times. This approach means that the need for 
calibrating different sensor surfaces is minimised, cost of consumables is reduced and risk of 
failure of the sensing surface during crucial analyses is mitigated. Most SPR sensor surfaces 
rely upon self-assembled monolayers (SAMs) to conjugate small molecules or antibodies to 
the sensor surface. This method of attachment lacks longer-term stability as do most direct 
immobilisations of proteins onto sensor surfaces. Typically such SAM surfaces only last 
about 100-400 binding and regeneration cycles (Yuan et al., 2007). 
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Given these significant challenges faced by small molecule SPR immunosensing it is very 
important to consider how such assays can be rationally designed to overcome problems of 
steric hindrance, biofouling, sensor surface stability and signal enhancement for greater 
sensitivity. In this chapter we examine the strategies taken in our laboratories to overcome 
these challenges and to help make SPR immunosensing a more practical technique for 
sensitive detection of small molecules, even in complex matrices. 
2. Rational design of steroid conjugates 
To optimise the sensitivity of SPR immunoassays of the steroid hormones, it is necessary to 
achieve maximum specific antibody binding to the antigen-conjugated sensor surface. The 
first step in ensuring this is to allow free access by the antibody to the specific parts of the 
steroid molecule that the antibody recognises, that is the epitopes. To do this one must 
conjugate the steroid through a position distant from these critical functional groups and not 
conjugate through an existing functional group. For the steroids, this can be done by 
conjugating to the A-ring 4-position using the formation of a thioether linkage (Fig. 1). This 
technique was selected after SPR analysis revealed much stronger binding to the 4-position 
for progesterone than was obtained through the more conventional 7-position (Wu et al., 
2002) (Fig. 2).  
In the case of estradiol, another conjugation technique utilising a Mannich reaction to 
conjugate at the 2-position of the A-ring was found to be equally useful in retaining strong 
binding responses. This was in contrast to hemisuccinate conjugation through the hydroxyl 
group at the 3-position, which gave only 2% as much binding (Mitchell et al., 2006). 
The next factor to consider is the length of the intermediate linker that spaces the antigen 
from the sensing surface (Bieniarz et al., 1996). The linker should project the antigen into the 
flow of fluid that passes through the biosensor flow cell and so allow optimal presentation 
of the immobilized antigen to the antibody thus ensuring maximum sensor signal. We have 
considered the effects of incremental changes in linker length for progesterone – protein 
conjugates, examining linkers of 4-, 11- and 18-atoms in length (Wu et al., 2002). The linker 
length was found to be crucial to the amount of antibody binding in the SPR flow-through 
biosensor format with binding responses increasing up to 18-atoms in linker length (Wu et 
al., 2002). Based on these observations, an oligoethylene glycol linker was attached to the 
steroid at the 4-position through a thioether bridge. This produced a 19-atom linker chain 






















Fig. 1. Synthesis of progesterone-4-thioether conjugate for attachment of linkers 
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Fig. 2. SPR sensorgrams showing the binding of progesterone – protein conjugates to a 
progesterone monoclonal antibody (mAb) functionalised surface. OVA: ovalbumin, 2-OVA: 
conjugate through the 7-position, 1-OVA: conjugate through the 4-position, 4-OVA: 4-
position conjugate with 11-atom linker, 6-OVA: 4-position conjugate with 18-atom linker. 
Reprinted from Steroids, 67, Mitchell, J. S.; Wu, Y.; Cook, C. J.; Main, L. (2002) Evaluation of 
progesterone-ovalbumin conjugates with different length linkers in enzyme-linked 
immunosorbent assay and surface plasmon resonance-based immunoassay. 565-572, 2002, 
with permission from Elsevier. 
(Kurusu et al., 2003) and biocompatible (Otsuka et al., 2003) thus minimising non-specific 
binding to the linker. It is hydrophilic and thus allows good projection of the antigen into 
the aqueous mobile phase. Furthermore, it has high chemical stability and the length can be 
incremented as required by addition of more ethylene glycol units. Attachment to one end 
of the chain is achieved by protecting the amine at the opposite end by attachment of a t-
butoxy carbonyl group which can be conveniently removed at the time of immobilisation. 
3. Covalent linker conjugation technology 
3.1 Immobilization 
High immobilization stability can be achieved by use of a totally covalent immobilisation of 
the steroid antigen to the sensor surface. In these studies, the most effective means of 
achieving this was to utilize a carboxymethylated (CM) dextran polymer coating applied to 
the gold surface. This dextran hydrogel extends for about 100 nm from the gold surface and 
is highly porous, giving a very high surface area. The polymer is studded with carboxylic 
acid groups which can be conveniently used as anchor or immobilisation points for covalent 
attachment of steroid-linker conjugates. This attachment is achieved by the formation of an 
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amide linkage between the carboxylic acid groups and the primary amines at the end of the 
oligoethylene glycol linkers. This can be further facilitated by use of N-hydroxysuccinimide 
(NHS) activation of the carboxylic acids. 
Immobilization was achieved by simply flowing a mixture of NHS and N-ethyl-N-(3-
dimethylaminopropyl)-carbodiimide (EDC) over the CM dextran surface to activate it and 
then flowing the steroid linker conjugate. This is ideally performed at low flow rates (5 
?L/min) to ensure maximum conjugation to the sensor surface. This technique provides 
high binding capacity surfaces without the need to disassemble the chip. Finally, 
ethanolamine solution (pH 8) can be passed over the surfaces to cap any un-conjugated 
carboxylic acid groups and so prevent them from reacting with proteins in the samples. 
3.2 Surface stability and regeneration 
To achieve a high throughput of samples and standards over a single surface, it is necessary 
to have very high sensor surface stability as the surface must be able to withstand multiple 
binding and regeneration cycles. The regeneration process involves exposing the surface to 
harsh regeneration “cocktails” which chemically remove the bound antibodies. The cocktails 
used in this work are typically 50 mM NaOH with 20%v/v acetonitrile, providing a 
combination of high pH and a chaotrophic reagent. Despite exposure to such a harsh 
mixture, progesterone conjugated surfaces are able to withstand more than 1100 binding 
and regeneration cycles without appreciable loss of binding capacity (Mitchell et al., 2005). 
This greatly extends the lifetime of a single sensor surface and allows extensive re-use 
without the need for immobilization of a fresh surface and in so doing, significantly reduces 
the costs per assay cycle.  
4. Assay format and gold nanoparticle signal enhancement 
The assay format adopted was a competitive inhibition assay. In this format, the small 
molecule analyte was covalently immobilised on the surface. The sample containing the 
small molecule was then mixed with a primary antibody raised against the analyte and the 
mixture injected over the sensor surface. Primary antibody that had not bound the “free” 
sample antigen, bound the surface immobilized antigen thus producing a refractive index 
change on the surface (Fig. 3). This SPR signal is inversely related to the concentration of the 
“free” antigen and a standard curve can be produced that takes the form of an S-curve. 
The sensitivity of the assay can be assessed as the amount of signal change achieved per unit 
of analyte concentration change and the limit of detection as the minimum concentration 
that can be statistically distinguished from the blank. Lower concentrations of the analyte 
can be detected by reducing the concentration of the primary antibody as less free antigen 
would be required to inhibit antibody binding to the antigen-immobilized surface. The 
problem with this approach in SPR, is that this will also reduce the signal by reducing the 
bound mass on the surface. To achieve a highly sensitive assay, it is therefore crucial to 
minimise the primary antibody concentration whilst retaining high signal. 
When the above assay design was applied to the SPR biosensor as described, it gave assays 
with a LOD of approximately 1 ng/mL in the case of progesterone. Whilst this LOD is 
suitable for measurement of steroids in human blood serum, it is far too high to measure 
steroids in other matrices such as saliva, where concentrations are typically 1% of those 
found in blood. To shift the assay curve to lower concentrations, it was necessary to further 
reduce the primary antibody concentration. To retain sensor signal, strategies for labelling 
Surface Plasmon Resonance Biosensors for Highly Sensitive Detection of Small Biomolecules  157














































Fig. 3. Schematic showing the steroid immobilised SPR sensor surface, binding of primary 
antibody and labelling with secondary antibody – gold nanoparticle conjugate. 
the binding interaction were applied. First, a secondary antibody that recognises the 
primary antibody, was bound in a separate binding step to add signal to the binding 
interaction and allow significant reductions in the concentration of the primary antibody 
(Fig 3.). LOD of 20.1 pg/mL could now be obtained for progesterone and signal was 
enhanced 8.1-fold (Mitchell et al., 2005) (Fig. 4).  
As well as using secondary antibody there are other means of adding high mass tags to the 
binding interaction. Gold nanoparticles have a high mass contained in nanospheres the 
diameter of which can be altered as required between about 1 nm – 100 nm by altering the 
conditions of their synthesis. This size range is ideal for tagging antibodies and furthermore, 
gold nanoparticles can be readily conjugated to proteins such as antibodies through charge 
interactions. Gold nanoparticle enhancement has been applied to large molecule 
immunoassays (Gu et al., 1998; Lyon et al., 1998; White & Rosi, 2008) but significant steric 
challenges exist for its use with small molecules. Gold nanoparticles of 25, 45, 55 and 70 nm 
diameters were examined as tags for secondary antibodies for signal enhancement in small 
molecule SPR immunosensing. 25 nm nanoparticles were found to give the highest signal 
enhancement and were applied in a progesterone assay. Signal enhancement further 
increased to 13-fold and the LOD could be reduced to 8.6 pg/mL for progesterone (Fig. 5) 
(Mitchell et al., 2005). By application of gold-secondary antibody signal enhancement, the 
LOD could thus be reduced by more than two orders of magnitude (Mitchell et al., 2005),  
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Fig. 4. Plots of SPR response (RU) vs. antibody concentration (?g/mL) for unenhanced mAb 
only assay (?) and secondary antibody enhanced assay (?). Reprinted from Analytical 
Biochemistry, 343, Mitchell, J. S.; Wu, Y.; Cook, C. J.; Main, L. Sensitivity enhancement of 
surface plasmon resonance biosensing of small molecules. 125-135, 2005, with permission 
from Elsevier. 
Progesterone Concentration (ng/ml)













Fig. 5. Progesterone SPR immunoassay standard curves for assay without signal 
enhancement (?) and with gold nanoparticle signal enhancement (?), showing 
improvements in LOD. Reprinted from Analytical Biochemistry, 343, Mitchell, J. S.; Wu, Y.; 
Cook, C. J.; Main, L. Sensitivity enhancement of surface plasmon resonance biosensing of 
small molecules. 125-135, 2005, with permission from Elsevier. (RSC) (www.rsc.org) 
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allowing sensitive detection of steroid hormones at the concentrations typically found in 
human saliva. The signal enhancement arising from the gold labelling could result not only 
from the added mass but also from cooperative plasmon coupling between the gold 
nanoparticles and the underlying gold sensor surface. This effect has been suggested before 
with large molecule binding targets (Lyon et al., 1999). 
Using bulky nanoparticles to enhance SPR signal strength, adds to the potential for steric 
hindrance in immunoassays of small molecules. These assays were constructed around a 
“double spacer” system whereby spacers or linkers project the antigen out from the sensor 
surface and hold the primary antibody out from the gold surface, thus allowing space for 
the antigen / antibody interactions and ensuring optimal sensor signal. Non-specific 
binding from the conjugated gold nanoparticles could be reduced significantly by the 
addition of polyethylene glycol (PEG)-400 or PEG-4000 (Mitchell et al., 2005). By using a 25 
nm gold nanoparticle, the risk of the colloid settling or aggregating over the course of the 
assay is minimised. Bovine serum albumin (BSA) could also be used to further reduce non-
specific binding (Mitchell et al., 2005). 
5. Small molecule analytes 
The immunobiosensor format outlined in the previous sections is quite generic and can be 
applied to a wide range of small molecules provided they have a suitable site for 
conjugation and have high affinity monoclonal antibodies available (Fig. 6). The SPR 
immunobiosensor approach outlined was first tried with progesterone as a model 
compound. Progesterone has well developed monoclonal antibodies and its measurement is 






















Fig. 6. Structures of steroid analytes covalently conjugated to SPR sensor surface through the 
4-position
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identification of pregnancy. The assay concept was later extended to 17?-estradiol which has 
an aromatic A-ring and so required a slightly different approach to the attachment of the 
thioether unit. Assays using secondary antibody enhancement gave an LOD of 25 pg/mL 
for 17?-estradiol (Mitchell et al., 2006). Other steroid hormones measured using this 
technique include cortisol (Mitchell et al., 2009) and testosterone (Mitchell & Lowe, 2009). 
Cortisol detection can be used in the diagnosis and management of conditions such as 
Addison’s disease (Lovas & Husebye, 2003) and as an indicator of stress (Riad et al., 2002). 
Testosterone is the principal male sex hormone and its concentrations are of interest in 
sports physiology (Crewther et al., 2006). For cortisol, an LOD of 13 pg/mL was obtained in 
buffer with secondary antibody enhancement (Mitchell et al., 2009) and for testosterone it 
was 35 pg/mL (Mitchell & Lowe, 2009). Both cortisol and testosterone used analogous 
conjugation techniques to that of progesterone. When the testosterone assay utilised gold 
nanoparticle enhancement, the LOD dropped further to 23 pg/mL (Mitchell & Lowe, 2009). 
Another positive feature of these assays is that the primary monoclonal antibody 
concentrations used are minimised to improve assay LOD. This also serves to lower the 
costs per assay and so individual determinations can usually be done for <NZ$2 in materials 
cost. The volumes of sample required are also very low (typically 50 ?L) making these 
techniques amenable to applications where samples are very precious. 
Extending the range of compounds beyond the steroids, the catecholamine dopamine was 
also conjugated to an SPR surface using an OEG linker attached to a mercaptothioether 
moiety conjugated ortho to a phenol group (Mitchell et al., 2007) (Fig. 7). This allowed 
conjugation at a point distant from characteristic functional groups and without 
compromising existing functional groups. Antibody binding interactions were then studied 
in this flow-through biosensor format and various conjugation techniques compared and 












Fig. 7. Covalent conjugation of dopamine to the SPR biosensor surface utilising a CM-
dextran polymer 
As well as examining SPR using a continuous gold underlayer as the sensor surface, the use 
of gold nanohole array substrates for biosensors are attracting attention (Brolo et al., 2004; 
Gao et al., 2007). They are of interest for use in biosensors as they have a lower 
functionalisation area giving rise to increased sensitivity, a simple optical set-up with 
transmission measurement of well-defined spectral features and they allow for optical field 
concentration giving interesting enhancement effects.  As a precursor to their use in 
immunobiosensors, immunochemical interactions were studied using a gold nanohole array 
where the signal response is expressed as a movement in the plasmon transmission peak of 
the array which can be simply measured using a UV-visible spectrophotometer (Sharpe et 
al., 2008). In this case, monoclonal antibody binding to immobilised cortisol could be clearly 
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detected as could enhancement with gold-nanoparticle labelled secondary antibody (Fig. 8). 
The system could also be regenerated and had low non-specific binding from the gold 
nanoparticles (Sharpe et al., 2008).  









Fig. 8. Schematic showing a gold nanohole array functionalised with analyte (cortisol) 
conjugated to a thiol linker. The analyte is bound by a primary monoclonal antibody and 
then labelled with a secondary antibody-nanogold conjugate. Reprinted with permission 
from Sharpe, J. C.; Mitchell, J. S.; Lin, L.; Sedoglavich, N.; Blaikie, R. J. (2008) Anal Chem, 80, 
6, 2244-2249. 2008 American Chemical Society. 
6. Measurement in saliva 
Human saliva contains very high concentrations of high molecular mass components such 
as mucins. These compounds can bind to SPR sensor surfaces and generate erroneous 
responses. This problem is particularly acute for small molecules, such as the steroid 
hormones, present at very low concentrations. Cortisol is present typically at 0.1 – 10 ng/mL 
in human saliva and testosterone at 29-290 pg/mL (Ellison et al., 2002). Measurement in 
saliva is particularly advantageous as it allows non-invasive detection of small molecules 
and regular sampling. Samples ideally need to be analyzed rapidly in near real-time, so 
chemical extraction and extensive pre-treatment of samples are not options.  
Standards of cortisol and testosterone spiked into stripped human saliva could be used for 
the measurement of salivary hormonal concentrations. These standards could be passed 
through a BIAcore SPR instrument without clogging of the microfluidics (Mitchell et al., 
2009). In the case of cortisol, saliva samples from human subjects were analyzed in the 
BIAcore without extensive pre-treatment through the addition of sodium dodecyl sulphate 
(SDS) to the antibody diluent at carefully controlled concentrations. The SDS is thought to 
minimise adhesion of salivary mucins to the sensor surface through charge repulsion, but at 
the concentrations used it did not affect the antibody or compromise the assay sensitivity 
greatly (Mitchell et al., 2009). The non-specific binding was reduced to a consistent and low 
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level enabling an assay curve to be formed without significant interference from high-
molecular mass species (Mitchell et al., 2009). An LOD of 49 pg/mL was obtained for 
salivary cortisol, well below that required for analysis of saliva samples. Additionally, a 
strong signal sensitivity of 162 RU.mL/ng was attained allowing accurate discrimination of 
concentrations ranging to below 1 ng/mL (Mitchell et al., 2009). Despite the use of SDS, 
interassay CVs of 13.5% were achieved, comparable to many ELISA (Mitchell et al., 2009; 
Mitchell et al. 2004). No clogging of the microfluidics was observed despite the high 
viscosity of saliva. To ensure the accuracy of the salivary cortisol measurements, samples 
from 40 healthy male volunteers were compared to results from RIA. The slope of the 
correlation line was close to 1 with an r = 0.94, showing good agreement between the two 
techniques (Mitchell et al., 2009) (Fig. 9). Binding and regeneration steps could be completed 
in 10 min per sample thus allowing for a fast throughput of samples. Another advantage of 
this method is that pre-concentration of samples is avoided as the technique has sufficient 
sensitivity to measure samples without complex pre-treatment (Mitchell et al., 2009). 
Furthermore, measurement can be made in small sample volumes (50 ?L of sample is 
sufficient). 
This SPR technique for measurement of salivary cortisol provides a useful means of 
monitoring hormone concentrations non-invasively in near-real-time and can be applied to 
both diagnostic and stress monitoring applications. As the technique is largely generic, it 
can be extended to other target small molecules found in human saliva. A later cortisol SPR 
study using a different sensor surface approach has failed to achieve comparably low LOD 
(Frasconi et al., 2009). 
Fig. 9. Correlation plot comparing concentration determinations made by the SPR cortisol 
immunoassay and salivary cortisol radioimmunoassay. Rapid ultrasensitive measurement 
of salivary cortisol using nano-linker chemistry coupled with surface plasmon resonance 
detection. Analyst, 134, 2, 380-386 – Reproduced by permission of The Royal Society of 
Chemistry 
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7. Context in wider plasmonic biosensor research 
The ever widening field of plasmonic biosensor research largely falls into three main areas. 
1. The use of SPR to study biomolecular interactions. This includes antibody, 
oligonucleotide, receptor and enzyme research and involves using SPR as a tool to probe 
biological systems. 2. The study of plasmon fields and their relationship to the noble metal 
surfaces from which they emanate (Lyon et al., 1999). This typically involves using 
quantum, electrical and optical physics to systematically investigate the plasmon resonance 
phenomenon at a fundamental level. 3. The use of SPR biosensors to detect large molecule 
targets, including proteins and DNA (Huang et al., 2008). The use of SPR for the sensitive 
measurement of low concentrations of small molecules has not received as much attention 
as assays for proteins and oligoneucloetides. There is now growing research interest in 
improving small molecule SPR immunoassay through design of the sensor interface 
(Mitchell et al., 2005; Miura et al., 2008; Shankaran et al., 2007). Recent studies have 
examined the use of SAM layers combined with protein conjugates to fabricate sensor layers 
for a herbicide (2,4-D, LOD of 10 pg/mL) (Kim et al., 2006), benzaldehyde (Gobi et al., 2007 
b) and a steroid hormone (progesterone, LOD of 4.9 pg/mL) (Yuan et al., 2007) either with 
or without protein or nanogold enhancement.  This approach has also been applied to 
measurement of the antimicrobial chloramphenicol (Yuan et al., 2008). Further work using 
direct covalent immobilisation to SAMs for TNT analysis has also been combined with 
secondary antibody signal enhancement (LOD of 50 pg/mL) (Mizuta et al., 2008) and a 
similar strategy developed for detection of benzaldehyde using PEG linker chains (Gobi et 
al, 2007 a). Immobilisation of histamine through a SAM layer without enhancement has 
yielded poorer LOD (3 ng/mL) (Li et al., 2006). Gold nanoparticle enhancement has also 
been used to improve LOD in the immunoassay of the metabolite estriol-16-glucuronide 
(LOD of 14 pg/mL) (Jiang et al., 2009) using protein conjugate immobilized on CM dextran. 
A protein conjugate to a small molecule dye has also been used as the high mass labelled 
antigen in a competitive SPR immunoassay with immobilised antibody (Aizawa et al., 2007) 
and biotin-BSA has been used as a high mass label for 2,4-D immunoassay (Kim et al., 2007).  
With gold nanoparticle enhancement of small molecule SPR immunoassays now well 
established, it is hoped that it will be successfully applied to an even broader range of 
compounds. The issue of biofouling in small molecule SPR is also receiving attention but 
often the techniques used involve total removal of the background matrix by time-
consuming methods such as flow filtering where blockages can occur and LOD are too high 
(Stevens et al., 2008) or else extensive dilution of samples (Gillis et al., 2002) which worsens 
the practical LOD.  
By combining surface and conjugation chemistry with immunology and optics, it is possible 
to create new sensor interfaces that offer significantly improved detection of small 
molecules, not only in buffer but also in real biological samples. The research detailed in this 
chapter represents several advances in the use of SPR to detect small molecules of biological 
significance at very low concentrations and particularly in a complex biological matrix. 
8. Conclusions and future research 
The sensitive measurement of very low concentrations of small molecule analytes is of great 
value in the diagnosis of disease, study of human and animal physiology and the 
monitoring of product quality and environmental integrity. Many small molecules are 
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routinely measured by traditional RIA or ELISA in expensive, time-consuming and 
centralised processes. In this chapter we have examined how SPR immunobiosensors can be 
used to measure very low small molecule concentrations accurately, quickly, affordably, 
with low labour requirements and even in complex biological matrices on highly re-usable 
sensor surfaces. The use of chemical linkers to covalently immobilise steroid antigens to the 
sensor surface allows the surface to be re-used many times even under harsh regeneration 
conditions. By selecting a conjugation position and linker length that optimises antigen 
presentation in the flow-through assay format, antibody binding can be maximised and high 
signal sensitivities obtained. The use of hydrophilic and non-immunogenic linkers also 
improves specific binding response. Secondary antibody labelling of the primary 
monoclonal antibody binding interaction is a convenient means of enhancing the sensor 
signal and further reducing LOD. Enhancement is further increased by the use of gold 
nanoparticles which add further mass and cooperatively enhance the plasmon shift. As the 
technology is generic, it can be applied to a wide range of small molecule targets. The 
application of this technology to the sensitive measurement of salivary cortisol has been 
demonstrated with the addition of SDS surfactant to minimise non-specific binding and 
allow measurement without chemical extraction or extensive pre-treatment of samples. 
To achieve the next generation of SPR biosensors for small molecules, future research will 
likely focus on expanding the types of small molecule analyte conjugated to the sensor 
surface and on examining alternative gold substrate designs to further improve sensitivity. 
The covalent nanolinker approach described in this chapter has been applied to a range of 
steroid hormones but it is also amenable to use with other small molecules such as 
pesticides, pharmaceutical residues and human and animal metabolites. Given that new 
regulations increasingly require sensitive measurement of many of these compounds, there 
is a very real role for SPR biosensors to play in semi-automated, high-throughput analysis of 
environmental and food samples. Biomedical testing laboratories may increasingly look to 
semi-automated alternatives to traditional plate-based assay formats as their sample loads 
increase for diagnosis and monitoring of medical conditions. Accessing new classes of 
analytes is limited only by the conjugation technique used to attach the linker to a point 
distant from existing functional groups. Alternative gold substrates that are attracting much 
attention include the use of “nano-islands” of deposited noble metal. These islands can 
generate localised surface plasmons (LSPs) particularly around their vertices and can 
generate very steep plasmon field gradients which could potentially result in greater 
sensitivity. Another emerging technique is the use of gold nanohole arrays as described 
above. Here, optical field concentration around the nanoholes offers the potential for further 
improvements in sensitivity. 
When developing biosensor technologies for highly sensitive detection of small molecules, it 
is crucial to consider the chemistry of the sensor / sample interface, as it is here that the 
critical binding interactions needed for measurement take place. By rationally designing this 
interface, one can greatly improve the performance of the biosensor by maximising specific 
binding interactions, minimising non-specific binding and biofouling and creating 
chemically stable and highly re-usable sensor interfaces. This approach combined with the 
rapid advances in plasmonic transduction technology, particularly plasmonic substrate 
design, offer great promise for even more sensitive and reliable small molecule biosensors. 
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1. Introduction      
Surface Plasmon Resonance (SPR) is an extremely sensitive optical technique to detect the 
changes in refractive index occurring at the metal interface, which can monitor the processes 
in real time without labelling requirements (Lee et al., 2006; Kanda et al., 2004; Homola, 
2003). Since 1989, our group have been focusing on SPR technology development. Several 
generations of SPR analytical platforms, including Reference SPR Analysis System, 
Electrochemical-SPR Analysis System, Portable SPR Analysis System, and High-
Throughput, Multi-analyte Imaging SPR Analysis System, have been designed, fabricated 
and tested for various applications. 
SARS (Sever Acute Respiratory Syndrome) is a kind of serious infection, which caused 
tremendous loss in China at 2003. It is caused by the infection with SARS-associated 
coronavirus (SARS-CoV) (Rota et al, 2003) and early diagnosis of SARS is very important for 
better control of future SARS epidemics (Drosten et al, 2003). There have been several 
diagnostic methods currently used in hospital, but none of them can be used for early 
detection with low cost. For example, ELISA cannot detect antibodies that were produced in 
the infected patients within the first two-week’s infections..  
In this chapter, a novel detection method of the SARS-CoV antigens was reported by using a 
home-developed Reference SPR Instrument, which can monitor reaction spots with control 
in a single flow cell. Monoclonal antibodies to SARS-CoV were immobilized only on the 
reaction spots via selective chemical modification, with no immobilization on the reference 
spots. Then a higher version of reference SPR analytical system: high-throughput, multi-
analyte imaging SPR (HMI-SPR) analytical system, was developed and tested successfully 
2. Theory 
Surface plasma resonance (SPR) is a physical phenomenon which occurs when a polarized 
light beam is projected through a prism onto a thin metal film (gold or silver). At a specific 
angle of the projected light, resonance coupling between light photons and surface plasmons 
of the gold can occur when their frequencies match. Because the resonance leads to an 
energy transfer, the reflected light shows a sharp intensity drop at the angle where SPR 
takes place. Resonance coupling of the plasmons generates an evanescent wave that extends 
100 nm above and below the metal surface. As an analytical tool it is important that a 
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change in the refractive index within the environment of the evanescent wave causes a 
change of the resonant angle, when the sharp intensity drop can be observed. Binding of 
single target biomolecue to immobilize single molecule on top of the metal (gold) surface of 
the sensor leads to a change of refractive index and could be recorded as a change of 
intensity in the reflected light by a detector. This setup enables real-time measurement of 
biomolecular interactions, with refractive index changes proportional to mass changes. 
Generally the Kretschmann configuration and resonance angle modulation are used in SPR. 
Kretschmann configuration (Kretschmann & Reather, 1968) is the most-common geometry 
setup of SPR platforms, in which the incident light comes from the high refractive index 
medium (prism) and reflects at the gold surface without travelling through the liquid. The 
resonance angle is defined according to the resonance peak of SPR, which is further defined 
based on the SPR curve, obtained by recording the change of light intensity of the reflective 
light along with the change of angle of the incident light. The resonance peak of SPR is at the 
lowest point of the SPR curve, where light absorption is the maximum and the light 
intensity of the reflective light is the minimum under a specific angle of the SPR curve.  
SPR is a well established technique for observing biomolecular binding reactions. In a usual 
setup, light traveling through a high refractive index (RI) substrate reflects from the 
substrate surface, which is coated with a thin layer of gold (50 nm). Certain biomolecules 
have been immobilized on the gold surface, which bind the targeted biomolecules in 
aqueous samples. As targeted biomolecules bind to the gold surface, the surface RI increases 
roughly proportional to the quantity of the molecules immobilized. The change of the 
surface RI results in the shift of the resonance peak of SPR and detection of the shift of the 
resonance peak of SPR monitors the reaction between biomolecules quantitatively such as 
the concentration of targeted molecules. Since the shift of the resonance peak of SPR could 
also be brought by other disturbances (e.g. temperature changes), it is necessary to use 
control signals to distinguish the shifts caused by the reactions from the shifts by other 
interferential factors.  
3. Experimental 
3.1 Reagents and materials 
Protein A (from Staphylococcus aureus), EDC, NHS, HEPES and ethanolamine were 
purchased from SIGMA company. Human Immunoglobulin G (IgG), rabbit IgG, goat anti 
human IgG, and goat anti rabbit IgG were purchased from Beijing Xinjingke Biotechnology 
Company.  
Sterilized SARS-CoV (PUMC-01 strain, TCID50 is 106puf/ml) and monoclonal antibodies 
(11G9, 2F1, 13D10, 11H12) to this virus were supplied by the Institute of Laboratory Animal 
Science, CAMS & PUMC.  
The others were purchased from Beijing Chemical Reagents Company. 
3.2 Bare gold slide patterning 
The patterns of bare gold slides with reaction areas and reference areas were designed in L-
edit and transferred to a photolithograph mask of chromium. The fabrication was as 
follows. The glass slides were spin coated with positive photoresist (AZ 1500) and patterned 
by an MA4 optical stepper (Karlsuss, Germany). The exposed photoresist was developed 
and the glass slides were coated with 2 nm of chromium plus 50 nm of gold in a JGP560B3 
type magnetron sputtering instrument (SDY Technology Development Co., LTD, Chinese 
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Academy of Sciences, China). After removing photoresist in acetone, the bare gold slides 
with patterned areas were finally obtained (Fig.1). Prior to each experiment, bare gold slides 
were washed in ethanol to remove fingerprints, oily residues and dust particles.  
Fig. 1. Schematic of a SPR biochip with a reference area and a reaction area  
3.3 SPR chip preparation  
The sensor chips were prepared in the following procedure. Firstly bare gold slides were 
treated in piranha solution ((H2O2 35%): (H2SO4 96%) = 3:7) at 90°C for an hour. After the 
slides were washed by deionized water and ethanol, they were soaked in the 16-mercapto-
hexadecan-1-ol solution (5×10-3mol/L 16-mercapto-hexadecan-1-ol in 80% ethanol and 20% 
water) to obtain a hydrophilic surface. Then the slides were soaked in the solution including 
0.4mol/L sodium hydroxide, diglyme and 0.6mol/L epichlorophdrin at 25°C for 4h.  After 
the slides were thoroughly washed by deionized water, ethanol and deionized water 
sequentially, they were soaked in the dextran solution (3.0g dextran T500 in10ml 0.1mol/L 
NaOH) at 25°C for 20h. Finally, a bromoacetic acid solution was only dropped on the 
detection gold areas of the slides at 25°C for 16h. A thin layer of carboxymethyl dextran was 
formed only on the detection gold areas of the slides, while nothing was immobilized on the 
reference gold areas.   
3.4 Protein immobilization online  
After a SPR chip was mounted in the home-developed Reference SPR Analytical System, the 
angle scanning was conducted to choose a proper position for the fixing angle detection. 
HBS buffer (HEPES, 0.01mol/L; NaCl, 0.15mol/L; Tween 20, 0.05%, pH7.4) was firstly 
introduced to wash the chip. Then the mixed solution of EDC and NHS (final concentrations 
were 0.2mol/L and 0.05mol/L, respectively) was used to activate the SPR chip.  
After activation, the chip was washed with HBS buffer. Then a protein solution (pH of the 
solution is less than PI of the protein) was introduced into the chip to react with the 
activated area for protein immobilization. 
In order to eliminate the activated sites without immobilizing proteins, the chip was 
deactivated by flushing in Ethanolamine (1M) to remove molecules adsorbed loosely on the 
chip (Johnsson et al, 1991). 
3.5 SPR instrument setup 
As shown in Fig. 2, a Reference SPR Instrument System, with the function of qualitative and 




control area of the system could be simultaneously detected in one flow channel by using 
this new Reference SPR Instrument System, resulting in recording two signals at one run in 
which one signal shows the curve of the reaction, and the other shows the curve of reference 
simultaneously. The range of the angle adjustment is 40°~70°, which makes it feasible for 
both the gas sample and liquid sample measurements. The detetion resolution of the 
resonance angle is 0.001°. And the detective range of refractive index is from 1.04 to 1.43 
with a sensitivity better than 1×10-5RIU.
Fig. 2. Photograph of the home-developed Reference SPR Instrument System 
4. Results and discussion 
4.1 Design of home-developed reference SPR analytical system 
As shown in Fig. 3, the reference SPR analytical system consists of a semiconductor laser (1), 
a system of a polarizing filter and lens (2), a prism (3), a high resolution detector (4), a 
computer (5), a sampling system (6), a SPR chip with reference (7) and a microfluidic devive 
with a microchannel (8). The laser and the optical system were installed on a circumrotated 
arm, while the high-resolution detector was installed on another circumrotated arm. The 
prism, the SPR chip and the microfluidic device were installed on an anti-floating surface 
between the two circumrotated arms. Both circumrotated arms were controlled by the 
stepper motor with the coding system. During experiments, a beam of the light from the 
semiconductor laser with the wavelength of 650nm through the optical system shined in the 
prism and reached the SPR chip. Then the beam of the light reflected into the detector. 
Finally, the intensity of the reflected light was recorded and exported to the computer. The 
sampling system controlled two peristaltic pumps and different solutions were introduced 
to the SPR chip by using the microfluidic device. 
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Fig. 3. Schematic of the home-developed Reference SPR Instrument System 
4.2 Detection of SARS-CoV by immobilizing antibodies directly 
In the type I design, the antibodies to SARS-CoV were immobilized directly on the 
experiment area after the chip was activated. The solution of the monoclonal antibodies to 
SARS-CoV (pH 4.6) was pumped into the microfluidic device for 2000s. Then ethanolamine 
(1M, pH 8.5) was pumped in to deactivate the chip for 10 min. Finally HBS buffer was 
pumped in to wash the SPR chip. The signal recording of the immobilization step is shown 
in Fig. 4. When introducing the monoclonal antibodies to SARS-CoV, the reaction line 
increased significantly and the light intensity of the reaction line after the deactivation was 
still higher than the intensity before the antibody immobilization. This light intensity 
increase of the reaction line with reference line unchanged demonstrated that the 
monoclonal antibodies to SARS-CoV were successfully immobilized on the reactive area. 
Fig. 4. Signal recording of immobilizing antibodies directly  
The green line is a reference curve. The red line is a reaction curve. 
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After the antibodies were fixed on the SPR chip, sterilized SARS-CoV (1:5 diluted with acetic 
acid buffer, pH 4.4) was pumped into the microfluidic device and the reaction between the 
antibodies and SARS-CoV was recorded in Fig.5.  However, from the Fig. 5, there was no 
obvious light intensity increase of the reaction line, which may be caused by spatial 
obstacles which keep antibodies from contacting SARS-CoV. 
Fig. 5. Detection of sterilized SARS-CoV by immobilizing antibodies directly  
The green line is a reference curve. The red line is a reaction curve. 
4.3 Detection of SARS-CoV by using Protein A 
In the type II design, 0.5mg/ml Protein A solution was pumped in after the activation step. 
The solution of the monoclonal antibodies to SARS-CoV (pH 4.6) was flushed in after the 
deactivation step, aiming to bind with immobilized protein A. Then the chip was washed 
with PBS buffer until the base-line signal was stable. After that, the same sterilized SARS-
CoV solution (1:5 diluted with acetic acid buffer, pH 4.4) was pumped into the microfluidic 
device to react with immobilized antibody. The entire procedure was recorded, shown in 
Fig. 6, which demonstrates that the antibody to SARS-CoV was immobilized efficiently onto 
the reaction area of the SPR chip with the detection signal of SARS-Cov increasing to 60 
units. It is 55 units higher than the reference signal with the binding rate about 1.4unit/min. 
Protein A has pseudoimmune interaction with the Fc fragments of immunoglobulins 
(Cedergreen et al, 1993) that could extend the distance between the antibodies and the 
surface so that the free degree of the antibodies could be increased. At the same time Fab 
fragments which react with antigens could face the solution side due to Protein A. Protein A 
seems to be a useful agent for antibody immobilization by increasing the binding efficiencies 
between antigens and antibodies.  
Reference area was used to detect absorption of impurity in analyte, in order to eliminate 
the disturbance of non-specific absorption. The sensitivity of SARS-CoV detection reached 1. 
66 ×104 PFU/mL. 
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Fig. 6. Detection of sterilized SARS-CoV using Protein A 
The green line is a reference curve. The red line is a reaction curve. 
4.4 Detection of IgG by using an improved reference SPR system 
This Reference SPR Analytical System used to detect SARS-CoV is an analytical instrument 
with one channel and two parameters in which only two analytes in one sample would be 
detected. The next generation of the reference SPR system: the high throughput, multi-
analyte imaging SPR (HMI-SPR) analytical system, has been designed, fabricated and tested, 
shown in Fig. 7.   
Fig. 7. Photograph of the high throughput, multi-analyte imaging SPR analytical system. 
A 5-spots sensor chip was used as an example to briefly demonstrate the functions of HMI-
SPR instrument. Firstly the 5-spots rare gold slides were modified by means of chemical 
methods. A thin layer of carboxymethyl dextran was immobilized on the gold spots of the 
slides to form a carboxyl-terminated surface. Then the mixed solution of EDC and NHS 
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(final concentrations are 0.2mol/L and 0.05mol/L) was used to activate the surface. 0.5?L
solutions containing 1mg/mL rabbit IgG were dotted on the left two gold spots, while 0.5?L
solutions containing 1mg/mL human IgG were dotted  on the right two gold spots with the 
middle gold spot unmodified.     
After the solutions were dotted on the gold areas, rabbit IgG and human IgG reacting with 
the dextran on the rare gold areas for 10min were fully immobilized on the chip. Then the 
sensor chip was deactivated by dipping in the ethanolamine solution of 1mol/L. During this 
process, the proteins which didn’t bind to the sensor chip firmly were removed. After that, 
the sensor chip was put into the deionised water to wash away the remained salt solution. 
Finally, the modified sensor chip was mounted in the HMI-SPR system for different 
immunoassay tests.  
The process of detection was conducted with the results of 5 real-time curves for 5-spots 
chip, shown in Fig. 8a. At first, HBS buffer was introduced for getting the base lines for 400s 
and then a solution containing 1.2mg/mL goat anti rabbit IgG was injected and stopped for 
reaction for 300s. Secondly, HBS buffer was introduced again for recovering the base lines 
for 400s and then a solution containing 0.5mg/mL goat anti human IgG was injected and 
stopped for reaction for 300s. Finally HBS buffer, HCl buffer and HBS buffer were 
introduced sequentially in which HCl buffer was used to bring the sensor chip back to the 
original setup. As shown in Fig. 8a, when goat anti rabbit IgG was injected, the 
immunoreaction occurred at rabbit IgG binding areas (curves 1 and 2). When goat anti 
human IgG was injected, the immunoreaction occurred at human IgG binding spots (curves 
4 and 5). After HCl buffer was injected, all the gold areas of the sensor chip restored to base 
lines.  
The linear calibration method of signal curves was performed to move base lines to zero and 
subtract the reference curve, shown in Fig. 8b.
Until now, we have designed, fabricated and tested 15-spot, 27-spot, 45-spot, 96-spot and 
144-spot sensor chips. 
5. Conclusion 
In this chapter, a home-developed Reference SPR Analytical System has been demonstrated, 
in which the successful detection of the SARS-CoV antigens has been recorded by the 
measurement mode of fixed angle in which Protein A has been used to obtain a higher 
sensitivity. Then an improved reference SPR system, high throughput, multi-analyte 
imaging SPR (HMI-SPR) analytical system, was briefly illuminated by using a 5-spot sensor 
chip to detect two kinds of Immunoglobulin G. By using a reference area, the performance 
of the SPR system has been improved to avoid the refractivity inference of different 
solutions, different temperatures, and even to eliminate the disturbances due to non-specific 
absorptions. Therefore, the home-developed Reference SPR Analytical System is promising 
to implement clinic diagnosis by directly detecting the crude patients’ samples without 
pretreatment procedures. 
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(a)
(b)
Fig. 8. SPR response curves for qualitative detections (a) before and (b) after data processed. 
Curves 1 and 2 for immobilization of rabbit IgG, Curves 4 and 5 for immobilization of 
human IgG, Curve 3 for reference. 
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1. Introduction  
The detection of pollutants in the environment is becoming a health and economic issues. 
The sector of water realises more than 700.000 analyses per year with an average price of 
approximately 15 euros/analysis. In 2001, the European Community published in the 
official journal a list of priority substances to be detected within the water framework 
(Decision N° 2455/2001/EC). Heavy metals like cadmium, lead and mercury belong to this 
list. The current measurement techniques are not applicable to the on line analysis of these 
pollutants because they are too expensive and complex to be applied in the field.  
Our laboratory develops since ten years alternative measurement methods of chemical 
pollutants in water and pathogenic bacteria in the food industry either as bioassay or 
biosensor. 
2. Generalities about bioluminescence, heavy metals and biosensors 
2.1 Bacterial bioluminescence 
The mechanism of the bacterial bioluminescence is studied since 1944 (McElroy & 
Ballentine, 1944). Today eleven bioluminescent bacterial species classified in four genus are 
listed. Three genus are coming from marine origin: Vibrio, Photobacterium and Alteromonas.
The fourth, more recently discovered is of terrestrial origin: Photorhabdus (ex Xenorhabdus)
(Meighen & Szittner, 1992). 
From the biological and ecological point of view, the interest of the bioluminescence is 
related to the symbiotic character of the bacteria. It was suggested that the metabolic 
function of the bacterial luciferase was connected to its capacity to the electrons transfer to 
oxygen rather than to its light output. Thus, it would be an alternative pathway for the 
electrons transport under low oxygen pressure like in fish organs (Hastings et al., 1985; 
Meighen, 1993) and the hosts would draw advantage from the light emitted by using it for 
communication or defence (Nealson & Hastings, 1979; Meighen, 1994; Visick et al., 2000). 
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Fig. 1. Bioluminescence reaction (adapted from Sung & Lee, 2004 and Tu & Mager, 1995) 
The reaction of bioluminescence is catalyzed by the luciferase enzyme coded by the luxAB 
genes (Figure 1) (Blum, 1997). Three key substrates modulate the light reaction: the 
dissolved oxygen provided by the surrounding environment, the reduced flavine 
mononucleotide coming from the bacterial metabolism and a long chain aldehyde such as 
decanal coded by the luxCDE genes (Meighen, 1991). When spectral emission from the 
whole bacteria was recorded from 400 to 750 nm with a highly sensitive spectrometer 
initially devoted to Raman scattering, two peaks were clearly identified, one at 491-500 nm 
(±5 nm) and a second peak at 585-595 (±5 nm) with the Raman CCD (Thouand et al., 2003). 
2.2 Heavy metals and bacterial resistance 
a. Heavy metals 
Among metals it is necessary to separate metals and metalloids essential to the biological life 
(for example copper, zinc, iron, selenium…), from non essential metals such as for example 
cadmium, mercury. However all metals according to their concentration have a toxicity with 
respect to living organisms. 
Heavy metals are naturally present both in the environment and in water at trace levels 
(5ng. L-1 Cd in water, INERIS, France), but the anthropogenic activity increases metals 
concentration found in the natural environments (Audry et al., 2004). Because of their great 
solubility in water heavy metals are easily absorbed by the living organisms and are found 
accumulated in human at the end of the food chain (Kurniawan et al., 2006). In fact the 
industrial wastes are mainly responsible for the current pollution of the rivers by heavy 
metals that are normally collected and treated by waste water treatment plants (WWTP). 
However, Karvelas et al, 2003, pointed out that even a fraction is adsorbed in the activated 
sludges, between 37 to 77% (depending to the metal) are rejected into the river. The WWTP 
can thus be a considerable source of pollution in spite of the existing standards of rejections 
and the treatments carried out. 
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b. Bacterial heavy metals resistance mechanisms 
Basically, heavy metals action in the bacterial cytoplasm leads to important oxydative 
stresses (Nies, 1999). The minimal inhibition concentrations of heavy metals/metal for 
Escherichia coli are reported in table 1. 





1.0 Co2+, Ni2+, Cu2+, Zn2+
2.0 Tl+, UO22-, La3+, Y3+, Sc3+, Ru3+, Al3+
5.0 Pb2+, Ir3+, Os3+, Sb3+, Sn2+, In3+, Rh2+, Ga3+, Cr3+, V3+, Ti3+, Be2+
10.0 Cr2+
20.0 Mn2+
Table 1. Minimal inhibition concentrations (MIC) of heavy metals to Escherichia coli (Nies, 
1999)
The entry of heavy metals into the bacterial cell is done by the regulation systems of the 
divalent cations or oxyanions. Indeed, heavy metals are not distinguishable for these 
transmembrane proteins, from the other divalent cations or oxyanions (for example: SO42-,
HPO42-, Fe2+, Mg2+, Mn2+, etc…). Bacteria have developed two kinds of resistance 
mechanisms to cure this passive entry. The first of them is fast, non specific and is based on 
the gradient of concentration or on proto-motive force. The second mechanism is more 
specific, inducible and is activated in the presence of a metal and generally requires ATP 
hydrolysis. 
This second inducible mechanism of resistance is subdivided in three types.  
- The first of them is a more or less specific system of cation/oxyanion efflux by ATPases 
pumps (ATPase CPx-type).  
- The second system is based on the complexation capacity of some divalent heavy 
metals with the -SH group of the gluthation or the metallothionines for cyanobacteria 
(Cavet et al., 2002).  
Lastly, the third mechanism, more specific for oxyanions, allows a reduction of them in a 
less toxic form. These reduced forms are then evacuated from the cytoplasm with a specific 
ATPases pumps (Nies, 1995; Nies, 1999; Nies, 2003). 
The bacterial mechanisms of regulation and resistance to heavy metals are summarised in 
figure 2. The efflux systems using ATPases pumps are preferred in the bacteria because their 
energy cost per cell is lower than the complexation of metals by the glutathion or the 
metallothioneins. Indeed one ATP molecule is enough to evacuate a divalent metal with an 
ATPase pump belonging to the family of the ATPases CPx-type, whereas 16 ATP are 
necessary to complex only one divalent metal (Nies, 1999). 
It is important to note that the mechanisms of inducible resistances, known to be specific, 
are thus not activated by only one metal even if their name seems to make it believe (Nies, 
2003). In the same way, only one metal can activate several systems of resistance (Moore et 
al., 2005; Wang & Crowley, 2005). 
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Fig. 2. Main heavy metals regulation and resistance mechanisms in bacteria. 
c. Molecular basis of the  ZntA/ZntR system of Escherichia coli 
The action of the MerR regulators consists first of all to the repression of the target promoter 
in the absence of the metal. This inactivation is due to a distortion of the DNA double helix 
on the RNA polymerase fixation site. The regulator, having fixed the metal pollutant, 
changes its conformation allowing the RNA polymerase to fix to the promoter. The 
regulation of the pzntA promoter, by the ZntR protein is an example of the mechanisms of 
regulation of the MerR type (Brocklehurst et al., 1999; Outten et al., 1999; Binet & Poole, 
2000) (Figure 3). 
The regulators of the MerR type are activators/repressors. This family of proteins has at its 
N-terminal part a site for DNA fixation and the ligands are fixed to the C-terminal. 
2.3 Detection of heavy metals with bioluminescent bacteria: choice of a heavy metal-
bacterial resistance mechanism. 
The inducible bioluminecent bacteria are used to detect specifically a pollutant or a family of 
pollutants or even the toxic effects. The action of the pollutants on the cells induces in this 
case the synthesis of the genes of bioluminescence and thus the emission of light. Thus, the 
choice of an inducible resistance system to build a sensitive strain is foremost justified by its 
sensitivity to metals in vivo. The sensitivity depends on the origin of the genetic system and 
the host strain. 
To obtain an interesting sensitivity, the resistance systems coming from less resistant 
bacteria such as Escherichia coli should be preferred. Indeed, the strain Ralstonia metallidurans
CH34 (Mergeay et al., 2003) which harbors a great number of resistance systems from the 
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Fig. 3. Regulation of the pzntA promoter by the ZntR protein 
pMOL28 and pMOL30 plasmids was the object of an insertion of the transposon Tn4431 
containing the luxAB genes (Corbisier et al., 1993; Tauriainen et al., 1998). The detection limit 
of the strain obtained was 1mM of Pb2+ against 30nM of Pb2+ for mechanisms resulting from 
the less resistant bacteria such as Escherichia coli and Staphylococcus aureus.
Table 2 reports the detection limits of three bioluminescent strains for heavy metals 
detection using various mechanisms of resistance from Escherichia coli: ZntA/ZntR, 
CopA/CueR and the ars operon. The three plasmidic constructions based on these resistance 
systems make it possible to detect a range of eleven heavy metals with detection limits 
sometimes lower than the standards for water. However, it should be noted that the ranges 
of detection of the CopA/CueR system and the ars operon are not studied completely in 
comparison with the ZntA/ZntR system. Indeed, the ars operon is also activated by bismuth 
(Bi) and antimony (Sb) and the CopA/CueR system is also activated by gold (Au) (Wu & 
Rosen, 1993). 
Various developments are proposed or were proposed on the market such as: the BIOMET® 
kit developed from transcriptional fusions between the luxCDABE operon and various 
resistance systems to heavy metals of the Ralstonia metallidurans strain (Vito, Belgium, 
http://www.vito.be/). One other kit using the inducible bioluminescent strains for arsenic 
or mercury (Biologically Heavy metal Assay kit) is distributed by Aboatox company 
following the works of Tauriainen et al. (1997, 1998). 
The team of S.Daunert (Lexinton, Irvine, the USA) developed an original microfluidic and 
analysis system integrated in a compact disc allowing arsenic detection with the arsenic-
sensitive E.coli pSD10 (parsR:: arsR:: gfpuv) (Rothert et al., 2005). Ivask et al. (2009) proposed 
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a set of 13 inducibles strains (Gram - and Gram +) covering a broad range of sensitivity. 
Lastly, Hakkila et al. (2004) described a bioassay with 8 inducible bioluminescent strains to 
heavy metals encapsulated to disposable fiber optics. 






 ZntA/ZntR CopA/CueR Ars operon 
DL
E.coli MG1655 









(Stocker et al., 
2003)
      
Cd  0.010µM / / 0.045µM 
Hg  0.3µM / / 0.005µM 
Pb  0.03µM / / 0.005µM 
Sb  10µM / / / 
As(V)  / / 0.4µM 0.135µM 
A(III)  / / 0.2µM 0.135µM 
Zn  1µM / / nc 
Ni  10µM / / 0.34µM 
Co  10µM / / nc 
Cr(VI)  30µM / / 1µM 
Cr(III)  30µM / / 1µM 
Ag  / 0.3µM / / 
Cu  / 3µM / 30µM 
Table 2. Detection Limits (DL) of the genetic constructions based on heavy metals resistance 
mechanisms of E.coli. *: Values obtained from INERIS (Institut National de l'Environnement 
Industriel et des Risques); /: unavailable data; nc: metal not concerned by a standard. 
2.4 Bioluminescent bacterial biosensors 
A biosensor is an integrated and autonomous device able to provide a quantitative or semi-
quantitative analytical information by using a biological element of recognition (the 
bioelement) retained to transducer (Figure 4) (Thévenot, 2001). The biosensors are 
distinguished from bioassay that are disposable kits. The microbial biosensors can be 
classified according to whether the bioelement is in liquid phase or immobilised phase. 
The liquid phase biosensors remains on the principle of reactor cultures in batch or 
continuous modes.  
In the reactors culture, sets of probes ensure the traditional control of the temperature, 
oxygenation and the pH. In many systems, measurements of bioluminescence and 
sometimes optical density are done in a second reactor for the pollutant measurement. Thus, 
if the sample injected is toxic, the bacteria in culture are not affected and the analyses can 
continue (Gu et al., 1999; Gu et al., 2002). Only one apparatus allows the simultaneous 
measurement of the bioluminescence and optical density in the same reactor (Thouand et 
al., 2003; Horry et al., 2004; Picart, 2004). 
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Fig. 4. Figures showing the two kinds of biosensors (type 1 and 2). CMOS = complementary 
metal oxyde semiconductor 
These biosensors often can use only one bioelement at the same time that limits the number 
of analyses, excepted a multi-reactors platform developed by (Lee & Gu, 2005). Another 
drawback of these systems is the dilution of the analysed sample after injection into the 
culture volume inside the reactor. 
Contrary to the biosensors in liquid phase, the biosensors in immobilised phase allow a 
direct contact between the micro-organisms, the transducer but also with the sample. The 
photomultipliers, associated with a beam of fiberoptics are mainly used as physical 
transducer (Polyak et al., 2001; Horry et al., 2006) but also the CCD camera (Charrier, Thesis, 
2006) or the CMOS (Complementary Metal Oxide Semi-conductor (Simpson et al., 1998). 
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Few bioluminescent bacterial biosensors multichannel match with the strict definition 
provided by the IUPAC were developed excepted for example Charrier (Thesis, 2006) and 
the systems approaching the biosensor but of single use, therefore being able to be regarded 
as bioassay (Kamidate et al., 2001; Philp et al., 2003; Tani et al., 2004; Lee & Gu, 2005; 
Maehana et al., 2006; Rabner et al., 2006). 
3. Experimental procedures 
3.1 Molecular biology 
V.fischeri luxCDABE operon was amplified from plasmid pRL1114 (luxCDABE V.fischeri,
KnR) (Fernandez-Pinas & Wolk, 1994) with Dynazime polymerase (Finzyme) and the 
following selected primers: 5’ACG TGA ATT CAT GAA TAA ATG TAT TCC AAT GA3’,
5’ACG TCT GCA GTT AAT CCT TTA TAT TCT TTT GTA TG3’. The PCR fragment was 
purified (QIAquick), digested by NruI and EcoRI restriction enzyme (NEB) and introduced 
(T4 DNA ligase, NEB) in pBtac2 (Roche) vector under the control of the ptac promoter to 
obtain the plasmid pBfiluxCDABE. This plasmid transformed in E.coli DH1 allowed a 
constitutive expression of bioluminescence. 
The pzntA promoter was amplified on a boiled preparation of E.coli DH1 by PCR using 
Deep Vent polymerase (NEB) and the following primers : 5’CAC TTC CTG ATC GTC CGC 
TCG CTG CT 3’, 5’AGC ATG AAT TCG GCA TCC TCC GGT TAA GTT T3’. Plasmid 
pBfiluxCDABE was digested by NruI and EcoRI, purified and cloned into the linearized 
vector to obtain plasmid pBzntlux (ApR, pzntA :: luxCDABE).
3.2 Bacterial strains and media 
E.coli DH1 strain (C.I.P. 104745, [F-, recA1, endA1, gyrA96, thi-1, hsdR17, supE44 relA1]) was 
used for all the experimentations of this study. 
LB medium supplemented with ampicillin (100µg.mL-1, Sigma) or kanamicyn (20µg.mL-1,
Sigma) was used for molecular biology. Solid LB was supplemented with 15g.L-1 of 
bacteriologic agar (Biokar Diagnostics).  
An acetate medium with a C/N/P ratio of 100/10/1 was used for the growth of E.coli DH1 
pBzntlux for biosensor applications. 1L of tap water was filtered through a 0.45 ?m filter 
(Sartorius) and supplemented with 2.835g acetate (panreac), 1.1919 g NH4Cl (Merck), 0.028 g 
K2HPO4 (Merck), 5 g NaCl, 0.5 g yeast extract (Merck) and 0.1 g tryptone (Biokar 
Diagnotics). The pH was adjusted to 7 and the medium was sterilized by autoclaving at 
100°C for 30 min. For biosensors application, the feeding media was acetate medium diluted 
ten times (1/10X) supplemented with ampicillin (final concentration 50µg.mL-1), in order to 
limit cell division in agarose matrix.  
Batch cultures were prepared at 30°C and shaken at 250rpm in 100ml Erlen flasks. Bacterial 
growth was monitored using a spectrophotometer (Unicam) and optical density 
measurement was reached at 620nm (OD620nm).
3.3 Cell immobilization procedure 
Agarose hydrogel matrix was used for cells immobilization in the biosensor chip according 
to previous published results (Pernetti, 2003; Horry et al., 2006). 
In a first step, E.coli DH1 pBzntlux was cultivated 14 hours in acetate medium at 30°C. The 
next morning, OD620nm of the culture was measured and cells were diluted with fresh 
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medium to OD620nm=0.2. At the same time a 4% agarose solution was prepared by dissolving 
at 90°C, 0,4g agarose LGT (Agarose Type VII-A Low Gelling Temperature of 26°C; Sigma, 
reference A0701) in 10mL of acetate medium on a warming magnetic stirrer. 5mL of this 
solution was preserved at 37°C in a water bath with a constant agitation. Then 5ml of 
bacterial solution diluted to OD620nm=0,2 then added to the 5mL 4% agarose solution 
preserved at 37°C. After homogenisation, the final solution obtained was at an OD620nm=0.1 
for a final agarose concentration of 2%. In a final step, this solution was pulled in the 
Lumisens2 biosensor chip (Horry et al., 2006). Agarose immobilized cells were used 
immediately in Lumisens2 biosensor for samples analysis without any conservation time. 
3.4 Chemicals 
Metals used were: CdCl2 (Panreac), HgCl2 (Prolabo France), PbCH3CH2O (Panreac), SnCl2
(Merck), ZnCl2 (Merck), NiSO4 (Labosi), CoCl2 (Labosi), K2Cr2O7 (Labosi), CrCl3 (Acros),
AgNO3 (Prolabo France), CuSO4 (Labosi), FeSO4 (Labosi), MnCl2 (Panreac) and As2O3
(Sigma). The purity of the metals was greater than 95%. Metal stock solutions were prepared 
at a high concentration (1M or 0.5M) in acidified distilled water (pH?5-6) and conserved at 
+4°C in brown bottles. Working dilutions of metals were made daily in distilled water 
acidified to pH?5-6.
3.5 Bioassay 
Measurements of bioluminescence were made at controlled temperatures (30°C or 37°C) 
using a microtiter plate luminometer (Microlumate L96V, EGG Berthold). Heavy metal 
detection with E.coli DH1 pBzntlux, after an overnight culture at 30°C, bacteria were diluted 
to an OD620nm=0.05 in fresh media. One hundred microliters of the dilution were added to a 
96-well microtiter plate. Bacterial bioluminescence was induced after the addition of 25µL of 
a 5X metal solution. 
3.6 Environmental samples treatment and analysis 
Environmental water samples were all coming from the city waste water treatment plant of 
La Roche sur Yon (Moulin Grimaud, capacity of 83000 population equivalent). The 
samplings were carried out at the exit of the station, before the effluent rejection in the Yon 
river.
In laboratory, samples were first filtered on 0.45µM membrane (Pall Corporation) and 
preserved at 4°C during one or two days. Filtration was necessary to withdraw the largest 
particles which would clog the fluidic biosensors system. 
Before their injection in the biosensor, samples were all supplemented with acetate media at 
1/10X final concentration and, for cadmium detection control, with 0.5µM of CdCl2.
DOC (Dissolved Organic Carbon) was measured in environmental samples with a 
TOCmeter : (COT-5000A Shimadzu). Total sulphate was measured with Hach Lange kit 
Sulfaver and total phosphate with the Briggs method. 
3.7 Description and operation of Lumisens2 biosensor 
Lumisens 2 (Horry et al, 2006) features three distinct parts: the fluidic layout, the disposable 
card and the optoelectronic equipment (Figure 5). The latter is composed of the power 
supply, the temperature regulation and the bioluminescence measurement device. The 
temperature, measured with a J thermocouple (TC Online), is regulated via a threshold 
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value given by the controller (Chauvin-Arnoult), connected to a heater (Radiospares), 
inserted close to the disposable card. The bioluminescence is monitored with a photon-
counting photomultiplier (Hammamatsu) connected to the disposable card with a fiber optic 
(Oriel). The light measurements are automatically recorded with a dedicated LabView®
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Fig. 5. Diagrams of Lumisens2 biosensor (A), its measurement chip (B) and Photo (C) 
modified according to Horry et al. (2006). (dimensions are in millimetres) 
The bacteria are immobilized in a 35 x 35 x 17 mm disposable parallelepipedic card designed 
in Ertacetal® plastic. The card is bored through the center to let the fluids come in contact 
with the bacteria. A 13 mm diameter enclosure has been placed at the depth in which the 
bacteria are immobilized and includes a measuring chamber of 1.32 cm3. An optical window 
(Edmund Optics) is hermetically stuck to the bottom of the measuring chamber on which 
the membrane of the bacteria is coated and maintained because of a 1 mm groove. 
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Inserted into its fixed pad, the disposable card closes the hydraulic layout, and the 
immobilized bacteria are in contact with the fluid diffusing into the immobilization agarose 
matrix. 
Three independent samples are linked to a remote controlled 10 channel multiposition valve 
(Valco AG) that allows their specific selection. Each channel can be periodically selected 
throughout the experiments with a Windows® Hyperterminal® protocol, allowing the 
design of sequences of liquid exposures. The liquids are drawn out of the disposable card 
with a peristaltic pump (Meredos, Germany) located between two anti-return valves to 
avoid the reflux of the liquids into the card. 
Measurement cycles were programmed with a soft specially dedicated to Lumisens2. 
Experimentations were all realised with a flow rate of  5mL.min-1. Induction medium was 
first injected in the biosensor during 100 minutes to induce bioluminescence. Then the 
biosensor switched automatically to the regeneration medium during 140 minutes to let the 
bioluminescence signal back to ground. Bioluminescence was measured each six seconds 
during all the experimentation and results were directly shown on the computer screen.  
Constant oxygenation of the feeding medium was realised by a continuous bubbling of 
sterile filtered air (0.22µM filters, Sartorius) among the measurement cell. 
4. Results 
The aim of this study was to demonstrate the applicability of a bioluminescent bacteria for 
the on line cadmium detection in waste water treatment plant. The strain E.coli DH1 
pBzntlux was immobilized in an agarose matrix and then used in the Lumisens 2 biosensor 
once described by Horry et al. (2006) for TBT detection. In our present study, every 
parameters describing the biosensor were carefully calculated before to applied the 
biosensor to environmental samples. 
4.1 Specificity and detection limits of E.coli DH1 pBzntlux 
The range of detected metals and their associated detection limits are listed in Table 3. Of 
the fourteen heavy metals used, eight were detected by E.coli DH1 pBzntlux. Detection 
limits for cadmium and mercury were under or equivalent to the recommended E.U. 
standards for water. Other heavy metals like lead, zinc, tin, cobalt, nickel and chromium (VI) 
were detected at levels above their E.U. limits. Chromium(III), silver, copper, iron, 
manganese and arsenic were not detected by E.coli DH1 pBzntlux. E.coli DH1 pBzntlux 
detects a large number of heavy metals and as a consequence it cannot be used as a specific 
sensor, rather it should still be considered as a general warning system for heavy metal 
water pollution. 
4.2 Flow rate effect on the bioluminescence measurement 
A first study was undertaken in order to evaluate the effect of various flow rates on the 
bacterial bioluminescence rate (Figure 6). The light production rates were comparable 
whatever the flow tested according to a statistical analysis (Test of Levene, ? =0,01). 
The fluids circulation rates inside the Lumisens2 biosensor thus do not influence 
significantly the detection efficiency by the immobilized bacteria in the range of the flows 
tested. However one can note a lower variability for 5mL.min-1, that was selected in all our 
following experiments. 
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Metal tested Specificity Detection Limit EU Pollution Standards* 
CdCl2 + 0.005µM 0.045µM 
HgCl2 + 0.005µM 0.005µM 
PbCH3CH2O + 5µM 0.005µM 
SnCl2 + 5µM ? 
ZnCl2 + 5µM NC 
NiSO4 + 50µM 0.34µM 
CoCl2 + 50µM NC 
K2Cr2O7 + 50µM 1µM 
CrCl3 - - 1µM 
AgNo3 - - ? 
CuSO4 - - 30µM 
FeSO4 - - NC 
MnCl2 - - ? 
As2O3 - - 0.135µM 
Table 3. Specificity and detection limits of E.coli DH1 pBzntlux in bioassay. 
+ = Heavy metal detected, - = Heavy metal not detected, NC = Not concerned by legislation 
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Fig. 6. Variation speed of the luminous intensity of E.coli DH1 pBzntlux according to the 
flow rate. (N=3 for each tested flow rate).  
Experimental conditions: E.coli DH1 pBzntlux was immobilized in agarose 2% (OD620nm?0,1). 
Tested flow rates were 2.5mL.min-1 , 5 mL.min-1 , 10 mL.min-1  and 23 mL.min-1  at 30°C with 
acetate medium 1/10X supplemented with  ampicilline (50µg.mL-1) and 0.5µM CdCl2
4.3 Reproducibility of the measurement 
The phases of induction and regeneration have a low signal variability (lower than 10%). The 
maximum of variation (17.1%) of the signal is observed at the peak of bioluminescence (Figure 7). 
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Fig. 7. Reproductibility of cadmium measurement by Lumisens 2 biosensor using E.coli DH1 
pBzntlux. Results are the average of 5 independent experiments.  
Experimental conditions : E.coli DH1 pBzntlux was immobilized in agarose 2% 
(OD620nm?0,1). Used flow rate was 5mL.min-1. Induction medium (?) containing acetate 
medium 1/10X supplemented with 50µg.mL-1 ampicilline and 0.5 µM CdCl2 was first 
injected during 100 minutes. Then regeneration medium (?) containing acetate medium 
1/10X supplemented with 50µg.mL-1 ampicilline was injected. Skye blue bands represent 
standard deviation (?). 
One can note a significant reproducible light decrease signal with the switch from induction 
to regeneration medium linked to a variation of oxygen in the bottle. The total time of the 
measurement cycle is 220 minutes, including 100 minutes of induction with the medium of 
test and then 120 minutes of regeneration. It should be noted that the time of arrival to the 
peak of bioluminescence is lengthened compared to the bioassay (45 minutes in liquid phase 
against 60 minutes in immobilized phase) 
4.4 Repeatability of the measurement 
In an application point of view, it is necessary to know the repeatability of the measurement 
for one single agarose membrane. The cycle of measurement 100 minutes of induction then 
120 minutes of regeneration was thus repeated on the same membrane until extinction of the 
bioluminescence signal (Figure 8). 
The intensity of the detection peaks decreased in an important way during time. However, 5 
analyzes producing a significant peak of bioluminescence were monitored in less than 20 H. 
This signal decrease affecting the repeatability could be attributed to: 
? parameters related to the environment of the bacteria:  
? Toxicity of cadmium by accumulation in the membrane  
? Availability of oxygen in the measuring chamber 
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? parameters related to the bacteria:  
? Growth of the bacteria in the membrane  
? Lack of aldehyde for the bioluminescence reaction  
? Adaptation of the microorganisms to cadmium 
These parameters were successively studied during various experiments in order to 
quantify their role in the signal. 
Fig. 8. Cadmium measurement repeatability. Experimental conditions were as described in 
Fig 7. 
4.5 Influence of several parameters on the repeatability 
a. Cadmium concentration monitoring inside the membrane  
The accumulation of cadmium inside the membrane could cause an increasing toxicity for 
the bacteria. The cadmium concentration was measured by ICP-MS (Inductively Coupled 
Plasma - Mass Spectrometry) at different time in the membrane (without bacterium) having 
undergoes several cycle- metal addition/washing (Figure 9).  
The agarose membrane contains an initial quantity of residual cadmium (51.6 nM), ten times 
higher than the detection limit of E.coli DH1 pBzntlux (5nM). This can partly explain the 
flush of bioluminescence at the beginning of the metal addition.  
As expected, the assay medium contains a cadmium concentration close to 500 nM  
(470 nM) that was never reached inside the membrane (305.1 nM and 356.7nM instead of 470 
nM). Moreover, after regenerations, the metal concentration does not go down to the  
initial Cd concentration (51.6nM) but remains at concentrations from 83 nM to149 nM 
(Figure 9).
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Fig. 9. Concentrations in cadmium in membranes without bacteria during several cycles of 
measure. (The bioluminescence curve of bioluminescence, with the initial peak is presented 
only for indication). 
Experimental conditions: Cadmium titrations were realized on membranes without bacteria 
by ICPMS in the departmental laboratory of analysis of Vendée (LDA85). For each measure, 
the membrane to be analyzed underwent the deliberate number of cycles and was then 
taken off for analysis. 
Hence, cadmium was not accumulated during all the cycles, but a fraction remained blocked 
in the agarose, while this material is not considered as an adsorbant according to Pernetti et 
al. (2004). 
b. Oxygen effect 
Oxygen is necessary both for the catabolism of the bacteria and the reaction of 
bioluminescence. The oxygen brought to the bacteria comes only from the assay and the 
regeneration media and dropped during the biosensor measurement (Figure 10). 
During the first induction, the oxygen concentration at the biosensor output decreased 
significantly (from 5.8 to 5.2mg.L-1) whereas it remained stable during the following 
regeneration (5.4mg. L-1). The oxygen fall was confirmed with the following cycle and can be 
at the origin of the decrease of bioluminesence.  
To address this steady lack of oxygen inside the card, a permanent bubbling device was 
designed to bring air inside the card. Figure 11 compares the results obtained with and 
without air bubbling. 
These results show a very significant improvement of the living time of the card with a 
constant air feeding allowing eleven cycles of measurement instead of five without air 
bubbling. However the bioluminescence signal disappeared after more than forty operating 
hours. Oxygen even in excess in the measuring cell did not seem to be the only limiting 
factor of the living time of the membrane. 
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Fig. 10. Evolution of oxygen concentration at the exit of the Lumisens2 biosensor 
measurement cell.
Experimental conditions were as described in Fig 7. Oxygen measurements were realized by 
a O2 probe (SCHOTT 9009/2) connected with an IT interface Reacell 1.11 (Jeulin). 
Fig. 11. Repetability of cadmium detection by Lumisens 2 biosensor and E.coli DH1 pBzntlux 
with and without oxygenation of the feeding medium. 
Experimental conditions were as described in Fig 7. 
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c. Bacterial growth inside the agarose matrix  
The carbon provided by the circulating medium (acetate medium 1/10X: DCO=148mg.L-1) is 
low, but could allow the cellular division. In order to check this hypothesis, the absorbance 
(OD 620nm) was measured in situ during a whole experiment after each medium 
substitution (Figure 12). 
As supposed the bacteria divided in the membrane and the optical density doubled in 24 
hours (from 0.068 to 0.127) with a low growth rate (µ=0.081h-1). As a consequence the 
opaqueness of the resulting agarose membrane led to a quenching of photon and caused a 
fall of the quantity of light collected by the fiber optic beam. Other consequences are 
possible, like a more important adsorption of cadmium onto the bacteria. 
Fig. 12. Evolution of OD620nm in the agarose membrane of bacteria during a repeatability 
experiment without added oxygen (The bioluminescence curve is presented only for 
indication). 
Experimental conditions were as described in Fig7. OD620nm was monitored at each switch 
between induction and regeneration medium. 
d. Other parameters influencing the repeatability 
Three other parameters were tested due to their possible effects on bioluminescence : 
- A lack of oxygen already addressed above but increased to avoid any limitation. 
- A lack of tetradecanal (resulting from the luxC,D et E genes activities) involved in the 
bioluminescence reaction. The tetradecanal is not produced at saturated concentration 
in the Vibrio genus and could be limited in E.coli DH1 pBzntlux too (Meighen, 1999). 
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- An adaptation to the Cadmium concentration. Another fundamental parameter, which 
can affect the answer of the bacteria during long and repeated exposures to the same 
cadmium concentration, is their adaptation to the toxic. Indeed, the ZntA/ZntR system 
that we used for the detection of heavy metals belongs to systems induced naturally to 
evacuate the cadmium from the cytoplasm of the cell.  
These different hypothesis were tested and the results are presented in the Figure 13.  
Fig. 13. Parameters influencing the repeatability of the cadmium detection by Lumisens2 
biosensor using E.coli DH1 pBzntlux. IM: Induction Medium; RM: Regeneration Medium. 
Experimental conditions were as described in Fig 7 with constant oxygenation of the feeding 
media.
The induction with more oxygen or the addition of decanal did not improve the signal. On 
the other hand, an induction carried out with more cadmium (1.5 µM instead of 500 nM) 
made it possible to obtain the same signal as the first cycles of analysis. This result would 
consolidate the assumption according to which the bacteria adapt to the metal concentration 
tested (500nM CdCl2). 
4.6 Detection limit 
The period of 15 to 20 hours, where the signal of the bacteria is stable, was used to 
determine the limit of detection of Lumisens2 for cadmium. For that, 5 cadmium 
concentrations were successively used on the same membrane and the experiment was 
repeated three times to determine the limit of detection when metal was added either in 
distilled water or in the waste water treatment plant of la Roche sur Yon (France) effluent 
(Figure 14). The detection limit of the biosensor for cadmium was 50 nM with or without 
environmental matrix. This value was close to the European standard for water (45 nM) but 
was ten times more important than the limit of detection observed for cadmium in bioassays 
in liquid or immobilised phase (5nM). 
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Fig. 14. Detection limit of Lumisens2 biosensor for cadmium detection either in distilled 
water (A) or in waste water from waste water treatment plant (B) using strain E.coli DH1 
pBzntlux.
4.7 Application to the detection of cadmium in a waste water treatement plant output. 
In a last stage, we wished to associate the biosensor for the detection of cadmium in an 
effluent from the urban waste water treatment plant (WWTP) of la Roche sur Yon (France). 
Since technically it was not possible to bring the biosensor on site, the samples of the WWTP 
were collected twice a day (morning and evening) during 4 days and tested in the 
laboratory. For each day, a card containing the E.coli DH1 pBzntlux bacteria was introduced 
into the Lumisens 2 biosensor and was used all the day without exceeding 5 cycles of 
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measurements to avoid the bioluminescence decrease. During these cycles, the two samples 
were introduced directly to check the presence of Cd in the effluent and after addition of 500 
nM of CdCl2 in order to confirm the response of the bacteria. 
The figure 15 shows that the bacteria of the biosensor did not detect metals because of a 
cadmium-free effluent or a concentration lower than the detection limit (50nM). On the 
other hand, the bioluminescence was monitored when metal was added in the effluent (for 
example Day 1) that confirmed the measurement’s capacity of the bacteria. 
Fig. 15. Detection of heavy metals in waste water treatment plant samples from city of La 
Roche sur Yon with Lumisens 2 biosensor and E.coli DH1 pBzntlux. 
It also appears that the produced bioluminescence ranged between 100,000 and 500,000 
RLU.s-1 according to the samples which received the same metal concentration. The 4B 
sample was positive while bioluminescence was weak but remained significant compared to 
the other samples. 
Experimental conditions: Each day tow samples of water were taken at the exit of the waste 
water treatment plant of La Roche sur Yon. For each day, samples were analysed with one 
chip of Lumisens 2 biosensor. Analysis cycles first start with the injection of the raw sample, 
in order to determine the presence of heavy metals, during 100 minutes (green curve). In a 
second step, regeneration medium was introduced to wash the membrane during 120 
minutes. In a third step, the same sample, supplemented with 0.5µM of CdCl2, was 
introduced in the biosensor during 100 minutes and in a final step the membrane was 
washed during 120 minutes. Flow rate was 5mL.min-1 with constant oxygenation and the 
temperature was 30°C. 
1A 1B  2A 2B  3A 3B  4A 4B 
DOC
(mg.L-1)  9.115 6.839  7.828 8.990  8.468 8.589  7.566 14.020 
Sulfate
(mg.L-1)  34 43  74 38  34 60  60 25 
Phosphate
(mg.L-1)  0.425 0.625  0.421 0.365  0.563 0.587  0.374 0.447 
Table 4. Chemical analysis results of all samples taken from waste water treatment plant of 
La Roche sur Yon. DOC analyses were realized with TOCmeter (COT-5000A Shimadzu), 
sulfate analyses with Hach Lange kit and phosphate analysis with the Briggs method. 
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The average bioluminescence was 312,000 RLU.sec-1 with a variability of 64%, exceeding the 
variability between membranes (see figure 7). We sought to identify external factors able to 
influence the signal of bioluminescence such as the dissolved carbon, the sulphates and 
phosphates, all three chelators of metals (Table 4). No correlation was identified between the 
fall of the optical signal and a strong content of one of the three measured elements.  No 
explanation could be given and it is finally possible to conclude that measurement is 
currently of all-or-nothing basis. In other word, if a metal is present at a concentration 
ranging from the limit of detection and the limit of toxicity, the biosensor is able to measure 
it without to quantify the concentration by the means of the luminous intensity. 
Background level 
Flow rate effect on the 
detection kinetic 
Reproducibility of the 
measurement 
Repetability of a 
measurement with the same 
membrane 
??Agar contains low but significant metals level 
that influence the bioluminescence signal at the 
beginning of the detection 
??No effect in the range 2.5 to 23 mL.min-1
??5mL.min-1 flow rate was chosen 
??Maximum variability of 17,1 for a flow rate of 
5mL.min-1 after 4 separate experiments 
??5 measurement cycles during 5 hours with a 
slight decrease of bioluminescence.  11 cycles 
during 40h but a strong bioluminescence 
decrease was recorded. 
??Strong effect of the oxygen on the life time of the 
membranes. 
??Strong bioluminescence decrease during time  
but : 
o No cadmium accumulation inside 
agarose 
o Slow growth of the bacteria inside the 
gel 
o No effect after more oxygen or aldehyde 
additions 
o Bioluminescence increased after 
addition of 3-times more cadmium.  
Detection limit (DL) 
??50nM of CdCl2, near the European standard 
(45nM). No matrix effect on the DL 
Environmental application ??Successful during 4 days but impossible to quantify the metal.  
Fig. 16. Summary of the main results obtained in this study with the  E.coli DH1 pBzntlux 
immobilized in the Lumisens 2 biosensor. 
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5. Discussion 
The study carried out with Lumisens2 made it possible to better understand and 
characterise the on line detection of a metal with an immobilised inducible bioluminescent 
strain: E.coli DH1 pBzntlux. The main results are summarised in figure 16. 
The reproducibility of the measurement of cadmium at the selected flow rate is acceptable. 
The lifetime of the same membrane in a continuous mode is forty hours and during this 
period, eleven analyses are possible. Lee et al., (2004) bring back a life time of  60 hours with 
their biosensor with only six possible analyses. Heitzer et al., (1994) describe a lifetime of 14 
days but they shown only 3 possible analyses in twenty hours. Our results in comparison 
with the above data, are thus satisfactory. However, as we noted, a progressive fall of the 
signal of bioluminescence was observed after a prolonged use of the same membrane, that 
could be attributed to two parameters (combined or not) discussed below. 
5.1 Bacterial growth effect 
The growth of the bacteria inside the membrane caused a fall of the bioluminescence while 
acting on three factors: the “quenching” of the light by the bacteria, the increase in the 
consumption of nutrient and oxygen (Figure 17). 
Fig. 17. Possible effects on cadmium detection of the bacterial growth in Lumisens2 
Biosensor chip. 
At the beginning of the experimentation, the immobilised bacteria are in low number in the 
membrane. The nutrient, oxygen and metal would be sufficient so that each bacterium emits 
a strong and detectable bioluminescence. However, after 16 hours of use, the growth of the 
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bacteria in the membrane of agarose limits the diffusion of the nutrients and metal. Affi et 
al. (2009) demonstrated that oxygen is the limiting factor since oxygen concentration moving 
from 100% saturation at the surface to 10% at the bottom off the gel. 
The calculation of instantaneous S0/X0 ratio (ratio between the mass of carbon, S0 versus 
the mass of bacteria, X0) in the measuring cell is 309 at the beginning of an experiment and 
265 at the end of the analysis. Those ratios allow the growth of the bacteria and a solution 
would be to limit the growth by decreasing the quantity of carbon available but certainly at 
the expense of the bioluminescence. 
5.2 Effect of the adaptation to the metal 
The adaptation of the bacteria to cadmium is a believable hypothesis because after addition 
of higher cadmium concentration (Figure 13), the levels of induction were restored. As 
shown in the figure 18, the presence of cadmium induces both the bioluminescence 
production and also the synthesis of the resistance mechanism to heavy metals ZntA/ZntR 
(Binet & Poole, 2000). The repeated exposure to metal would cause an important synthesis 
of the ZntA protein into E.coli DH1 pBzntlux cytoplasm. According to our assumption, the 
quantity of transmembrane ATPases pumps would become sufficient so that the cadmium 
once entered in the cytoplasm would be immediately evacuated outside the bacteria. This 
phenomenon would prevent the fixation of metal by the ZntR protein and the activation of 
the synthesis of the luxCDABE operon. The strain would thus be adapted to the presence of 
the same cadmium concentration. Moreover, the resistance system ZntA/ZntR is not alone 
and other systems of efflux or complexation of heavy metals can amplify this phenomenon 
of adaptation and thus take part in the progressive fall of the signal of bioluminescence 
(Nies, 1992; Ferianc et al., 1998; Nies, 1999; Spain, 2003; Wang & Crowley, 2005). 
6. Conclusions 
The Lumisens2 biosensor designed with the E.coli DH1 pBzntlux bacteria made it possible to 
better understand the on line detection of a metal. In spite of the signal bioluminescence 
decrease attributed to adaptation and growth effect, we showed that lifetime for the same 
membrane is 40 hours (eleven analyses), that the reproducibility of measurements was 
satisfactory with a reproducibility of 17% and finally that the limit of detection of cadmium 
was 50nM. A card can be used with a stable signal during one day and it is possible to 
monitor the pollution of an effluent of a WWTP during 4 days. 
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Fig. 18. Synthetic plan of cadmium activated mechanisms in E.coli DH1 pBzntlux. 
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1. Introduction     
Driven by the demand of the bioelectronics market, many biosensors need to work in 
parallel or in a controllable way to achieve complicated biodetections, however the limited 
scale, speed, cost, complex signal processing, and bulky circuit routing problems prohibit 
the discrete biosensor solutions (Drummond et al., 2003). Nowaday biosensor are usually 
integrated on the same substrate to form biosensor array to improved the scale and 
efficiency, and solve the signal routing difficulties.  
CMOS technology emerges since the mid-1960s, and rapidly captured the IC market. The 
aggressive scaling of CMOS technology following the famous Moore’s Law enables the 
realization of high-speed digital circuits, analog and mixed-signal circuits, as well as radio-
frequency (RF) communication circuits. A single chip monotonically integrating all 
components of a complex electronics systems or laboratory systems which contain digital, 
analog, mixed-signal, and RF communication, microelectromechanical systems (MEMS), 
and other experimental functions, i.e. lab-on-a-chip (LOC) is avidly to be implemented to 
possess the capabilities of high-efficiency characterization, high-speed complex signal 
processing and communication, mass production, large scale, low cost, and low power as 
well. Fortunately, most of the fabrication processes of biosensors are compatible with the 
standard CMOS technology either directly or via the post-CMOS processes, e.g. DNA 
sensors fabricated on Si-nanowire (Li et al., 2004) and gold surface (Cheng et al., 2005) etc, 
which makes it possible to integrate the biosneosr arrays and CMOS IC on a single chip as a 
CMOS integrated biosensing system (IBS) (Augustyniak et al., 2006; Prakash et al., 2006; 
Thewes et al., 2005; Han et al., 2007). 
The CMOS IBS usually composes of four parts in its system circuitry: integrated biosensor 
array, interfacing circuits, analog-to-digital (A/D) conversion, and digital signal processor 
(DSP), as shown in Fig. 1(a). In some system requiring feedback controlling during the 
characterization, digital-to-analog (D/A) converters are also included depending on the 
applications, as shown in Fig. 1(b). In the system architecture of CMOS IBS, the overall 
performance such as noise, bandwidth, sensitivity etc are mainly governed by the 
performances of interfacing circuits which controls the electrolyte potential and directly 
acquires signals from the integrated biosensor array.
The three electrode system, as shown in Fig. 2, is the most popular electrode architecture of 
the integrated biosensor array in nowadays CMOS IBS. The system is composed of reference 
electrode, working electrode, and counter electrode (it is also called auxiliary electrode 
sometimes). 
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Fig. 1. System architectures of CMOS IBS. (a) Feedforward sensing. (b) Feedback controlled 
sensing. 
Reference electrode is an electrode with a stable and well-known electrode potential. There 
are many types of reference electrode used in electrochemical systems, such as hydrogen 
electrode, copper-copper(II) sulphate electrode, silver chloride electrode etc, among which 
the silver chloride (Ag-AgCl) electrode is commonly employed in the IBS. In some systems 
with feedback stabilization, the reference electrode made from inert metals such as gold 
(Au), platinum (Pt) etc are also utilized to simplify the fabrication process. 
Working electrode is an electrode in the IBS on which reaction of interest is occurring. 
Common working electrode is usually implemented in inert metals such as Au, Ag, Pt, etc. 
Most biosensors apply a control voltage on the working electrode in contact with the 
electrolyte while measuring the current by a signal acquisition circuit, as shown in Fig. 2. 
Counter electrode is an electrode used in the IBS from which the sensing current is expected 
to flow and is also made from inert metals in most cases. The potential on this electrode is 
opposite in sign to that of the working electrode. Counter electrode is usually connected 
with the reference electrode by a potentiostat in a negative feedback loop to stabilize the 
electrolyte potential with respect to a reference during the biosensing process, as shown in 
Fig. 2. In some systems, acquisition circuit is combined into the potentiostat, but which is 
not against the architecture of the interfacing circuits we are discussing here.  
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Fig. 2. Interfacing circuits in the CMOS IBS. 
2. Potentiostat 
The on-chip potentiostat circuit serving for stabilizations of electrolyte potential and 
accommodation of electrochemical current (Augustyniak et al., 2006; Prakash et al., 2006; 
Thewes et al., 2005) is one of the major components in the IBS, which is usually realized as 
an operational transconductance amplifier (OTA) (Zhang et al., 2009). Table 1 shows the 
specifications of the potentiostat OTA from a typical biosensor system based on nano-
particle assembly. 
Typical assembling voltage 1.8 ± 0.2 V 
Min. assembling voltage ~1 V 
Electrolyte potential range 0 to 1.8 V 
Max. potential variation 5 mV 
Assembling current range ~10 nA to ~100 µA 
Max. signal bandwidth < 100 kHz 
Table 1. Sepcifications of potentiostat OTA from the experiment.  
It can be seen that the assembling voltage range falls in the typical supply voltage range of 
standard CMOS technology, but due to the aggressive scaling of CMOS technology, typical 
supply voltage of mainstream CMOS process can barely satisfy the specifications in Table 1. 
For this reason, a potentiostat OTA with rail-to-rail input common-mode range is highly 
preferred in the CMOS IBS. On the other hand, considering the loading capability required 
by the assembling current range, a Class-AB output stage should also be incorporated for its 
bidirectional loading capability and high power efficiency.  
The potentiostat OTA has been designed and illustrated in Fig. 3. The potentiostat OTA uses 
the complimentary folded-cascode input stage composed of transistor M0 to M13 to achieve 
the rail-to-rail input common-mode range to enable the required assembling voltage, and 
reduce the input-referred noise to stabilize the potential as well, while incorporates the 
Class-AB output stage composed of transistor M29 to M32 to provide the maximized loading 
capability and accommodate the assembling current requirement. Transistors M14 to M21
function as the common-mode feedback circuit and provide biasing voltage for the folded-
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cascode input stage. M25 to M28 are two source follower to match the DC voltage between 
stages, while the other biases are served by M22 to M24 from a current IB. Simulation results 
show that biasing at a current of IB=1 µA the circuit is capable of providing a rail-to-rail 
input and output dynamic range and a unit gain bandwidth up to 42.7 MHz, while the 
output current headroom, Imax, is over 450 µA, which meet the specifications in Table 1. 
Fig. 3. Transistor level implementation of the potentiostat OTA with rail-to-rail input 
common-mode range and Class-AB output stage. 
The potential variation is due to: (I) finite transconductance of the potentiostat OTA, (II) 
input referred noise, and (III) the input referred offset. If GmDC is the DC transconductance of 
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According to the noise theory, transistors M0, M1, M5, M6, M7, M8, M12, and M13 in the first 
stage contribute to the overall noise. The noise power spectral density, SI, in a MOS 










?   (2) 
where ? is the thermal noise parameter, gm is the transconductance, Ids is the drain-source 
current, Cox, W, and L are the gate capacitance per unit area, transistor width and length, 
respectively, and k, T, and f are the Boltzman constant, temperature, and frequency, 
respectively. KF, AF, and EF are flicker noise parameters with the typical values of 2×10-25, 2, 
and 1, respectively. Since the corner frequency fc, where thermal noise and flicker noise 
exhibit the same power density, is calculated as 5.4 Hz by using parameters provided by the 
foundry, much smaller than the unit gain bandwidth, therefore, flicker noise is negligible in 
the proposed OTA, and the input referred noise voltage Virn can be characterized by 
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where gmj is the transconductance of transistor Mj, j = 0, 1,…, 32. 
Virn can be diminished by increasing the biasing currents and aspect ratios of the input 
differential pairs, but trades off with the power consumption and the physical area. The 
spectral density input referred noise of proposed OTA on different common-mode input 
voltages are shown in Table 2. 
Monte-Carlo simulation is also performed to characterize the input referred offset by 
utilizing the mismatch parameters provided by the foundry, and the results are also shown 
in Table 2. In the worst case with VCM = 0 V, the overall potential variation due to the above 
three issues is 4.12 mV, which implies an 8 bit of potential resolution and satisfies the 
boundary condition in Table 1. The other circuit performances are summarized in Table 2. 
Parameters VCM = 0 V VCM = 0.9 V VCM = 1.8 V 
DC transconductance 2.22 S 5.43 S 3.90 S 
3-dB bandwidth 1.97 kHz 2.07 kHz 1.94 kHz 
Phase margin >75o >80o >75o
Max. output pull 
current
451 µA 451 µA – 
Max. output push 
current
– 459 µA 459 µA 
Input referred offset 3.51 mV 1.60 mV 2.75 mV 
Input referred noise 61.8 nV/?Hz 38.2 nV/?Hz 57.7 nV/?Hz
Overall potential 
variation
4.12 mV 1.93 mV 3.24 mV 
Potential resolution 8 bit 9 bit 9 bit 
DC power dissipation 40.4 µW 50.3 µW 58.0 µW 
Power supply 1.8 V 1.8 V 1.8 V 
Table 2. Summary of performances of the potentiostat OTA 
3. Acquisition circuits 
The design of acquisition circuits in the IBS is circumscribed by the sensing mechanism of 
the biosensor. In the electrical biosensing, there are two major schemes in analyte detection: 
direct current (DC) sensing and alternative current (AC) sensing.  
In the DC sensing, a DC voltage is usually applied to the working electrode in an IBS, and 
the current flowing from counter electrode to the working electrode is measured 
(Augustyniak et al., 2006; Thewes et al., 2005). This method suffers from the large 
background noise in the electrolyte seriously, which prevent it from the applications 
requiring high sensitivities of biosensing.  
In the AC sensing, the acquisition circuit senses the AC modulation current by applying an 
AC voltage superimposed on a DC biasing on the working electrode (Huang & Chen, 2008). 
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Since only the background noise within the band-of-interest deteriorates the signal-to-noise 
ratio, the AC sensing has much better sensitivity than the DC sensing scheme.  
DNA releasing  voltage 0.9 V 
DNA modulation voltage ±0.5 V 
Current headroom ±100 nA 
Current sensitivity ~100 pA 
Max. signal bandwidth 10 kHz 
Min. sensor impedance ~5 M?
Table 3. Specifications of a typical DNA IBS 
A desirable acquisition circuit should usually accommodate both schemes of biosensing, 
however, as summarized in Table 3, the fastidious requirements, such as sensitivity, 
bandwidth, input range, etc., for the following circuits make great challenges to analog 
integrated circuit designers. There are various methods and circuits dealing with the 
ultralow current in biosensing applications, e.g., current integrator (sometimes it is called as 
potentiostat) (Ayers et al., 2007; Narula & Harris, 2006), transimpedance amplifiers 
(Rodriguez-Villegas, 2007; Basu et al., 2007), and ultralow current-mode amplifiers (ULCA) 
(Zhang et al., 2007; Ramirez-Angulo et al., 2004; Steadman et al., 2006; Zhang et al., 2009). 
The current integrator is capable of providing sub-picoampere sensitivity, however, the 
circuit bandwidth is typically below 1 kHz, which cannot fully accommodate the bandwidth 
of AC sensing. Transimpedance amplifiers possess wider bandwidth and good sensitivity, 
however, its dynamic range is limited by the supply voltage, which becomes a serious issue 
along with the scaling of supply voltage in today’s CMOS technology. The ULCA turns out 
to be a favorable candidate with high sensitivity, sufficient bandwidth, and wide dynamic 
range for IBS with AC sensing capabilities.  
3.1 Circuit design of ULCA 
In ULCA design, conventional transistor-strong-inversion-based current-mode circuits are 
out of consideration due to the large noise background induced by the dc quiescent current, 
and weak-inversion-based (subthreshold) current-mode circuits emerge as the candidates. 
Since the subthreshold circuits suffer from supply voltage fluctuations and die-to-die 
process fluctuations (Mead, 1989), they are usually closely integrated with other adjacent 
stages on a single die and share the same supply voltage, along with careful considerations 
on the matching, symmetry, and biasing issues (Linares-Barranco et al., 2003; Linares-
Barranco et al., 2004; O’Halloran & Sarpeshkar 2004). 
Some ULCA topologies have been reported (Zhang et al., 2007; Ramirez-Angulo et al., 2004; 
Steadman et al., 2006), as shown in Fig. 4. The circuit in Fig. 4(a) is working in the Class A 
mode. It uses a regulated current mirror to achieve the current amplification. The quiescent 
currents are provided by current sources, whereas the bandwidth is limited by capacitor C0.
Although the circuit provides good linearity over the input range, since the quiescent 
current I0 should be low enough to reduce the noise level and meet the requirement of 
sensitivity, the specified current headroom (in both positive and negative directions) can 
hardly be achieved. One can certainly introduce the Class B complementary topology in Fig. 
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4(b) to meet the headroom requirement and increase the sensitivity by removing the noise 
background induced by I0; however, this comes at the cost of substantially losing bandwidth 
in the low-input cases. 
                                  (a)                                                                                 (b) 
Fig. 4. Conventional current-mode amplifier topologies. 
To meet the specifications in Table 3, a Class AB ULCA aiming at biosensing amplification 
has been designed and verified in SMIC 0.18-µm CMOS mixed-signal technology (Zhang et 
al., 2009). The design elaborately considered the issues and tradeoffs over gain, bandwidth, 
noise, and offset. The experimental results show that the ULCA can completely satisfy the 
requirements of typical DNA-based IBS and is eligible to serve for the preamplification of 
ultralow biosensor signals in the IBS. 
The ULCA schematic is shown in Fig. 5. In this circuit, the current from DNA biosensors is 
input to a complementary regulated current mirror consisting of an N-type opamp AN0, a P-
type opamp AP0, and transistors M0, M1, M3, and M4, where it is amplified by a factor of 10 
(20 dB). The opamps AN1 and AP1 and the transistors M6?M11 compose a voltage limiter. 
Fig. 5. Circuit schematic of the ULCA. 
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Due to the “virtual short” mechanism, “IN” is fixed at “REF” by AN0 and AP0, and a 
quiescent current of Iref is established in M0 and M3 by AN1 and AP1. When a positive input is 
applied Vn, the output of the opamp AN1 reduces, thus turning off M2. The current of M0 and 
M1 is sunk by AP0. On the other hand, since Vp tends to drop down, the current provided by 
AN0 becomes smaller. However, M5 is turned on by AP1 to compensate the current at node 
Vp, which limits Vp from dropping and maintains the quiescent current of M0 and M3 equal 
to the reference current Iref provided by M6?M9, even if the input current IIN is much larger 
than Iref . A similar conclusion can also be made for the negative input cases. 
It can be seen that M2 and M5 alternatively sustain the quiescent current for the current 
mirror, which in turn keeps a constant bandwidth as the input varies between positive and 
negative directions. Furthermore, Iref can be designed small enough to achieve the required 
sensitivity and noise level without being restricted by the current headroom, since the 
current headroom no longer depends on the magnitude of the quiescent current in the 
ULCA. Therefore, the circuit can provide an extremely high sensitivity and a large current 
headroom at the required bandwidth. Due to the variation and pad leakage issues, Iref is 
unpractical to be provided off-chip. Therefore, three steps of current mirroring are 
introduced by M12?M16 in the biasing stage, where each step achieves a conversion factor of 
0.1. A microampere-level off-chip current is downconverted 1000 times to relax these 
unwanted impacts. Capacitors C0 and C1 serve for frequency compensation and bandwidth 
limitation purposes in the circuit. 
                                              (a)                                                           (b) 
Fig. 6. Auxiliary N- and P-type opamps in the ULCA. 
The auxiliary N- and P-type opamps are shown in Fig. 6(a) and (b). In the circuit, M0, M1,
M3, and M4 consist of a differential input stage. M0 and M1 are biased in their subthreshold 
regions for the purpose of noise reduction; meanwhile, they are chosen as large dimensions 
to improve the matching and reduce the offset and flicker noise. Transistors M5 and M6
consist of a transconductance output stage that provides current for the following circuits. 
Capacitors Cn and Cp represent the load capacitances of the opamp. 
As shown in Fig. 5, when a positive input is applied, the gain is provided by the regulated 
current mirror consisting of M0, M1, and opamp AP0, whereas M3?M5 and opamp AP1 are 
serving as current sources providing the quiescent current for the stage, which can be 
simplified to the circuit shown in Fig. 7(a). A complementary discussion of the negative 
input case leads to the topology shown in Fig. 7(b). 
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3.2 Small signal AC analysis 
The small-signal equivalent circuit for ac analysis is shown in Fig. 7(c). In this circuit, gm, gmb,
go, and Cgs are the gate transconductance, body transconductance, output conductance, and 
gate capacitance of the MOSFET, and goa, Cia, and Coa are the output conductance, input 
capacitance, and output capacitance of the opamp, respectively. Ci is defined as Cgs0 + Cgs1 + 
C0 (or C1). The transconductance of the opamp is modeled as gma(s), considering the delays 
introduced by the parasitic capacitances of its internal nodes. As suggested in (Linares-
Barranco et al., 1992), gma(s) can be written as 







  (4) 
where gma is the DC transconductance, and ?a models the delay. 
                                      (a)                                                                         (b) 
(c)
Fig. 7. (a) Simplified circuit of ULCA when a positive input is applied. (b) Simplified circuit 
of ULCA when a negative input is applied. (c) Small-signal equivalent circuit of a simplified 
ULCA.
Detailed analysis of the equivalent circuit results in the characterization function of 
as2+bs+c=0, where: 
? ? maia i oa a i oa a
a
ga C C C C C? ?
?
? ?
? ? ? ?? ?
? ?
  (5) 
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and the parameters are defined as follows: 
Cia: Input capacitance of opamp. 
Coa: Output capacitance of opamp (Cn or Cp). 
Ci: Cgs0+Cgs1+C0 (or C1).
gm: Transconductance of MOSFET. 
gmb: Body transconductance of MOSFET. 
go: Output conductance of MOSFET. 
goa: Output conductance of opamp. 
To maintain the ac stability, all the poles of the circuit transfer function must be placed in 
the left-hand side of the Laplace plane, i.e. a>0, b>0, c>0 must be satisfied, resulting in the 
conditions of gNma, gPma > gm1, C0 > gPma/?a, and C1 > gNma/?a. Moreover, it can be found that 
provided the quiescent current Iref , by adjusting C0 and C1, the bandwidth of the ULCA can 
be confined at the expected value. 
3.3 Noise characterization 
It is known that three kinds of noises are considered in the CMOS circuit: thermal noise and 
shot noise, which are white noise, and flicker noise or 1/f noise. According to the noise 
theory and the characterizations in (Linares-Barranco et al., 2003) and (Linares-Barranco et 
al., 2004), the subthreshold noises in the MOSFET are basically contributed by shot noise 







? ?   (8) 
where ID is the drain–source current of the MOSFET, W and L are the channel width and 
length, Cox is the gate capacitance per unit area, and q, f, and K represent the unit charge, 
frequency, and a process-dependent parameter, respectively. In the 0.18-µm technology, the 
typical value of Cox is about 1.08 × 10?2 F/m2, and K is 2 × 10?24 F2/m2 for nMOS and 4 × 10?26
F2/m2 for pMOS. 
By equaling the two terms in (8), one can derive the noise corner frequency as fc =
KID/2qWLC2ox. In a W = 10 µm and L = 1 µm sized nMOS, fc is around 8 Hz when biased at ID
= 1.5 nA, which is no more than 0.1% of the required 10-kHz bandwidth, whereas for pMOS, 
fc is two orders lower. In the DNA biosensor, the modulation signal is usually band limited 
with a typical bandwidth of 10 kHz and a lower frequency of 10 Hz; therefore, shot noise 
dominates over the whole signal band of interest from the above design.  
The noise performance of the ULCA can be characterized by two noise sources vn and in
with the corresponding power densities of Svn and Sin, which can be calculated as usual by 
evaluating the output noise current with the input open or shorted to the ground and 
dividing by the gain. The simplified expressions are reported as 
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where A is the current gain of the ULCA, and Sva is the input referred noise power density of 
the opamp. From (9) and (10), Sin and Svn can be reduced by decreasing the input-referred 
noise of the opamp and the quiescent current Iref, however trading with the power 
consumption and the bandwidth of the ULCA. 
3.4 Mismatch considerations 
The performances of the practical circuit also suffer from process fluctuations due to 
transistor mismatches, e.g., variations of W, L, and threshold voltage VT , which would 
induce the input-referred offset (IRO) Ioff, gain error ?A, and bandwidth variation ?BW of the 
ULCA. More specifically, one can find that Ioff is due to the IROs Voff of opamps AN0 and AP0
and the mismatches of M0, M1, M3, and M4; ?A is caused by mismatches of M0, M1, M3, and 
M4; whereas ?BW is mainly induced by Voff of opamps AN1 and AP1. It is known that the 
variances of W, L, and VT due to process fluctuations are inversely proportional to the area 
of the MOSFET; therefore, as a first-order approximation, Ioff, ?A, and ?BW are inversely 
proportional to ?WL, which can be reduced by increasing the sizes of M0, M1, M3, and M4
and the input differential pairs of opamps in the ULCA, provided that the bandwidth 
specification is satisfied. 
Incorporating the above considerations on stability, noise, and mismatch, HSPICE 
simulations are made on the circuit to meet the circuit specification in Table 3, and the 
optimized quiescent current is designed as Iref = 1.5 nA, whereas capacitors C0 and C1 are set 
to 1 pF. Monte Carlo simulation based on the design kit of SMIC 0.18-µm CMOS technology 
also shows that Ioff and BW are within ?30~120 pA and 12~16 kHz, whereas ?A/A is less 
than ±5%, when the channel length is chosen as L = 1 µm, and the aspect ratios (W/L) of N 
and P transistor units are 10 and 20, respectively. 
3.5 Experiment and discussions 
The ULCA is realized in the SMIC 0.18-µm CMOS mixed-signal technology, and Fig. 8 
shows the die micrograph of the chip. The box encloses the ULCA circuitry, which occupies 
about 230 × 80 µm2 of the chip area. The performance of the ULCA is measured in terms of 
gain, bandwidth, noise, offset, etc. The results are shown and discussed in this section. 
To test the performance of the ULCA, very large resistors (from 1 to 10 G?) are used to 
convert the voltage into input currents down to the picoampere or sub-nanoampere range, 
which may further keep the input noise current small since the input noise current spectrum 
density due to the resistor is inversely proportional to the resistance. The whole circuit is 
placed in an aluminum box with Bayonet Neill-Concelman (BNC) connectors to shield from 
unwanted interferences. In the experiment, VREF is biased at 0.9 V to provide maximized 
input range on both positive and negative directions while satisfying the voltage range 
specifications in Table 3. The input voltage varies between 1.9 and ?0.1 V to provide the 
positive and negative input currents by replacing the resistors. 
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Fig. 8. Die micrograph of the ULCA circuit. 
Fig. 9. DC gain and bandwidth as functions of input currents ranging from ?1 to 1 µA. The 
black squares represent the dc gain, whereas the circles illustrate the bandwidth. 
The DC gain as a function of input currents ranging from ?1 to 1 µA is plotted in Fig. 9, 
which is 0.5% lower than the designed value of 20 dB and implies about 2% of the overall 
mismatch on transistors M0, M1, M3, and M4 due to fabrication variations. The gain error 
over the input range is less than 0.3%. One can certainly increase the transistor dimensions 
to further reduce the mismatch and achieve better linearity, however trading with the 
bandwidth performance. 
The bandwidth has been characterized by analyzing the step response of the ULCA, which 
is cascaded by a commercial transimpedance amplifier, and the result as a function of input 
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currents is also illustrated in Fig. 9. It can be seen that the bandwidth basically linearly 
increases with the input current levels on both positive and negative directions from around 
20 kHz to 1 MHz. The minimal bandwidth of 15 kHz occurs in the low-input cases, 
satisfying the 10 kHz requirement in the application. The overshoot of the bandwidth is 
because the offset of opamps AN1 and AP1 and the threshold mismatch shift the actual 
quiescent current of M0 and M3 up to around 2 nA (estimated value) from the designed 
value of 1.5 nA. A larger bandwidth may slightly degrade the noise performance and 
sensitivity, but it could be adjusted by somewhat tuning the biasing current Iref down for 
compensation.  
The IRO is analyzed by keeping the input open while measuring the mean current at the 
output and dividing by the gain, which is found to be 96.6 pA at VOUT = 0.9 V. The IRO 
corresponds to the offsets of opamps and mismatches at the output node; however, it is not 
critical for the application. One can either slightly modify VOUT for compensation or do the 
calibration after acquisition and analog-to-digital conversion in the digital domain by a 
simple subtraction.  
Fig. 10. IRNC and SNR as functions of input currents ranging from ?1 to 1 µA. The black 
squares represent the IRNC, whereas the circles illustrate the SNR. 
The noise performance of the ULCA is characterized in terms of the input-referred noise 
current (IRNC) by measuring the mean-square-root value of the output current fluctuation 
at each input current level and dividing by the gain. The result is shown in Fig. 10. It is 
noticed that the IRNC of the ULCA starts at 37.6 pArms at zero input and basically remains 
at the same level for |Iin| < 1 nA, whereas it linearly increases for larger input levels. The 
target current sensitivity of ~100 pA is satisfied. The signal-to-noise ratio (SNR) increases for 
|Iin| < 10 nA and gradually saturates at values around 36 dB for larger input levels. The 
SNR is smaller on the positive input side than on the negative side; this is due to the fact 
that nMOS exhibits a higher current noise than pMOS. It is worth mentioning that the 
minimal noise current is larger than the simulated value of 12 pArms but falls in the range 
provided by Monte Carlo simulation by utilizing parameters from the foundry, which can 
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be explained from two aspects: 1) the actual quiescent current of M0 andM3 is slightly larger 
than the designed value due to offsets of the opamp; and 2) the mismatches of M0, M1, M3,
and M4 degrade the symmetry of the ULCA topology, thus increasing the noise level. 
Linearity is presented by the gain versus input characteristic in Fig. 11. The gain 
approximately remains at 19.9 dB for the input range of ?100 to 100 µA and degrades for 
larger input levels. The maximal input current is estimated to about ±0.4 mA as determined 
by the 1-dB (or 10% in the linear scale) degrading point of gain, which implies 141 dB of 
headroom-to-noise ratio or equivalent to 23 bit. Moreover, depending on the electric 
properties of the DNA sensor and the buffer solution, the minimal impedance from the 
biosensor electrode is around 5 M?. The input impedance of the ULCA is measured as 15.5 
k?, which is much lower than the biosensor impedance in the application, satisfying the 
interface condition. 
Fig. 11. Gain versus input current over the entire input range. 
DC gain 19.9 dB 
3-dB bandwidth 15 kHz 
Current sensitivity 37.6 pArms 
Potential variation 583 nVrms 
Input-referred offset 96.6 pA 
Input impedance 15.5 k?
Max. input current ±0.4 mA 
Input dynamic range 141 dB 
DC power consumption 35 µW 
Power supply 1.8 V 
Table 4. Summary of circuit parameter of the ULCA. 
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A novel subthreshold Class AB ULCA aiming at the application of signal preamplification 
in the IBS has been demonstrated in SMIC 0.18-µm CMOS technology. Experimental results 
show that the ULCA completely accommodates the application and can provide a current 
gain of 19.9 dB, 3-dB bandwidth of 15 kHz, and an input range of ?0.4 to 0.4 mA, whereas 
the IRO and the noise current are less than 96.6 pA and 37.6 pArms, respectively. Table 4 
shows the summarized parameters of the circuit. The ULCA can also be used for ultralow 
current amplification in other types of biosensor interfaces, nanoscale device sensing, and 
optical sensing in the future. 
4. Discussion 
4.1 A few trade-offs 
In order to accurately acquire signals during the sensing process, CMOS IBS has to work on 
a stable electrolyte potential, which is precisely controlled by the potentiostat through the 
reference and counter electrodes from a negative feedback mechanism. The potential 
variation is mainly due to the offset and noise of the potentiostat OTA. Offset can be 
reduced by increasing the size of input differential pair of the OTA, or introducing a digital 
correction circuit via a D/A converter and logics, but trades with the circuit area. On the 
other hand, noise can be reduced by either increasing the size or biasing current of input 
differential pair, but trades with the area and power, respectively.  
The sensitivity of CMOS IBS is mainly governed by the acquisition circuits, which translates 
to the IRNC of ULCA. One can reduce IRNC by reducing the DC quiescent current, but 
trading with the bandwidth required in the biosensing. In some biosening systems with low 
electrolyte impedance, noise voltage (potential variation on the working electrode) of ULCA 
also becomes a concern, which also trades with the power and area of the circuit.  
In general, interfacing circuits is the bottle neck of the CMOS IBS design. A good design 
comes with various requirements of a specific biosensing system, which differs from one 
system to another. Various trade-offs must be considered in the circuit design according to 
the system specifications as well as power and area budgets.  
4.2 Future research 
Future research of CMOS IBS covers a number of directions to further improve the 
efficiency and performance of the system. One of the methods is to incorporate a 
preamplification step such as polymerase chain reaction (PCR) or rolling circle amplification 
(RCA) before the electrical sensing, which increases the analyte concentration in the 
electrolyte and biosensing current level, thus relaxing the sensitivity requirements of the 
interfacing circuit. Keeping the same sensitivity, one can further shrink the dimension of 
electrodes and increase the scale of IBS to improve the throughput and sensing efficiency. 
As the scale of IBS growing up, asymmetry due to the electrode layout also becomes an 
issue, because the current density distributes from the counter electrode to all the working 
electrodes in the electrolyte, which could be quite different from each other depending on 
the positions. Some structures such as multiple counter electrodes, interlacing electrodes, 
partition, etc are being investigated. Further research also needs to be invested to 
characterize the current distribution in the electrolyte for a specific electrode layout when 
the number of electrode scales up. 
From the circuit angle, the sensitivity can be further improved by using the lock-in filtering, 
which extracts the current only at the vicinity of frequency-of-interest therefore minimizing 
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the background noise contributions and maximizing the signal-to-noise ratio. The challenge 
part is that a high resolution A/D conversion is required to translate current signals into 
digital domain before the digital lock-in filtering. Logarithmic transimpedance amplification 
is another candidate to achieve high sensitivity and satisfying the bandwidth requirements, 
while ameliorating the dynamic range limitations by compressing output voltage range. The 
signal decompress can be realized by digital circuits after the voltage digitization.  
5. Conclusion 
The CMOS IBS research and production continue to offer a fertile ground for innovation. In 
this chapter, design considerations on the CMOS IBS interfacing circuits, including the 
integrated biosensor array, potentiostat, and acquisition circuits, have been introduced. A 
number of circuit design trade-offs between potential variation, sensitivity, speed, dynamic 
range, power, and physical area have also been discussed. Finally, future research directions 
to further improve the IBS performances in terms of efficiency and sensitivity are reviewed.  
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1. Introduction    
Technological advancement, miniaturisation of electronic devices and progress in ad-hoc 
network routing protocols and embedded systems have facilitated developments in the field 
of biosensors and biosensor networks.  Biosensor networks are a collection of biosensor units 
that collect information about biological responses and process it in order to make a decision 
for a desired outcome. In today’s market there is a demand for ultra low power consumption, 
portability and wireless connectivity from the biosensors for information exchange. This 
chapter introduces a new paradigm of biosensors which have processing capability with an 
intelligent and adaptive wireless communication module. The adaptive communication 
module efficiently reconfigures its hardware components according to the changes in 
operating environment in order to reduce system power consumption and optimally utilise 
resources. Due to the intelligent wireless communication module, the biosensor unit becomes 
a state of the art independent system as well as part of a wireless biosensor network (WBSN).  
The WBSNs find applications in areas such as medical parameter monitoring, 
environmental monitoring, chemical/biological detection, food and water analysis, soil 
monitoring, security and safety. These applications of the WBSNs potentially cover the 
current market trends and will significantly contribute to benefits of technological 
advancement for the community.  
The chapter is structured as follows. Section 2 presents intelligent biosensor node, its 
functionality and design requirements. It also discusses the remote patient monitoring 
application and lists potential applications of WBSNs. Section 3 proposes to use Ultra 
Wideband (UWB) impulse radio as a communication module for biosensor nodes. It also 
discusses the potential problems and possible solutions for the use of UWB impulse radio 
architecture for biosensor node. Digital UWB impulse radio architecture suitable for 
biosensors is described in section 4. Section 5 discusses the parallelism requirement analysis, 
proposes real time reconfigurability algorithm (RTRA) and discusses its design 
requirements. Section 6 presents the design and implementation of the RTRA. Conclusions 
are drawn in section 7 followed by references in section 8. 
2. Wireless biosensor network and applications 
A wireless biosensor network consists of a number of biosensor nodes having the capability 
of communicating with each other in an adhoc network, collecting data, sending them to a 
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sink/base station (gateway) and receiving instructions from the sink/base station via a 
wireless network. The WBSN applications require low to medium data communication rates 
ranging from a few hundreds of Kbps to a few Mbps over a distance range of 10-30m and 
are categorized under IEEE 802.15.4a standard for wireless sensor networks (IEEE, 2009). A 
typical wireless biosensor network scenario is presented in Fig. 1 (a).  
A modern biosensor node as presented in Fig. 1 (b) consists of a biosensor unit to sense the 
biological parameters and convert them into equivalent electric quantities. The low power 
digital signal processing unit analyses these signal and takes decisions according to the 
application and conditions. The radio block provides the wireless link for communication 
between the biosensor node and the central base station as well as other biosensor nodes. 
Information such as the current parameter measurement, the biosensor status and decisions 
taken are communicated between the biosensors and central base station. In the modern 
adhoc WBSNs, the decisions taken by a biosensor node are also dependent on this data 
communication and condition of the network as a whole. The actuator unit is commanded 
as per the decisions taken to take various actions.  
With the above functionality requirements from the various components of the WBSN, ultra 
low power consumption is the most critical design requirement as the biosensor nodes are 
battery operated. Every component of the WBSN node has to be designed for low power 
consumption as it directly affects the system reliability, efficiency and life. In a typical 
intelligent biosensor node which comprises of a sensing element, signal conditioning 
circuits, a processing element and a transceiver for communication, more than 50% of power 
is consumed by the transceiver, of which 80% is consumed by the receiver section (Karl & 
Willig, 2003). This makes the design of the communication module and its receiver section 





















Fig. 1. (a) Typical wireless sensor network scenario (b) Sensor node block diagram 
The potential of the biosensor node to sense, communicate, process and act in a WBSN 
represent a new paradigm for extracting data from the environment and enable reliable 
monitoring and networking for variety of applications. One of the promising areas of WBSN 
application is the remote patient monitoring and health care. In this application wearable or 
implanted miniature biosensors monitor different medical parameters such has heart beat, 
blood pressure, blood sugar level etc. The data from each body sensor is obtained and sent 
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over a low data rate wireless link to the central data collection unit at regular intervals of 
time. This data is then collectively sent for examination via internet or any other long range 
communication method to remotely placed hospital or medical practitioners. The data is 
analysed and suggestion can be made regarding medications or the actions to be taken by 













Data rate few 100 
Kbps to few Mbps Data rate ~100 Mbps
UWB Communication
Central Data Collection Unit 
Fig. 2. WBSN application for remote patient monitoring 
The remote patient monitoring system will result in a significant reduction in the medical 
costs, time and efforts, both for patient as well as the medical practitioner. It will improve 
the efficiency of the medical system and contribute to community wellbeing. Also, it has the 
potential of low cost implementation and reusability.  
In this chapter we propose to use UWB radio for the communication module, as presented 
in Fig. 2, in the biosensor node due to its low power design and communication potentials 
which will be discussed in the next section. In addition to the remote patient monitoring 
system WBSNs with UWB connectivity find applications in a wide range of areas such as: 
? Soil monitoring and smart irrigation, which will improve the efficiency of the 
agriculture industry and save large amounts of water; 
? Real time data collection/monitoring for marine and coral research. These WBSNs can 
be extended to monitor changes in the marine activities and predict unusual weather 
patterns; and 
? Safety of firemen and workers working in extreme conditions by installing bodily 
biosensors that sense different parameters and communicate to the central unit.  
3. Ultra wideband radio as a communication module for WBSN 
Low power design of a communication module in a WBSN is very critical due to battery 
operation. At the same time reliable communication, reusability of components and design 
flexibility are also important factors. UWB technology can be efficiently employed for the 
communication module in wireless biosensor nodes because of the following features: 
? Capability to achieve data rates of few hundreds of Kbps to a few Mbps at 10-30m 
distance ranges; 
? Wide bandwidth of over 8GHz; from 0 - 960MHz and 3.1 - 10.6GHz;  
? Unlicensed communication with limited transmit power in above bands  
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? Potential for location tracking and precision ranging; and  
? System-on-Chip implementation of radio facilitating ultra low power digital design, 
flexibility and scalability (Porcino & Hirt, 2003). 
Digital UWB impulse radio proposed in (O'Donnell & Brodersen, 2005), is one of the most 
suitable architectures for achieving low data communication rates and potentially low 
power implementation for WBSNs as it is a carrierless communication scheme that reduces 
analog circuitry in the receiver. The possibility of digital implementation of the UWB 
impulse radio provides a potential to achieve low power design. However, due to the 
channel uncertainties, changes in the channel conditions, low transmit power and pulsed 
nature of UWB communication the digital UWB impulse receiver architectures use 
significant parallel hardware to ensure correct operation in these conditions. This 
parallelism results in high power consumption by the UWB receiver.  This will deter the 
UWB receiver from being employed in WBSNs.  
Also, as regulation and standardisation of commercial UWB operation is fairly new, 
different researchers and industries are attempting to propose various methods of making 
UWB communication work. Majority of the proposed transceiver architectures use parallel 
architectures as they concentrate on performance and data rates leading to high power 
consumption. Limited research attempts on power consumption reduction methodologies 
leads to a potential gap and provides an opportunity of thorough investigation and 
proposal of a possible solution for power saving.  The research conducted for this chapter is 
carried out in order to fill those gaps and explore this potential. It presents the thorough 
investigation and analysis of parallelism requirements for different channel conditions and 
provides a solution for power consumption reduction by incorporating real time 
reconfigurability of the parallel blocks in the UWB impulse radio receiver. The 
reconfiguration of the parallel blocks will result in effective utilisation of the hardware, 
reduction in average power consumption and at the same time maintenance of data error 
rate performance as a normal receiver. 
4. Digital UWB impulse radio 
This section presents the design and functionality of the digital UWB impulse radio 
transceiver architecture. In the UWB impulse radio transceiver the transmitter uses short 
Gaussian derivative pulses spread over the 0-960MHz frequency band for communication. 
The receiver uses coherent detection to recover the data and performs three major 
operations viz. acquisition and synchronisation of transmitter/receiver, tracking and data 
detection (Chen, 2002), (O'Donnell & Brodersen, 2005). 
4.1 UWB transmitter  
The UWB transmitter block diagram is presented in Fig. 3. The binary data to be transmitted 
is spread using a pseudo random noise (PN) sequence in order to provide system processing 
gain. The length (N) of the PN code depends on the required processing gain. Any PN code 
can be used for spreading, but barker code is used in this design due to good cross-
correlation with the side-lobe values and uniform distribution. One raw data bit is 
represented as ‘N’ bits of PN code individually known as a ‘chip’. The entire spread data bit 
is termed as a ‘symbol’. Each chip in the symbol modulates the Gaussian derivative pulse 
using binary phase shift keying (BPSK) modulation. These modulated pulses are repeated at 
a certain pulse repetition period (PRP) (PRP=128ns for this design). The transmit packet 
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consists of a preamble for receiver acquisition and synchronisation  operation and data bits 












Fig. 3. UWB transmitter block  diagram 
4.2 UWB Receiver 
The analog frontend of the receiver consists of an antenna and amplifier to receive and 
amplify the signal as presented in Fig. 4. Filtering follows the amplifier, which suppresses 
interferers in the mobile phone band around 900MHz, frequency modulation (FM) radios 
and most Very High Frequency (VHF) television signals below 110MHz. A bank of parallel, 
time-interleaved ADCs, sample the received signal at an effective sampling rate of 2 GHz. 
The ADC is brought as close as possible to the receiver antenna in order to utilise digital 
domain processing potential (O'Donnell, 2006).  
Fig. 4. UWB receiver block  diagram 
As the bandwidth of the UWB signal is 1GHz, minimum required ADC sampling frequency 
at the receiver is 2GHz. A single ADC working at 2GHz can be implemented to sample the 
entire PRP, but its power consumption will be very high. Therefore, a bank of parallel time 
interleaved 1-bit ADC’s, each operating at a much lower frequency is used. This bank 
consists of 32 parallel ADCs, each sampling the received signal at 62.5MHz to provide an 
effective sampling rate of approximately 2GHz. As each of the ADC operates at low 
frequency, power consumption is low. The 1 bit sampling of a 128ns PRP signal at 2GHz 
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results in 256 bits of the received pulse which are parallel inputs to the digital backend 
(Chen, 2002), (O'Donnell & Brodersen, 2005) (O'Donnell, 2006).  
Clock generation module, bank of parallel digital pulse matched filters (PMFs), bank of 
parallel pseudo noise correlators (PNCs), peak detector, local PN generator, data recovery 
and control block together constitute the digital-backend. The digital backend employs a 
bank of PMFs and PNC to perform acquisition and synchronisation operation followed by 
tracking and data detection. 
Fig. 5 presents the block diagram of the digital backend (Chen, 2002), (O'Donnell & 
Brodersen, 2005). The banks of parallel PMF’s and PNCs perform acquisition and 
synchronisation operation over the entire preamble. PMF’s resolves the time delay in the 
received pulse to ensure maximum energy capture within the sampling window. Length of 
the PMF is 128ns corresponding to worst case delay spread of 64ns (O'Donnell & Brodersen, 
2005). A single PMF for time delay resolution will need it to operate at sampling frequency 
of 2GHz which will consume significantly large amount of power and result in longer 
acquisition time. Therefore, 128 parallel PMF’s process the 256 samples of the received pulse 
simultaneously. Each PMF now operates at pulse repetition frequency (1/PRP) instead of 
sampling frequency (1/Tsample) due to the parallel operation.  
Fig. 5. UWB receiver digital backend (O'Donnell & Brodersen, 2005) 
128 PNCs correlate 128 outputs of PMF’s, to resolve the PN phase over symbol period. In 
order to further reduce the acquisition and synchronisation time, 11 such PNC banks 
operate simultaneously (Chen, 2002), (O'Donnell & Brodersen, 2005). Synchronization is 
declared once the PMF capturing maximum energy within the PRP and correct PN phase is 
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detected, by the peak detector. Data detection is then performed with a hard decision, 
depending on the sign of maximum correlation output.  
In the acquisition and synchronisation mode all 128 PMF’s and 128 x 11 PN correlators are 
in operation, where as in data detection, only the one capturing maximum energy is ‘on’. 
Due to this the power consumption in the acquisition and synchronisation mode is high as 
compared to the data detection.  
5. Real time reconfigurability algorithm  
In order to meet the ultra low power requirement of WBSNs, it is required to reduce power 
consumption of the UWB receiver during the acquisition and synchronisation mode. In 
order to achieve this, the number of parallel PMF’s and thus the successive PN correlators 
used in the acquisition mode needs to be reduced. 
5.1 Parallelism requirement 
The parallelism in the digital backend facilitates the receiver to cope with the worst case 
channel condition and different time delays in the received signal. However it is unlikely 
that always the channel condition will be worst and the receiver would not require all the 
parallel hardware for successful acquisition and synchronisation. In an indoor environment 
the received UWB signal is a collection of different paths reflected from different surfaces 
(walls, ceiling, floor, furniture etc) constituting multipaths and thus delay spread. The UWB 
indoor channel delay spread may vary from 20ns-60ns (O'Donnell & Brodersen, 2005) 
(Cassioli et al, 2002). Also in the non line of sight (NLOS) environment the direct path at the 
receiver may not be the strongest one. Due to the NLOS nature of the environment, different 
reflected multipaths and transmitter-receiver separation distance a time delay is observed in 
the received signal.  This time delay is resolved by the PMF bank and is an important factor 
to be considered while collecting the energy from the received pulse.  
According to the parallelism analysis in (Naik et al, 2007), time delay in the received signal 
controls where the maximum received energy lies within the PRP and therefore determines 
the number of parallel PMF’s required for acquisition and synchronisation operation for a 
particular channel condition. The channel taps (amplitudes of individual reflected paths) 
also contribute in determining the energy captured by each PMF.  
The analysis simulates the acquisition and synchronisation mode using all 128 parallel PMFs 
and successive PNCs in operation. Transmit signal is passed through 100 different channel 
impulses generated using IEEE 802.15.4a channel model (Siwiak, 2004). The time delay is 
varied from 0ns to 50ns for each channel condition and the PMF number capturing the 
maximum energy as reported by the peak detector for each condition is determined. This 
number represents the least number of PMF’s required to be in operation for successful 
acquisition and synchronisation operation for the current operating channel impulse and 
time delay. The analysis results show that: 
? Number of PMF’s required for processing the received signal for different channel 
impulses are different; 
? For same channel impulses if time delay increases, PMF reported by the peak detector 
increases significantly; and 
? In very few channel impulse cases and higher time delay values all the 128 parallel 
PMF’s are required for operation. 
The real time reconfigurability of the parallel blocks according to the changing channel 
condition and time delay has the potential to reduce the power consumption during the 
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acquisition and synchronisation mode without affecting the bit error rate performance of the 
receiver (Naik et al, 2007). 
5.2 Real time reconfigurability algorithm proposal and design requirements 
The majority of the parallelism of the digital UWB receiver is in the digital backend. The 
banks of 128 PMFs and 11 x 128 PNCs employed in the digital backend, constitute of more 
than 80% of its hardware (Chen, 2002). According to the receiver operation presented in 
section 4.2, the entire bank of 128 PMFs and 11 banks of 128 PNCs each, are in operation 
simultaneously during acquisition and synchronisation mode (during preamble). On the 
other hand, in tracking and data detection mode, only three adjacent PMFs and PNCs are in 
operation. This results in high power consumption in the acquisition and synchronisation 
mode as compared to the tracking and data detection. 
From all the above considerations it can be concluded that, it will be most effective to use as 
many parallel PMFs and PNCs that are required for receiver operation for the  current 
channel conditions and switch off the remaining ones, for the rest of the acquisition and 
synchronisation mode. In a very good channel condition only a few PMFs and PNCs would 
be required for correct receiver operation, therefore, the remaining ones can be switched off 
to save significant power consumption. This number will increase as the channel condition 
gets worse. As major percentage of the digital backend hardware will be reconfigured with 
this strategy, it has the potential to result in significant reduction in the average power 
consumption. Therefore, reconfiguration of the PMF and PNC banks according to the 
changing channel condition during majority of the acquisition and synchronisation mode is 
the most effective reconfiguration strategy. 
Fig. 6 presents the block diagram for the proposed real time reconfigurability algorithm 
(RTRA) architecture. It consists of an estimation block which estimates significant energy 
received within the PRP and time delay in the received signal for current channel condition. 
The translation block translates this information into the number of PMF’s required and the 
control block finally generates the enable/disable signals to turn on the required number of 
PMF’s and successive PNCs in the bank and switch off the unwanted ones. 
The primary aim of the RTRA is to facilitate average power saving in the acquisition and 
synchronisation mode of the receiver. The design constraints and important considerations 
for the RTRA are as follows: 
? It should be simple and should introduce least hardware. Its power consumption 
should be low to justify the power saving; 
? The algorithm should perform all the operations in the first few received pulses in order 
to save as much power as possible in the remaining preamble (acquisition and 
synchronisation mode); and  
? The estimation and translation should be accurate in order to maintain the data 
detection error rate performance of the receiver. 
6. RTRA design and implementation 
6.1 Estimation algorithm 
The transmitted signal in an indoor wireless channel undergoes reflections from various 
objects. Thus, the received signal is a collection of all reflected components at different 
times, called multipaths. Equation (1) represents the generalised channel response. 
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Fig. 6. Real time reconfigurability algorithm architecture 
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Where al is the attenuation, tl is the time delay, L is the number of multipaths. In the channel 
response, values of attenuation and time delay change with respect to time and environment 
of operation Molisch, (2006). A pulse train of Gaussian 1st derivative pulses of width 3ns 
and PRP of about 128ns is used. Typical channel delay spread varies from 20-60ns 
(O'Donnell & Brodersen, 2005) (Cassioli et al, 2002), which means that the 3ns transmitted 
pulse has reflected components and the total energy received can be distributed over 20-
60ns within the PRP. Also, due to time delay, the significant energy in the received signal 
can lie anywhere within the PRP.  
For implementing the RTRA, some sort of channel and time delay estimation needs to be 
performed in order to obtain the information of significant energy received within the PRP. 
Traditional channel estimation methods are used for BER improvement. For estimation in 
this case, the aim is to extract sufficient information from the received signal in order to 
facilitate parallelism reduction. Implementing traditional, complex channel estimation 
algorithms would not server the purpose in this case as they require very high sampling 
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rates, additional pilot symbols and perform channel estimation over the entire preamble. 
Also, majority of them are implemented for offline processing where signal quantisation is 
not an issue. However, in our case the received signal is quantized for 1-bit resolution. This 
factor is one of the big challenges for RTRA implementation.      
In the estimation block we propose to estimate the location of the last significant energy 
sample number within the PRP of the received pulse. This last significant sample 
information can be used to estimate the PMF capturing the maximum energy. This 
information can be obtained from the first few received pulses and used for translation. 
As the received signal is sampled by 1-bit ADCs, the input data for the digital backend is a 
256-bit long vector with each bit representing one sample in the received pulse. The last 
significant sample number estimation becomes as simple as determining the last sample 
which is ‘1’ within the 256-bit long pulse sample vector and its sample number. For this we 
propose to use a priority encoder algorithm, which will take the 256-bit vector as input and 
output 8-bit last significant sample number.  
In order to validate this estimation method, received signal pulses for 100 different channel 
impulses are obtained and last significant sample number is obtained for each case without 
any quantisation. Later, these received signals are quantized by 1-bit ADC and last 
significant sample number is estimated for each case using the 256-bit priority encoder 
algorithm. Fig. 7 presents the last significant sample number determined for no quantisation 
case and that determined by the priority algorithm after quantisation. 






























Linear (LSS 1-bit Quantization)
Fig. 7. Last significant sample results for priority encoder algorithm for 1 bit input 
It can be seen in Fig. 7 that the last significant sample estimation for 1-bit quantisation by 
priority encoder algorithm resembles very closely to that with the one without quantisation 
for majority of the cases. The difference between the last significant sample number values is 
mainly due to quantisation. The priority encoder can be very easily implemented with less 
hardware and its processing is fast and simple. The small error between actual and 
estimated last significant sample numbers can be easily compensated in the translation 
block.
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6.2 Translation and control algorithms  
Translation is the process in which the last significant sample information obtained from the 
estimation block is translated to number of parallel PMFs required for the acquisition and 
synchronisation operation. For an effective translation, number of PMFs estimated by RTRA 
(Tpmf) should be equal to or more than the PMF reported to capture the maximum energy in 
a normal receiver (pmf_ref), for the same channel condition. If Tpmf < pmf_ref, then the 
translation method is said to fail and can cause an error in data detection. However, the 
probability of data detection error depends on the closeness of Tpmf to pmf_ref, due to the 
energy capture principle.  
In translation of the last significant sample information to number of PMFs required for 
acquisition and synchronisation operation, we assume that the last significant sample lies in 
the centre of the PMF capturing the maximum energy. This ensures that the translated 
number of PMFs actually cover the part of the PRP where significant energy is received. 
Translation method 1 (TM1) is defined by Equation (2) where LSS is the last significant 
sample. 
LSSif LSS 64 then, Tpmf ;2






In order to validate the translation method, the transceiver is modeled in simulation 
environment. PMF numbers reported by the peak detector after acquisition and 
synchronisation operation for a normal receiver are determined for 100 different channel 
impulses and time delay varying from 0-50ns. Later, for each of these channel impulses and 
time delays, estimation is performed using priority encoder and translation is performed 
using the translation methods. Percentage of failure cases, the figure of merit used to 
validate the translation methods is the percentage of channel impulses in which Tpmf < 
pmf_ref. Fig. 8 presents the percentage failures cases for the translation methods.  























Fig. 8. Percentage failure cases for translation methods (TMs) 
 Biosensors 236
It can be seen from Fig. 8 that translation method 1 results in approximately 50% failure 
cases for most time delay values. However, individual simulations show that Tpmf values 
are very close to pmf_ref, which reduces probability of data detection error.  Nevertheless, 
such a high percentage of failure cases for lower time delay values from 0-30ns, may lead to 
high data detection errors, as significant energy within the PRP may not be captured due to 
low value of Tpmf. However, for higher time delay values, this does not have such an effect 
as the chances of loosing significant energy is reduced due to higher values for Tpmf.
Average relative power saving percentage after reconfiguration is estimated assuming that 
100% power is consumed when all 128 PMFs are ‘on’ and is presented in Fig. 9. It shows that 
the average relative power saving percentage varies from 90% to less than 10% with 
increasing time delay. 



































Fig. 9. Average relative power saving percentage 
In order to reduce the percentage of failure cases for lower time delay values in translation 
method 1, translation method 2 uses a guard band of 32 PMFs and is defined by Equation (3) 
if Tpmf 32; then Tpmf Tpmf 32;1 2 1




With the guard band, the percentage failure cases are reduced for lower values of time 
delays, as seen in Fig. 8. However, this improvement comes at a cost of reduced average 
power saving, as seen in Fig. 9. Also, probability of data detection error is considerably 
reduced for lower time delay values.  
In order to validate the maintenance data detection error, 5000 sample data bits are used. 
The data detection error before reconfiguration and after reconfiguration is estimated. Fig. 
10 presents the percentage data detection error comparison. The results of this analysis 
show that the proposed RTRA performs better than normal receiver with 0.5% reduction in 
the detection error for time delay values of 0-20ns, a marginal increase of 0.6% in detection 
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errors for time delays of 30-40ns and same detection error for remaining time delays.  
Therefore, translation method 2 maintains the data detection error. The small increase in 
data detection error for certain cases can be easily compensated in the error detection and 
correction block of the receiver.  


























Fig. 10. Percentage data detection error comparison 
The percentage data detection error comparison provides enough evidence that the 
proposed estimation and translation methods can efficiently reconfigure the UWB receiver 
digital backend and maintain the data detection error rate of the normal receiver. Once 
translation is done the control block generates enable/disable signals to switch off the 
unwanted PMFs and PNCs. 
6.3 RTRA hardware design  
The acquisition and synchronisation mode hardware, which include the PMF and PNC 
banks, constitutes of 80% of hardware of the receiver digital backend (Chen, 2002). The 
major percentage of this hardware is the PMF bank. Power efficient hardware design for a 
single PMF is presented in (Naik & Singh, 2007) is designed to suit the stringent low power 
design requirements. 
In order to simulate the acquisition and synchronisation mode operation of a normal 
receiver and that with RTRA, a bank of 128 PMFs is implemented with each PMF having an 
enable signal. A 256-bit input buffer stores the received input samples from the ADC bank. 
Each PMF in the bank processes consecutive windows of 128 samples each, which are one 
sample apart. When all the 128 PMFs are enabled, this PMF bank implementation represents 
normal receiver operation. Fig. 11 presents the block diagram of the PMF bank 
implementation for the normal receiver. It also presents the RTRA blocks that are added to 
the normal receiver in order to reconfigure the PMF bank.  
For the RTRA, a 256:8 bit priority encoder is implemented as the estimation block, which 
results in 8-bit last significant sample number. The translation methods presented in 
equations (2) and (3) are implemented using digital combinational and sequential logic. The 
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Fig. 11. PMF implementation bank for normal receiver and that with RTRA 
Finally the control block is a decoder which decodes the 7-bit Tpmf value and generates 128 
enable/disable signals which then enable/disable the PMFs according to the changing 
channel condition.   
The PMF bank for acquisition and synchronisation operation for a normal receiver and that 
with RTRA, as presented in Fig. 11, is implemented using the semi-custom design flow 
using ST-Microelectronics 90nm technology. Both the designs process received data samples 
at the same pulse repetition frequency. Fig. 12 presents the post place and route view of the 
reconfigurable PMF bank for the UWB receiver with RTRA. Table 1 presents the hardware 
implementation results and the comparison of normal receiver to that with RTRA. The 
power consumption results are obtained by performing a simulation based power analysis 
with the input signal for different channel conditions and time delays.  
It can be observed in Table 1, that the number of instances, nets, wire length and core area 
for PMF bank with RTRA implementation for reconfigurable receiver increases as compared 
to the normal receiver PMF bank due to additional hardware for the RTRA implementation.  
Due to the simplicity of the estimation, translation and control algorithms of this additional 
hardware results in a 3.75% increase in area.  
The power consumption results show a 25.16% reduction in the core power consumption 
and 23.76% reduction in the average power for receiver with RTRA over the normal receiver 
for the test input data. As 90nm process technology is used, leakage power is high and 
dominates total average power consumption. 
These two designs were also implemented on an Altera Stratix II Field Programmable Gate 
Array (FPGA) device to verify the power saving. A significant 28.57% reduction in the 
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average current consumption was observed by the PMF bank with RTRA for reconfigurable 
receiver as compared to that for the normal receiver. The FPGA implementation results 
correspond with those of the ASIC implementation. 






Number of Instances 1202852 1234395 2.55% ?
Number of Nets 855647 872565 1.93%  ?
Total wire length (?m) 9792686 10495531 6.69%  ?
Area (?m2) 2517148 2611764 3.75% ?
Core Power (mW) 181.72 135.99 25.16% ?
IO power (mW) 10.67 10.67 ?
Avg power (mW) 192.38 146.67 23.76% ?
Table 1. Hardware implementation results and comparision 
7. Conclusion 
This chapter presented a new paradigm of biosensors which have processing capability with 
an intelligent and adaptive wireless communication module. The adaptive communication 
module efficiently reconfigures its hardware components according to the changes in 
operating environment in order to reduce system power consumption and optimally utilise 
resources. The chapter presented several significant applications of wireless biosensor 
networks which hold enormous potential to benefit the community. It also identified that 
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low power consumption is one of the critical design parameters for biosensor node design 
due to battery operation and UWB communication is one of the most suitable technologies 
to be used for communication. 
Further the chapter presented the potential challenges of parallel hardware and high power 
consumption in the UWB receiver architecture and proposed a real time reconfigurability 
algorithm to address that. The real time reconfigurability algorithm senses the current 
operating condition and intelligently reconfigures the receiver hardware to optimal size in 
order to reduce the average power consumption. The results show approximately 25% 
power saving in the receiver’s digital backend with the implementation of the real time 
reconfigurability algorithm for ASIC as well as FPGA implementations. At the same time 
the reconfigurability maintains the data detection error rate as the normal receiver.  This 
significantly contributes in reducing the overall system power consumption and makes 
UWB transceiver a better candidate to be used in the biosensor unit for WBSN applications.  
Thus the proposed novel intelligence in the communication module of the biosensor unit is 
one of the important steps in the development of a sophisticated and smart biosensors and 
WBSN.
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1. Introduction    
Neurochemical pathways involved in brain physiology or disease pathogenesis are mostly 
unknown either in physiological conditions or in neurodegenerative diseases. Nowadays 
the most frequent usage for biotelemetry is in medicine, in cardiac care units or step-down 
units in hospitals, even if virtually any physiological signal could be transmitted (FCC, 2000; 
Leuher, 1983; Zhou et al., 2002). In this chapter we present a wireless device connected with 
microsensors and biosensors capable to detect real-time variations in concentrations of 
important compounds present in central nervous system (CNS) and implicated in brain 
energetic metabolism (Bazzu et al., 2009; Calia et al., 2009).  
Molecular Oxygen (O2), an essential molecule for life, is utilized not only for cellular 
respiration but also for biosynthesis and metabolism of various important biomolecules 
such steroids, eicosanoids and neuroactive substances (Watanabe et al., 1997). It is also 
implicated in several biochemical reactions involving, for instance, ATP in the brain (Bazzu 
et al., 2009). To monitor istantaneous oxygen concentrations and relative variations could 
give important information about brain energetic metabolism related to glucose (Fillenz, 
2005) or lactate consumption (Aubert et al., 2005). Eletrochemical reduction of oxygen is 
amperometrically obtained by means of complex transformations occurring at a carbon-
epoxy sensor surface by applying a potential of -400 mV vs Ag/AgCl reference electrode 
(RE) (Bazzu et al., 2009; Calia et al., 2009) as follows: 
 O2 + 2H+ + 2e-? H2O2  (1) 
 H2O2 + 2H+ + 2e-?  2H2O  (2) 
Because of its anatomical characteristics and physiology, the central nervous system (CNS) 
is assumed to be particularly sensitive to oxidative stress (Emerit et al., 2005). Oxidative 
stress in CNS is now known as responsible for involvement of reactive oxygen species (ROS) 
and reactive nitrogen species (RNS). This particular kind of stress is crucial for the 
modulation of fundamental cellular functions as apoptosis, calcium mobilization, ion 
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transport and all phenomena involved in excitotoxicity (Emerit & Edeas, 2005). Oxidative 
stress takes place from a disparity, involving the physiological antioxidant capability and 
free radicals synthesis (Andersen, 2004), so the dynamics concerning antioxidants in CNS 
are extremely important. 
Ascorbic acid (AA) is the most important component of antioxidant pool in the brain (Serra 
et al., 2002). Low molecular weight antioxidant AA is a water soluble vitamin that owns 
radical scavenger properties against ROS and RNS (Serra et al., 2002). As it is not produced 
in human organism but introduced with diet (Hediger, 2002), the presence of a specific 
transporter (SVCT2) allows its cytosolic internalization in neurons. Ascorbic acid is readily 
oxidized to dehydroascorbate (DHAA) which can undergo irreversible hydrolysis to 2,3-
diketo-L-gulonic acid, but because of its crucial role in CNS, DHAA is easily converted to 
the reduced form for preventing vitamin C depletion. AA is as well implicated in the 
protection against excitotoxicity due to high glutamate concentration through ascorbate-
glutamate hetero-exchange (Rice, 2000). Ascorbic acid is readily oxidized on epoxy-carbon 
electrode surface at + 120 mV against Ag/AgCl as follows: 
 L-Ascorbic acid (+120 mV) ? DHAA + 2e- + 2H+  (3) 
Several biologically interesting compounds are not directely oxidizable at a sensor surface, 
in this case it is needed a biosensor (Pantano et al., 1995). Biosensor combines a trasducer 
with an enzyme that is capable to give sensitivity and selectivity to the device (Scheller et al., 
1997).
Glucose (GLU) is actively involved in ATP synthesis and its concentration in extracellular 
spaces is the most important factor for energetic metabolism (Lowry et al., 1998; Magistretti 
et al., 1999, Fillenz et al., 2005). GLU detection is possible by means of loading on a Pt 
surface transducer glucose oxidase (GOx) enzyme. GOx is covalently linked with flavin 
adenine dinucleotide (FAD) (Serra et al., 2007) and is extremely reliable because of its good 
sensitivity to the enzyme substrate and high stability when immobilized on Pt electrodes by 
means of poly-orthophenylenediamine (OPD) (Wilson et al., 1992; Lowry et al., 1998). The 
biosensor-based detection of GLU occurs as follows: 
?-D-Glucose + FAD+-GOx? D-Glucono-?-Lactone + FADH2-GOx  (4) 
 FADH2- GOx + O2?FAD+-GOx + H2O2  (5) 
As glucose, lactate (LAC) is an important molecule involved in brain energetic metabolism 
as product of glicolysys (Fillenz, 2005) or energetic substrate for neurons (Magistretti et al., 
1999). LAC is oxidized by lactate oxidase (LOx), an enzyme with a covalently-linked FAD 
cofactor (Serra et al., 2007). After the oxidation of the substrate, the further oxidation of 
FADH2 to FAD+ produces H2O2 in the presence of O2.
 L-Lactate + FAD+-LOx? Pyruvate + FADH2-LOx  (6) 
 FADH2- LOx + O2?FAD+-LOx + H2O2  (7) 
The application of a positive potential (+700 mV vs Ag/AgCl) to a Pt working electrode 
generates a current proportional to the concentration of the H2O2. Reactions occur as 
follows: 
 H2O2? O2 + 2e- + 2H+  (8) 
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where the amount of current produced by the previous oxidation (8) is proportional to the 
quantity of substrate (GLU or LAC) transformed by the enzyme. The intrinsic chemical 
characteristics of each indicated molecule allow using specific telemetric devices able to 
work in oxidation mode (Calia et al., 2009) or in reduction mode (Bazzu et al., 2009; Calia et 
al., 2009). In this chapter we describe the implementation of a distributed biosensor NET, 
composed by implantable biotelemetry devices and derived from previously published 
systems (Bazzu et al., 2009; Calia et al., 2009), successfully used in conjunction with micro-
biosensors for the in-vivo measurement of brain O2, AA, glucose and lactate. The analysis of 
signals derived from the above sensors allowed the real-time study of biochemical pathways 
involved in brain energetic metabolism. The design, construction and operation of the 
hardware, firmware and software are described. The proposed system, based on simple and 
inexpensive components, could be used as a rapid and reliable model for the real-time study 
of the effects of different drugs on brain neurochemicals and offers the possibility of 
expanding the biotelemetric NET simply and quickly. 
2. Biotelemetric system hardware    
The electronic circuit of the implantable biotelemetric device (Fig. 1) was built using surface 
mount components and comprised two different parts: the amperometric module and the 
microcontroller/transceiver module.  
Fig. 1. Pictures showing the biotelemetry system developed during this study (see text).  
As schematized in figures 2 and 3, the amperometric module was made soldering a quad 
operational amplifier (MCP6042), a Zener diode (ZXRE4001), two resistors, a 
potentiomenter and one capacitor on a 28 mm x 17 mm PCB. The MCP6042 can operate 
from a single-supply voltage with “rail-to-rail” inputs and outputs; it has been designed for 
micropower applications consuming only 600 nA per OPA with low input bias current (1 
pA) and high input resistance (>1013?).
The zener diode plays a pivotal role in the amperometric circuitry; as bandgap voltage 
reference, it generates a fixed voltage (Vz = 1.22 V) consuming around 10 µA in virtue of a 
limiting resistance (150K).  
The not inverting input of the potentiostat was connected to Vz (Bazzu et al., 2009; Calia et 
al., 2009) for working with O2 microsensors (reduction mode, Fig. 2).  
In oxidation mode (Fig. 3), the above mentioned input of the potentiostat was grounded 
resulting in a positive potential applied to working electrode (WE) ranging from ground 
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Fig. 2. Schematic of the amperometric module of the biotelemetric device working in 
“reduction mode”.  
(GND) to Vz. The inverting input of the potenziostat was directly connected to RE while its 
output wired to the auxiliary (AE) electrode. This allows the implementation of a feedback 
circuit in which RE and AE potentials are maintained at the same potential of the not-
inverting input (potentiostatic circuit). 
The buffered voltage divider, composed by the potentiomenter and the voltage follower, 
generated the potential necessary to polarize the WE in a range comprised between 0 and 
1.22 V (Vz, controlled by ZXRE4001).  
Fig. 3. Schematic of the amperometric module of the biotelemetric device working in 
“oxidation mode”.  
The current-to-voltage (I/V) converter is a single-supply adaptation of a classic 
transimpedance amplifier and derived form a previously-published design (Serra et al., 
2007; Rocchitta et al., 2007). The transfer function of the I/V converter is: 
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 VOut = -(Iredox · R) + VApp  (9) 
in which  Iredox is the current flowing through the WE, R is the feedback resistor and VApp is 
the potential applied to the WE (versus ground). For example, working in reduction mode, a 
current of 0 nA corresponds to VApp (0.8 V, -0.4 V vs Vz) while with a cathodic current of -30 
nA VOut is equal to 0.5 V (R=10M?).  The maximum allowable current is ? -80 nA (VOut = 0.0 
V). Instead, when the system is configured in oxidation mode, a maximum anodic current of 
18 nA can be read without saturation (VApp = 0.7 V; VOut = 2.5 V; R =100M?). The feedback 
resistor (R) has a capacitor in parallel (C) to complete a low-pass filter with a cut-off 
frequency (Fcut-off) of 5 Hz. The value of C was calculated in Farads according to the 
equation:
 C = 1 / (Fcut-off • 2? • R)  (10) 
A dummy cell was made based on a previously published design (Serra et al., 2007) for 
testing the amperometric module of the biotelemetric device before sensors calibration. The 
aim of the design was to devise a Thevenin current source that would reproduce the 
constant amperometric response of a true electrochemical cell. The voltage applied to the 
dummy cell was generated between the WE and RE/AE and is equal to the voltage 
difference between the above electrodes. The resulting currents were converted in an output 
voltage (VOut) as illustrated above. Data obtained from electronics calibration are similar to 
those obtained in previous studies (Bazzu et al., 2009; Calia et al., 2009). 
The MSP430F2274 (Texas Instruments, TI) is the heart of the digital module. This is a 16-bit 
CMOS IC with ultra-low power features equipped with internal 10 bit ADCs. The 
microcontroller unit (MCU) performed the A/D conversion of VOut, VBatt, VApp and in-chip 
temperature using a 2.5 V internal reference. After the digital signal processing (DSP) of 
acquired raw data, a serial data packet was generated and sent to the transceiver: the TI 
CC2500 multi-channel RF transceiver, designed for low-power wireless applications (2.4 
GHz).
Several pins of the microcontroller were connected to the CC2500 providing the data lines of 
the transceiver. In conjunction with the MCU, this component allows the realization of a 
serial data transmitter working at the speed of 9600 baud. A miniaturized chip antenna was 
integrated in the PCB board. The in-circuit-serial-programming (ICSP) bus provides the 
possibility of programming the MCU “on-board” in a few seconds. The digital module (Fig 
1B; Fig. 1C) is commercially available pre-assembled by TI (eZ430-RF2500). A 210 mAh, 3 V 
lithium coin battery (Maxell CR2032) provided the power to the biotelemetric device for up 
to one week in continuous transmission (1 Hz). A small plastic enclosure (3.2 x 2.1 x 1.4 mm; 
Fig. 1A) completed the implantable device (Fig. 1B, inset). The weight of the implantable 
device (Fig.1, inset) is 12.4 grams including battery. A second digital module (wired unit, 
Fig. 1C), connected to a personal computer (PC) by means of an USB-programmer, coupled 
the implanted biotelemetric device with the software running on the PC side (Fig. 4). 
3. Firmware and software   
The firmware to drive the MSP430F2274 MCUs was realized in C language using IAR 
Embedded Workbench (version 5.20, KickStart) freely available from www.ti.com. The 
program, which runs on the biotelemetry device, consists of two routines: the main 
procedure and a timer-interrupt routine called every second as illustrated in Figure 5. 
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Fig. 4. Schematic of the biotelemetric system developed and used in this study. 
Fig. 5. Firmware running on the implantable biotelemetric device. 
When the analogue signal VOut was digitized, the hardware ADC resolution (10 bit) was 
improved following the oversampling and averaging method (Pagnacco et al., 1997): 
 Fos = 4w · Fs  (11) 
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where w is the number of additional bits of resolution (2), Fs is the sampling frequency (1 
Hz) and Fos is the oversampling frequency. In accordance with the Nyquist’s theorem Fs was 
calculated as follows: 
 Fs = 2 · Fmax  (12)
in which Fmax has been fixed to 2 Hz. To do that, the MCU acquired and accumulated 64 
consecutive samples then divided the result by 26 (Fig. 5). This technique increased the ADC 
resolution from 10 to 12 bits. The RF data packets (1 per second), sent by the MCU, were 
encapsulated in an Open Source Stack (SimpliciTI™), implemented by Texas Instruments 
for the development of low power wireless NETs. Up to 100 implantable units, with an 8 bit 
ID memorized in their E2PROM, can share the same transmission channel. The interrupt-
driven routine on the receiver unit, mounting a second MSP430F2274, communicates to the 
PC using USB and filters the IN-OUT data. The firmware was downloaded to the MCUs 
using the TI USB programmer connected to the ICSP bus (Fig. 6). 
Fig. 6. Program process of MSP430F2274 consisting on edit-compile-download cycle. 
The software, running on the PC under Windows XP Professional™ or Vista™,
communicates thought the USB by using the low-level driver freely available from 
www.ti.com. The graphic user interface (Fig. 7) was developed using Profilab Expert®
(version 4.0 from Abacom) while the dynamic link library (DLL) serial-data-parser was 
programmed in C (Dev-C++ ver. 4.9.9.2).  
The application (capable of plotting, storing and retrieving data) interfaces the system with 
a printer via USB and a Local Area Network (LAN) and Internet via TCP/IP (Fig. 4). A 
software alarm was generated if VBatt< 2.7 V, signal strength (RSSI) too low or a data 
reception time-out occurred. 
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Fig. 7. Simple graphic user interface of the data-acquisition software running on the PC. 
4. Statistical analysis    
Concentrations of O2 were expressed in µM while AA, glucose and lactate in mM. Oxygen, 
ascorbate and H2O2 signals were expressed in nA and given as baseline-subtracted data 
(?nA). The sensors in-vitro response was characterized immediately before implantation and 
the electrochemical parameters evaluated before in-vivo experiments. The changes of brain 
tissue neurochemicals were calculated as absolute variations versus the corresponding 
baselines and their striatal concentrations were estimated using pre-implantation in-vitro
calibrations.  
Statistical significance of changes was evaluated using paired t-tests between the means of 
300 consecutive recordings before (baseline) and during the maximum magnitude of 
neurochemical changes as a result of physiological stimulation (tail pinch).  
Pearson's correlation coefficient was used to show correlation significance of current 
variations induced by tail pinches among O2, AA, glucose and lactate. Immediately after the 
stimulus application, the first five minutes of raw data (n=300) were compared point-by-
point. The null hypothesis was rejected when p < 0.05. 
5. Design, construction and calibration of oxygen and ascorbic acid 
microsensors 
Oxygen microsensor construction and calibration were performed as previously described 
(Bazzu et al., 2009; Calia et al., 2009). Briefly, 1 mm silver wire (25 mm in length; Ø=125 µm, 
Advent Research Materials, Suffolk, UK) was introduced in a silica capillary tube (10 mm in 
length; I.D. Ø=180 µm, Polymicro Technologies, Phoenix, USA), partially filled with epoxy-
carbon (EC) obtained mixing 450 mg of graphite with 350 mg epoxy resin (Araldite-M®, 
Sigma-Aldrich, Milan, Italy). A 180 µm diameter carbon composite disc electrode was made 
up and left 12 hours at 60°C. A conical shape was provided to the microsensor by drilling 
the tip. 
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The final oxygen microsensors (Fig. 8) had a length about 250 µm, a surface of 0.00145 cm2
and a tip < 25 µm. Nitrocellulose (NC, collodion) treatment was carried out dipping the 
microsensor in the collodion solution (4% nitrocellulose in ethanol/diethyl ether) 3 times 
and drying it for 1 hour at 40 °C after each coating. Cellulose nitrate membrane, because of 
its hydrophobic properties, sets a barrier for large organic molecules, as proteins, avoiding 
poisoning of microsensor surface while can be crossed by small charged ions and gases 
(Bazzu et al., 2009). 
Fig. 8. Schematic representation of the oxygen microsensor used in this study.  
O2 reduction potential was experimentally determined in a previous study (Bazzu et al., 
2009) using cyclic voltammetry and fixed at at -400 mV vs Ag/AgCl reference electrode. 
Constant potential amperometry (CPA) was used for in-vitro and in-vivo calibrations and 
experiments. No significant interferences were remarked on exposing sensors to other 
electroactive molecules (AA, UA, DA, DOPAC and HVA) present in the striatal extracellular 
fluid at pharmacologically significant concentrations (Calia et al., 2009). O2 microsensor was 
calibrated by adding known volumes of a standard O2 solution (100%) to nitrogenated PBS 
and only sensors with sensitivity lower than 10 µM were chosen. All in-vitro calibrations of 
oxygen microsensors were carried out 24 h after manufacture, immediately before 
implantation, using a previously-described electrochemical cell (Serra et al., 2007; Rocchitta 
et al., 2007) appropriately set for oxygen (Bazzu et al., 2009). The calibration (Fig. 9) 
exhibited good linearity showing a slope of -254 ± 32 pA µM-1 of O2 (R2=0.999; n=6), in line 
with previous observations (Calia et al., 2009). 
AA microsensors (Fig. 10) were manufactured in the same way as oxygen microsensors 
without the collodion layer or any further surface modification. 
In-vitro calibrations of ascorbic acid microsensors were carried out in fresh PBS at room 
temperature (25 °C) before implantation. A constant potential of +120 mV was applied and 
after a stabile baseline was reached, known amount of ascorbic acid stock solution were 
added to PBS in order to obtain concentrations ranging from 0 to 5 mM.  
AA microsensors, calibrated before implantation (Fig. 11), showed good sensitivity and 
good linearity (2.96 nA ± 0.1 mM-1, R2= 0.998, n=6). 
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Fig. 9. Oxygen microsensor in-vitro calibration.  
Fig. 10. Schematic representation of the ascorbic acid microsensor used in this study. 
Fig. 11. Ascorbic acid microsensor in-vitro calibration.  
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6. Design, construction and calibration of glucose and lactate biosensors  
The design of the glucose biosensors (Fig. 12) has been previously described in detail (Serra 
et al., 2007). Briefly, 1 mm platinum (Pt) cylinder, obtained cutting Teflon-insulated Pt wire 
(Ø=125 µm, Advent Research Materials, Suffolk, UK), was immersed for 5 min into a 
solution of glucose oxidase (GOx) to allow adsorption. After 10 min drying at room 
temperature, the biosensor was placed in the cell filled with 5 ml of nitrogenated PBS 
containing the o-phenylenediamine monomer (OPD, 250 mM). The electrosynthesis of poly-
o-phenylenediamine (p-OPD) was carried out at +700 mV vs Ag/AgCl reference electrode 
for 15 min. After electropolymerization, the biosensor was stored in fridge (4°C).  
Fig. 12. Schematic representation of the glucose biosensor used in this study.  
The in-vitro calibration of glucose biosensor was made in air-bubbled PBS performing ten 
successive injections of glucose (0.2, 0.4, 0.6, 1, 2, 10, 20, 60, 100, 140 mM). The calibration 
data (Fig. 13) well fitted with the Michaelis-Menten equation (R2=0.984, n=6) with a VMAX of 
59.6±0.8 nA and a KM of 5.6±0.4 mM. The response to low concentration of glucose (0-2 mM; 
Fig. 13, inset), revealed excellent linearity (R2=0.999, n=6) and a slope of 8.9±0.08 nA mM-1.
Fig. 13. In-vitro calibration of glucose biosensor (see text). 
The fabrication of the lactate biosensors (Fig.14) has been derived from a previously 
described procedure used to make glutamate biosensors (McMahon et al., 2006). A Pt 
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cylinder (1 mm) was placed in the electrochemical cell containing nitrogenated PBS and 
OPD monomer and p-OPD was electrosynthesized as previously described for glucose 
biosensor. The Pt/p-OPD cylinder was immersed (quick dip) into a solution of 
polyethylenimmine (PEI, 0.5%in water)-LOx (25 U/50 µl of PBS) to allow oxydase 
adsorption. After 5 min drying at room temperature, the dipping procedure was repeated 
four times.
With the purpose of increasing the KM of the biosensor, a diffusion-reducing membrane 
(Schuvailo et al., 2006) was applied on top of the PEI-LOx layers by dipping the biosensor in 
a polyurethane (PU) solution (2.5% in tetrahydrofurane). Finally, the biosensor was stored in 
fridge.
Constant potential amperometry (CPA) was used for in-vitro and in-vivo experiments fixing 
the H2O2 oxidation potential at +700 mV (Serra et al., 2007) vs Ag/AgCl.. All in-vitro
calibrations were performed in fresh PBS 24 h from sensors’ manufacture as previously 
described in detail (Rocchitta et al., 2007).  
Fig. 14. Schematic representation of the lactate biosensor used in this study.  
The in-vitro response of lactate biosensor was determined only before implantation adding 
known amounts of lactate in the electrochemical cell giving concentrations ranging between 
0 and 150 mM.  
Calibrations showed a classical Michaelis-Menten kinetic (R2=0.944, n=6) with VMAX and KM
equal respectively to 92.8±2 nA and 8.7±0.9 mM (Fig. 15). Linear region was evaluated at 
low concentration (0-5 mM) and it showed good linearity (R2=0.997, n=6) with a slope of 
6.7±0.2 nA mM-1 (Fig. 15, inset). 
No significant interference signals were observed on exposing biosensors to AA or other 
electroactive molecules present in the striatal extracellular fluid, even at pharmacologically 
relevant concentrations (Calia et al., 2009).  
7. Animals and neurosurgery 
Male Wistar rats (Morini R. Emilia, Italy), weighing 250-350 g were used in all experiments. 
Rats were kept under standard animal care conditions with 12 h light/dark cycle, and room 
temperature 21°C, food and water ad libitum. 
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Fig. 15. In-vitro calibration of lactate biosensor (see text). 
All procedures were licensed under the European Community directive 86/609 included in 
Decreto No. 116/1992 of the Italian Ministry of Public Health.  
Stereotaxic surgery was performed under chloral hydrate (400 mg Kg-1 i.p.) anesthesia and 
body temperature during anaesthesia was maintained at 37 °C by means of an isothermal 
heating pad. 
Before each experiment, the health of the animals was assessed according to published 
guidelines (Wolfensohn and Lloyd, 2003). 
O2 and AA microsensors, glucose and lactate biosensors were implanted in the right 
striatum (Fig. 16) using the following coordinates from the atlas of Paxinos & Watson 
(Paxinos & Watson, 2007): A/P +0.5 from bregma, +2.5 M/L, and -4.0 D/V from dura. 
Reference and Auxiliary electrodes were implanted in the parietal cortex. 
Fig. 16. Amperometric sensor inserted in the right striatum by means of sterotaxic surgery. 
The sensor was wired to the biotelemetric device fixed to the skull (inset).  
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The biotelemetric device was fixed by mean of two screws inserted in the skull (Fig. 16, 
inset), as previously described (Bazzu et al., 2009; Calia et al., 2009).  
Following surgery, the animals were housed in large Plexiglas bowls (45 cm diameter), and 
maintained in a temperature- and light- controlled environment, with free access to food 
and water. The sensors were connected 24 h after surgery. The monitoring of 
neurochemicals started with the animal in its home bowl allowing the rat free movement 
(Fig. 17).
Fig. 17. Biotelemetric device implanted in a freely-moving rat.  
8. In-vivo experiments and results  
Baseline recordings and physiological stimulation were carried out within the first day after 
stereotaxic surgery, starting 24 h after implantation. The Oxygen microsensor reached a 
stable baseline (-24.3 ± 2.7 nA) after a period of about 50 minutes from the application of the 
working potential. Considering that the background current of the microsensor in nitrogen-
saturated PBS was -14.2 ± 0.9 nA, it is possible to estimate the concentration of O2 using in-
vitro pre-calibration; this was found to correspond to 39.8 ± 7.1 ?M, a value in agreement 
with previous results (Bazzu et al., 2009; Calia et al., 2009). Physiological stimulation as five-
minute tail pinch (Fig. 18), administered in order to increase neural activity and to promote 
regional cerebral blood flow (rCBF), led to an increased motor activity yielding to a striatal 
O2 current of -2.97 nA, corresponding to +11.69 µM, statistically different from baseline 
(p<0.001; Fig. 18, inset). 
Striatal oxygen dynamics, following physiological stimulation, resulted in a rise in the local 
O2 signal, mainly related to an increase of rCBF during neural activation in agreement with 
previous findings (Bazzu et al., 2009; Calia et al., 2009).  
A stable AA baseline was reached after a period of about 25 minutes. The calculated AA 
baseline corresponded to a concentration of 566 µM, in line with previous findings (Calia et 
al., 2009).  A physiological increase (p<0.001; Fig. 19, inset) of striatal AA current (+0.447 nA 
corresponding to +228 µM) was observed immediately after the administration of a 5 min 
tail pinch (Fig. 19). 
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Fig. 18. Effect of physiological stimulation (5 min. tail pinch, vertical band) on striatal 
dissolved oxygen.  
Fig. 19. Effect of a 5 min. tail pinch (vertical band) on striatal AA. 
This result is consistent with the activation of the AA/glutamate heteroexchange system 
(Rice, 2000) in which AA release is related to glutamate release and uptake subsequent to 
neural activation (Miele et al., 2000). 
Glucose biosensor in-vivo experiments were carried out using the same procedures as 
oxygen and AA ones. Thirty minutes after biosensor activation a stable anodic current 
corresponding to 4.6±0.24 nA (517±26 µM from in-vitro calibration) was reached. 
Physiological stimulation (Fig. 20) produced a significant decrease of glucose signal (-167 
µM; Fig. 20, inset) followed by its increase after stimulus suspension. 
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Fig. 20. Effect of a 5 min. tail pinch (vertical band) on striatal glucose. 
A stable baseline was observed 40 min after lactate biosensor polarization and corresponded 
to 5.09±0.43 nA (759±62 µM from the above in-vitro calibration). A five-minute tail pinch 
(Fig. 21) resulted in a significant increase of lactate signal during stimulus administration 
and after stimulus suspension (+544 µM, p<0.001; Fig. 21, inset).  
Fig. 21. Effect of a 5 min. tail pinch (vertical band) on striatal lactate. 
These results are suggestive of glucose consumption and lactate production during neural 
activation followed by an increase of extracellular levels of glucose subsequent to astroglial 
glycogenolysis (Fillenz et al., 1999). Figure 22 shows Pearson's correlation analysis of current 
variations induced by tail pinches among O2, AA, glucose and lactate. 
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Fig. 22. Pearson's correlation analysis of striatal neurochemical changes during neural 
activation. 
It is important to remember that an increase in anodic currents (AA, glucose and lactate) 
reflects a striatal increase of the above neurochemicals while an increase in extracellular 
dissolved O2 levels, corresponds to an increase in cathodic oxygen current, resulting in a 
more negative signal. Results of correlation analysis are summarized in Table 1. 
Ascorbic Acid Glucose Lactate 
Oxygen r = -0.819 
P<0.0001
r = 0.401 
P<0.0001
r = -0.457 
P<0.0001
Ascorbic Acid r = -0.266 
P<0.0001
r = 0.518 
P<0.0001
Glucose r = -0.388 
P<0.0001
Table 1. Results of correlation analysys of striatal neurochemical changes during neural 
activation. 
After each experiment, rats were sacrificed with an injection of chloral hydrate (800 mg Kg-1
i.p.). The location of each sensor was established by post-mortem histology. Brains were 
fixed in formal saline and 50 µm coronal sections were made with a cryostat. The slices were 
stained with cresyl violet and examined under a microscope.  
9. Discussion and conclusion 
In this chapter we have described the development of a distributed sensor NET for 
biotelemetric monitoring of brain neurochemistry using amperometric microsensors and 
biosensors. The implantable biotelemetric units, based on simple and inexpensive 
components, have been successfully used for accurate transduction of the electrochemical 
signals generated on the surface of the sensors implanted in the striatum of freely-moving 
rats. At this stage of development the system exhibits high stability and excellent linear 
response in the nanoampere current range. The choice of low-power CMOS technology 
makes the project suitable of further improvements such as the reduction of the power 
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consumption. The use of surface mount components and careful PCB design will make it 
possible to further miniaturize the circuitry. As result of in-vivo experiments, we have 
shown some preliminary data obtained monitoring important brain molecules during short-
time neural activation (5’ tail pinch). The study was carried out using new microsensors, 
biosensors and the newly-developed biotelemetric device in order to record real-time 
changes of key neurochemical markers of brain bioenergetic metabolism. Indeed, all studied 
species (oxygen, AA, glucose and lactate) are implicated in brain energetics.  
Recently, Castro and coworkers (Castro et al., 2009) proposed a new pivotal role for AA as 
modulator in the metabolic switch between glucose and lactate as energetic substrate of 
neurons. This review paper, mainly based on in-vitro results, summarizes the evidences of 
the relationships among glutamate, AA, glucose and lactate during neural activation. In 
figure 23, we repropose the model suggested by Castro, updated on the basis of our in-vivo
results. In brief, in normal conditions both neurons and astrocytes use glucose as energetic 
substrate. After neural activation, cortico-striatal endings release glutamate (1) in the striatal 
extracellular compartment (Miele et al., 2000). Immediately after, GLU is taken by astrocytes 
from the synaptic cleft and exchanged (Rice, 2000) with AA (2).  The in-vivo increase of 
extracellular AA during tail pinch is in accord with this mechanism. The glutamate entry 
into astrocyte stimulates glucose internalization (3), glycolysis (4) and lactate efflux (5). We 
observed a reduction of extracellular glucose and an increase of lactate during tail pinch in 
agreement with this model. Finally, ascorbic acid enters neurons (6) through a specific 
transporter (SVCT2) and activates the metabolic switch (Castro et al., 2009), stimulating lactate 
uptake in neurons (7) and inhibiting glucose consumption (8). The rise in the local O2 signal, 
Fig. 23. Neurochemical pathway involved in brain energetic metabolism during neural 
activation. Glut: glutamate; Gluc: glucose; Lac: lactate; Pyr: pyruvate; GLUT: glucose 
transporter; SVCT: AA transporter; MCT: lactate transporter. 
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during neural activation, might reflect an increase of rCBF (Bazzu et al., 2009; Calia et al., 
2009). Immediately after the end of the physiological stimulation, AA current inverted its 
trend and slowly (10 min) returned to baseline levels. Oxygen and lactate currents 
continued to rise for 5 min after the end of the tail pinch then slowly decreased to baseline 
levels. The drop of glucose during neural activation was followed by its increase as result of 
astroglial glycogenolysis (Fillenz et al., 1999). Post-activation data are complex to interpret 
and suggest the return to normal (inactive) condition with glucose as energetic substrate for 
neurons. It is important to remember that AA is oxidized to DHAA by ROS and RNS in 
neurons (Serra et al., 2002). DHAA, secreted in the extracellular space, enters astrocyte 
through GLUT1 transporter and is back-reduced to AA (Hediger, 2002). A sustained 
increase of extracellular glucose could interfere with AA/DHAA cycle resulting in oxidative 
stress, AA loss and neuron damage. 
These in-vivo results indicate that, during neural activation in physiological conditions, 
extracellular striatal changes of the above neurochemicals mainly reflect astrocyte response 
to glutamatergic stimulation. Further in-vivo pharmacological studies are necessary to 
confirm in-vitro evidences on bioenergetic substrates used by neurons in different 
experimental conditions. 
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Information Assurance Protocols for Body 
Sensors using Physiological Data 
Kalvinder Singh1 and Vallipuram Muthukkumarasamy2




Wireless sensors and actuators have the potential to significantly change the way people live 
and interact. As the sensors permeate the environment they can monitor objects, space and 
the interaction of objects within a space. Sensors can monitor a wide range of diverse 
phenomena by collecting information such as vibrations, temperature, sound, and light. 
Different sensors have different associated costs. For example, a sensor simply detecting 
light will have different costs to a sensor recording sound. However, less costly sensors can 
be used to detect a phenomenon before alerting the more expensive sensors to start their 
monitoring. 
The aging population and the increase of chronic diseases have placed an immense financial 
burden on health services. Body sensors can be used to help reduce their costs. Sensors can 
be used to remotely monitor elderly patients suffering from chronic diseases and allow them 
to have relatively independent lives. The uses of body sensor networks are inherently 
complex. For instance, blood pressure increasing due to exercise is normal. However, blood 
pressure increasing while at rest could mean a serious medical condition. Sensors may not 
just measure physiological values, but also body motions, which can lead to a number of 
different sensors needing to communicate with each other. As the number of heterogeneous 
sensors increases, so will the complexity of interactions between the sensors. 
There are many different types of sensor environments, ranging from large areas covered by 
sensors, to many sensors in a small area (Kuorilehto et al., 2005). Different environments 
have a wide range of varying characteristics. For instance, sensors placed in large open area 
are not as physically secure as sensors implanted in an individual’s body. The protocols 
proposed in this paper are mainly designed for our home health care system, although these 
protocols can also be applied to other environments that have similar security 
characteristics.
Context awareness is an important aspect of body sensor networks (Thiemjarus & Yang, 
2006). For instance, blood pressure increasing due to exercise is normal. But if the blood 
pressure increases while at rest then that could mean a serious medical condition. Sensors 
may not just measure the physiological values, but also the body motions, and can lead to a 
number of different sensors needing to communicate with each other. 
Figure 1 gives a diagrammatic representation of our proposed home health care system. The 
diagram shows a patient at home with a number of body sensors that can communicate with 
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Fig. 1. Architecture and service platform of a BSN for telemedicine and m–health 
a camera sensor, the health controller, and a PDA. The cameras may only start recording if 
the body sensors detect that there may be a medical emergency, such as the patient lying 
horizontal in the kitchen. Surveillance software, such as S3 (Hampapur et al., 2004), can be 
used to detect if the patient is cleaning the kitchen, or getting something from the ground, or 
there actually is an emergency. If the software does detect an emergency, the hospital staff 
are notified, examine the information, and decide on the best course of action. The PDA is 
used to give feedback to the patient about the condition of their body, as well as the status of 
the sensors. The PDA can notify the patient of any detected emergency, allowing the patient 
to report back a false alarm if one has occurred. The PDA can be replaced with a mobile 
phone or any other hand held communication devices. 
Some of the data recorded from body sensors include the heart rate, blood pressure, 
temperature, and blood oxygen level. They require a data rate of around 2 bits per second 
(Balomenos, 2001; Yeatman & Mitcheson, 2006). However, other information sent with the 
message, such as the location of the sender node (8 bits), a MAC (we have specified the size 
to be the same as the size of the physiological data), and a counter to stop replay attacks (32 
bits) raises the data rate to around 10 bits per second. This paper, therefore, assumes the 
data rate of 10 bits per second for body sensors. Another type of sensor is a surveillance 
camera, and the data rate requirement for video streams (Axis, 2007) is much greater than 
that of body sensors. A single camera normally requires 1–4 Mbits per second bandwidth. 
Providing secure data transfer between sensors is a requirement for our home health care 
system. 
Health information collected from sensors needs to be secured and in some countries (for 
example the USA) security is mandated (USA, 2003). Securing a home health care system 
becomes more difficult mainly because of the different requirements for various 
components. For instance, the sensors have dramatically more resource constraints than the 
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constraints found in mobile phones, cameras or desktop computers. With differences in 
computing power, as well as differences in communication costs, different security protocols 
may be required throughout the entire system. For instance, an efficient key establishment 
mechanism specifically for body sensors was created using physiological data (Singh & 
Muthukkumarasamy, 2007). However, the home health system may send physiological data to 
medical staff, or to an analytics engine (Espina et al., 2006). The physiological data may also be 
sent to an actuator to release medicine into the body (Espina et al., 2006). 
When the same physiological data is used for more than one purpose (as well as the 
complexity of a heterogeneous environment), it becomes important from a security or 
information assurance point of view to have a formal methodology. A formal methodology 
is also important to insure that the information sent to medical staff and actuators to 
dispense medicine is accurate, and the correct actions are taken. The formal methodology 
has a requirement that it can model both the security and privacy aspects as well as the 
application correctness. In this paper, we show that Behaviour Trees can be used as a formal 
methodology to verify both the system and the security. 
A number of researchers have used environmental data as the only source of secret 
information to establish keys between body sensors (Bao et al., 2006; Poon et al., 2006; Bao et 
al., 2005; Bao & Zhang, 2005; Venkatasubramanian & Gupta, 2006). The major benefit of 
using environmental data is that body sensors can use this information to authenticate that 
the other sensor is also on the same person and not of another individual. However, these 
researchers have citepd a number of problems with that approach. 
The problems include the following: 
? only cryptographically strong environmental data can be used. 
? the environmental values can become compromised, in which case the new session key 
is also compromised. 
These problems limit the use of environmental data for establishing keys to only a few cases. 
The other difficulty our system encounters is in the key establishment scheme of the PDA 
with sensors at home and in the body. It is envisaged that the patient will simply be users of 
the system, and will not be able to set up security certificates or keys. 
In this paper we propose and develop a number of protocols to address these problems. We 
show that password protocols can be used to establish keys between body sensors, if 
passwords are replaced by physiological data. A new protocol is developed to allow a 
patient to connect a PDA to the home health care system thus able to view information 
about each of the sensors (ranging from cameras to body sensors). The proposed protocol 
does not require traditional encryption to transport the new session key. We show that the 
sensor nodes can establish keys even if no previous shared keys exist between them. 
2. Notation 
This paper will use the notations shown in Table 2 to describe security protocols and 
cryptographic operations. 
3. Background 
A sensor network can consist of many different computing devices. Some have more 
computational power (and memory) than others. A Body Sensor Network (BSN) is a 
network of wearable heterogeneous sensors (Aziz et al., 2006). The sensors are spread over  
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Notation  Description  
A, B  The two nodes who wish to share a new session key  
S A trusted server  
NA, NB Random numbers generated by nodes A and B respectively
[[M]]K Encryption of message M with key K to provide confidentiality  
[M]K One–way transformation of message M with key K to provide integrity
, 'AB ABK K
The long–term key initially shared by A and B and the new session key 
respectively
KAS, KBS Long–term keys initially shared by A and S, and B and S respectively
X, Y  The concatenation of data strings X and Y
A? B: m A sends a message m to B
m?? Another way to define sending of message m
? Exclusive–or function  
Table 1. Notations 
the entire body, and monitor and communicate a range of health related data. BSNs are used 
in the health industry to monitor a patient’s physical and biochemical parameters 
continuously, in different environments and locations where ever the patient needs to go. 
BSNs can also be used by athletes to measure their performance. Another use for BSNs is 
controlling characters in video games (Aziz et al., 2006). Health information collected from 
sensors needs to be secured and in some countries, for example the USA, security is 
mandated (USA, 2003). 
Key establishment protocols are used to set up shared secrets between sensor nodes, 
especially between neighbouring nodes. When using symmetric keys, we can classify the 
key establishment protocols in WSNs into three main categories: Pair–wise schemes; 
Random key predistribution schemes; Key Distribution Center (KDC). The Pair–wise 
schemes and Random key predistribution schemes are designed for open environments, 
where there can be many individual sensors (Liu & Ning, 2007). A difficulty with the above 
schemes is that updating the keys between the nodes is still an unsolved problem. Another 
drawback is that, when using the random key predistribution schemes, the shared keys 
cannot be used for entity authentication, since the same keys can be shared by more than a 
single pair of nodes (Hämäläinen et al., 2006). The KDC mechanisms by themselves are not 
suitable for large scale WSN environments, although combinations of a KDC mechanism 
and the previously mentioned schemes have created hybrid protocols (Chan & Perrig, 2005). 
Some of the limitations with using a sensor node as a KDC mechanism are: 
? The KDC scheme relies upon other schemes to create the trusted intermediary. 
? The key sizes in sensor nodes are not large enough, so over a period the key between 
the sensor and the trusted intermediary may become compromised. If the KDC protocol 
messages were captured and saved by an adversary, then the adversary may calculate 
the new keys created. 
? Some sensor networks may not need an encryption algorithm, although KDC protocols 
require an encryption algorithm to encrypt the new key. 
A password has been proposed as a way to initiate key establishment (Singh et al., 2006). 
However, the use of a PIN code or a password is not applicable to BSNs since many of the 
sensors do not have a user-interface. Sensors also may be placed in hard–to–reach places, 
with some of the sensors implanted into the body. To complicate matters, the sensors may 
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harvest energy directly from the body (Kansal & Srivastava, 2005), thus allowing the sensors 
to exist for long periods of time. Updating keys is therefore an important function. 
This paper uses the generic name Secure Environmental Value (SEV) referring to sensed 
data that can be obtained by sensors in an environment. The SEV is usually hard to obtain 
through other means. Examples of an environment where SEVs may be found include: 
? Human body, where it is difficult to attach a device on the body without the knowledge 
of the person. 
? A secured location, for instance a military base or unmanned vehicle, such as UAVs, or 
a secure home environment. 
? Hard to reach places, for instance a satellite in orbit. 
The example environment used in this paper is the human body, where BSNs have been 
developed to measure the physiological values found in individuals (Aziz et al., 2006). 
Health sensors can use Inter–Pulse–Interval (IPI) (Poon et al., 2006) or Heart Rate Variance 
(HRV) (Bao et al., 2005) as good sources for cryptographically random numbers and the 
physiological values can be used as a one–time pad. Protocols (Venkatasubramanian & 
Gupta, 2006; Bao & Zhang, 2005) have been developed that used these physiological values 
to encrypt a new key between a sensor pair. For instance, Venkatasubramanian and 
Gupta(Venkatasubramanian & Gupta, 2006) used a single message to send a new key to the 
neighbouring sensor node, as shown in Protocol 1. 
Protocol 1 Venkatasubramanian BSN protocol  
A? B : NA, [NA]RANDKEY, RANDKEY ? SEV 
Venkatasubramanian and Gupta noted that finding additional cryptographically sound 
physiological values is still an open research problem. Only cryptographically strong 
physiological values, such as IPI and HRV, can be used. Also, modern wireless technology 
(ultra wideband – UWB, radar (Staderini, 2002)) may be used to remotely capture the heart 
rate. It may encounter security risks when only using IPI and HRV to secure the 
communication. Other cryptographically weaker physiological values, such as blood 
pressure, and iron count, are less susceptible to those remote attacks. 
4. Using physiological data to establish keys 
Even though PINs and passwords may not be used in body sensors, we show that password 
protocols can be used. Passwords have low randomness, and therefore have similar 
characteristics to many SEVs. A four digit PIN contains less than 14 bits of randomness and 
can be used in a password protocol. A typical password length of eight characters has less 
than 48 bit of randomness, if we randomly choose upper and lower case letters as well as the 
digits 0 to 9. We investigate the suitability of password protocols for the sensor 
environment. Password protocols have the special property of allowing secrets with small 
entropy to be used for key establishment. Password protocols are designed so that both off– 
line and on–line attacks are not feasible. A feature or by–product of most password 
protocols is that if the password is compromised, then any keys created before the password 
was compromised will not be compromised. 
Key sizes in sensor networks are small, normally 64 bits, so that the encryption or integrity 
tests do not consume a large amount of energy (Karlof et al., 2004). Small key sizes lead to 
the need to update keys on a regular basis. 
 Biosensors 266
Researchers have shown that password protocols can be implemented in sensor networks 
(Singh et al., 2006). The password protocols were using either a human–entered password 
on the sensor, or an existing 64 bit key. Instead we propose that environmental data can be 
used in the absence of using small keys or passwords. Also, previous approaches for sensor 
environments only used elliptic curve cryptography. However, RSA password protocols 
that can be converted to ECC have large exponent such as 1024 bits. When the protocol is 
converted to use ECC, then 160 bit arithmetic is required. 
We instead investigated the EKE protocol, which is an RSA based password protocol where 
the exponent only needs to be 160 bits (Bellovin & Merritt, 1992). The EKE protocol is chosen 
because other variants of password protocols require exponents of size 1024 bits. The EKE 
protocol is diagrammatically shown in Protocol 2. A drawback of the EKE protocol is that it 
cannot use ECC (Boyd & Mathuria, 2003). 
The EKE protocol contains four messages. Node A sends the first message to node B, the 
message contains the location of A (the location value is in the clear), and the first part of 
Diffie–Hellman, tA, is encrypted by the weak key SEV1. After the first message is sent, node 
B will calculate the second part of the Diffie–Hellman scheme and hence be able to calculate 
the session key KAB. Node B then sends the second part of the Diffie–Hellman scheme 
encrypted by the weak key SEV2 to node A. The nonce nB is also sent, encrypted by the 
session key KAB. The last two messages authenticate both A and B, as well as confirming that 
they have the session key KAB. The encryption of tA, tB, nA, and nB can be implemented with 
an exclusive–or function, as originally described by (Bellovin & Merritt, 1992). 
Depending on which environmental value is measured, and how long the protocol will run, 
different SEVs may be used for the request and response. However, if the SEV stays 
constant throughout the running of the protocol, then both SEV1 and SEV2 will be the same. 
The EKE protocol is designed for a constant password throughout the running of the 
protocol, so similar or same data for both SEV1 and SEV2 will not adversely affect the 
protocol.
The EKE protocol was originally designed to handle small entropy secrets, so that off–line 
and on–line dictionary attacks are infeasible for an adversary. Another useful feature is that 
even if the secrets SEV1 or SEV2 are compromised or available freely after the running of the 
key establishment protocol, the session key KAB will remain secure and safe. 
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Both nonces nA and nB are cryptographically strong random numbers, allowing the 
exclusive–or function to be used for encryption. If any nonce was not cryptographically 
strong then either nA ? KAB or nB ? KAB operation would allow an adversary to significantly 
reduce the number of valid KAB values. A characteristic of the EKE protocol is that the 
nonces are never sent out in the clear, since the nonces are used to encrypt the new key KAB.
The value of p should be chosen wisely (Bellovin & Merritt, 1992).The value of p should be 
as close to 2N? 1 as possible for the best security. 
Even though exclusive–or and block cipher symmetric cryptography is suitable in an RSA 
environment, it is not suitable when converting to elliptic curves (Boyd & Mathuria, 
2003).The EKE (RSA) protocol is compared with a ECC based password protocol (Singh et 
al., 2006). 
Using the RSA implementation (Dutta et al., 2006) from the Deluge system and porting it to 
the mica2 mote system, and only using 160 bit exponents, we found that the total number of 
cycles is 147879. Password protocols that can use an ECC implementation inherently require 
1024 bit exponents when in RSA mode (Boyd & Mathuria, 2003). When measuring the 
number of cycles by using the ECC implementation for sensors (Liu et al., 2007), including 
an implementation of the square root function, we get a total number of 18790689. The key 
size was 160 bits, which is equivalent to 1024 bits in RSA. When moving to the ECC 
protocols, more secure keys are required. There is a significant number of extra cycles in a 
ECC implementation over the RSA implementation. 
We also examine the memory of the application, as shown in Table 4. The combination of 
.bss and .data segments use SRAM, and the combination of .text and .data segments use 
ROM. The .text contains the machine instructions for the application. The .bss contains 
uninitialized global or static variables, and the .data section contains the initialized static 
variables.
Memory  RSA  ECC  
ROM  1942  9720  
RAM  177  859  
.data  60  8  
.bss  117  851  
.text  1882  9712  
Table 2. Memory Overhead In Bytes On MICA2 Platform 
We used the values provided by the TOSSIM simulator (a part of the TinyOS installation) to 
obtain an indication of the power consumption when sending a message. In our calculations 
we do not take into account any collision avoidance times. On the mica2 mote, the cost of 
sending an extra 20 bytes is 28.1 microjoules. There is a substantial startup cost for each 
message sent, and then there is an added cost for every bit that is sent. 
4.1 Securely connecting the PDA 
When a patient starts up a PDA or obtains a new PDA. Keys need to be created with the 
PDA and the sensors (both body and camera sensors). The mechanism we use is that the 
patient, when starting up the PDA, will need to enter either a password or PIN. The 
remainder of this section discusses a protocol that can be efficiently used to establish keys 
with all the sensor devices in the household and one of the sensors on the body (normally 
the body control sensor). 
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We assume that the body sensors, especially any body sensors that are leader nodes, have 
obtained the session keys from other sensors in the house. It is envisaged that when the 
controller sensor was added to the body, it had embedded a key with a central server. Then 
by using a KDC protocol, it can obtain keys with all the other sensors in the house. When 
the body sensors establish or update keys between themselves, they can use the password 
protocols (as described earlier in this paper). However, a hand held device, such as a PDA 
or mobile phone, may be purchased from a local store and will not have any keys. If patients 
are required to set up certificates or keys themselves, then the security system may be set up 
incorrectly. Also, if the device becomes lost or stolen, then an adversary is able to physically 
obtain any long–term keys held on the device. Our solution is to propose a multiple server 
protocol that can create session keys between the sensors in the house and the body 
controller sensor, with the PDA. A multiple server protocol has previously been developed 
for normal sensor networks (Singh & Muthukkumarasamy, 2006). The main reason for a 
multiple server protocol is that if sensors exists in an open environment, then KDC nodes 
can be physically compromised. In our sensor environment, the sensors are less likely to be 
physically compromised (either they be sensors implanted in the body, or the cameras 
placed in the home). However, multiple server protocols are still important for a home 
health care system. The reasons for a multiple server protocol are: 
? Increase the randomness of the new key, by having multiple parties adding 
randomness to the new key. 
? A camera may break down, or run out of power. A multiple server protocol increases 
the availability of the key establishment service. 
? The key between the camera and the sensor may become compromised. The keys used 
by the sensors are normally small in size, since cryptographic algorithms consume more 
energy when larger keys are used. 
In our attempt to create an efficient multiple server protocol, we specified n servers where 
each server corresponds to a camera. The Proposed Protocol 1 shown below, represents each 
of the cameras as Si. The PDA device is labelled as A, and sends the first message, A,B,NA, to 
each of the cameras. Each camera sends their message to back to the PDA. The PDA will 
calculate the keys KASi and the cross checksums, and sends the cross checksums as well as 
parts of the messages from the cameras to the body sensor. The body sensor creates its own 
cross–checksums and compares them against the cross– checksums created by the PDA. At 
this stage, the keys KS and KAB are created by the body sensor. The body sensor sends NB, the 
keying data, and the its newly created cross–checksums to the PDA. The PDA can now also 
create the keys KS and KAB. The final message completes the key confirmation between the 
PDA and the body sensor, as shown in Proposed Protocol 1. If key confirmation is not vital, 
then the final message can be removed. 
The Proposed Protocol 1 provides key authentication, key freshness and key confirmation, 
using multiple authentication servers. In our Proposed Protocol 1, the following constructs 
are used: ??is the password or SEV, A is the PDA, B is a body sensor, Si is a camera, tASi and
tSiA are the Diffie–Hellman values, mASi = [[tASi ]]?, m?ASi = [[tSiA]]?, AUTHAi = [A,B,Ki]KASi ,
MASKAi = [[AUTHAi]]KASi , AUTHBi = [A,B,Ki]KBSi , and MASKBi = [[AUTHAi]]KBSi
The PDA, the body sensor and the cameras contribute to the key value. The values NA and 
NB are generated by the PDA and the body sensor respectively as input to the MAC 
function, that determines the session key. The key used with the MAC function is generated 
by the servers. Both the PDA and body sensor compute the session key as KAB = [NA,NB]KS .
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The keys KASi are generated by computing the diffie–hellman part of the protocol. The PDA 
and body sensor should have a minimum number of cameras returning valid results before 
confirming that the key is valid. The PDA will calculate ccA(i) ?i ??1, . . . ,n.
(1)
Where EM is an error message; an example will be the value zero. There is a remote chance 
a valid case may be zero. If the valid value is zero, the camera needs to be considered a 
compromised server (even though it is not a malicious server). 
The body sensor will calculate ccB(i), and compare it with ccA(i). If they are the same, then 
the server Si is valid. Below is a way the PDA and body sensor compare the cross checksum 
for ccA(i) and ccB(i).
(2)
After the comparison of the entire cross checksums, a set of valid keys V1, . . . ,Vm should 
remain. The creation of KS is defined as follows. 
(3)
Where Vi is the ith valid key given by a server, and m is the total number of valid servers t ?
m ? n, where t is the minimal number of trusted servers. Another advantage of the proposed 
protocol is that the cameras will not be able to calculate KS. The calculated ccB(i) values are 
returned to the PDA, where the PDA performs similar checks as the body sensor and 
calculates KS.
Once the PDA has established a key with one of the body sensors, then a KDC protocol can 
be used to establish keys with the other body sensors. 
4.2 Analysis and discussion 
Our Proposed Protocol 1 has a number of advantages, one of which is that the body sensor 
does not need good random number generators to create the nonces. The body sensor could 
even safely use a counter for their nonce values. Another advantage is that if a camera or a 
number of cameras are unavailable, the authentication service itself still exists through the 
working cameras. If one or more cameras become compromised, the authentication service 
or the security of the system is not compromised. 
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The proposed protocol only encrypts random information. If the encryption cipher uses an 
IV value (such as RC5 and SKIPJACK currently used in TinyOS (TinyOS, 2007)) then we can 
use a constant IV value. However, the constant IV value chosen for our protocol must only 
be used to encrypt the random data and should never be used to encrypt other information. 
Also, a wide variation of different ciphers can safely be used. 
Some MACs have vulnerabilities when the message sizes are variable. All of our message 
sizes are of constant value, allowing us to safely use a wider range of MACs than previously 
available. The size of the MACs sent to the body sensor can be lower than that of 
conventional protocols. The integrity checking is performed by the body sensor. If x is the 
size of the MAC in bits, then an adversary has 1 in 2x chance of blindly forging a valid MAC 
for a particular message. The adversary should be able to succeed in 2x?1 tries. Because of the 
low bandwidth of sensor nodes, a 4 byte MAC, requiring 231 packets, will take years to 
complete. If an adversary did attempt this attack, the sensor node would be non–functional 
within that period. In addition, an adversary will need to forge 2t MACs; t MACs to A and t
MACs to B, and stop traffic from the other base stations before they can determine the value 
of KAB.
In the proposed protocol, the device that is most sensitive to energy restrictions is the body 
controller sensor. The message M3 is of the most concern, since it the largest message sent to 
the controller sensor. We calculate the size of the message as M3 = (n +1)a0 + a1 + na2 + na3
bytes. Where a0 is the size of the location, a1 is the nonce size, a2 is the key size, a3 is the MAC 
size, and n is the number of cameras. Assuming that the location is 1 byte in size (maximum 
256 possible sensors), the nonce is 1 byte in size, the key is 8 bytes in size, and the MAC is 4 
bytes in size, we get M3 = 13n + 2 bytes. If we assume that a packet size is 28 bytes, a 
configuration with more than two cameras will require multiple packets sent between the 
PDA and the body controller node. If there is no or little concern about whether the cameras 
or the camera keys are compromised, then the PDA can select two cameras to send to the 
body controller sensor. 
The computational complexity for the body sensor depends on the number of valid servers 
the PDA forwards to the sensor, the number is defined as m. The computational cost of the 
MACs is 4m + 2, and the cost of the encryption operations is m. The number of exclusive–or 
operations is 2m.
5. Formal verification 
Formal analysis of communication protocols for traditional networks has been used since at 
least 1978 (West, 1978), with significant improvements in recent decades (Clarke & Wing, 
1996). Sithirasenan et al. (Sithirasenan et al., 2006) have compared different modeling 
techniques, and listed advantages for each of the techniques. 
Verifying a protocol is proving that the claims for the protocol are correct and is a significant 
step in analysing the protocol. The complexity of security protocols makes their verification 
a difficult task. Informal arguments about protocol correctness are not reliable or acceptable, 
leading to a formal analysis to verify that a claim made by a protocol is correct. 
Computer assisted formal methods for verifying security protocols can be divided into two 
major categories: 
? Model Checking: considers a finite number of possible protocol behaviours and allows 
checking that satisfy a set of correctness conditions. This method works well for finding 
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attacks on a protocol, rather than proving their correctness Clarke et al. (2000); Lowe 
(1996); Mitchell et al. (1997). 
? Theorem Proving: considers all possible protocol behaviours, and checks that they 
satisfy a set of correctness conditions. This method works well for proving protocol 
correctness, rather than finding attacks on protocols Meadows (1996); Paulson (1998); 
Song (1999). 
Both model checking and theorem proving methods require computer assistance to aid with 
the analysis. However, methods based on theorem proving are less automated than those 
based on model checking. 
A useful feature of model checking methods is that they can prove an attack when a 
protocol is found not to satisfy a correctness condition. The failure to find an attack indicates 
that the protocol is correct. However, model checkers do not provide a symbolic proof that 
can explain why a protocol is correct and thus are uninformative when checking a correct 
protocol. Another important limitation of model checking methods is that they only 
guarantee correctness of a scaled down version of the protocol. 
Theorem proving mechanisms have their own strengths and limitations. One of the 
strengths of theorem proving methods is that they can provide a symbolic proof when a 
protocol is found to be correct. Their main limitation is that they generally require more 
expert human guidance than methods based on model checking. 
Sitherasenan et al. Sithirasenan et al. (2006) have used Genetic Design Methodology to check 
the correctness of the 802.11i wireless security protocol. The requirements of the protocol 
was placed into a number of Requirement Behaviour Trees. The requirements were then 
verified by integrating them into a single Integrated Behaviour Tree. Thereafter, the 
Behaviour Tree model was translated into SAL formal notations for theorem proving. This 
mechanism shows that both model checking and theorem proving can be performed using 
the same analysis tool. However, the model checking was mainly focused on the protocol 
correctness and not the security. We will show that this analytical tool can perform both 
model checking and theorem proving on the security of a protocol. 
One of the major advantages is that the genetic design methodology produces graphical 
models that are derived and integrated from the original requirements. The models can be 
used to verify that security protocols correctly work in a complex system. A home health 
care system is a complex system, where it is difficult to track how sensed data is used in the 
system. When the sensed data is also used in security protocols, tracking the use of sensed 
data becomes even more important. For example, some key establishment protocols require 
the sensed data never to be sent in the clear or to an untrusted third party, whereas other 
protocols do not need such restrictions. 
The genetic design methodology creates behaviour trees, which in turn can generate SAL 
code (Sithirasenan et al., 2006). A model checker can then be used to verify the SAL code 
and thus verify the protocol in the sensor environment. The main steps with the genetic 
methodology are: translation of requirements to behaviour trees; integration of behaviour 
trees; architecture transformation; component behaviour projection; component design. 
When modelling the entire system, genetic design has significant advantages over UML, 
state charts or other methods. The advantages include: 
? Allows designers to focus on the complexity and design of individual requirements 
while not having to worry about the detail in other requirements. The requirements can 
be dealt with one at a time (for both translation and integration). 
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? The component architecture and the component behaviour designs of the individual 
components are emergent properties of the design behaviour tree. 
? The methodology concentrates on discovery behaviour gaps, which in turn discovers 
requirement gaps. The focus of direct translation of requirements to design makes it 
easier to see and find gaps. 
? An automated method of mapping changes in requirements to changes in design. 
An important part of the genetic design methodology is the behaviour trees. Dormey 
(Dromey, 2003) defined Behaviour Trees as: a formal, tree–like graphical form that represents 
behaviour of individual or networks of entities which realize or change states, make decisions, 
respond–to/cause events, and interact by exchanging information an/or passing control.
Each requirement can be represented as a behaviour tree; this representation is specifically 
called a Requirement Behaviour Tree. 
Another mechanism to verify that a protocol is secure is to use a mathematical proof Canetti 
& Krawczyk (2001). Problems with using mathematical proofs include: 
? With each small change in the protocol a new proof needs to be constructed. 
? Security proofs run to several pages of mathematical reasoning and is difficult to 
understand to the average practitioner. 
? There are relatively few protocols with mathematical security proofs. 
? As a system becomes more complex, constructing mathematical proofs becomes more 
challenging. 
Informal verification, machine analysis (either using model checking, or theorem proving), 
and mathematical proofs are all important approaches to gain assurance on the security of 
the protocol. 
5.1 Modelling 
In order to verify the BSN system, the Behaviour Tree technique is used to represent the 
home health care system. The modelling was completed after several stages. The initial 
stages involved obtaining the requirements of the Venkatasubramanian and Gupta protocol 
and EKE password protocol. The major requirement is to establish a cryptographic key 
between two nodes. The Venkatasubramanian and Gupta protocol properties include that 
SEV needs to be cryptographically strong, and the SEV should never be sent in the clear. The 
EKE protocol does not have as many restrictions because of the following properties: 
? Sensor nodes only possess a secret of small entropy, 
? Off–line dictionary attacks are not feasible, 
? On–line dictionary attacks are not feasible, and 
? The key must have forward secrecy. 
From the properties of the key establishment protocols, we developed the Requirement 
Behaviour Trees (RBTs). While developing the RBTs, we found that the previous definitions 
and properties of the protocols did not have a consistent method to define the need for the 
sensor to sense the physiological data. The RBT is designed for, and has built–in syntax for, 
external events, so this requirement was easily added to our RBTs. The feature for quickly 
adding external events makes RBTs suitable for a sensor environment. The RBTs were then 
placed into an Integrated Behaviour Tree (IBT) to display the entire system. The IBT was 
then used to create other models for us to investigate and analyse. The Component 
Interaction Network (CIN) was used to show the relationship between the components in 
the system and gave a representation of the component architecture. The Component 
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Behaviour Trees (CBTs) and Component Interface Diagrams (CIDs) gave us views of each of 
the individual components. The final RBT for the EKE protocol is shown in Figure 2. The 
RBT for the Venkatasubramanian and Gupta protocol has a similar structure. 
Fig. 2. EKE password protocol for Sensors 
The RBT has four major components, the first three components belong to Requirement 1 
(R1), whereas Sensor C sensing data belongs to Requirement 2 (R2): 
? Sensor A sensing data every 10 seconds 
? Sensor B sensing data every 10 seconds 
? Sensors A and B Establishing a key 
? Sensor C sensing data every 10 seconds 
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In the above diagram, establishment of the key is initiated by Sensor A. It will create tA and
then send it to Sensor B. In our RBT we have made the sending of the message from Sensor 
A to Sensor B non–deterministic. In this case, Sensor B could have received a malicious 
message from another node. Verification of the key is the last step. We have this as a 
separate RBT, since it overcomplicates the diagram. The verification of the key involves the 
key confirmation steps described in the protocol. 
By using behaviour trees, we were quickly able to find all of the possible inputs and outputs 
that a sensor can obtain, either through wireless communication or through their sensing 
devices. This also helps us to verify that each component that we are developing has the 
needed features to run in our environment. When there are a large number of sensors, this 
requirement becomes difficult to track. The next step is to generate SAL code from this 
behaviour trees, and verify the protocol in a sensor environment. 
5.2 Specification of SAL 
Before we could test our requirements on the key establishment protocol, we first needed to 
specify the network and body into SAL code. To specify the network in SAL, we were able 
to utilize previous SAL libraries (Rushby, 2003). However, we found no existing SAL 
libraries to specify obtaining SEVs from the body. We defined the body within SAL as 
having two operations: getSEV; changeSEV. Sensors can obtain a SEV by calling getSEV and 
afterwards a changeSEV can be called to create a new SEV. 
We then generated the SAL code from the RBTs. The first SAL code generated is for the 
Venkatasubramanian and Gupta protocol. Due to limitations in the SAL generation, we 
modified the SAL code to read the physiological data from our body SAL code. We have a 
requirement R2 where a sensor sends physiological data to an external third party system. 
We want to show that requirement R2 will break requirement R1, since for the protocol to be 
secure we needed to ensure that the sensed data is never sent in the clear. The following 
theorem is used to verify that no other sensor reads the same sensed data as the pair that is 
establishing the new session key. 
           
SAL code was also generated for the EKE protocol. Wemodified the SAL code to read the 
physiological data from our body SAL code. We have a requirement R2 where a sensor 
sends physiological data to an external third party system. We want to show that the 
requirement R2 will not break the requirement R1, since we also placed a delay into the 
sensors in requirement R1, where the sensor will wait 30 seconds before sending out the 
physiological data. It should be noted that the Venkatasubramanian and Gupta protocol still 
is broken if the physiological data is sent out with a delay. The following theorem is used to 
verify that another sensor delays its send when reading the same sensed data as the pair that 
is establishing the new session key. 
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6. Comparison of different implementation 
We implemented and compared different cryptographic primitives that can be used in body 
sensor security protocols on a Crossbow mica2 MPR2600 mote (Crossbow, 2006). Before 
comparing the different cryptographic primitives, and the benefits that one implementation 
has over another, we created skeleton code based on TinyOS 2.x (TinyOS, 2007). The 
skeleton code initializes the sensor node, and after the sensor is initialized, we obtained the 
initial time in milliseconds. We then run a cryptographic primitive in a loop for 2000 
iterations, before obtaining a new time. We subtracted the new time from the initial time to 
obtain the elapsed time in milliseconds to run our cryptographic primitive for 2000 
attempts. The elapsed time was then sent via the serial connection, to a PC running a Linux®
distribution where we have a Java® application reading the TinyOS packet from the serial 
port, and report that data to the user. 
The key establishment protocols uses exclusive–or (xor) to encrypt the new session key. We 
compare this method with other methods of encrypting the new session key for body sensor 
networks. Singh et al. (Singh & Muthukkumarasamy, 2008; 2007) have shown how RC5, 
SKIPJACK, HMAC–MD5, RSA, and ECC cryptographic primitives can be used in BSNs, 
however, their work and comparisons were based on simulations, and on TinyOS 1.x. We 
have implemented these cryptographic primitives on real hardware, and for TinyOS 2.x. To 
our knowledge these cryptographic primitives have not (until now) been ported to the latest 
version of TinyOS. Previously, Singh et al. did not separate the square root function from 
the elliptic curve cryptography. However, in our comparison we found significant 
information when separating them. 
Table 6 shows the time it takes to run 2000 iterations of each of the algorithms. We have 
ordered the algorithms on the time elapsed. The Lines of Code indicates the complexity for 
the coder to implement the algorithm. The Size (bytes) indicates the size in bytes of the 
application. 
Algorithm  Time  Lines of Code  Size (bytes)  
xor  2 milliseconds  80  6340  
RC5  500 milliseconds  506  7168  
SKIPJACK  700 milliseconds  697  8138  
HMAC–MD5 20 seconds  507  19054  
RSA  43 seconds  1456  7814  
SQRT  80 seconds  3366  8610  
ECC  78 minutes  5038  16328  
Table 3. Time measurements for different algorithms 
The RC5 application took considerable more effort than the exclusive–or (xor) application. 
We found an RC5 implementation for TinyOS 1.x in the TinySEC library (Karlof et al., 2004), 
however, it has yet to be ported to TinyOS 2.x. Most of our effort was spent porting the code 
to the new platform. The SKIPJACK application had similar problems as the RC5 
application. Where there was an implementation for TinyOS 1.x in the TinySEC library but 
there was not one for TinyOS 2.x. Once again, most of our effort was spent porting the code 
to the platform. For HMAC–MD5 application we could not find any previous 
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implementations of HMAC–MD5 in any version of TinyOS. In this case we obtained code 
from RFC1321 (Rivest, 1992) and RFC2104 (Krawczyk et al., 1997) and ported the code to 
first the nesc language and then to the TinyOS application. This was considerably more 
effort then either RC5 or SKIPJACK implementations. The RSA application also had similar 
problems as the RC5 and SKIPJACK implementations. We found code in the Deluge System 
(Dutta et al., 2006), however, the RSA code was based off TinyOS 1.x. Effort was required to 
port this code to TinyOS 2.x. We used a 160 bit exponent as required by the EKE protocol. 
The SQRT application had the most difficulties since we implemented it from pseudo–code 
rather than porting any code. We used Newton’s Method (Press et al., 2007) for finding 
square roots to implement the SQRT application. The ECC application also had similar 
problems to the RSA, RC5 and SKIPJACK implementations. We ported an ECC library (Liu 
et al., 2007) developed for TinyOS 1.x to TinyOS 2.x. The ECC application used a 160 bit 
points, since password protocols that could be converted to use ECC require stronger keys 
(Singh & Muthukkumarasamy, 2007). 
The xor application is the quickest by several orders of magnitude compared to the other 
cryptographic primitives. The size of the application is smaller, and the number of lines is 
less then the other applications. The xor application is the quickest, whereas the ECC 
application is the slowest. This verifies existing research into the differences in speed for 
password protocols of RSA and ECC implementations in TinyOS simulators (Singh & 
Muthukkumarasamy, 2007). The HMAC–MD5 application is the largest, however the 
application was a straight port from the RFCs, where the code was not intended for sensors. 
7. Future research directions 
We have proposed a multi–server key establishment protocol that allows a PDA to obtain 
session keys with most of the sensors in our home health care system. We implemented 
salient features of the password protocols and compared the energy consumption of the 
nodes. The password protocols that could be converted to use ECC had a larger 
computational overhead than the EKE protocol, because of the stronger keys required by the 
ECC–based password protocols. Due to the EKE protocol only requiring 160 bit exponents, 
the message sizes of the EKE protocol were comparable to the ECC– based password 
protocols. The impact on memory by adding elliptic curves to a sensor application was 
analyzed, revealing that there is additional costs associated with an ECC solution over a 
RSA solution. Future work includes using cryptographic protocol verifiers to confirm that 
our protocols are secure. 
Genetic design methodology is used to gather the requirements of the health care system. 
We examined two existing key establishment protocols that use physiological data to 
establish keys between body sensors, where the sensors have no other prior secret. We 
showed how the requirements of the EKE protocol can be placed into a Requirement 
Behaviour Tree. SAL code is generated from the behaviour tree, as well as SAL code created 
to model the events from the body. A SAL model checker is used to verify the protocol 
formally within our system. Implementation of the protocols involved either porting 
libraries or creating new libraries in TinyOS 2.x. The time elapsed, complexity of the code, 
and memory requirements are analysed in detail on mica2 sensors. The password protocols 
that use ECC had a larger computational overhead than the EKE protocol, confirming 
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existing work performed using simulations. Future work will include the full 
implementation and analysis of both the RBTs and code for each of the key establishment 
protocols on our sensor network. 
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1. Introduction  
Numerous psychological studies have shown that humans develop various stylistic patterns 
of motion behaviour, or dynamic signatures, which can be in general, or in some cases 
uniquely, associated with an individual. In a broad sense, such motion features provide a 
basis for non-verbal communication (NVC), or body language, and in more specific 
circumstances they combine to form a Dynamic Finger Print (DFP) of an individual, such as 
their gait, or walking pattern.  
Human gait has been studied scientifically for over a century. Some researchers such as 
Marey (1880) attached white tape to the limbs of a walker dressed in a black body stocking. 
Humans are able to derive rich and varied information from the different ways in which 
people walk and move. This study aims at automating this process. Later Braune and 
Fischer (1904) used a similar approach to study human motion but instead of attaching 
white tapes to the limbs of an individual, light rods were attached. Johansson (1973) used 
MLDs (Moving Light Displays; a method of using markers attached to joints or points of 
interests) in psychophysical experiments to show that humans can recognize gaits 
representing different activities such as walking, stair climbing, etc. The Identification of an 
individual from his/her biometric information has always been desirable in various 
applications and a challenge to be achieved. Various methods have been developed in 
response to this need including fingerprints and pupil identification. Such methods have 
proved to be partially reliable. Studies in psychology indicate that it is possible to identify 
an individual through non-verbal gestures and body movements and the way they walk.  
A new modelling and classification approach for spatiotemporal human motions is 
proposed, and in particular the walking gait. The movements are obtained through a full 
body inertial motion capture suit, allowing unconstrained freedom of movements in natural 
environments. This involves a network of 16 miniature inertial sensors distributed around 
the body via a suit worn by the individual. Each inertial sensor provides (wirelessly) 
multiple streams of measurements of its spatial orientation, plus energy related: velocity, 
acceleration, angular velocity and angular acceleration. These are also subsequently 
transformed and interpreted as features of a dynamic biomechanical model with 23 degrees 
of freedom (DOF).  
This scheme provides an unparalleled array of ground-truth information with which to 
further model dynamic human motions compared to the traditional optically-based motion 
capture technologies. Using a subset of the available multidimensional features, several 
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successful classification models were developed through a supervised machine learning 
approach.
This chapter describes the approach, methods used together with several successful 
outcomes demonstrating: plausible DFP models amongst several individuals performing the 
same tasks, models of common motion tasks performed by several individuals, and finally a 
model to differentiate abnormal from normal motion behaviour.     
Future developments are also discussed by extending the range of features to also include 
the energy related attributes. In doing so, valuable future extensions are also possible in 
modelling, beyond the objective pose and dynamic motions of a human, to include the 
intent associated with each motion. This has become a key research area for the perception 
of motion within video multimedia, for improved Human Computer Interfaces (HCI), as 
well as its application directions to better animate more realistic behaviours for synthesised 
avatars.
2. Dynamic human motions used in bodily communication 
Bodily communication or non–verbal communication (NVC) plays a central part in human 
social behaviour. Non-verbal communication is also referred to as the communication 
without words. Face, hands, shrugs, head movements and so on, are considered as the NVC. 
These sorts of movements are often subconscious and are mostly used for: 
- Expressing emotions 
- Conveying attitudes 
- Demonstrating personality traits 
- Supporting verbal communication (McNeil, 205) 
Body language is a subset of NVC. Body language is used when one is communicating 
using body movements or gestures plus, or instead of, vocal or verbal communication.  As 
mentioned previously these movements are subconscious, and so many people are not 
aware of them although they are sending and receiving these all the time. Researchers have 
also shown that up to 80% of all communications is body language. Mehrabian (1971) 
reported that only 7% of communication comes from spoken works, 38% is from tone of the 
voice, and 55% comes from body language. 
A commonly identified range of NVC signals have been identified (Argyle, 1988) such as: 
- Facial expression   -     Bodily contact 
- Gaze and pupil direction  -     Gesture and other bodily movements 
- Posture    -     Spatial behaviour 
- Non–verbal vocalizations  -     Smell 
- Clothes, and other aspects of appearance 
In addition to this as Argyle described the meaning of a non–verbal signal can be different 
from sender or receiver’s points of view. To a sender it might be his emotion, or the message 
he intends to send and to the receiver can be found in his interpretation. Some NVC signals 
are common among all the different cultures where some others might have different 
meanings in different cultures. According to Schmidt and Cohn (2002) and Donato et al. 
(1999) there are 6 universally recognized facial expressions: 
  1. Disgust   2. Fear 
  3. Joy    4. Surprise 
  5. Sadness   6. Anger 
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But there are other emotions that could be recognized through body movements including 
anxiety, nervousness, embarrassment, lying, aggression, boredom, interest, tiredness, 
defensive, curiosity, agreement, disagreement, and even some states such as thinking and 
judging. Some emotions are expressed as a sequence of movements, so one will need to use 
prior or posterior information from movements in order to be able to recognize such specific 
emotions.
2.1 Body parts and related emotions 
Certain movements of one body part often need to be associated with the movements of 
various other parts in order to be interpreted as an emotion. Table 1 details a basic list of the 
parts that one is is able to acquire data from their movements and the emotions related to 
those movements are described.  
member movement interpretation 
lowering  defensive or tiredness. 
raising interest, visual thinking. 
tilting interest, curiosity. 
oscillating up & down agreement. 
oscillating left & right disagreement. 
head
touching thinking. 
expanding aggression arms 
crossing anxiety 
holding behind lying, self confidence 
palms up or down  asking 
rubbing together extreme happiness. 
hands
repetitive movements anxiety, impatience.. 
neck touching fear. 
raised tension, anxiety or fear. shoulder 
lowered relax 
chest rubbing tension and stress. 
belly Rubbing or holding tension 
standing with feet together anxiety 
crossing tension and anxiety 
legs
repetitive movements anxiety, impatience 
thighs touching readiness 
curling extreme pleasure 
stamping anger and aggression 
feet
moving anxiety, impatience, lying 
Table 1. Noted emotions for associated body movements (Straker, 2008). 
These interpretations are acquired from different psychological researches through different 
web sites and dissertations. Interpretation would clearly depend on cultural and other 
context. 
Table 1 infers a highly complex multidimensional space in which a human body can relay 
emotional expressions as various spatial articulations at any point in time. This together 
with any associated temporal sequence surrounding an observed postural state, combine to 
provide an extremely challenging context in which to capture and further model the 
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dynamics of human motions. A rich array of initial, contributory intentions further 
obfuscate matters. The decidedly successful analysis of facial micro expressions by Ekman 
and others (Ekman, 1999) has proven insightful for identifying the underlying emotions and 
intent of a subject. In a related but possibly more prosaic manner, it is the intended to 
establish three basic goals from the analysis and modeling of dynamic motions of a human 
body, these are to:  
1. develop a sufficient model of dynamic finger printing between several individuals 
2. model distinctive motion tasks between individuals 
3. formulate a model to identify motion pretence (acting) as well as normal and abnormal 
motion behaviours 
Successfully achieving some or all of these goals would provide invaluable outcomes for 
human behavioural aspects in surveillance and the detection of possible terrorism events as 
well as medical applications involving dysfunction of the body’s motor control. 
3. Motion capture data 
Given the three distinct task areas it became prudent to utilise, were ever possible, any 
existing general motion capture data that may be available, as well as record specific motion 
data that addressed more specific task needs. To this end the Carnegie Mellon University 
(CMU) Motion Capture Database (2007) has been utilized explore the second goal, that is to 
investigate plausible models for the identification of distinctive motion tasks between 
individuals. This database was created with funding from NSF EIA-0196217, and has 
become a significant resource providing a rich array of motion behaviours that have been 
recoded over a prolonged period. Alternatively, the first and last goal objectives require 
more specific, or specialised captured motion data. For these areas, a motion capture system 
based on a network array of inertial wireless sensors, as opposed to the more traditional, 
optical multiple camera based system.   
3.1 Inertial motion capture 
Data recorded from this technology is being acquired using an inertial movement suit, 
Moven® from Xsens Technologies, which provides data on 23 different segments of the 
body kinematics such as position, orientation, velocity, acceleration, angular velocity and 
angular acceleration as shown in Fig. 1. 
In capturing human body motion no external emitters or cameras are required. As explained 
by Roetenberg et al. (2007) mechanical trackers use Goniometers which are worn by the user 
to provide joint angle data to kinematic algorithms for determining body posture. Full 6DOF 
tracking of the body segments are determined using connected inertial sensor modules 
(MTx), where each body segment's orientation, position, velocity, acceleration, angular 
velocity and angular acceleration can be estimated. The kinematics data is saved in an 
MVNX file format which is subsequently read and used, using an intermediate program 
coded in MATLAB. 
Using the extracted features, a DFP (Dynamic Finger Print) can be generated for each 
individual. DFP is used to identify the individual or detect departure from his/her expected 
pattern of behaviour. Using this comparison, it is possible to find the smoothness or stiffness 
of the movement and find out if the person is concealing an object. In order to recognize 
identity of an individual, different measurements will be made to extract the unique 
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                        (a)                                                                                 (b) 
Fig. 1. Inertial Motion Capture: (a) Moven®, light weight latex motion suit housing a 
network of 16 MTx inertial sensors (b) distribution of MTx sensors including the L and R 
aggregation and wireless transmitter units— adapted from (Xsens Technologies, 2007). 
Dynamic Finger Print (DFP) for that individual. The data produced by the suit consists of 
kinematics information associated with 23 segments of the body. The position, velocity, 
acceleration data for each segment will be then analyzed and a set of feature of derived will 
be used in classification system. 
3.2 Feature extraction 
The determination/selection and extraction of appropriate features is an important aspect of 
the research. All the classification results would be based on the extracted features. The 
features should be easy to extract and also must contain enough information about the 
dynamics of the motion. The selected features should be independent of the location, direction 
and trajectory of the motion studied. In the case of a sequence of walking motions (or gait) it 
would be reasonable to deduce that the most decisive/important facets to consider would be 
the legs, feet and arms. Features are extracted in a gait cycle for each individual. The gait cycle 
is a complete stride with both legs stepping, starting with the right leg as shown in Fig. 2. A 
typical recording session of a participant wearing the suit is shown in Fig. 3. 
Fig. 2. A sample gait cycle: as received from the wireless inertial motion suit and animated 
on a 23 DOF avatar within the Moven Studio? software. 
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The data produced by the Moven system is stored in rich detail within an MVNX (Moven 
Open XML format) file which contains 3D position, 3D orientation, 3D acceleration, 3D 
velocity, 3D angular rate and 3D angular acceleration of each segment in an XML format 
(ASCII). The orientation output is represented by quaternion formalism. 
Fig. 3. Recording of the Body Motions; on average, each participant walked between ground 
markers, white to black, and return in some seven seconds.  
The extracted features chosen are the subtended angles of the following body elements: 
- Left and Right Foot Orientation, 
- Left and Right Foot, 
- Left and Right Knee, 
- Left and Right Thigh, 
- Left and Right Elbow, 
- Left and Right Arm. 
In total 12 features per individual was extracted, were each angle is given in radians. The 
location and interpretation of these features is illustrated on the animated motion avatar in 
Fig. 4.   
                           (a)                                                 (b)                                                  (c) 
Fig. 4. Selected features annotated of the Moven avatar; (a) Foot Orientation Angle and Foot 
Angle, (b) Knee Angle and Thigh Angle (c) Elbow Angle and Arm Angle. 
An example plot combining all of the 12 selected features, for five participants (p6-p10), can 
be seen in Fig. 5. These have been concatenated together for comparison; the extent of each 
individual is delineated by grey vertical lines—each individual marking some 3 to 4 gait 
cycles in-between. This amounted to some 3 to 4 seconds for a subject to walk from one 
marker to the other, and for a sample rate of 120Hz this equates to some 360 to 480 captured 
data frames per person.
One can readily appreciate several various differences in gait amongst these participants—
such as the marked variations in angular extent of foot orientations (Left Foot O, Right Foot 
O), and their associated temporal behaviour. Despite this array of other differences the leg 
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period of each remains approximately similar as their variation of height is not significant, 
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Motion capture samples @ 120Hz
Fig. 5. Temporal trends for the 12 selected features across participants p6—p10. 
Fig. 6. Parallel Coordinate Plot: providing visualisation of all selected features, for all 




































Although there degrees of diversities between the trends in Fig. 5 of all selected features, 
one may still remain unconvinced that a set of dynamic finger prints ultimately exists, and if 
so how could they possibly be reliably extracted? Part of this difficulty arises from observing 
the distinct feature dissimilarities as a function of time. A more pragmatic approach would 
be to transform these into alternative domains such as FFT or Wavelets. However, an 
alternative to either of these might be to visualise the features through a Parallel Coordinate 
Plot (PCP), as illustrated in Fig. 6, in order to explore the multivariate data without the 
coupling effect of time.  
The PCP of Fig. 6 obtained via a visualisation tool Ggobi (Cook and Swayne, 2007), here, 
arranges a series of parallel coordinates axes, one for each feature, scaled to represent the 
normalised range of each. The right-most axis of this plot further provides a numerically 
ordered array of the 10 participants. Every frame of the motion capture data, although 
constrained to the 12 selected features, is represented by a distinct line that intersects each 
feature coordinate axis at an appropriate (normalised) value. By colour coding (brushing) 
the data fames for each participant, one can more readily appreciate potentially unique 
signatures of profile patterns (or DFP) across the combined feature space. In comparison, 
both Fig. 5 and Fig. 6 are derived from the same data; however the participants in the former 
are essentially contrasted with each other (but only half of these for clarity) in the temporal 
domain. However, in the latter case of Fig. 6 all participants are explicitly compared with 
each other solely in the feature domain, which also reveals strong visual evidence for the 
existence of motion signatures amongst the various individuals.  
4. Symbolic modelling of DFP 
The principal benefit of symbolic machine-learning (modelling), as opposed to other 
approaches such as physical modelling (or knowledge-driven modelling), is that it is 
essentially an empirical, or data driven, modelling process which endeavours to represent 
only the patterns of relationships or process behaviours (here human movements). Hence, it 
is readily able to cope with significantly higher dimensionality of data. Non-symbolic 
machine learning approaches, such as artificial neural networks also address such problems, 
but lack the major benefits offered by symbolic modelling —these being the transparency of 
learnt outcomes or patterns, plus an adaptive process of the model structure to scale to 
accommodate data. These abilities are necessary in order to critique and understand 
patterns and knowledge that may be discovered.    
In order to examine the Dynamic Finger Print hypothesis, the ten individuals wearing the 
Moven suit, undertook four repetitions of a simple walking task. From these tasks, the 
selected features, across the individuals were collected and recorded for an identification 
trial. For this trial, the goal was to clearly identify an individual based purely on a 
combination of the subtended joint angles. In addressing this recognition challenge, the 
machine learning, rule induction system known as See5 (RuleQuest, 2007) was used. This 
system, being a supervised learning algorithm was utilised to induce symbolic classification 
models, such as decision trees, and or rule sets, based on the range of chosen features 
(attributes), including a priori known classes. The final decision trees and rule sets were 
created through adjustment of the various pruning options, but primarily through the 
(major) pruning control for the minimum number of cases option (M). 
Essentially a large tree is first grown to fit the data closely and then pruned by removing 
parts that are predicated to have relatively high error rate. The pruning option, M, is 
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essentially a stopping criterion to arrest the expansion formation of a decision tree and any 
associated rule set derived from it. It specifies the minimum number of cases that are 
required before any leaf classification node is formed and essentially constrains the degree 
to which the induced model can fit the data. In order to obtain a more reliable estimate of 
the predictive accuracy of the symbolic model n?fold cross validation is used as illustrated in 
Fig. 7.  


































Tree size 40.5 39.1 34 29.2 22.3 16.6 12.9 10.4 4.7
Rules size 33.7 32.9 29.3 25.4 19.4 14.5 11 10 0
Tree accuracy 99.3% 98.9% 97.9% 96.8% 93.1% 90.0% 86.1% 83.1% 46.0%
Rules accuracy 99% 99% 98% 97% 93% 90% 86% 83% 12%
2 4 8 16 32 64 128 256 512
Fig. 7. Model size and accuracy variations as measured by 10?fold cross validation. 
The cases in the feature data file are divided into n?blocks of approximately the same size 
and class distribution. For each block in turn, a classifier model is induced from the cases in 
the remaining blocks and tested on the cases in the hold?out block. In this manner, every 
data frame is used just once as a test case. The error rate of a See5 classifier produced from 
all the cases is then estimated as the ratio of the total number of errors on the hold?out cases 
to the total number of cases (See5, 2002). Here, the number of folds has been set to 10.  
As can been seen in Fig. 7 there is a nonlinear trade-off between model size and accuracy. 
Given that the intended use of the model can be guided as to the most dominant factor. 
Which at the two extremes can be either; a greater generalisation with a reduced model size 
or, alternatively, a larger, more sensitive model that is less likely to produce miss-
classifications. The objective in this task was to model potential motion signatures, and as an 
example we have chosen a model size that generally reflects a 90~95% accuracy, here M=64.  
Once a suitable classifier performance level has been identified using the cross validation 
trends, the resultant model is generated as illustrated by the rule set model in Fig. 8. 
For this task we are seeking to establish an individual motion signature for all participants, 
thus there are ten classes p1?p10. Participants undertaking the experiments were 5 males 
and 5 females between 18 to 40 years of age. According to Fig. 8, the average error rate 
achieved is some 6.8% and number of rules is 18. 
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Rule 1: (1119/728, lift 3.3) 
Left Foot O > 1.124812 
Right Elbow <= 2.901795 
=> class p1  [0.350] 
Rule 2: (296/28, lift 9.7) 
Left Foot O > 1.124812 
Right Elbow > 2.901795 
Left Elbow > 2.918272 
=> class p2  [0.903] 
Rule 3: (66/28, lift 6.2) 
Right Foot O > 1.260007 
Left Foot O <= 1.124812 
Right Elbow > 2.640656 
=> class p2  [0.574] 
Rule 4: (225/3, lift 10.7) 
Left Foot O > 1.124812 
Right Foot <= 2.100667 
Right Knee <= 2.866177 
Right Elbow <= 2.901795 
Left Elbow > 2.795459 
Left Arm > 0.1387282 
=> class p3  [0.982] 
Rule 5: (191/21, lift 9.6) 
Left Foot O > 1.124812 
Right Foot <= 2.100667 
Right Knee <= 2.866177 
Right Elbow <= 2.901795 
Right Arm <= 0.2898046 
=> class p3  [0.886] 
Rule 6: (65/25, lift 6.7) 
Right Foot O > 1.053137 
Left Foot O <= 1.124812 
Right Elbow <= 2.640656 
=> class p3  [0.612] 
Rule 7: (350, lift 10.9) 
Left Foot O <= 1.124812 
Left Arm > 0.4538144 
=> class p4  [0.997] 
Rule 8: (395, lift 9.4) 
Left Foot O > 1.124812 
Right Elbow > 2.901795 
Left Elbow <= 2.918272 
=> class p5  [0.997] 
Rule 9: (224/15, lift 8.1) 
Left Foot O > 1.124812 
Right Knee > 2.866177 
Right Elbow <= 2.901795 
Left Elbow > 2.795459 
=> class p6  [0.929] 
Rule 10: (188/15, lift 8.0) 
Left Foot O > 1.124812 
Right Elbow <= 2.901795 
Left Elbow > 2.795459 
Right Arm > 0.2898046 
Left Arm <= 0.1387282 
=> class p6  [0.916] 
Rule 11: (80/13, lift 7.2) 
Right Foot O > 1.00804 
Right Foot O <= 1.260007 
Left Foot O <= 1.124812 
Right Elbow > 2.640656 
=> class p6  [0.829] 
Rule 12: (615/311, lift 4.3) 
Left Foot O > 1.124812 
Right Elbow <= 2.901795 
Right Arm <= 0.3535621 
=> class p6  [0.494] 
Rule 13: (326, lift 10.7) 
Right Foot O <= 1.053137 
Left Foot O <= 1.124812 
Right Elbow <= 2.640656 
=> class p7  [0.997] 
Rule 14: (838/435, lift 4.3) 
Right Foot O <= 1.00804 
Left Foot O > 0.1827743 
Left Foot O <= 1.124812 
Right Elbow > 2.640656 
Left Arm <= 0.4538144 
=> class p8  [0.481] 
Rule 15: (295/16, lift 11.1) 
Right Foot O <= 1.00804 
Left Foot O > 0.1827743 
Left Foot O <= 1.124812 
Right Elbow > 2.640656 
Left Elbow <= 2.852491 
Left Arm <= 0.4538144 
=> class p9  [0.943] 
Rule 16: (169/28, lift 9.7) 
Right Foot O <= 1.00804 
Left Foot O <= 1.124812 
Left Knee <= 3.004622 
Right Elbow > 2.838296 
Left Elbow <= 2.879424 
Left Arm <= 0.4538144 
=> class p9  [0.830] 
Default class: p6 
Evaluation on training data (3837 motion frames)
Decision Tree Rules   
Size       Errors No       Errors 
Rule 17: (302, lift 9.3) 
Right Foot O <= 1.00804 
Left Foot O <= 0.1827743 
Right Elbow > 2.640656 
Left Arm <= 0.4538144 
=> class p10  [0.997] 
Rule 18: (228/28, lift 8.2) 
Right Foot O <= 1.00804 
Left Foot O <= 1.124812 
Right Elbow <= 2.838296 
Left Elbow > 2.852491 
Left Arm <= 0.4538144 
=> class p10  [0.874] 18   270( 7.0%) 18   261( 6.8%) 
Fig. 8. An example motion signature model for participants, p1?p10.
Each rule in Fig. 8 consists of an identification number plus some basic statistics such as (n, 
lift x) or (n/m, lift x) these, in fact, summarize the performance of each rule. Here, n, is the 
number of training cases covered by the rule and m, where it appears, indicates how many 
of the cases do not belong to the class predicted by the rule. The accuracy of each rule is 
estimated by the Laplace ratio (n ? m +1)/(n + 2) . The lift x, factor is the result of dividing a 
rule’s estimated accuracy by the relative frequency of the predicted class in the training set. 
Each rule has one or more antecedent conditions that must all be satisfied if the rule 
consequence is to be applicable. The class predicted by the rule is show after the conditions, 
and a value between 0 and 1 that indicates the confidence with which this prediction is 
made is here shown in square brackets (See5, 2002).  
The overall performance of the signature model can be readily observed in the confusion 
matrix of Fig. 9 which details all resultant classifications and miss-classifications within the 
trial. The sum of values in each row of this matrix represents the total number of true 
motion frames that are derived from the associated participant (p1?p10). Any off-diagonal 
values in Fig. 9 represent miss-classification errors, such as 13 motion frames of participant 
p5 was very similar to those exhibited by p2. Here an ideal classifier would register only 
diagonal values in Fig. 9. 
All extracted features were available to the induction algorithm as it constructed its various 
classifier models, however not all of these were ultimately utilised in the final rules. For 
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example considering the model of Fig. 8, the number of times that each feature has been 
referred in the rules, which reflects its importance in classifying a person, is shown in Table 
2. According to Table 2 the features, Left Foot, plus the, Left Thigh and Right Thigh, angles 
have not been used in classifier at all, and the two most important features are angle of the 
Left Foot Orientation and that of the Right Elbow. 
(p1) (p2) (p3) (p4) (p5) (p6) (p7) (p8) (p9) (p10) <= classified as 
384 15    7     p1 
 306 21   29     p2 
  311   42     p3 
   350       p4 
 13   395      p5 
  3   436     p6 
6  25    326    p7 
 28      347 28 28 p8 
        327  p9 
        16 394 p10 
Fig. 9. Confusion matrix analysis of the motion signature model for participants p1?p10.
Feature Usage Percentage of usage of all features 
Left Foot O 18 26.1% 
Right Elbow 17 24.6% 
Right Foot O 9 13.0% 
Left Arm 8 11.6% 
Left Elbow 8 11.6% 
Right Arm 3 4.3% 
Right Knee 3 4.3% 
Right Foot 2 2.9% 
Left Knee 1 1.4% 
Left Foot 0 0% 
Right Thigh 0 0% 
Left Thigh 0 0% 
Table 2. Usage of features, highlighting three redundant attributes. 
Although we had originally included all of the apparently, seemingly important bodily 
attributes, the induced model has found these, Left to be redundant. These leads to an 
obvious suggestion of not manually selecting or limiting the range of available attributes, 
but rather allow the algorithm to choose an appropriate sub-set of these. This in fact is one 
of the specific approaches employed in Section 5. 
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Ultimately the various rules in such classifiers all define specific hyper-cubes within the 
multidimensional feature space. As an example, four rules from an initial version of the 
signature model are overlaid on a 2-dimensional projection of the 12-dimensional feature 
space. This was observed in some preliminary data visualisation work carried out on the 
motion data using Ggobi (Cook & Swayne, 2007). Using projection pursuit visualization, the 
rotating projection was paused whenever a significant 2D segmentation could be observed. 
Here, in Fig. 10 one can clearly identify participants 9 and 10, and also conceptualize four 
hyper-cubes encompassing the array of these points (motion data frames) with rules 13, 14, 
23 and 24. 
Fig. 10. Selective symbolic model rules identifying participants 9 and 10 with a 2D projection 
of the 12 dimensional feature?space.
The primary aim of this study was to identify a person based on a combination of subtended 
angles at the feet, knees, thighs, arms, and elbows. In this process 12 features were extracted 
and using a decision tree and converting this into a rule set classifier 93.2% accuracy was 
achieved. The participants were 5 males and 5 females between 18 to 40 years of age, 
indicating that the results obtained were not dependent to specific characteristics of 
participants. The extracted features could also be used in gender classification, or even 
different motion classifications. In order to be able to use the described method in a real 
application, an image processing and computer vision section for data acquisition should be 
added to the system. The goal in this section is only to test the hypothesis that a plausible 
Symbolic Modelling of Dynamic Human Motions  293
signature model to recognize specific individuals could be developed from an appropriate 
set of features. 
5. Symbolic modelling of distinctive motion tasks 
This section progresses the development of symbolic modelling to see if it can be used to 
model various distinctive tasks of human movement skills. As mentioned in Section 3, the 
CMU Motion Capture Database (2007) offers a significant array of general motions, which 
would take a considerable period of time to replicate. This data, however, is  freely available 
from the Carnegie-Mellon Motion Capture Database, in the Acclaim ASF/AMC format 
(CMU Motion Capture Database, 2007).  
The data consists of motion capture sequences for various activities such as sports, walking, 
running, dancing, and nursery rhyme actions. These are captured at a rate of 120 frames per 
second. For each frame, the optically inferred x, y and z axis rotation for each bone of the 
body are recorded with respect to the degrees of freedom available for the bone, e.g. the 
upper arm (humerus) has x, y and z rotations while the forearm (radius) has only x-axis 
rotation from the elbow. 
In total, there are 28 bones in the model as shown in Fig. 11, with the 29th bone (root point) 
representing the rotation and translation of the whole body. This root point serves as the  
Fig. 11. Names and locations of the bones as per the CMU database used in this work. 
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point of origin for the whole skeleton and is situated between the lower back, left hip joint 
and right hip joint, as illustrated in Fig. 11. A plot showing an example of the dataset is 
shown in Fig. 12. In Fig. 12, the x-axis represents the frame number of the motion and the y-
axis represents the degree of rotation applied to each bone in the skeleton. Fig. 12 shows the 
x, y, and z axis rotation of the lower back bone for two walking motions and a golf swing. 
For the purposes of this work, four types of motions consisting of walking, running, golf 
swing and golf putt were used. The motions were chosen to provide visually similar 
motions (walking and running), visually dissimilar movements but which utilised a similar 
set of bones (golf swing and golf putt).  
Fig. 12. The plots of x, y, and z axis rotations of the lower back bone of two walking motions 
and a golf swing with different lengths. Each curve represents rotation of the back bones in 
the skeleton vs. time. 
5.1 Symbolic motion classification using see5 
In this section, multiple experiments in developing symbolic models of the motion data 
using a See5 decision trees were performed where the M value was increased by power of 2 
up to 32,768. For each experiment, the size of the decision tree, rule set and the average 
classification accuracy of each (which was confirmed by 10-fold cross-validation) were 
recorded. An example of the resulting decision tree for M=8 is shown in Fig. 13. In Fig. 13, a 
motion is classified by first looking at the root node of the tree, which contains a threshold 
decision about the left humerus, x-axis rotation. If the condition is not true, then the next 
node visited specifies that the left wrist, y-axis rotation be examined. Continuing down the 
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Fig. 13. Symbolic motion decision tree for: walk, run, golfswing and golfputt, using M=8. 
tree to one of the leaf nodes, a data frame of a motion can be classified as a golf swing, golf 
putt, walk or run motion. It can be readily observed in Fig. 13 that to in order to classify 
these four motion classes, only seven bone tracks out of a possible 62 in the motion data base 
are actually used, and that these seven are the most important features for differentiating 
between the four motion classes.  































Tree size 9.6 10 9 8.5 7.3 7 5.2 5 5 4 4 2 1 1 1
Rules size 8 8 9 8 7 7 5 5 4 4 4 0 0 0 0
Tree accuracy 100% 100% 100% 100% 100% 100% 99% 99% 98% 96% 90% 67% 35% 35% 35%
Rules accuracy 100% 100% 100% 100% 100% 100% 99% 99% 98% 96% 90% 35% 35% 35% 35%
2 4 8 16 32 64 128 256 512 1024 2048 4096 8192 16384 32768
Fig. 14. Symbolic Model size and accuracy variations as measured by 10? fold cross 
validation for four motion classes (walk, run, golfswing, and golfputt). 
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From the graph presented in Fig. 14, the tree in Fig. 13 would perform classification with 
99.9% accuracy per-frame, which results in 100% accuracy in motion classification. Plots of 
the M value vs. tree size vs. classification accuracy are shown in Fig. 14. 
It is evident that in Fig. 14 that, there is a knee point in the graph approximately where 
M=1024, beyond which the classification accuracy begins to decrease significantly i.e., for 
M=1024 and M=2048, classification accuracies are 96% and 90%, respectively. A typical 
confusion matrix for such models is illustrated in Fig. 15. In Fig. 14 there is a further 
observed knee point at around M=2048, after which for greater values of M the accuracy rate 
again drops significantly (67% for M=4096 and 35% for M=8192).  
(golfswing) (golfputt) (walk) (run) <= predicted as
4463 4   golfswing 
1 2507   golfputt 
  6616  walk 
   1608 run 
Fig. 15. Typical confusion matrix of the motion model (M=128) for golfswing, golfputt, walk 
and run. 
It is also of note that parameters of M=2 up to M=32 yields almost 100% classification 
results. Fig. 14 also shows that M=8 for this dataset provides the best classification 
performance (99.95%), where using smaller M values was not observed to improve 
classification performance. Using M=8, the resulting decision tree is relatively small with 17 
nodes and seven bone motion tracks in total. Hence for the purpose of this work, 
experiments were performed using decision tree generated with M=8. 
5.2 Symbolic modelling of normal and abnormal motion behaviours 
In order to investigate the concept of being able to detect normal and abnormal motion 
behaviours, a further series of experiments, again involving the Moven inertial motion suit 
were designed. In this context individuals were asked to carry a back pack with a 5kg 
weight in it. From these tasks, the same range of features (as used in Section 3) was used 
again, for the various individuals undertaking the trial.  
For this trial, the goal was to clearly identify if a person is carrying a weight or not. 
However, in addition to this each participant was invited to subtlety disguise their gait on 
occasions of their choosing, informing the investigators at the end of any recording trial if 
they had do so. Thus motion data was collected for individual walking gaits that were 
influenced, or not, by an unfamiliar extraneous weight and also, or not, by a deliberate 
concealing behaviour of the participant. Again symbolic models of these motion behaviours 
were induced using the See5 algorithm (RuleQuest, 2007) from the participants using 
various combinations of subtended joint angles. The algorithm formulates symbolic 
classification models in the form of decision trees or rule sets, based on a range of several 
concurrent features or attributes. The model development process followed the same 
procedure previously discussed in the pervious sections. 
For this particular work it was decided to formulate two parallel classifiers to identify both 
the gender of an individual as well as attempting to deduce if the individual was in fact 
carrying a weight. The layout of the system is shown in Fig. 16. 
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Fig. 16. Symbolic model proposal to identify: a weight induced gait anomaly; or an 
abnormally motion arising from some premeditated disguise. 

































Tree size 134.5 120.9 95.5 77.6 57.9 38.4 21.9 12.9 7.2 4.3 2
Rules size 63.7 59.1 50.5 42 33 24.4 14.7 8.3 5.5 2.1 0
Tree accuracy 97.3% 96.7% 96.1% 93.6% 91.3% 86.9% 81.4% 76.3% 69.6% 65.0% 56.5%
Rules accuracy 98% 99% 96% 95% 92% 88% 82% 77% 70% 63% 55%
2 4 8 16 32 64 128 256 512 1024 2048
Fig. 17. Symbolic Model size and accuracy variations as measured by 10? fold cross 
validation for detecting weight induced gait anomalies. 
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Tree size 77.2 71.6 60.5 44.2 36.8 27 18.7 9.6 5.9 3 2
Rules size 38.2 36.5 33.3 27.3 25.8 17 12.8 5.5 3.9 3 0
Tree accuracy 98.5% 98.0% 97.1% 95.8% 94.7% 91.0% 86.0% 78.0% 74.2% 65.3% 61.3%
Rules accuracy 99% 98% 98% 96% 95% 91% 87% 78% 74% 65% 52%
2 4 8 16 32 64 128 256 512 1024 2048
Fig. 18. Symbolic Model size and accuracy variations as measured by 10–??fold cross 
validation for detecting disguised gait related motion behaviours. 
Motion data for all 12 subtended joint angles was used in both rule sets in an attempt to 
classify disguised motion behaviours, and or, individuals that may be carrying an 
extraneous weight. As in the Sections, 3 and 5, a series of plausible models were firstly 
analyzed as illustrated in Figs. 17 and 18, before their appropriate formal forms were 
realized as illustrated in Figs 19 and 20. 
The participants undertaking these motion experiments were 4 males and 5 females between 
18 to 40 years of age. The primary aim of this study was to identify if a person is carrying an 
object and maybe concealing the object under his clothes based on a combination of the 
subtended angles at their feet, knees, thighs, arms, and elbows. In this process, again 12 
features were extracted and using decision tree and rule set classifier models, more than 
87% accuracy was achieved for detecting  individuals carrying an extraneous weight, and an 
accuracy of at least 89% was also achieved in detecting unnatural (pretense) in gait motions. 
6. Conclusion 
The results from Section 4 and Section 5 clearly support all of the three objectives discussed 
at the end of Section 2. These being to firstly; develop a plausible model for dynamic finger 
printing of motion data between individuals. Secondly, investigate a model that could to 
also identify distinctions between various motion tasks, and finally to formulate a model to 
identify motion pretence, or acting, as well as normal and (physically induced) abnormal 
motion behaviours. 
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Rule 1: (182, lift 2.2) 
Right Foot O <= 1.282073 
Left Foot O <= 1.515643 
Right Elbow > 3.057076 
    => WithWeights [0.995] 
Rule 2: (479/6, lift 2.2) 
Right Foot O > 1.282073 
Left Arm <= 0.1065039 
=> WithWeights [0.985] 
Rule 3: (216/11, lift 2.1) 
Left Foot O <= 0.2262519 
Left Foot <= 2.165244 
Right Elbow > 2.876776 
Left Elbow > 2.802877 
=> WithWeights  [0.945] 
Rule 4: (400/21, lift 2.1) 
Left Foot O <= 1.515643 
Right Elbow > 3.027218 
Left Elbow <= 3.027386 
Right Arm <= 0.2105112 
=> WithWeights  [0.945] 
Rule 5: (175/26, lift 1.9) 
Left Elbow <= 2.605653 
Left Arm <= 0.3550883 
=> WithWeights  [0.847] 
Rule 6: (475/74, lift 1.9) 
Right Foot O <= 0.05478672 
=> WithWeights  [0.843] 
Rule 7: (146/25, lift 1.8) 
Right Foot O > 0.05478672 
Left Foot O > 1.515643 
Left Elbow > 3.02983 
Right Arm > 0.1455698 
=> WithWeights  [0.824] 
Rule 8: (260/49, lift 1.8) 
Right Foot O <= 1.282073 
Right Elbow <= 2.399449 
Left Elbow <= 2.802877 
=> WithWeights  [0.809] 
Rule 9: (528/139, lift 1.6) 
Left Foot O > 0.3129601 
Left Foot O <= 1.515643 
Right Knee <= 2.996378 
Right Elbow <= 3.057076 
Left Elbow <= 2.802877 
Left Arm <= 0.3550883 
=> WithWeights  [0.736] 
Rule 10: (1092/294, lift 1.6) 
Right Foot O > 1.282073 
Left Foot O <= 1.515643 
Left Elbow <= 3.027386 
Left Arm <= 0.3550883 
=> WithWeights  [0.730] 
Rule 11: (297/80, lift 1.6) 
Right Foot O <= 1.282073 
Left Foot O > 1.422201 
Left Foot O <= 1.515643 
Left Elbow > 2.802877 
Right Arm <= 0.3095023 
=> WithWeights  [0.729] 
Rule 12: (141, lift 1.8) 
Left Foot O > 1.515643 
Left Elbow > 3.02983 
Right Arm <= 0.1455698 
=>WithOutWeights  [0.993] 
Rule 13: (259/7, lift 1.8) 
Right Foot O <= 1.282073 
Left Foot O > 1.422201 
Right Arm > 0.3095023 
=>WithOutWeights  [0.969] 
Rule 14: (267/17, lift 1.7) 
Right Foot O > 1.282073 
Right Elbow > 3.027218 
Right Elbow <= 3.083863 
Right Arm > 0.2105112 
Left Arm > 0.1065039 
=>WithOutWeights  [0.933] 
Rule 15: (556/77, lift 1.6) 
Right Foot O > 0.05478672 
Right Foot O <= 1.282073 
Left Foot O > 1.422201 
Right Elbow <= 3.057076 
Left Arm > 0.1278452 
=>WithOutWeights  [0.860] 
Rule 16: (6287/2659, lift 1.1) 
Right Foot O > 0.05478672 
=>WithOutWeights  [0.577] 
Default class: WithOutWeights 
Evaluation on training data (6762 motion frames) 
Decision Tree Rules   
Size       Errors No       Errors 
26   926(13.7%) 16   819(12.1%) 
Fig. 19. An example motion model for detecting subjects carrying an additional 5kg weight. 
Rule 1: (145, lift 2.1) 
Right Arm > 0.6420745 
Left Arm <= 0.432619 
=> Abnormal  [0.993] 
Rule 2: (344/12, lift 2.0) 
Right Foot O <= 0.9345771 
Left Foot O > 0.206346 
Left Foot O <= 1.478905 
Right Knee <= 3.012932 
Right Arm > 0.2752825 
Left Arm <= 0.432619 
=> Abnormal  [0.962] 
Rule 3: (298/12, lift 2.0) 
Right Elbow <= 2.419674 
Left Arm > 0.432619 
=> Abnormal  [0.957] 
Rule 4: (246/12, lift 2.0) 
Right Elbow > 2.905675 
Right Elbow <= 3.027221 
Left Elbow <= 3.013905 
Left Arm <= 0.432619 
=> Abnormal  [0.948] 
Rule 5: (395/59, lift 1.8) 
Right Foot O > 1.3187 
Right Foot O <= 1.408431 
Left Foot O > 0.206346 
Right Elbow <= 3.027221 
Right Arm > 0.2752825 
=> Abnormal  [0.849] 
Rule 6: (4467/2094, lift 1.1) 
Left Foot O > 0.206346 
=> Abnormal  [0.531] 
Rule 7: (144, lift 1.9) 
Left Thigh > 0.5184123 
Left Arm <= 0.432619 
=> Normal  [0.993] 
Rule 8: (655/80, lift 1.7) 
Left Foot O <= 0.206346 
=> Normal  [0.877] 
Rule 9: (371/58, lift 1.6) 
Right Knee > 2.892806 
Right Elbow > 2.419674 
Left Arm > 0.432619 
=> Normal  [0.842] 
Rule 10: (3128/1117, lift 1.2) 
Right Arm > 0.1541919 
Left Arm <= 0.432619 
=> Normal  [0.643] 
Rule 11: (202/73, lift 1.2) 
Left Foot > 1.776459 
Right Elbow <= 3.032689 
Right Arm <= 0.1541919 
=> Normal  [0.637] 
Default class: Normal 
Evaluation on training data (5122 motion frames) 
Decision Tree Rules   
Size       Errors No       Errors 
19   606(11.8%) 11   554(10.8%) 
Fig. 20. Motion model for detecting subjects manifesting disguised gait motion behaviours. 
 Biosensors 300
Motion capture data of human behaviour is necessarily by its nature highly complex and 
dynamic. Alternative approaches often seek to avoid where ever possible the so-called 
“curse of dimensionality” (Bellman, 1957) by developing methods to reduce this 
dimensionality to a tractable lower number of dimensions. Whilst these methods made 
succeed to various degrees they essentially smother or aggregate out fine detail and various 
nuances of motion behaviours.   
In contrast, the application of symbolic machine learning is able to readily cope with the 
multidimensional properties of motion data, as evidenced by the example models 
developed in the previous sections. In effect, an appropriate (symbolic and inductive) DM 
algorithm will structure and or adjust numerous internal relationships between all of the 
input features that relate to and support the corresponding output, thereby avoiding, or 
significantly mitigating, the "curse of dimensionality".   
However, whilst such models were often pruned significantly, which may also reduce the 
domain dimensionality the models address, this process always provides a transparent view 
of any resultant rules, patterns—often leading to new discovered knowledge. Thus the 
developer is able to readily critique and further explore various properties and 
consequences, often through a visualization process, that an individual element of existing 
or discovered knowledge poses in relation to any reduction in a models resolution (Asheibi, 
2009).
Apart from this, motioning the induced symbolic patterns also provides a diagnostic ability 
guiding the often cyclic and interactive nature of applying machine learning in general. 
Previous other studies have validated this approach by combining together  
with unsupervised mixture modelling for gait recognition (Field et al., 2008)(Hesami et al., 
2008).
The premise of this proposed work is that all humans have, by the stage of adolescence  (or 
maturity) developed various stylistic signatures or patterns of motion behaviour that can be 
typically (uniquely) associated with an individual. These become (fundamentally) imprinted 
as patterns within the central nervous system (CNS) and govern everyday motions such as 
walking gaits, various gesticulations and other dynamic movements (trunk rotations) of an 
otherwise static body (Cuntoor et al., 2008). As is obvious, much of these motions can be 
unconsciously affected or modulated by underlying emotions (Dittrich et al., 1996) or by 
some conscious intent in order to conceal one’s true identity.  
 In particular, the highly coupled nature of such complex data provides numerous 
opportunities for the discovery of actionable knowledge patterns, which in turn can be 
adapted for abnormal motion detection and tracking in two-dimensional (2D) video 
streams. 
It is conjectured that the study of these dynamic (spatiotemporal) multidimensional 
manifestations will facilitate a new approach to anomaly pattern detection for human 
motions. By employing (symbolic) machine learning and other related data mining 
techniques, on a comprehensive range of motion capture trials, it is envisioned that a unique 
ontology (“structure or science of being”, or taxonomy) of such manifest anomaly patterns 
could be formulated. This would provide a valuable resource structure of (manifest) pattern 
relationships. Amongst other future goals this research should address is that the motion 
ontology framework should be utilized to facilitate the derivation of various 2D images and 
silhouette maps to be subsequently utilized in video pattern analysis for anomaly?
identification and ultimately tracking. 
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